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ABSTRACT 
In the case of an unwanted pregnancy, access to abortion services should 
be easily available, regardless of a woman’s residence, age, socio-economic 
status, or cultural and religious background. Nevertheless, in Victoria, one of the 
three Australian jurisdictions where abortion is legalised, abortion provision is 
mostly confined to major cities and remains sparse in regional and rural areas. 
While the medication abortion method has the potential to expand the pool of 
abortion providers in underserved regions, the uptake among general practices 
in Victoria remains low. A key strategy to improve abortion access is to increase 
the involvement of primary health care nurses in the medication abortion 
provision process, an approach that is already successfully and effectively 
implemented in many countries all over the world. 
The aim of this study was to develop a nurse-led model of care for 
medication abortion provision in the primary health care setting of regional and 
rural Victoria to improve abortion access. Additionally, the study explored the 
current and potential future involvement of general practitioners and primary 
health care nurses in regional and rural Victoria in the delivery of medication 
abortion services, as well as the factors that might hinder or enable medication 
abortion provision uptake or implementation of the nurse-led model. 
The study used a mixed-method approach consisting of two separate but 
interconnected studies. The first study used a cross-sectional survey design. A 
convenience sample participated, consisting of 69 general practitioners and 
primary health care nurses from regional and rural Victoria. For the second 
study, the Delphi technique was used and a total of 24 experts took part in three 
iterative survey rounds. 
While only a small percentage (11%) of the surveyed participants were 
currently involved in medication abortion provision, there was quite a high 
overall interest (61%) in receiving medication abortion training. Participants, 
however, perceived a range of barriers for medication abortion provision uptake, 
such as a lack of training opportunities, a lack of supportive systems, 
 x 
uncooperative colleagues, legal uncertainties and social stigma. The Delphi 
findings showed great support for nurse-led medication abortion provision and 
data analysis led to the formation of three nurse-led models. The first and 
preferable model is a fully autonomous nurse-led model. However, due to 
federal government restrictions on abortion medication prescriptions, the health 
care system, and the lack of financial remuneration for nurse-led medication 
abortion provision, the extent of the primary health care nurse’s involvement in 
medication abortion provision is currently limited. Therefore, a second, legally 
feasible, nurse-led medication abortion model was constructed. The third 
included model can be used by primary health care nurses in situations when a 
non-supportive general practitioner is present. 
The proposed models can inform and guide key players who want to 
become involved with nurse-led medication abortion provision. However, the 
study identified that a lack of training opportunities and support services, as well 
as the influence of stigma, can deter the implementation of nurse-led 
medication abortion provision model. Further, there is an urgent need for 
general and specialised education on medication abortion provision and for an 
independent reimbursement of primary health care nurses’ medication 
abortion-related activities. Finally, to implement a fully autonomous nurse-led 
model, prescription rights policy review is required as well as a health care 
reform to end current health care system rebate constraints. 
This study provides insight into the current roles of general practitioners 
and primary health care nurses from regional and rural Victoria in medication 
abortion provision and their perceived barriers for medication abortion provision 
uptake. Further, the study findings suggest that in the legal and social climate of 
Victoria, implementation of a nurse-led model of medication abortion provision 
is feasible. However, to facilitate this process, the perceived lack of medication 
abortion awareness, knowledge and training needs to be addressed to ensure 
that abortion access for regional- and rural-residing women will be improved.
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CHAPTER 1 
INTRODUCTION 
 
Throughout history, women all over the world, regardless of their origin, 
religion or cultural background, have used induced abortions as a solution for 
unwanted pregnancies. Currently, the most prominent reason for unintended 
pregnancies is contraception failure, mainly caused by incorrect use or the 
unmet need for family planning (Sitruk-Ware, Nath & Mishell 2013; World Health 
Organization (WHO) 2012). Thus, despite the progress in effective and safe 
contraceptive methods, unintended pregnancies remain unavoidable and 
induced abortions will continue to be practised (Cohen 2012; Sitruk-Ware, Nath 
& Mishell 2013). An induced abortion, further referred to as ‘abortion’, is the 
termination of a pregnancy with the use of surgical methods (such as vacuum 
aspiration and dilatation and evacuation) or pharmacological drugs (Family 
Planning NSW 2013).  
Over the years, abortions have proven to be very safe and effective 
medical procedures when performed by skilled providers with correct medical 
techniques or pharmaceutical regimens (WHO 2012). Nevertheless, access to 
safe abortion services is often restricted, either legally or because of a lack of 
service providers, which can result in unsafely performed procedures that pose a 
serious risk to women's physical health (WHO 2012). Although nearly all (97%) 
unsafe abortions and related complications occur in developing countries, access 
to abortion in Australia is certainly not without barriers (de Moel-Mandel & 
Shelley 2017; Ganatra et al. 2017; Kumar et al. 2004; WHO 2012). The 
termination of a pregnancy is still a criminal act in most Australian jurisdictions 
(see section 1.4.1) and abortion provision is particularly sparse in regional and 
rural communities, owing to the ongoing perception of abortion as an extremely 
controversial procedure, which makes physicians reluctant to become involved 
(de Moel-Mandel & Shelley 2017; Shah & Ahman 2009). While a range of 
developed countries have addressed provider-shortage problems by using 
primary health care nurses (PHCNs) for the delivery of medication abortion (MA) 
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services, this evidence-based practice is not yet integrated in Australia’s general 
practices (WHO 2015b). 
This chapter provides the context for the current study. The first section 
gives an overview from a global perspective of the history, safety, efficacy and 
legality of induced surgical and MAs. The second section recognises access to 
safe abortion services as a reproductive and human health right, while the third 
section introduces Saurman’s Theory of Access framework as the tool that was 
used to guide the study’s research process. Next, abortion access in Australia is 
examined, followed by the situation in Victoria, as this state was chosen as the 
setting of the study. Section 1.5 proposes nurse-led MA provision as an approach 
to increasing abortion access in Victoria’s regional and rural areas. Finally, in the 
last section, an outline of all chapters in this thesis is presented. 
 
1.1 ABORTION – THE GLOBAL CONTEXT 
Globally, approximately 41 percent of all pregnancies are unintended, 
and around half of these unintended pregnancies will end in an abortion, 
resulting in approximately 56 million abortions each year (Ganatra et al. 2017; 
Sedgh, Singh & Hussain 2014; WHO 2012). While abortions have been practised 
throughout history, it was only since countries started to legalise abortion that 
procedures became more safe and effective (Joffe 2009). Yet, currently, due to 
the worldwide variety in abortion legality and social, cultural and religious 
beliefs, unsafe abortions persist, resulting in maternal morbidity and mortality 
(Culwell & Gerdts 2014; WHO 2012). In this section, these aspects will be further 
explored. 
 
1.1.1 The history of abortion procedures 
While the ethics of abortion have been questioned since Greek and 
Roman times, the acceptability of abortions only became an issue in the 
nineteenth century because of the rising knowledge about foetal development 
and medical advances (Baird & Porter 2010). Constraints on abortion were 
introduced not only to protect women from the often-fatal practices of 
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abortionists, but also to protect foetal life and punish women for the sin of 
terminating a pregnancy (Berer 2017). This further led, through a succession of 
laws, to the criminalisation of abortion, which was first enacted in the United 
Kingdom (UK) with the Offences Against the Person Act 1861 (Baird & Porter 
2010). Soon, other countries, such as Japan and the United States (US) followed, 
and by the end of the Second World War, abortion became a highly-restricted 
procedure all over the world (Baird & Porter 2010; Finer & Fine 2013). Around 
the 1950s, a gradual global trend of the relaxation of these legal restrictions 
began in Central and Eastern Europe, and around 1985, most industrialised 
countries had liberalised their abortion laws (Finer & Fine 2013). 
Alongside the relaxing abortion laws, procedures to end unwanted 
pregnancies also evolved. The more invasive surgical ‘dilatation and curettage’ 
and ‘dilatation and evacuation’ methods were replaced by the manual or electric 
vacuum aspiration technique for pregnancies up to 12 weeks. These advanced 
procedures proved to be very safe, with less than 0.1 percent of women 
requiring hospitalisation due to serious complications, and a case–fatality rate of 
0.1 per 100,000 interventions before nine weeks of pregnancy, or 0.7 per 
100,000 interventions overall (Sedgh et al. 2016; WHO 2012). Further, the often 
ineffective and dangerous use of chemical and herbal compounds to induce 
abortions, described in many historic manuscripts, became abandoned when the 
strong abortive effect of prostaglandins was discovered in the 1970s (Fiala & 
Gemzel-Danielsson 2006; Santow 1998). Misoprostol, initially used for the 
treatment and prevention of peptic ulcer disease, became the prostaglandin of 
choice because it was inexpensive, had few side-effects and proved to function 
orally as well as via oral mucosa (Gomperts 2014; Schaff 2010). This discovery led 
to an evolution of MA regimens. 
 
1.1.2 Advancements in effective, efficient and safe MA regimens 
In 1982, French scientists discovered that the addition of the anti-
progestogen mifepristone, also known as RU486, potentiated the abortion effect 
of misoprostol and further reduced most common side-effects (Fiala & Gemzel-
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Danielsson 2006). Over time, a variety of dosages, routes and timing of 
administration were trialled. Current evidence-based guidelines recommend, for 
pregnancies in the first 63 days of gestation, the use of mifepristone 200 mg 
orally followed within 36–48 hours by misoprostol 800 mcg taken buccally, a 
regimen that has proven to be as effective as surgical abortions (Chen & Creinin 
2015; Goldstone, Walker & Hawtin 2017; Raymond et al. 2013; The Royal 
Australian and New Zealand College of Obstetricians and Gynaecologists 2016 
(RANZCOG); WHO 2012). 
Abortions induced with medication are not only very effective, but also 
efficient and one of the safest procedures in contemporary medicine. Chen and 
Creinin (2015, p. 17) defined an efficient MA as one ‘in which the pregnancy was 
expelled from the uterus without need for surgical evacuation’. Three large 
studies (Chen & Creinin 2015; Goldstone, Michelson & Williamson 2012; 
Goldstone, Walker & Hawtin 2017) investigated the efficiency and safety of MA 
procedures for pregnancies less than nine weeks’ gestation, using the evidence-
based regimen. The most recent of the three studies, an observational cohort 
study of 15,008 women, showed a success rate of 95.2 percent (Goldstone, 
Walker & Hawtin 2017). This study, conducted at Australian Marie Stopes 
International clinics, had similar findings to Chen and Creinin’s (2015) systematic 
review, and Goldstone, Michelson and Williamson’s (2012) observational study 
of 13,345 women, which reported success rates of 96.7% and 96.5%, 
respectively. Abortion method failure not only includes incomplete abortions, 
which can be managed medically or require a surgical intervention, but also 
ongoing pregnancies. The rate of ongoing viable pregnancies after the MA 
procedure was almost identical for all three studies (0.6–0.8%), and occurred 
more often in parous women, older women with previous abortions, and more 
gestationally advanced pregnancies (The Royal College of Obstetricians and 
Gynaecologists (RCOG) 2011). 
The side-effects of an MA procedure are comparable to a spontaneous 
abortion, which is defined as the loss of a pregnancy without outside 
intervention before 20 weeks' gestation, when the embryo or foetus is not 
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capable of surviving independently (WHO 2012). Side-effects include uterine 
cramping and bleeding for the duration of, on average, nine days, as well as 
nausea, vomiting, diarrhoea, headache and dizziness (WHO 2012). Serious side-
effects not related to method failure, on the other hand, such as infections or 
severe bleeding requiring transfusion, were rare (see Table 1.1). 
 
Table 1.1 Method failure and serious side-effects of MA (≤ 63 days) 
Study Efficiency 
rate 
(%) 
Incomplete 
abortion 
requiring 
surgical 
intervention 
(%) 
Continuing 
viable 
pregnancy 
(%) 
Infection 
(%) 
Bleeding 
requiring 
transfusion 
(%) 
Goldstone, Walker & 
Hawtin (2017) 
95.2 4.8 0.8 0.1  0.1 
Chen & Creinin 
(2015)1 
96.7 Not provided 0.8 0.01-0.5 0.03-0.6 
Goldstone, 
Michelson & 
Williamson (2012) 
96.5 2.9 0.6 0.2 0.08 
Note: Studies with up to 70 days’ gestation are included. 
 
Ectopic pregnancies, where the fertilised egg nestles outside the 
endometrial layer of the uterus, are a significant cause of morbidity and 
mortality in women of reproductive age (Rana et al. 2013; Shannon et al. 2004). 
While MA regimens do not terminate ectopic pregnancies, pre-abortion 
screening methods that include bimanual examination, last menstrual period 
dating, serum pregnancy test measurements (human chorionic gonadotropin (β-
hCG)) and/or vaginal ultrasonography, do reduce after-treatment diagnosis 
(Shannon et al. 2004). Ectopic pregnancy rates after MA procedures range 
between 0.007% and 0.03%, which are very low compared to the overall 
worldwide incidence of ectopic pregnancies (1-2%) (Cleland et al. 2013; Gaudu, 
Crost & Esterle 2013; Orazulike & Konje 2013; Shannon et al. 2004). The 
diagnosis of ectopic pregnancies in early pregnancies, however, still poses 
considerable challenges, as ultrasonography is often non-diagnostic (Lichtenberg 
& Paul 2013; Shannon et al. 2004). 
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Since its introduction, the use of mifepristone for early MA has increased 
exponentially and MA is currently provided in more than 60 countries worldwide 
(Jones et al. 2017). In the US in 2014, for example, approximately 45 percent of 
abortions up to nine weeks’ gestation were medication procedures, while in 
England and Wales in 2016, this proportion was as high as 62 percent 
(Department of Health 2017a; Jones & Jerman 2017). Nevertheless, despite the 
availability of efficient and safe abortion options for women with an unwanted 
pregnancy, still 45 percent of all abortions worldwide are performed unsafe, due 
to restrictive abortion laws (Ganatra et al. 2017). 
 
1.1.3 The relationship between restrictive abortion laws and unsafe 
abortions 
While over the years most Westernised countries adopted relatively 
tolerant abortion laws, almost all developing countries in Africa, Latin America, 
the Middle East and Southern Asia still vastly restrict abortions (Theodorou & 
Sandstrom 2015). Data shows that 26 percent of all countries worldwide only 
allow abortions as a solution to save the woman’s life, and that in countries such 
as El Salvador, Nicaragua, Dominican Republic, Malta and Vatican City, abortion 
is illegal in all circumstances (Theodorou & Sandstrom 2015). In 2017, this total 
ban on abortion was eased in Chile, with the introduction of a new law that 
allows abortions when the life of the pregnant woman is at risk, in the case of 
rape, or if the foetus is not viable (Vivanco & Undurraga 2017). 
Despite common assumption, restrictive laws do not prevent women 
from having an abortion (WHO 2012). Women still pursue abortion services, 
which are consequentially often performed in clandestine and unsafe 
circumstances (WHO 2012). Worldwide every year, about 25.1 million abortions 
are performed unsafely, resulting in the death of at least 47,000 women and 
another five million women who will end up with a permanent disability 
(Ganatra et al. 2017; WHO 2012). Therefore, it is of the utmost importance that 
abortions are decriminalised, safe and accessible, and that abortion laws and 
policies need to protect a woman’s health and her human rights (Sedgh et al. 
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2016; WHO 2012). It has been demonstrated that the implementation of a 
human rights-based approach will not only reduce abortion numbers but also 
maternal mortality and morbidity caused by unsafe abortions (Shaw 2010). 
 
1.2 ABORTION, A REPRODUCTIVE AND HUMAN HEALTH 
RIGHT 
The right to access safe abortion care and a woman’s freedom to make 
decisions on the number, spacing and timing of children are incorporated in 
international human rights treaties and global consensus declarations (WHO 
2012). The first Universal Declaration of Human Rights, which acknowledged the 
dignity and human rights of every human being, emerged in 1948 with the 
formation of the United Nations as a reaction to the atrocities of the Second 
World War (Shaw 2010). Over the years, global consensus declarations on 
human rights, which include the rights to life, liberty, health, privacy and non-
discrimination, were progressively recognised in international treaties and 
conventions, and endorsed in the constitutions and laws of most countries 
(WHO, 2012). Reproductive rights, positioned as a subsection of human rights, 
were first defined and accepted in 1994 at the International Conference on 
Population and Development (ICPD) in Cairo, Egypt (United Nations (UN) 1994). 
The reproductive rights’ focus moved away from population control through 
fertility regulation towards a rights-based approach to protect sexual and 
reproductive health (Campo 2013). Reproductive rights became recognised as 
‘the basic right of all couples and individuals to decide freely and responsibly the 
number and spacing of their children and to have the information and means to 
do so’ (UN 1994, para 7.3). Although the ICPD report specified that governments 
needed to ‘deal with the health impact of unsafe abortion as a major public 
health concern’, abortion prevention was given a much higher priority (UN 1994, 
para 8.25). The ICPD agreement further stated that in the case of an unwanted 
pregnancy, women should have access to trustworthy information, counselling 
and medical support, as well as post-abortion care and family planning services 
to avoid repeat unplanned pregnancies (UN 1994). In addition, it was 
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determined that in states where abortion was legal, abortion provision should be 
safe (UN 1994). However, the ICPD ‘Programme of Action’ did not identify the 
need for states to legalise abortion, despite the fact that legalisation has proven 
to be crucial for the reduction of unsafe abortions (Fine, Mayall & Sepúlveda 
2017). 
The last few decades witnessed dramatic health problems related to 
human sexuality and sexual behaviour, such as sexually transmitted infections, 
the HIV pandemic, unsafe abortions and sexual violence (WHO 2015c). Together 
with an increased understanding of discrimination and inequality related to 
sexual and reproductive health, which includes abortion, these changes led to 
the construction of a range of sexual health promoting human rights standards, 
which were made operational through laws and policies at state levels (WHO 
2015c). National laws thus determine the framework for sexual health-related 
policies, programs and services, and they can either protect human rights, or 
generate restrictions (WHO 2015c). 
The strong correlation between the legality of abortion and safe abortion 
provision, as discussed in Section 1.1, and the recognition of unsafe abortion as a 
major public health problem, resulted in an increase in human rights advocacy 
for abortion, with law reform supported as a public health intervention (Erdman 
2014; Zampas & Gher 2008). A key development after the ICPD report was the 
Protocol to the African Charter on Human and Peoples’ Rights on the Rights of 
Women in Africa (the Maputo Protocol) (African Commission on Human and 
Peoples’ Rights (ACHPR) 2003). This protocol, adopted by the African Union in 
2003, warrants women’s right to health, including sexual and reproductive 
health, and it recognises ‘abortion, under certain conditions, as a women’s 
human right, which they should enjoy without restriction or fear of being 
prosecuted’ (ACHPR 2003, p. 2). While the treaty only involved the African 
continent, elsewhere other regional human rights bodies also began to address 
abortion as a human rights imperative (Zampas & Gher 2008). In 2008, for 
example, the Parliamentary Assembly of the Council of Europe approved a 
report that encouraged its 47 representing countries to decriminalise abortion 
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and guarantee a woman’s right to access safe and legal abortion (Fine, Mayall & 
Sepúlveda 2017). Further, in 2016, the United Nations Committee on Economic, 
Social and Cultural Rights explicitly included the right to abortion in the right to 
reproductive health, and acknowledged that access to safe and legal abortion 
services is a fundamental component of the right to achieve the highest standard 
of health (Sifris & Belton 2017). 
Over the years, the principles of reproductive rights became rooted in a 
constellation of international human rights standards (Center for Reproductive 
Rights (CRR) 2010). The principles not only support the view for abortion on 
request, but they also suggest that any restriction on the access to safe abortion 
is an obstruction of a woman’s human rights (CRR 2010; Zampas & Gher 2008). 
Although to date these standards are certainly not acknowledged by all 
international treaty-monitoring bodies, they can be used by abortion advocates 
to improve women’s full reproductive autonomy (Fine, Mayall & Sepúlveda 
2017; Zampas & Gher 2008). The endorsement of International Human Rights 
treaties in Australia is outlined in Section 1.4. 
The following section uses a theory of access framework to discuss the 
right to have access to health care services, including safe abortion services. 
 
1.3 DIMENSIONS OF ACCESS TO HEALTH CARE SERVICES 
Access to health care, including the provision of abortions, is considered 
to be a human right and implies an adequate supply of health services available 
when wanted or needed (Gulliford et al. 2002; Russell et al. 2013; WHO 2015a). 
Access to health care is of particular concern for people living in regional and 
rural areas, where socio-economic disadvantages, travel distances and workforce 
shortages can contribute to poorer health outcomes for the population 
concerned (Saurman 2016; Wakerman et al. 2008). 
The term ‘access’, however, was not well-defined until 1981 when 
Penchansky and Thomas (1981, p. 139) conceptualised access as a measure of 
‘the fit between characteristics of providers and health services, and 
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characteristics and expectations of clients’. In other words, access is influenced 
by the features of health care resources and their potential consumers 
(Levesque, Harris & Russell 2013). Penchansky and Thomas (1981) proposed a 
classification of the concept of access by dividing access into five distinct but 
interconnected dimensions: 
1. Availability – the volume and types of health care services in relation to 
the health care needs of the population. 
2. Accessibility – the location of health care services and the ease and 
capacity with which the population can reach the service. 
3. Acceptability – the populations’ attitudes about the expected 
characteristics of the health care provider in relation to the actual 
provider’s characteristics, and vice versa. 
4. Affordability – the ability of the population to pay for the health care 
service. 
5. Adequacy – the ways in which health care services are organised in 
relation to the population’s perception of the ability to contact or reach 
the service when required. 
It was proposed that to deliver effective health care services, access must 
be assessed on each of the defined dimensions, with none of the dimensions 
being sufficient in its own right (Gulliford et al. 2002). 
Over the years, a multitude of studies interpreted access to health care in 
a variety of ways. Access dimensions were left out, labelled differently, or they 
were combined, depending on the context and the type of health problem 
addressed (Levesque, Harris & Russell 2013; Obrist et al. 2007). Margolis et al. 
(1995), for instance, only used three dimensions of access (structural, financial 
and personal) to describe the access barriers to health care for socially 
disadvantaged children in the US. Peters et al. (2008), on the other hand, used 
four dimensions of access (geographic accessibility, availability, financial 
accessibility and acceptability) for their framework, to describe health service 
access inequalities in low- and middle-income countries. Their framework 
considered each access dimension to have a supply and demand factor. Jacobs 
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et al. (2011) described a similar classification in their proposed framework that 
was applied in low-income Asian countries. They (2011, p. 290) defined supply-
side factors as ‘aspects inherent to the health system that hinder service uptake 
by individuals, households or the community’, and demand-side factors as 
aspects that effect ‘the ability to use health services at individual, household or 
community level’. Jacobs et al.’s (2011, p. 291) classification is reproduced and 
presented in Table 1.2. The classification shows an almost equal distribution of 
access factors between the supply-side and demand-side, except for the 
availability dimension. To ensure equitable access to health care services, both 
sides of each dimension need to be addressed by researchers and policy makers 
(Russell et al. 2013). Despite the geographical focus on Asia, the framework by 
Jacobs et al. (2011) is applicable to the Australian context, as access barriers are 
fairly similar globally, and framework adjustments are mainly required for local 
socio-economic and cultural characteristics. 
 
Table 1.2 Supply-side and demand-side factors across four dimensions of health services 
access 
Dimension of 
access 
Supply-side factors Demand-side factors 
Accessibility Service location Indirect costs to household 
(transport) 
Means of transport available 
Availability Unqualified health workers, staff 
absenteeism, opening hours 
Waiting time 
Motivation of staff 
Drugs and other consumables 
Non-integration of health services 
Lack of opportunity 
Late or no referral 
Information on health care 
services/providers 
Education 
Affordability Costs and prices of services 
Private–public dual practices 
Household resources and willingness 
to pay 
Opportunity costs 
Cash flow within society 
Acceptability Complexity of billing system 
Inability for patients to know prices 
beforehand 
Staff interpersonal skills 
Households’ expectations 
Low self-esteem / assertiveness 
Community and cultural preferences 
Stigma 
Lack of health awareness 
Source: Reproduced from Jacobs et al. (2011, p. 291). 
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Another modification of Penchansky and Thomas’ (1981) approach was 
applied by Saurman (2016), who supplemented Penchansky and Thomas’ five 
dimensions with a sixth ‘awareness for access’ dimension. The need for 
awareness as an additional access dimension was recognised during the 
evaluation of an emergency tele-psychiatry program that provided access to 
specialist emergency mental health care in rural and remote communities across 
western New South Wales, Australia (Saurman 2016). Saurman (2016) argued 
that for a health care service to be effective, users as well as providers need to 
know that it exists. Awareness through effective communication and information 
provision was recognised as particularly important in rural and remote 
communities, which are often affected by population mobility and health 
workforce instability (Saurman 2016). The importance of this dimension was also 
recognised by Russell et al. (2013), who included awareness in their framework 
for policy makers, to be used to improve the access to health care of Australia’s 
rural and remote population. Given the setting and the focus of the current 
study, Saurman’s (2016, p. 37) Theory of Access framework (reproduced in Table 
1.3) was adopted as a practical tool to guide the research process and to address 
the abortion access and uptake barriers in regional and rural Victoria that 
emerged from the key research questions. 
The next section first outlines the endorsement of International Human 
Rights treaties in Australia and how these treaties are integrated through 
legislation into Australia’s domestic law. The section then discusses surgical and 
medication abortion access and provision in Australia, and specifically access in 
the state of Victoria.  
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Table 1.3 Access to health care framework 
Dimensions of access Definition Dimension components and examples 
Accessibility Location An accessible service is within reasonable 
proximity to the consumer in terms of time 
and distance 
Availability Supply and demand An available service has sufficient services 
and resources to meet the volume and 
needs of the consumers and communities 
served 
Acceptability Consumer perception An acceptable service responds to the 
attitude of the provider and the consumer 
regarding characteristics of the service and 
social or cultural concerns. For instance, a 
patient’s wish to see a female doctor may 
determine whether a service is considered 
acceptable or not 
Affordability Financial and incidental 
costs 
Affordable services examine the direct costs 
for both the service provider and the 
consumer 
Adequacy Organisation An adequate service is well organised to 
accept clients, and clients are able to use 
the services. Considerations of adequacy 
include hours of operation (after-hour 
services), referral or appointment systems, 
and facility infrastructures (wheelchair 
access) 
Awareness Communication and 
information 
A service maintains awareness through 
effective communication and 
information strategies with relevant users 
(physicians, nurses, patients, the 
broader community), including 
consideration of context and health 
literacy 
Source: The dimensions of access (Saurman 2016, p. 37). 
 
1.4 ABORTION ACCESS IN AUSTRALIA 
Abortion access in Australia is complex, as there is no national abortion 
legislation, rather the legality of abortion is a matter for the states and 
territories. Further, abortion is currently legalised in five jurisdictions and still 
considered a crime in South Australia, Western Australia and New South Wales 
(de Moel-Mandel & Shelley 2017). This section explores current abortion 
legislation in Australia and describes the estimated incidence of abortions. Then, 
the postponed introduction of mifepristone in Australia is explained, and finally, 
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a description is provided of the current abortion access situation in Victoria, the 
setting of this study. 
 
1.4.1 The legal barriers to abortion access in Australia 
Australia has endorsed most of the International Human Rights treaties, 
which include the International Covenant on Civil and Political Rights, the 
International Covenant on Economic, Social and Cultural Rights, the Convention 
on the Rights of the Child, and the Convention on the Elimination of All Forms of 
Discrimination against Women (which specifically asserts the reproductive rights 
of women) (Attorney-General's Department 2018). However, not all the treaties’ 
terms are integrated through legislation into Australia’s domestic law (Sifris & 
Belton 2017). According to the obligations grounded in these international legal 
standards on human rights, specifically in the field of reproductive rights, 
abortions in Australia should be legally obtainable on request, or on broad social 
and economic grounds, and abortion services should be easily accessible and 
available (CRR 2004; 2013). The current Australian abortion legislation, however, 
is incapable of achieving this goal. The law that regulates abortion practice in 
Australia derives from the English Offences against the Person Act 1861, and is 
not regulated at the federal level, but separately controlled by each of the six 
states and two territories (Costa et al. 2015). From the early 1970s, surgical 
abortions became somewhat more liberally available, as jurisdictions started to 
make their own different reforms and amendments to this criminal act (Baird 
2015). Nevertheless, despite reform legislation and an expansion of some of the 
circumstances under which abortion can be lawfully performed, abortion is 
currently only decriminalised in five jurisdictions (the Australian Capital Territory, 
Tasmania, Victoria, Northern Territory and recently (2018) Queensland) and is 
still defined in the criminal law in South Australia, Western Australia, and New 
South Wales (Termination of Pregnancy Bill 2018 (Qlnd)  ; Costa et al. 2015; de 
Moel-Mandel & Shelley 2017). Table 1.4 provides an overview of Australia’s 
different laws and regulations and the circumstances that allow an abortion in 
each jurisdiction.
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Table 1.4 Current abortion laws in Australian states and territories 
Jurisdictiona (population 
×106) 
Name of law Reform 
legislationb 
Abortion 
legalised 
Abortion 
legal on 
request 
Abortion criteria Conscientious 
objection 
clausec 
Australian Capital 
Territory (0.41) 
Medical Practitioners (Maternal 
Health) Act 2002 
Health (Improving Abortion 
Access) Legislation Amendment 
Bill 2018 
- 2002 Yes An abortion is managed like any other medical 
procedure 
An abortion may only be carried out by a registered 
medical practitioner  
Yes 
Victoria (6.32) Abortion Law Reform Act 2008 - 2008 <24 weeks ≥24 weeks: approval required of second doctor that 
abortion is in woman’s best interest 
Yes 
Tasmania (0.52) Reproductive Health (Access to 
Terminations) Act 2013 
- 2013 ≤16 weeks >16 weeks: approval required of second doctor that 
abortion is in woman’s best interest 
Yes 
Northern Territory (0.25) Termination of Pregnancy Law 
Reform Act 2017 
- 2017 <23 weeks ≤14 weeks: if qualified doctor agrees that a woman’s 
physical, mental or social health is endangered,  
14-23 weeks: if consulted second doctor considers an 
immediate physical, mental or social maternal health 
risk 
Yes 
South Australia (1.72) Criminal Law Consolidation Act 
1935 
Amended in 1969 - - <28 weeks: abortion is permitted after approval of two 
medical practitioners on maternal and foetal health 
grounds. Pregnant woman must have been resident in 
South Australia for at least 2 months 
Abortions can only take place in hospitals 
No 
Western Australia (2.58) Criminal Code 1913 and Health 
Act 1911 
Amendment Act 
1998 
Termination of 
Pregnancy Law 
Reform Act 2017 
- - Abortion for a woman <16 years requires parental or 
legal guardian consent 
<20 weeks: justified only on serious maternal or foetal 
medical grounds 
≥20 weeks: permission required from minimum two 
doctors from minister-appointed panel and performed 
in selected facility 
No 
Queensland (4.93) Termination of Pregnancy Bill 
2018 
- 2018 ≤22 weeks Abortion available upon request. >22 weeks: 
consultation second doctor required 
Yes 
New South Wales (7.86) Crimes Act 1900 - - - Allowed in case of severe danger to maternal physical or 
mental health including economic and social issues 
No 
Notes: a. Australia's estimated resident population at 30 June 2017 was 24,598,900 people (Australian Bureau of Statistics 2017). b. Despite reform legislation, 
abortion is still defined in the criminal law in South Australia, Western Australia, and New South Wales. c. Doctors must refer women in the case of conscientious 
objection to non-objectors. 
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1.4.2 Abortion incidence in Australia 
Despite abortion not being decriminalised across all Australian states and 
territories, it is estimated that approximately 40 to 50 percent of all pregnancies 
in Australia are unplanned and that about half of the women with an unplanned 
pregnancy will decide to have an abortion (Family Planning NSW 2013; Rowe et 
al. 2016). Further, about one in three women will have an abortion during their 
life, with most (90%-92%) performed in the first 11-14 weeks of gestation 
(Hutchinson, Joyce & Cheong 2013; Scheil et al. 2017; Victorian Law Reform 
Commission (VLRC) 2008). Unfortunately, up-to-date, reliable national estimates 
of annual abortion numbers are difficult to determine, as each jurisdiction has its 
own abortion-reporting mechanism, and only South Australia and Western 
Australia routinely collect and publish abortion statistics (Chan & Sage 2005). 
The latest national incidence study dates from 2005, and conservatively 
estimated a total number of 84,460 (surgical and medical) terminations 
performed in 2003, equating to an abortion rate of 19.7 per 1,000 women aged 
15-44 (Chan & Sage 2005). This estimate was calculated using Medicare1 data 
and private health insurance claims (for privately insured women), as well as 
public hospital morbidity data. More recent state specific data suggest total 
abortion rates of 13.5 per 1,000 women aged 15-44 in South Australia in 2015 
and 16.4 per 1,000 women aged 15-44 in Western Australia in 2012 (Hutchinson, 
Joyce & Cheong 2013; Scheil et al. 2017). The rates in both South Australia and 
Western Australia have dropped since 2003, from 16.7 to 13.5 and from 18.6 to 
16.4 for every 1,000 women, respectively. Further, when South Australia’s data 
is extrapolated nationally, the number of abortions (surgical and medical) in 
2015 is approximated to be 65,000 (Branley & Scott 2017). Additionally, the 
Medicare Benefits Schedule2 (MBS) item most commonly used for surgical 
abortions indicates 47,683 abortions were performed in 2016 (Department of 
Human Services 2018). Taken together, this data suggest that total abortion 
                                            
1 Medicare is Australia’s national health care scheme that provides eligible citizens’ access to a 
range of health services at reduced or no cost, as well as free treatment in public hospitals 
(Department of Human Services 2017b). 
2 The MBS lists all Medicare services subsidised by the Australian Government. 
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rates have decreased since 2003 (Branley & Scott 2017). The following section 
discusses the introduction and evolution of MA provision in Australia. 
 
1.4.3 Medication abortion provision in Australia 
MA has only been widely available in Australia since 2012. While there is 
a paucity of data available on current national MA provision, the most recent 
data from Western Australia (2010-2012) and South Australia (2015) show that 
11.1 percent and 29.5 percent, respectively, of all performed abortions (as 
discussed in section 1.4.2) were induced with medication (Hutchinson, Joyce & 
Cheong 2013; Scheil et al. 2017). Yet, Dawson et al. (2016) reported that despite 
the recognised multiple advantages of MA, specifically regarding administration 
and privacy, service provision remains limited. 
Before the official registration of mifepristone in Australia, early 
abortions were sometimes performed with misoprostol in combination with 
methotrexate, a chemotherapy agent that affects rapidly dividing cells, and is 
generally used for the treatment of psoriasis and cancer (de Costa et al. 2007). 
Neither drugs were licensed for abortions, and thus used ‘off-label’, which is 
common medical practice, recognised by the Therapeutic Goods Administration3 
(TGA) (de Costa & de Costa 2006). This regimen, however, was less effective and 
had more side-effects when compared with the currently used combination of 
mifepristone-misopristol (de Costa et al. 2007). 
Trials with the mifepristone and misoprostol combination in Australia 
were initiated and approved in 1994 by the TGA in collaboration with the World 
Health Organisation (WHO) (Baird 2015; Petersen 2010). The trials, however, 
triggered a range of anti-abortion responses, and in 1996, the Federal Liberal–
National Coalition Government of Australia, led by Prime Minister John Howard, 
agreed to amend the Therapeutic Goods Act 1989 to get anti-abortion senator 
Harradine’s support for the partial privatisation of the government-owned 
telecommunications company, Telstra. This amendment to the Therapeutic 
                                            
3 Australia's regulatory agency that oversees the use of medications in Australia. 
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Goods Act resulted in a ban on the importation and the use of mifepristone 
(O’Rourke, Belton & Mulligan 2016; Petersen 2010). For the next 10 years, the 
Therapeutic Goods Amendment Act 1996, known as the ‘Harradine 
Amendment’, provided the Federal Health Minister with the right to veto the 
import applications for mifepristone, thus disallowing the women of Australia 
the choice of a safe alternative to surgical abortion (Petersen 2010). In 2006, 
however, after persistent lobbying by reproductive health groups and four 
female Federal parliamentarians, the Harradine Amendment was overturned 
and the new bill gave the TGA the power of approval (de Costa et al. 2007; 
O’Rourke, Belton & Mulligan 2016). Strict regulations remained, resulting in only 
a slow increase of mifepristone use, but over time, authorised prescribers moved 
from being solely gynaecologists to general and sexual health practitioners, and 
private abortion providers such as Marie Stopes International Australia 
(hereafter called Marie Stopes) (de Costa 2012). In order to improve 
mifepristone’s accessibility, MS Health, a subsidiary of Marie Stopes, successfully 
applied in August 2012 to the TGA for the import and distribution of 
mifepristone in Australia (Baird 2015; O’Rourke, Belton & Mulligan 2016; TGA 
2012). One costly condition was that MS Health was required to develop a risk 
management program, consisting of a web-based register, the provision of 
mandatory online training, and a 24-hour telephone advice service for women 
(O’Rourke, Belton & Mulligan 2016). Further, the TGA mandated prescribing 
medical practitioners and dispensing pharmacists to register with the MS 
Prescribing Program (O’Rourke, Belton & Mulligan 2016). Seven months later, 
when mifepristone and misoprostol became listed under the Pharmaceutical 
Benefits Scheme (PBS)4, purchase costs considerably reduced (Baird 2015). 
TGA registration was initially obtained for mifepristone 200 mg and 
misoprostol 800 mcg (four 200 mcg tablets) for abortions up to 49 days’ 
gestation, but in 2015 an extension was approved for gestations up to 63 days 
(Baird 2015). The combination of mifepristone, taken orally at a clinic, and 
                                            
4 The Pharmaceutical Benefits Scheme works in conjunction with Medicare and subsidises the 
cost of a range of prescribed medicines (Department of Human Services 2017b). 
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misoprostol, taken buccally 36-48 hours later at home, has been endorsed by 
The Royal Australian and New Zealand College of Obstetricians Gynaecologists 
(RANZCOG) (2016) since 2013 and, according to a large study by Goldstone, 
Walker and Hawtin (2017), with 15,008 women attending Marie Stopes clinics in 
Australia, has proven to be an efficient and safe choice for abortions within the 
nine weeks’ gestational limit. 
Currently, mifepristone can be sold and used all over Australia, but within 
the legal context of the different state and territory laws, as discussed in Section 
1.4.1. In most parts of Queensland, for instance, where a new legislation for MA 
was included within the Criminal Code in 2009, it is not easy to access abortion 
services due to the lack of clear legal precedents, which make physicians, nurses 
and women reluctant to become involved (de Costa 2012). Local requirements 
also determine where and by whom the drugs can be dispensed. For example, 
abortion laws in South Australia limit the provision of MA to hospitals, which 
excludes home use of misoprostol and may thus restrict abortion access to 
women living in rural and remote areas (Belton et al. 2016; de Moel-Mandel & 
Shelley 2017).  
The next section will discuss the legality of abortion and access to 
abortion services in the Victorian context. 
 
1.4.4 The Victorian context 
In Victoria before 2008, the Crimes Act 1958 was in operation, which 
made the provision of abortions an indictable offence, with the judiciary to 
decide if the reason for an abortion was deemed lawful or unlawful (VLRC 2008). 
From 1969, Victorian abortion law was based on the Supreme Court ruling of 
Justice Menhennitt in the case of R v Davidson. The Menhennitt ruling 
considered abortion lawful when the act was: 
necessary to preserve the woman from a serious danger to her life or her 
physical or mental health (not being merely the normal dangers of pregnancy 
and childbirth) which the continuation of the pregnancy would entail; and in the 
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circumstances not out of proportion to the danger to be averted. (VLRC 2008, p. 
19). 
Nearly 40 years later, in 2008, Victoria legalised abortion, with the 
passing of the Abortion Law Reform Bill 2008 (Vic). This Act (Abortion Law 
Reform Act 2008 (Vic)) allows any woman in Victoria to have a surgical or 
medication abortion up to 24 weeks’ gestation, when performed by a registered 
medical practitioner. A late-term abortion, post 24 weeks, can only be 
performed when a qualified physician—defined as a person licensed to practice 
medicine— after consultation with another physician believes the abortion is 
appropriate in regard to ‘all relevant medical circumstances and the woman’s 
current and future physical, psychological and social circumstances’ (Abortion 
Law Reform Act 2008 (Vic), p. 4). Included in the new Act is also a regulation 
regarding conscientious objection, which is defined by Zampas and Andion-
Ibanez (2012, p. 232) as ‘the refusal to participate in an activity that is 
considered incompatible with somebody’s religious, moral, philosophical or 
ethical beliefs’. Whereas in the rest of Australia, except Tasmania (Reproductive 
Health (Access to Terminations) Bill 2013 (Tas)), health professionals have the 
right to invoke conscientious objection to abortion, health practitioners with 
conscientious objection in Victoria and Tasmania, while not required to 
participate in elective abortion procedures, are obliged to notify women about 
their beliefs and to refer them to providers without conscientious objection 
(Abortion Law Reform Act 2008 (Vic)). For medication-induced terminations of 
pregnancies up to 24 weeks, the Victorian Act states that registered pharmacists 
or registered nurses authorised under the Drugs, Poisons and Controlled 
Substances Act 1981, may dispense or administer the abortifacient drugs 
prescribed by a medical practitioner (Abortion Law Reform Act 2008 (Vic)). 
Even though abortion provision in Victoria is legal, abortion access is still 
compromised due to a range of non-legal factors, such as a lack of providers, 
privacy concerns or fear of stigma, which reflect a reluctance of society as well as 
government towards the provision of abortion services (International Planned 
Parenthood Federation 2008). Abortion access barriers, together with 
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unintended pregnancies, were identified by the Victorian Women’s Health 
Services (2015) as an immediate concern for the health of Victorian women. 
Their ‘Priorities for Victorian Women’s Health 2015–2019’ report (2015) showed 
the need for the State Government to develop and implement a sexual and 
reproductive health strategy to support women’s right to health via the 
provision of safe, legal and accessible abortion service provision. Chapter Two 
discusses the non-legal abortion access barriers in more depth. 
 
1.5 A NURSE-LED MA PROVISION MODEL AS A SOLUTION 
TO IMPROVE ABORTION ACCESS IN REGIONAL AND RURAL 
VICTORIA 
The diversities in legal restrictions in Australia, and the resulting 
uncertainties about the boundaries of the law, together with social, economic 
and health system influences, can affect the willingness of doctors to provide 
abortion services (Culwell & Hurwitz 2013; de Costa et al. 2015; de Moel-Mandel 
& Shelley 2017). Provision is mostly confined to private clinics in metropolitan 
areas, and consequently, abortion access for women living in Australia’s rural 
and remote areas is highly restricted (Doran & Hornibrook 2016). 
The existing inequities in abortion access across Australia may be 
improved by an increased use of medication, rather than surgical methods for 
induced abortions (de Costa 2005). MA is particularly suitable to be delivered at 
the primary care level, as no specific surgical facilities, instruments or a full range 
of staff are required (Finer & Wei 2009; Hwang et al. 2005; WHO 2012). General 
practitioners (GPs) in regional and rural areas are specifically well placed for MA 
provision, as they already provide most sexual and reproductive health 
consultations due to a lack of local family planning services (Lorch et al. 2015). 
While the involvement of GPs in abortion service provision has the potential to 
considerable improve abortion access to women residing in underserved 
regions, their uptake of MA provision remains low, and very little is known about 
the underlying factors that determine a GP’s decision to become a provider 
(Dawson et al. 2017; Grossman & Goldstone 2015; Newton et al. 2016a). 
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An acceptable and achievable approach for the delivery of safe MA care 
in the primary health care sector, is the practice of task shifting and task sharing 
(WHO 2015b). Task shifting and sharing addresses the shortage of physicians and 
the time-intensive aspect of the MA process by increasing the tasks of associate 
health workers in the MA provision process (WHO 2015b). This public health 
strategy is currently applied in a number of countries, including the US, France, 
Great Britain and Sweden, and may be a solution for the presently low provision 
of MA in Australian general practice (Berer 2009; Jackson 2011). When 
appropriately trained, PHCNs have been proven to provide MA services as safe 
and effective as physicians (Warriner et al. 2011). 
Australian PHCNs currently already play an important role in the delivery 
of PHC services to women of reproductive age, including health promotion, 
illness prevention and health maintenance (Australian Nursing and Midwifery 
Federation (ANMF) 2011). According to local practice needs, PHCN involvement 
in MA provision may vary, and can include counselling, referral provision, MA 
management as well as the delivery of follow-up care (Advancing New Standards 
in Reproductive Health 2015; Kishen & Stedman 2010; Newton et al. 2016a). A 
nurse-led MA provision model would be particularly ideal for the outpatient 
setting in Australia’s regional and rural areas, as the average number of GPs per 
1,000 population is relatively lower, and the average number of PHCNs per 1,000 
population is considerably higher when compared to metropolitan areas 
(Department of Health and Human Services (DHHS) 2015a). Further, in Victoria, 
abortion is legalised and PHCNs are allowed to be involved in the prevention and 
management of unintended pregnancies, which includes MA provision (ANMF 
2011; 2014; VLRC 2008). 
While data is available on the implementation and the clinical outcome of 
one nurse-led MA service at a sexual health clinic in Wodonga, Victoria, (Tomnay 
et al. 2018), nothing is known about the barriers and facilitators to the 
implementation of extended PHCN roles in MA provision. To achieve equitable 
abortion access across Victoria, more innovative models of service delivery are 
Chapter 1 | Introduction 
 
23 
needed. This study, therefore, aimed to explore the feasibility of a nurse-led 
model of MA provision in the PHC setting of regional and rural Victoria. 
 
1.6 OVERVIEW OF THE THESIS 
This thesis is structured into nine chapters. In this first chapter, the 
context of the study has been presented together with a proposed solution to 
improve abortion access in regional and rural Victoria. In addition, the choice of 
Saurman’s (2016) dimensions of access as the guiding framework for this 
research was articulated. Chapter Two provides a review of the available 
literature. Abortion access barriers in Australia’s regional and rural areas are 
discussed by emphasising the importance of MA service provision in the PHC 
sector, and existing models of nurse-led care are examined together with two 
approaches currently used in Australia to improve abortion access in regional 
and rural areas. In Chapter Three, an overview of the study methodology is 
provided along with contextual detail of the setting for this study (i.e., the state 
of Victoria). Chapter Four details the methods of the cross-sectional study and 
Chapter Six describes the Delphi study. These chapters explain the study design, 
sampling and recruitment methods, instrument development, data collection 
and data analysis. The findings of the cross-sectional study and the Delphi study 
are described in Chapter Five and Seven, respectively. Chapter Eight discusses 
the main findings of the study in relation to the available literature, the three 
proposed nurse-led models of care for MA provision, as well as the study 
strengths and limitations. Finally, Chapter Nine presents the study conclusion 
and provides implications and recommendations for practice, policy and future 
research. 
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CHAPTER 2 
LITERATURE REVIEW 
 
Chapter Two first gives a review of the available evidence on the range of 
non-legal factors that currently hinder access to abortion services in Australia. 
These factors are divided and discussed into the different dimensions of 
Saurman’s (2016) access to health care framework (see section 1.3). Next, a 
review is provided of the gradual recognition of PHC as the centre of effective 
and sustainable health care systems globally, as well as in the Australian context. 
The use of nurse-led models of care is outlined as an essential strategy for the 
improvement of PHC infrastructure, and some examples of Australian nurse-led 
models are provided. To increase safe abortion access in Australia’s regional and 
rural areas, different options of nurse-led MA models are explored, particularly 
of models that are compatible with the requirements of Victoria. The chapter 
finishes with an overview of two innovative approaches of MA provision that are 
currently employed in Australia. 
 
2.1 ACCESS BARRIERS TO ABORTION SERVICES IN 
AUSTRALIA 
Populations should be able to access adequate and appropriate health 
care services when required (Russell et al. 2013; WHO 2015a). It has been 
recognised, however, that people living in regional and rural areas specifically 
encounter access barriers to health care, due to socio-economic disadvantages, 
travel distances and workforce shortages, which can contribute to poorer health 
outcomes for the population concerned (Saurman 2016; Wakerman et al. 2008). 
In Australia, the National Health and Hospital Commission’s Report (2009) and 
the National Primary Health Care Strategic Framework (Australian Government 
2013) both identify equitable access to PHC services for all Australians as a 
priority area for action. Currently, approximately 29 percent of Victoria’s 
regional population encounter considerably reduced access to PHC providers 
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and health services, including abortion provision (Australian Institute of Health 
and Welfare (AIHW) 2016a). 
Apart from the legal factors that can hinder access to abortion services, 
as previously discussed in Section 1.4.1, there are also a range of non-legal 
factors that can hinder abortion access, which include the shortage of abortion 
providers, abortion costs, confidentiality and stigma (Doran & Hornibrook 2014; 
2016; Rice 2008; VLRC 2008). These non-legal barriers to abortion access can be 
categorised into the six access dimensions of Saurman’s access to health care 
framework (2016) (see section 1.3), which include availability, accessibility, 
acceptability, affordability, adequacy and awareness. These dimensions will be 
discussed in the following four sections. The access dimensions of accessibility, 
availability and adequacy are presented together, due to their interrelatedness. 
 
2.1.1 Availability, accessibility, and adequacy 
Availability, accessibility and adequacy are three interconnected access 
dimensions that relate to logistical factors that can hinder access to abortion 
services and providers in regional and rural areas, including travel-related 
logistical problems and limited clinic options. It is widely acknowledged that the 
availability of abortion services in the regional and rural areas of developed 
countries around the world, including Canada, the US and New Zealand, is 
limited (Jones & Jerman 2013; Norman et al. 2013; Silva & McNeill 2008). While 
a similar situation exists in Australia’s regional and rural areas, the available 
Australian research on family planning access is sparse (Doran & Hornibrook 
2014; Kruss & Gridley 2014; Nickson, Smith & Shelley 2006). The lack of access to 
safe abortion services is linked with the recognised shortage of trained abortion 
providers, which is globally one of the most critical barriers for regional and rural 
women accessing safe abortion services, and particularly for women who are 
socially or economically disadvantaged (de Moel-Mandel & Shelley 2017; WHO 
2015b). De Costa, Douglas and Black (2013) suggested that the low number of 
abortion providers in New South Wales and Queensland is partly the result of 
the existing legal ambiguities, which may make doctors reluctant to become 
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involved. Nevertheless, in Victoria, where the influence of legal ambiguities is 
not applicable since law reform in 2008, the number of abortion providers has 
not increased and, therefore, access to abortion provision has not improved 
(Keogh et al. 2016). Besides in Tasmania that recently closed its sole abortion 
clinic, forcing women to travel interstate, most Australian abortion clinics remain 
located in the metropolitan centres of each jurisdiction (Burgess 2018; Children 
by Choice 2018b). In Western Australia, for example, nearly all abortions are 
performed in private clinics around the capital city, Perth, and less than five 
percent of abortions take place in rural public hospitals (Hutchinson, Joyce & 
Cheong 2013). A similar situation exists in Victoria, where all abortion services 
are located in and around Melbourne, with the exception of two MA providing 
sexual health clinics in Wangaratta and Wodonga, two cities in the north-east of 
Victoria (Better Health Channel 2018; Gateway Health 2018b). The lack of 
available regional and rural abortion providers, and the consequential 
diminished accessibility of abortion services, was reported by the participants of 
six Australian studies (Doran & Hornibrook 2014; Hulme-Chambers et al. 2018; 
Kruss & Gridley 2014; Quine et al. 2003; Shankar et al. 2017; Victoria's Regional 
Women's Health Services 2012). The qualitative study by Quine et al. (2003), for 
instance, explored the rural-urban differences among adolescents in the 
accessibility of health services in New South Wales. The rural youth reported 
that accessing health services was a major problem because of the distance and 
the limitations in public transport. Additionally, Kruss and Grimley (2014), who 
interviewed 11 professionals, acknowledged an overall lack of women’s health 
and family planning services in Victoria’s rural areas. 
The lack of trained abortion providers can potentially improve by shifting 
MA provision into the PHC setting. However, despite the relative ease to obtain 
abortion medication, the simple mode of administration and the overall 
acceptance of MA among providers and the public, service provision remains 
limited (Dawson et al. 2016; Hulme-Chambers et al. 2018). Before 2015, the 
narrow window of up to 49 days’ gestation may have been difficult to adhere to 
regarding timely appointments with physicians and services (Grossman & 
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Goldstone 2015). Further, GPs interested in MA provision were obliged by 
medical indemnity insurance providers to obtain the same level of coverage as 
surgical abortion providers, which involved very high costs (Grossman & 
Goldstone 2015). While time limits and insurers policies, two significant barriers 
to providing MA, have changed, and the number of certified prescribers has 
grown since 2015, MA service provision is still mainly provided in the private 
health sector in major cities, significantly increasing the costs involved with the 
service (Grossman & Goldstone 2015). 
 
2.1.2 Affordability 
Abortion costs vary considerably. Fee-free or low-cost treatments only 
apply for procedures undertaken in public hospitals, or for MA procedures 
provided by the two bulk-billed Gateway Health clinics in Wangaratta and 
Wodonga, Victoria (AIHW 2016b; Gateway Health 2018b). Nearly all abortions in 
Australia, however, except in South Australia and the Northern Territory, are 
provided in private clinics, as public hospitals mainly terminate pregnancies in 
the case of a foetal abnormality (Belton 2018; de Costa et al. 2015). Considering 
the fact that only approximately 50 percent of the population has some form of 
private hospital insurance cover, abortions can, therefore, be expensive, with 
prices up to $800 AUD for first trimester procedures (Children by Choice 2018a). 
Additional influential factors for the affordability of abortion procedures are the 
extra costs involved in obtaining an abortion, which are specifically relevant to 
women residing in regional and rural locations (Nickson, Smith & Shelley 2006). 
Travel costs, overnight accommodation and the prolonged time spent away from 
home, with subsequent absence from work or study, as well as the possible 
necessity for child care, were all recognised in Australian studies as indirect 
expenses that increased the overall costs of the abortion procedure (Doran & 
Hornibrook 2016; Hulme-Chambers et al. 2018; Nickson, Smith & Shelley 2006; 
Rice 2008; Shankar et al. 2017). Extra out-of-pocket expenses were reported by 
41 percent of the 2,326 women undergoing an abortion in one of Marie Stope’s 
clinics in Australia, with a median amount of $150 AUD (Shankar et al. 2017). 
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2.1.3 Acceptability 
The acceptability of abortions can be considered from a supply-side 
perspective (the provider and the health system) as well as from a demand-side 
perspective (the consumer). Both sides, however, are highly influenced by the 
fact that, independent of legalisation, abortions remain highly stigmatised 
procedures, which are still censured politically, religiously, or otherwise (Grimes 
et al. 2006). Lipp (2011) acknowledged that abortion stigma can never be fully 
eradicated, because of religious, ethical and personal principles. Abortion stigma 
is defined by Kumar, Hessini and Mitchell (2009, p. 628) as ‘a negative attribute 
ascribed to women who seek to terminate a pregnancy that marks them, 
internally or externally, as inferior to ideals of womanhood’. Kumar et al. (2004) 
blame the impact of stigma on state and societal control over abortion, fed by 
religious beliefs and ethical views, as the reason why a procedure as common 
and safe as abortion is still silenced and ignored. They argued that women who 
seek abortions are commonly perceived as a threat to existing gender norms and 
control over female sexuality, as they inadvertently defy three common 
assumptions about the ideal conduct of women: sexual behaviour solely for 
reproduction; motherhood; and protection of the vulnerable. 
From a supply-side perspective, it has been argued that abortion stigma, 
associated with the procedure as well as the provider, could be the main reason 
for the failure to incorporate abortion provision into hospitals and general 
practice (Sheriff 2009). This position was confirmed by Freedman et al. (2010), 
who interviewed obstetrician-gynaecologists in the US who had undergone 
abortion training, about barriers experienced when wanting to implement 
abortion provision in their practice. All interviewees agreed that abortion stigma 
and ideological disagreement were the main barriers responsible for practice 
restrictions and collegial pressure. 
Related to the influence of stigma on abortion access is the practice of 
conscientious objection, or the refusal to participate in an activity that is 
considered incompatible with somebody’s religious, moral, philosophical or 
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ethical beliefs (Zampas & Andion-Ibanez 2012). Conscientious objection to 
abortion provision can result in a refusal to provide information, to refer or to 
offer post-abortion support (O'Rourke, De Crespigny & Pyman 2012). 
Conscientious objection seems to be increasing worldwide, with percentages of 
physicians who refuse to perform abortions ranging from 10 percent (in the UK) 
to 70 percent (in Italy) (Chavkin, Leitman & Polin 2013). A survey conducted by 
de Costa, Russell and Carrette (2010) gained insight into the views and practices 
of Australian gynaecologists and obstetricians regarding abortion. Findings 
revealed that most respondents supported the availability of abortion in 
Australia. Only 15 percent of responders indicated being totally against 
abortions, although the quality of the data may be affected by the relatively 
small proportion of respondents (49%) as well as by the questionable 
representativeness of the sample due to the controversial topic (de Costa, 
Russell & Carrette 2010). Health professionals in Australia have the right to 
invoke conscientious objection, except in Victoria (Abortion Law Reform Act 
2008 (Vic)) and Tasmania (Reproductive Health (Access to Terminations) Bill 2013 
(Tas)), where health practitioners with conscientious objection to abortion need 
to notify women about their beliefs and refer them to providers without 
conscientious objection. The conscientious objection clause, however, still 
incites harsh responses from religious organisations that declare the obligation 
to refer an attack on the freedom of religious beliefs and conscience (O'Rourke, 
De Crespigny & Pyman 2012). 
From a demand-side perspective, studies have shown that abortion 
stigma can negatively influence a woman’s social, psychological and physical 
behaviour (Major et al. 2009). Major et al. (2009), therefore, contended that 
perceived social stigma has more effect on a woman’s mental health than the 
procedure itself. All participants in a qualitative study in the UK (Astbury-Ward, 
Parry & Carnwell 2012) perceived their abortions as socially unacceptable and 
they feared being judged and negatively labelled. The women, therefore, 
decided to keep their abortion a secret from others, while additionally some 
experienced self-blame and self-stigmatisation (Astbury-Ward, Parry & Carnwell 
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2012). A study by Women’s Health Victoria determined that abortion 
stigmatisation is the main reason that women living in rural and regional areas 
often prefer to travel to metropolitan areas to ensure confidentiality and privacy 
(Rice 2008). Quine et al. (2003) reported that teenage pregnancy was mainly 
recognised as a major health problem in the rural areas of New South Wales, 
with concerns about confidentiality and visibility as a barrier for obtaining 
contraceptives or seeking an abortion. 
Abortion stigma not only marginalises providers and users, but it can also 
encourage harassment and violence, which may, in turn, dissuade health 
professionals from abortion provision (Martin et al. 2014). In the US, and 
particularly in the Midwest and the South, most (84%) abortion-providing 
facilities experienced at least one form of anti-abortion harassment, such as 
picketing or harassing phone calls, and sometimes also more serious attacks, 
including bombings, vandalism and arson (Jerman & Jones 2014). Several US 
studies have researched the impact of anti-abortion harassment on abortion-
seeking women and abortion providers. Doan (2007), for instance, reported that 
anti-abortion harassment could potentially result in a delay in the abortion 
procedure and a decrease in the number of abortion providers, and additionally 
can cause a range of psychological responses in women. The effect of 
harassment on women’s emotional response to abortion was also examined by 
Foster, Dobkin and Upadhyay (2013). They found that levels of distress were 
higher in women who were stopped by the anti-abortion protestors, who were 
spoken to, as well as by women who reported having had difficulties with their 
abortion decision. 
It is, however, questionable if all these study results are applicable to 
Australia, where, with the exception of the 2001 murder of a clinic security guard 
in Melbourne, harassment experience has been fairly moderate (Sifris 2013). 
Nevertheless, Tasmania (Reproductive Health (Access to Terminations) Bill 2013 
(Tas)), the Australian Capital Territory (Health (Patient Privacy) Amendment Bill 
2015 (Act)), Victoria (Public Health and Wellbeing Amendment (Safe Access) Bill 
2015 (Vic)), and just recently New South Wales (SBS News 2018), all established 
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legislation for safe access zones around abortion clinics to prevent protesters 
from harassing women. 
 
2.1.4 Awareness 
Abortion access can also be hindered by a lack of awareness, which, just 
as with the acceptability of abortions (see section 2.1.3), applies to the supply-
side as well as the demand-side of abortion care. For example, a provider or 
service needs to be aware of the local context and target population to deliver 
suitable and effective services (Saurman 2016). Awareness of the service, on the 
other hand, is required for potential users when they want to be able to access 
and utilise the service (Saurman 2016). Evidence shows that awareness is one of 
the main factors that ensures the provision of safe and accessible abortions for 
women, and is particularly important for users with low levels of health 
knowledge and/or low familiarity with local availability of health services (Phillips 
et al. 2012; Russell et al. 2013). 
Newton et al. (2016b) suggest that Victorian women, particularly those 
residing in regional areas, have low levels of awareness of MA as an alternative 
to surgical abortion. Further, they found that women in regional areas often do 
not expect to be able to access MA in their own community. A study by Phillips 
et al. (2012) among tertiary students in Far North Queensland also revealed that 
more than half of the students were not aware that first-term abortions were 
provided in metropolitan Cairns. Even though abortion is only lawful in 
Queensland when there is serious danger to the woman’s physical or mental 
health, a 2013 government guideline (Queensland Clinical Guidelines 2013) 
recognises that medical practitioners may consider social and economic factors 
impacting on the woman’s life and health. However, despite the presence of 
expensive abortion providing private surgeries in the main cities, abortion access 
in the public sector or through GPs remains very restricted (Children by Choice 
2016). Low awareness as a barrier for abortion access was also reported by 
Grindlay, Lane and Grossman (2013) in their evaluation of the provision of MA 
via telemedicine in Planned Parenthood clinics in Iowa, US. Their report showed 
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that awareness of the telemedicine service was low in the community and that 
women needed to be better informed about the availability of the local service. 
Solutions to overcome most of the mentioned non-legal access barriers 
to abortion services will be now be discussed, highlighting the importance of 
health service provision in the PHC sector, together with the potential role of the 
PHC setting in MA provision. 
 
2.2 PRIMARY HEALTH CARE: THE CENTRE OF AUSTRALIA’S 
HEALTH SYSTEM 
Primary health care (PHC) brings ‘promotion and prevention, cure and 
care together in a safe, effective and socially productive way at the interface 
between the population and the health system’ (WHO 2008, p. 41). Health 
systems are defined by WHO (2000, p. 5) as all the organisations, institutions and 
resources whose ‘primary purpose is to promote, restore or maintain health’. 
Health systems include the consultations of regular medical professionals, the 
actions of alternative health providers, all medication use, health care delivered 
at home, as well as all public health and health promotion interventions (WHO 
2000). Health systems are expected to improve the overall health of the 
population and offer protection against the financial cost of ill health (WHO 
2000). 
While people have been protecting their health and treating diseases for 
thousands of years, a distinct health care system reform only emerged after the 
Second World War (Cutler 2001). In 1978, WHO and United Nations Children’s 
Fund (UNICEF) prepared, as a joint initiative, the Alma Ata Declaration (WHO 
1978a), a ground-breaking document in the global development of PHC 
(Chiarella 2008; WHO 2000). The declaration, which was unanimously adopted 
by all WHO member countries, including Australia, essentially recognised PHC as 
a strategy to achieve the social and political goal of ‘Health for All’ (WHO 2000). 
The Alma Ata conference confirmed the unacceptability of the global inequality 
in health status, with health—defined as ‘a state of complete physical, mental 
and social wellbeing, and not merely the absence of disease or infirmity’—
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declared as a fundamental human right (WHO 1978b, p. 1). In the decades 
following the Alma Ata Declaration, however, countries failed to implement 
comprehensive PHC (Gauld et al. 2012). To reach ‘health for all’ required a 
reorientation of health systems and a re-strengthening of the PHC movement, 
which was documented in WHO’s ‘Primary Health Care: now more than ever’ 
report (2008). 
The health care system of Australia consists of a mix of public and private 
health services, and is based on the principle that all citizens and permanent 
residents have the right to equal health care access (Willis, Reynolds & Keleher 
2016). One of the driving forces of this system is Medicare, Australian’s public 
health insurance system (Willis, Reynolds & Keleher 2016). Despite some of its 
flaws, this health care system provides very good health outcomes, and 
contributes to male and female life expectancies that are among the highest in 
the world (Willis, Reynolds & Keleher 2016). However, it should be noted that 
the system is also responsible for the gap in the estimated life expectancy of 
Australia’s Indigenous population, which is approximately 10 years lower than 
the life expectancy of non-Indigenous residents (AIHW 2014). 
Up until 2008, Australia’s health system was predominantly focused on 
hospitals and the provision of acute care, but, with the ageing population and 
the increasing rates of non-communicable diseases and health workforce 
shortages, the health system and health care resources had come under 
pressure (Doggett 2007; Willis, Reynolds & Keleher 2016). In her paper for the 
Centre of Policy Development, Doggett (2007) recognised the values of the Alma 
Ata Declaration (WHO 1978b) by emphasising that health systems needed to 
focus on primary care as opposed to tertiary (hospital) care to achieve better 
health outcomes for less money. Doggett (2007) advocated for PHC reform, a 
strategy that would improve the health of Australia’s population and assure a 
sustainable health system for the future. The National Health and Hospitals 
Reform Commission’s report (2009) and the Department of Health and Ageing’s 
First National Primary Health Care Strategy (2010a) also acknowledged the 
importance of equitable access to PHC. Community-based PHC became 
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identified as ‘the frontline’ of the health care system for most citizens, and 
usually involves the first contact of individuals with health care services, such as 
health promotion, prevention and screening, and disease treatment and 
management (Department of Health 2013). Currently, approximately 30 percent 
($35 billion AUD) of the total government health expenditure in Australia is 
spent on PHC, compared with approximately 41 percent ($47 billion AUD) spent 
on public hospital services (AIHW 2017). 
Most PHC services are provided through GPs, but providers also include 
nurses, midwives, pharmacists, dentists, and allied and Aboriginal health 
professionals, who can deliver PHC in a community-based setting or in the home 
(Department of Health 2013). The First National Primary Health Care Strategy 
(Department of Health and Ageing 2010a) was the policy driver for the abolition 
of Divisions of General Practice, which coordinated PHC services offered by GPs 
since 1992, and the formation of 61 Medicare Locals in 2012, with the intention 
to reduce service fragmentation and improve local community-level PHC services 
(Willis, Reynolds & Keleher 2016). Three years later, however, Medicare Locals 
were replaced, under the new government, by 31 Primary Health Networks, to 
provide and organise the infrastructure required to support general practice, 
including practice nurses (Lane et al. 2017). The strategy (Department of Health 
and Ageing 2010a), however, mainly focused on GPs providing selective PHC in 
the private sector, which consists of interventions for disease treatment and 
management. There was no mention of comprehensive services, which are 
based not only on health but also on social needs, and include approaches to 
address health inequities (Willis, Reynolds & Keleher 2016). The strategy also 
failed to address community and women’s health services, even though they are 
recognised to have their place in the PHC system (Willis, Reynolds & Keleher 
2016). 
The importance of PHC for women’s health was recognised in three 
policy documents that were published in addition to the above-mentioned 
documents that only focused on PHC in general. The first document was the 
National Women’s Health Policy 2010. This policy was built upon the foundations 
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of Australia’s National Policy on Women’s Health in 1989 that led to the 
adoption of priority women’s health issues in women’s health programs that 
were firmly founded on the social model of health (Bennett 2009). The National 
Women’s Health Policy 2010 continued to shape an environment that ensured 
the health and wellbeing of all Australian women (Department of Health and 
Ageing 2010b). The policy identified six key health areas for action, with one 
specifically addressing sexual and reproductive health (Department of Health 
and Ageing 2010b). The second document was the position paper Women and 
Sexual and Reproductive Health, published by the Australian Women’s Health 
Network (2012). This paper advocates that all women, including those residing in 
regional, rural and remote areas, should have appropriate access to affordable 
and comprehensive sexual and reproductive health care. The paper specifies 
seven key areas for women’s health needs, with two of the areas addressing 
abortions: 
• Developing women’s health literacy through information transparency 
about pregnancy termination services; and 
• Increasing reproductive choice including equality in access to legal 
termination services. 
The most recent document, published by the Victorian Government 
(Department of Health and Human Services 2017), recognises access to sexual 
and reproductive health services as a fundamental right for every woman. The 
document ‘Women’s sexual and reproductive health strategy - Key priorities 
2017–2020’ specifically focuses on increasing access to MA in regional and rural 
Victoria through innovative PHC models, ensuring that women have access to 
health services as close to where they live as possible (Department of Health and 
Human Services 2017). 
Critical to PHC reform, however, is the improvement of the PHC 
infrastructure to enhance the quality and accessibility of PHC services, including 
MA provision (Department of Health and Ageing 2010a). Infrastructure 
improvement requires the development of new models of care for service 
delivery, which should be multidimensional, collaborative and transdisciplinary 
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(Davidson et al. 2006; Department of Health and Ageing 2010a). Davidson (2006, 
p. 49) defines a model of care as ‘an overarching design for the provision of a 
particular type of health care service that is shaped by a theoretical basis, 
evidence-based practice and defined standards’. A well-defined model of care 
can clarify the work of involved health professionals, enabling them to achieve 
their shared goals and evaluate outcomes (Davidson et al. 2006). 
In the following sections, nurse-led models of care are introduced as a 
different approach for the delivery of PHC services. Section 2.3 outlines the 
current role of nurses in the PHC setting of Australian general practice. Next, in 
Section 2.4, different variations of nurse-led models of care in the Australian 
context are reviewed, and Section 2.5 considers the potential of nurse-led 
models of care for the provision of MA. 
 
2.3 THE ROLE OF NURSES IN AUSTRALIAN GENERAL 
PRACTICE 
In Australia, GPs are usually the first contact people have with the health 
care system in the case of a health problem (Britt et al. 2014). Around 85 percent 
of Australians visit a GP each year and, as previously mentioned, the PHC setting 
is especially well equipped for the implementation of screening, disease 
prevention and chronic disease management programs (Britt et al. 2014; 
Halcomb et al. 2008a). However, the recommended preventative care that 
addresses lifestyle risk factors, especially for patients with socio-economically 
and socio-demographic disadvantaged backgrounds, is often inadequate due to 
a range of organisational and structural factors (Harris et al. 2013). Hoare, Mills 
and Francis (2011) contend that Australian GPs are often not able to manage the 
huge and diverse range of care that is required for their patients, and that 
practice nurses in general practices are underused. In the UK, on the other hand, 
nearly all chronic conditions are almost fully managed by nurses, which allows 
GPs to have more time for patients with more complicated medical conditions 
(Hoare, Mills & Francis 2011). Deployment of nurses is especially important in 
Australia’s regional and rural areas where the total number of nurses remains 
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fairly constant compared to other health care professionals, whose numbers 
reduce with remoteness (Sullivan, Francis & Hegney 2008). Further, the average 
length of stay of GPs in regional and rural practice is significantly less than for 
doctors practicing in metropolitan areas, and has slowly declined over the years 
to 7.2 years in 2016 (Li et al. 2014; Rural Health Workforce Australia 2017). 
In contrast, over the last few decades, the number of nurses working in 
Australian general practice has steadily increased (Australian Medicare Local 
Alliance 2012). It was estimated that in 2012 approximately 63 percent of all 
general practices employed one or more nurses, compared to 40 percent in 
2003, and that this increase is ongoing (Australian Medicare Local Alliance 2012; 
Halcomb et al. 2014). Nurses who work in general practice are most commonly 
either ‘enrolled nurses’, trained for 12 to 18 months at certificate or diploma 
level, or ‘registered nurses’, a three-year tertiary level degree, but less often 
nurse practitioners, who have a more extended level of training, or midwives 
(Australian Medicare Local Alliance 2012; Jacob, Sellick & McKenna 2012). In 
Australian general practice, registered nurses and enrolled nurses work side by 
side. A registered nurse is required to supervise the enrolled nurse’s practice, 
regardless of whether a GP is present (ANMF 2014). A registered nurse is defined 
as being ‘responsible and accountable for their own practice, and as such does 
not require supervision or provide care for and on behalf of other health care 
professionals’ (ANMF 2011, p. 2). Patient care is provided by nurses in 
collaboration with GPs and other health care professionals (ANMF 2011). For the 
purpose of this thesis, the overarching term ‘primary health care nurse’ (PCHN) 
will be used when referring to nurses working in any PHC setting, including 
general practices, community, domiciliary, educational, occupational and other 
informal settings (Australian Primary Health Care Nurses Association 2015). 
Additionally, the title of ‘practice nurse’ will be used for nurses who only work in 
general practice clinics. 
Over the years, the workforce size as well as the role of the Australian 
general practice nurse gradually evolved, facilitated by a range of government 
funded incentive programs (Department of Health 2012b; Jolly 2007). In 2001, 
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the government initiated the ‘Nursing in General Practice Initiative’, to 
encourage growth in the number of practice nurses and improve access to 
primary care services, particularly for practices located in rural and remote 
settings (Joyce & Piterman 2011; Price 2007). The initiative also aimed to 
improve the prevention and management of chronic diseases and to contribute 
to quality, evidence-based practice and learning systems for practice nurses 
(Joyce & Piterman 2011; Price 2007). As a result, GPs were able to claim specific 
practice nurse activities, like Papanicolaou (Pap) smears (cervix cytology), 
immunisations, wound management, antenatal check-ups and chronic disease 
care plans, via the MBS (Halcomb et al. 2008b; Joyce & Piterman 2011). While 
the initiative resulted in a substantial increase in general practice nurses, it also 
appeared to restrict the practice nurse’s scope of practice to the MBS-defined 
services, as well as their autonomy, as they were often just regarded as income-
generating employees (Joyce & Piterman 2011; Parker, Walker & Hegarty 2010; 
Price 2007). Further government support to encourage the employment of 
nurses was provided with the ‘Practice Nurse Incentive Program’ (PNIP), which 
was introduced in 2012 (Department of Human Services 2017d). This program 
aimed to simplify the previous funding arrangement of individual task-based 
billing by offering general practices a single quarterly incentive payment, with an 
additional rural loading of up to 50 percent. The new funding covers a range of 
nurse services, independent of Medicare item numbers, to meet the individual 
needs of work environments, decrease the workload of GPs, and to enable 
practice nurses to work to the full extent of their scope of practice (Lane et al. 
2017; McKenna et al. 2015). In addition to the PNIP, the ‘Practice Incentives 
Program’ (PIP) aims to support GPs with extra incentives for activities that 
involve asthma, diabetes, sexual health care and cervical screening for under-
screened women (Department of Human Services 2017c). Although practice 
nurses, under the new PNIP scheme, can no longer individually claim a cervical 
screening via the MBS, a short GP consult after the test will still trigger an 
incentive payment (Department of Human Services 2017c). There is, however, 
no PIP available for MA provision. 
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Australia's PHC policy necessitates the establishment of productive 
relationships between nurses, GPs and other health care providers (Adrian 
2009). International and national studies acknowledge that the involvement of 
PHCNs in care functions will improve accessibility, costs, patient satisfaction, the 
adherence to evidence-based professional guidelines and the overall health 
status of patients (Chiarella 2008; Eley et al. 2013; Hoare, Mills & Francis 2011; 
Parker, Walker & Hegarty 2010). PHC models of care, however, require more 
than multidisciplinary and inter-professional collaboration, as the needs of the 
individual, as opposed to the professional, indicate which health professional is 
required and when it is required (Chiarella 2008). The transdisciplinary approach 
allows for greater effectiveness, efficiency and access to PHC provision, in 
particular for patients with chronic and complex conditions (Adrian 2009; 
Davidson et al. 2006). Nurses have proven to be capable of making autonomous 
decisions, and to deliver effective and equitable PHC services (Adrian 2009). 
Therefore, moving towards nurse-led models, especially in service-poor areas, 
can be an essential public health strategy that ensures an optimisation of the 
health workforce, improve health outcomes, is cost effective, and increase 
access to PHC services (Adrian 2009; Wakerman et al. 2008; WHO 2015b). 
 
2.4 NURSE-LED MODELS OF CARE IN THE AUSTRALIAN 
CONTEXT 
The ageing population and the continuing trend to shift care from 
hospitals to PHC services require a more effective use of the PHC nursing 
workforce. PHCNs are capable to provide a range of essential PHC services, 
including direct patient care, health promotion, chronic disease management 
and health assessments (Howe 2016). Therefore, one efficient way to improve 
health outcomes is through the development of nurse-led clinics. A review by 
Richardson et al. (1998), covering 17 studies from the US, Canada and the UK, 
suggests that between 25 percent and 70 percent of the work that is undertaken 
by physicians could be carried out by nurses. The international and national 
literature describe a multitude of variations in nurse-led models of care (Keleher 
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et al. 2007; Laurant et al. 2004). The two most commonly used models of 
practice are the ‘substitution model’, in which the practice nurse takes on a 
delegated part of a GP task, and the ‘collaborative model’, where the practice 
nurse is an autonomous provider of an aspect of patient care (Keleher et al. 
2007). It is still unclear which one of the models is the most appropriate for 
practice nurses in Australia, as practice-nurse roles have varied extensively, 
ranging from traditional assistance and task delegation through to autonomous 
practice in disciplines, such as chronic disease management and preventive care 
(Keleher et al. 2007). 
However, despite the internationally recognised success of nurse-led 
models, the up-take of advanced roles by practice nurses in Australia is low, and 
currently the majority of practice nurses are still only involved in procedural 
activities, like injections, wound dressing and check-ups (Britt et al. 2014). Role 
development is impeded by a lack of clear career pathways, restricted 
possibilities for specialised education programs and a perceived lack of 
collaboration with GPs (Halcomb et al. 2014). Lane et al. (2017) argued that to 
overcome some of these barriers, ongoing support, such as educational, network 
building and advocacy initiatives is required from a range of stakeholder 
organisations, and PHC organisations in particular. 
Nevertheless, there have been some nurse-led initiatives, in which 
practice nurses provide specialist roles in chronic diseases and women’s health 
care (Britt et al. 2014; Eley et al. 2013; Porritt 2007). One example is the delivery 
of Pap tests by nurses. Nurses have been identified to improve access to cervical 
screening as well as the overall number of women participating (Holmes, Mills & 
Chamberlain-Salaun 2014; Mills et al. 2012; Tomnay et al. 2018). Data on nurse-
provided Pap tests, however, are currently only routinely available in Victoria. 
While the practice nurse role in the Victorian Cervical Screening Program is 
undeniably very important, especially in regional and rural areas, most screening 
in Victoria is still provided by doctors, possibly because of inadequate 
remuneration fees and the existing traditional hierarchical paradigm between 
GPs and practice nurses (Holmes, Mills & Chamberlain-Salaun 2014; Mills et al. 
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2012; Nguyen & Ang 2014). In the UK, on the other hand, where nurses have 
been involved in cervical screening since the 1970s, almost 90 percent of all 
practice nurses are currently accredited cervical screeners and responsible for 
approximately 75 percent of the tests conducted in general practices 
(Greenfield, Stilwell & Drury 1987; Holmes, Mills & Chamberlain-Salaun 2014). 
Overall, in order to cope with the growing burden of chronic and complex 
diseases and the ageing population, general practices must consider new styles 
of patient care delivery with a renegotiating of the traditional doctor-nurse 
distribution of labour. The demand and supply gap of health service provision is 
especially noticeable in regional and rural communities, with the shortage of 
health care providers for the delivery of induced abortions as a typical example 
(Wakerman et al. 2008). Access barriers to safe abortion services in regional and 
rural areas could be addressed by introducing a nurse-led model of care for MA 
provision. 
 
2.5 NURSE-LED MODELS FOR THE PROVISION OF 
MEDICATION ABORTION 
In this section, models of nurse-led MA provision are discussed, starting 
with the rationale for the use of the models in regional and rural settings and 
including examples of the different levels of care. Next, the current service 
delivery requirements for MA provision in Australia will be explained, and finally, 
the potential of a full-service nurse-led MA model in Victoria is discussed. 
 
2.5.1 The different levels of care in nurse-led MA models 
As mentioned before, the lack of skilled abortion providers is globally one 
of the most critical barriers for women accessing safe abortion services (WHO 
2015b). This lack of skilled abortion providers is caused by a shortage in abortion 
training, stigma and a range of other barriers that are associated with the 
provision of abortion care (Whaley & Betstadt 2016). Further, the geographical 
spread of the skilled health workforce is in most countries favoured towards 
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metropolitan areas and/or the private sector, which disproportionally affects 
women living in rural areas and those that are socially or economically 
disadvantaged (WHO 2015b). A similar situation exists in Australia (de Moel-
Mandel & Shelley 2017). Moving beyond specialist physicians and allowing other 
health workers to be involved with abortion provision could potentially increase 
and improve access to health care, especially for people with difficulty accessing 
traditional services (McKenna et al. 2015; WHO 2015b). This shift also provides 
women with choice and flexibility, which is indispensable to their reproductive 
autonomy and, thus, to their overall welfare (Sorhaindo & Morris 2016). As 
nurses play an important role in the provision of PHC services for women of 
reproductive age, their involvement has become a key strategy to improve 
access to safe abortion (Jackson 2011). 
The use of abortion drugs instead of surgical methods has the potential, 
in low- and high-resource settings, to expand the pool of abortion service 
providers, in particular at primary care level (Finer & Wei 2009; Hwang et al. 
2005). The provision of MA by mid-level providers (such as nurses and 
midwives), discussed in Section 1.5, has been endorsed by WHO (2012) since 
2003, and is currently applied in a number of countries all over the world (Berer 
2009; Jackson 2011). Evidence shows that trained health workers can provide 
early MA and associated tasks as effectively, safely and satisfactorily as 
physicians, and women do not need to travel long distances to abortion clinics 
(Barnard et al. 2015; WHO 2015b). Additionally, potential harassment, more 
easily encountered when entering specialised abortion clinics, would be 
minimised (Kishen & Stedman, 2010; Yarnall et al., 2009). 
Abortion care tasks, provided by PHCNs or midwives, vary from country 
to country, depending on local legal requirements, and range from managing 
aspects of the MA procedure under supervision of a physician, to functioning 
autonomously (Yarnall, Swica & Winikoff 2009). At full-service institutions, the 
physician is often only present in a consultatory or supervisory role and to 
prescribe the required drugs (Kishen & Stedman 2010; Yarnall, Swica & Winikoff 
2009). In the UK, for example, most MA units are run by PHCNs. PHCNs are, 
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however, not permitted to sign authorisation forms or prescribe abortion 
medication, and the physician thus remains responsible for the care of the 
woman (Kishen & Stedman 2010). A termination of pregnancy framework was 
published by the UK Royal College of Nursing (RCN) to guide nurses in this 
procedure and to help them develop their roles (RCN 2017). Currently, nurse 
practitioners, practice nurses, physician’s assistants or midwives routinely 
manage most aspects of the MA process in 14 US states, Sweden, France, 
Denmark, South Africa, China, India, Vietnam, Cambodia, Tunisia, Bangladesh, 
Cambodia, Nepal and Mozambique (Berer 2009; Jackson 2011; Kishen & 
Stedman 2010; Kopp Kallner et al. 2014; Warriner et al. 2011; Yarnall, Swica & 
Winikoff 2009). Guidelines for MA provision vary per country. The following 
section discusses the service delivery requirements for MA provision in Australia. 
 
2.5.2 Service delivery requirements for MA provision in Australia 
Service delivery requirements for MA provision in Australia are guided by 
a selection of statements issued by the RANZCOG (2016). The statements 
indicate that prescribing practitioners are responsible for the entire process, 
from medication administration to the follow-up procedures, which include 
management of complications, although they acknowledged that some of the 
care could be delivered by other qualified health care providers or services. The 
report (RANZCOG 2016) further agreed that for abortions less than 63 days’ 
gestation, misoprostol could safely be self-administered at home in settings with 
easily accessible emergency care, and in the presence of an accompanying 
person to assist and access support if required. The RANZCOG (2016) also 
provides guiding statements specific for the MA process, prior to and after the 
procedure (Table 2.1).  
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Table 2.1 Guidelines for the MA procedure 
Prior to the MA procedure After the MA procedure 
Provide women with accurate information 
and counselling, if required 
Give information on what to expect, and the 
follow-up requirements 
Assess case history and undertake physical 
examination 
Provide instructions on how to access advice 
and help in the case of an emergency 
Assess co-morbidities and contraindications 
to medication 
Ensure completion of the abortion by clinical 
assessment, and hCG estimations and/or 
ultrasound examination on indication 
Confirm gestation and exclude ectopic 
pregnancy with the mandatory use of 
ultrasound examination 
Confirm effective use of contraception of 
choice 
 
Assess blood group and Rhesus status  
Consider screening for sexually transmitted 
diseases and/or antibiotic prophylaxis 
 
Decide on future contraception and arrange 
for implementation 
 
Provide written information about treatment 
and follow-up care 
 
Obtain written consent   
Source: The use of mifepristone for medical termination of pregnancy (RANZCOG 2016). 
 
Some of these recommendations, however, may limit the use of MA 
services, especially for women residing in low resource settings in Australia, and 
can increase the costs involved with the procedure. One example is the 
RANZCOG (2016) requirement for routine pre-abortion ultrasound scans. 
Although ultrasounds have shown to improve gestational dating in early 
pregnancies, the guideline on ‘The Care of Women Requesting Induced Abortion’ 
of the RCOG (2011), and a review by Kaneshiro et al. (2011), both advise to use 
ultrasounds only when women are not sure of the date of their last menstrual 
period, or when deviant dates or an ectopic pregnancy are suspected (see 
section 1.1.2). The available evidence thus suggests that a lack of ultrasound 
facilities should not hinder MA provision. 
Currently in Australia, two or more visits to the health facility are usually 
required for the MA process; however, a single consultation for women who live 
long distances from a clinic can be offered (Goldstone, Walker & Hawtin 2017; 
Hulme-Chambers et al. 2018). The requirement for multiple visits adds additional 
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time and cost burdens for women, and health care providers have reported this 
requirement as a barrier for MA provision up-take and continuation (Blum et al. 
2012; Jackson et al. 2012). Therefore, if a single visit can be offered to women 
who live long distances away, then that barrier to MA provision up-take would 
be removed. Jackson et al. (2012) hypothesised if women are able to accurately 
self-assess a complete abortion, the elimination of the follow-up visit can 
increase abortion access, and costs will be reduced. They argued, however, that 
an objective method for the assessment of abortion completion, such as 
sonography or serum hCG, is required as symptoms can only moderately predict 
MA failure. This proposed method is endorsed by the RCOG (2011) that 
recommends that for most women, follow-up with telephonic clinical 
assessment, together with an urine or serum pregnancy test is sufficient.  
In regard to the RANZCOG’s (2016) advice to offer (self-collected) 
chlamydia screening and antibiotic prophylaxis, the literature identified differing 
positions. The RCOG (2011), for instance, advises screening of all women for 
Chlamydia Trachomatis, and if indicated for other sexually transmitted diseases, 
while WHO (2012) advises that without any clinical signs of an infection, the 
abortion should not be postponed while waiting for the test results. The RCOG 
(2011) also recommends use of antibiotic prophylaxis against chlamydia and 
anaerobe infections in MA. WHO (2012), as well as the American College of 
Obstetricians and Gynecologists (Creinin & Grossman 2014), on the other hand, 
do not require this use without any clinical infection signs, as they proclaim that 
the risk of an intrauterine infection after MA is very low. 
Another recommendation under debate is the prophylactic, post-MA 
administration of anti-Rhesus (D) immunoglobulin (anti-D) to Rhesus-negative 
(Rh-negative) women to ensure protection from immunisation against Rh-
positive blood. When a Rh-negative woman is pregnant with an Rh-positive 
foetus, she can develop antibodies, which may, in a subsequent pregnancy with 
a Rh-positive foetus, destruct this foetus’ red cells, causing foetal morbidity or 
even mortality (Fiala, Fux & Gemzell Danielsson 2003). Prophylactic 
immunisation to the D-antigen has proven to be very effective in women with 
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miscarriages, surgical abortions and ectopic pregnancies (Jabara & Barnhart 
2003). While currently most countries, such as the UK (RCOG 2011), the US 
(Creinin & Grossman 2014) and Australia (RANZCOG 2016), recommend passive 
immunisation of all Rh-negative women within 72 hours after a first trimester 
MA, there is still no conclusive evidence-based support for this treatment (Fiala, 
Fux & Gemzell Danielsson 2003; Raymond et al. 2015). Therefore, WHO (2012) 
acknowledged the risk for Rh-sensitisation in pregnancies up to 63 days’ 
gestation to be very low and that an Rh-status test and anti-D prophylaxis are 
not required if Rh-immunoglobulin is not easily available. 
With these guidelines and recommendations in mind, the following 
section will discuss the possibility of a full-service nurse-led model of MA in 
Victoria. 
 
2.5.3 The potential for a full-service nurse-led model of MA 
provision in Victoria 
The extension of nurse involvement in the provision of MA varies across 
Australia according to jurisdictional legal requirements and regulations. Within 
the context of Victoria, however, there is scope for the development and 
implementation of a full-service nurse-led MA model. Qualified registered nurses 
in Victoria are, since 2008, entitled by law to administer or supply mifepristone 
for pregnancies up to 24 weeks (although the TGA (2014) restricts the use of MA 
in PHC settings to gestations up to 63 days) and certified physicians, while still 
required for the prescription of mifepristone, do not need to be present when 
women take the pills (Abortion Law Reform Act 2008 (Vic)  ; Grossman & 
Goldstone 2015; RANZCOG 2016). The current legislative climate of Victoria thus 
provides a perfect setting for nurse-led MA provision in regional and rural areas, 
although a range of political and economic barriers still restricts the full 
expression of nurses’ scope of practice, which encompasses the prevention and 
management of unintended pregnancies, including MA (ANMF 2011; 2014; 
Scanlon et al. 2015). Barriers include factors such as responsibility, trust, 
accountability and costs (Jakimowicz, Williams & Stankiewicz 2017). 
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The actual scope of practice of PHCNs, however, includes all the essential 
clinical competencies required to provide MA with mifepristone and misoprostol 
(ANMF 2011). The available evidence demonstrates that properly trained 
practice nurses can expand their scope of practice to independently provide and 
manage safe and effective early MA, without direct supervision from a physician 
(WHO 2015b). Nurse involvement has the potential to expand safe abortion 
access at many levels and can include counselling, referral provision and MA 
management, as well as the delivery of the follow-up care (Advancing New 
Standards in Reproductive Health 2015; Kishen & Stedman 2010). Further, 
nurses are able to recognise and manage complications, and they can provide 
post-abortion contraception (WHO 2015b). Full-service MA provision by PHCNs 
in Victoria can, therefore, include the tasks presented in Table 2.2. However, in 
the hypothetical case of full-service MA provision, the local physician would still 
be required for pathology referrals and drug prescription. 
The next section discusses two currently used approaches to improve the 
access of MA provision in the regional and rural areas of Victoria. 
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Table 2.2 Full-service tasks of PHCNs in MA provision 
Full-service tasks of PHCNs in MA provision 
Provision of independent pre-abortion pregnancy counselling and accurate information 
Conduct of a medical and physical assessment, including estimation of gestational age 
Ruling out contra-indications and co-morbidities 
Diagnosis and dating of pregnancy (with ultrasound) 
Screening for ectopic pregnancy 
Assessment of blood group and Rhesus status 
Discussion of available abortion methods and services, and the respective potential 
complications  
Obtaining consent required for the chosen procedure 
Planning future contraceptive needs and decision of commencement date 
Testing for sexually transmitted diseases, treatment and partner notification (if required) 
Arranging appropriate and prompt referral to other services when required 
Administration of mifepristone 
Providing instructions for self-administration of misoprostol at home and management of 
side-effects 
Provision of written information leaflets about treatment, complications, how to access help 
in an emergency, and the follow-up process 
Assessing completion of abortion process (depending on local protocols: either clinically, with 
an hCG test and/or with ultrasound) 
Provision of Anti-D IgG to non-sensitised RhD negative women 
Ongoing support when required 
Source: The RCN (2017) and the RANZCOG (2016). 
 
2.6 TWO INNOVATIVE, ALTERNATIVE APPROACHES TO MA 
PROVISION IN AUSTRALIA 
Currently in Australia, most medication abortions are still provided via 
costly, private and mainly metropolitan-located services (Black & Bateson 2017). 
Public service provision remains poor, especially outside metropolitan locations, 
and, despite the support and interest for MA provision in general practice, only a 
small number of GPs are certified prescribers (Dawson et al. 2017; Grossman & 
Goldstone 2015; Shankar et al. 2017). In the years following the legal availability 
of MA in Australia, two innovative approaches were introduced to improve MA 
access for women residing in regional and rural locations. 
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The first approach was initiated in 2014 by Gateway Health, a public 
sector PHC service provider in North East Victoria. Gateway Health offers MA via 
their sexual health clinic, using a nurse-led model of care with GP support 
(Hulme-Chambers et al. 2018). As patients at the clinic are bulk-billed, women 
are only required to pay for the price of the ultrasound and PBS prescription, 
thus keeping the out-of-pocket costs for the procedure low (Hulme-Chambers et 
al. 2018). Women are, in general, required to visit the clinic twice; however, in 
the case of long travel distances or for pregnancies nearing the 63 days’ 
gestation limit, a one-appointment-only procedure can be considered (Hulme-
Chambers et al. 2018). After the second visit, women bring their prescription to 
the local pharmacy, where the mifepristone medication is taken under the 
observation of the pharmacist (Tomnay et al. 2018). The second phase of the 
two-step medication regimen is to be taken at home and is followed by a repeat 
pregnancy test and telephone follow-up (Tomnay et al. 2018). Hulme-Chambers 
et al. (2018) interviewed a self-selected sample of 18 women who had previously 
visited the clinic for an MA. Most women had contacted their local GP first and 
were then referred to Gateway Health, with travel distances to the clinic varying 
from five to 234 kilometres. Approximately one-third of the contacted GPs did 
not refer the women correctly or willingly to the MA provider. Further, about 
half the women reported the compulsory ultrasound to be a negative, 
stigmatising experience. All women, though, had a very positive, non-judgmental 
and informative experience with the clinic nurses (Hulme-Chambers et al. 2018). 
Overall, Hulme-Chambers et al. (2018) demonstrated that the Gateway Health 
model provides affordable and acceptable MA services, but they concluded that 
indirect costs, due to long travel, and experienced stigma from local GPs, 
pharmacists and sonographers, required an increase in MA providers in regional 
and rural areas. 
The second innovative approach in Australia was introduced in 2015, 
with the utilisation of telemedicine for the service provision of MA. 
Telemedicine, or telehealth, delivers health care services with the use of 
information and communication technology, to provide patient care at a 
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distance when specialist care is limited (Grossman et al. 2011). Globally, the use 
of telemedicine has expanded enormously in many areas of medicine, and can 
range from electronic communications between provider and patient to 
revolutionary, remotely controlled medical procedures (Boonstra 2013). MA 
early in the pregnancy is an ideal fit for telemedicine as contraindications can be 
easily assessed with an interview, pathology tests or physical examinations are 
not explicitly required, and abortion completion can be evaluated using hCG 
tests or ultrasonography (Raymond, Chong & Hyland 2016). Through self-
administration of the medication at home, this approach will remove the need 
for patients to travel to a clinic and, thus, improve access to abortion services 
(Raymond, Chong & Hyland 2016). 
Telemedicine MA provision can be delivered via three different models. 
The ‘clinic-to-clinic model’ was initiated in 2008 by the reproductive health care 
services network Planned Parenthood of the Heartland in Iowa, one of several 
states in the US that require physicians to dispense the MA drugs (Finer & Wei 
2009; Grossman et al. 2011). As Planned Parenthood physicians usually operate 
near large-volume surgical abortion centres, the model enabled MA provision in 
remote clinics that stock mifepristone but do not have a physician on-site 
(Wiebe & Grossman 2014). At these clinics, a trained staff member counsels, 
screens and provides information to the abortion requesting woman, and 
organises laboratory tests and an ultrasound. The results are reviewed by a 
physician off-site, and if clinical criteria are met, a video teleconference is 
organised to discuss the procedure, after which the clinic will be authorised to 
dispense the medication under video surveillance (Wiebe & Grossman 2014). 
Two weeks later, the woman is required to return for a follow-up consultation 
with the staff member. A similar model has been used since 2011 at several 
remote clinics in Alaska (Grindlay & Grossman 2017). The Iowa method proved 
to be as safe and effective as in-person provision, with similar odds of having an 
adverse event, although study results were limited by the low response rate 
(35%) of contacted emergency departments (Grindlay, Lane & Grossman 2013; 
Grossman & Grindlay 2017). Nearly all (94%) women were satisfied with the 
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service, mainly because of the relatively quick process before the start of the 
actual procedure, and because they could obtain the abortion close to home 
(Grossman & Grindlay 2017). About 25 percent of the women, however, 
indicated that they would have preferred to be in the room together with the 
physician (Grossman & Grindlay 2017). 
The second telemedicine model is the ‘clinic-to-woman-at-home’ 
approach, which is offered at an abortion clinic in Vancouver, Canada, for 
women who reside in the licensed province of British Columbia but live more 
than a two-hour drive from the abortion-providing clinic (Wiebe 2017). The 
women have a Skype video-conference with the abortion provider from home, 
and are directed to a local facility for laboratory tests and, if required, an 
ultrasound. If they are deemed eligible, a prescription for the abortifacients is 
faxed to a local pharmacy, or mailed directly to the woman, and the outcome of 
the procedure is monitored via a follow-up consultation by Skype a few weeks 
later (Wiebe & Grossman 2014). This model is currently also employed in a 
research project for women residing in the US states of Hawaii, Oregon, 
Washington and Maine (Gynuity 2017). According to Wiebe (cited in Raymond, 
Chong & Hyland 2016, p. 585), no serious complications were reported for the 
33 women provided with MA. 
The third model uses a ‘direct-to-woman’ approach and is similar to the 
‘clinic-to-woman-at-home’ method. This approach is used by the website 
organisation ‘Women on Web’ (2017) that refers women who are eligible and 
live in a country where access to safe abortion is restricted, to a licensed doctor 
who can deliver the abortion pills (Wiebe & Grossman 2014). When an abortion 
via ‘Women on Web’ is not a possibility, the website (2017) provides information 
on alternative ways to obtain the medication and how to self-apply a safe 
abortion for pregnancies up to 12 weeks’ gestation with misoprostol only. The 
self-management of abortion, in which women obtain the drugs from informal 
routes, such as pharmacies, drug sellers or online services, and subsequently 
self-manage the abortion process, is a trend that has become increasingly 
common and feasible in settings with legal and/or non-legal abortion access 
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barriers (Kapp et al. 2018). Aiken et al. (2017) analysed data of 1,023 women 
from the Republic and Northern Ireland, where abortion laws, until recently, 
were very restrictive, who underwent a MA with pills obtained online via 
Women on Web. Approximately 95 percent of the abortions were effective, 
comparable to in-person provision. The prevalence of adverse events was low 
(3%), and all women sought medical attention when necessary, as advised (Aiken 
et al. 2017). One limitation of the study was the reliance on women’s self-
reporting, which can be subject to recall or social desirability bias. Further, it was 
not possible to obtain definite gestational age of the pregnancies at the time of 
the abortions, as some women might have been more weeks pregnant than they 
were willing to reveal, or there could have been delays in the taking of the pills 
(Aiken et al. 2017). Similarly, self-managed abortions are progressively used by 
women in the US because of of restrictive state-level legislations, long-distance 
travel to clinics, a lack of information, or a need for privacy (Aiken et al. 2018).  
Alternatively,‘Women on Waves’ (2017), a ‘Women on Web’ related, Dutch-
registered organisation, provides email support and advice for women in 
situations where safe abortions are not available. Women on Waves can bring 
women from countries where abortions are illegal, such as Mexico and 
Guatemala, on ships outside the country’s 12-mile radius territorial waters, 
where it is legal under the Dutch law to provide MA (Women on Waves 2017). A 
more recent initiative of Women on Waves is the provision of abortion pills with 
the help of drones, as was done in Poland and Northern Ireland with drones 
flying from Germany and the Republic of Ireland, respectively (O’Rourke, Belton 
& Mulligan 2016; Women on Waves 2017).  
 
Overall, all telemedicine studies (Aiken et al. 2017; Grindlay & Grossman 
2017; Grindlay, Lane & Grossman 2013; Grossman & Grindlay 2017; Raymond, 
Chong & Hyland 2016) showed that telemedicine provision of MA, irrespective of 
the method used, seemed to be as effective and safe when compared to in-
person provision. Telemedicine is, therefore, recognised as ‘a reasonable 
alternative for those who may not otherwise have access to safe, high quality 
and effective abortion care’ (Gill & Norman 2018, p. 3). 
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Telemedicine was introduced to Australia in 1929 with the pedal radio 
network of the Australian Aerial Medical Service, which was later to be renamed 
the Royal Flying Doctor Service (Australian College of Rural and Remote 
Medicine 2012). This service expanded with trials of video communications in 
the 1970s to video consultation services to rural areas in the 1990s. With the 
spread of broadband, starting around 2005, connection costs were reduced, and 
the telehealth network increased rapidly (Australian College of Rural and 
Remote Medicine 2012). Nowadays, Medicare rebates and financial incentives 
are available for a range of online consultations across a range of medical 
specialties (Australian College of Rural and Remote Medicine 2012). Since 2015, 
telemedicine for MA abortions in Australia has been available through the 
Tabbot Foundation, Marie Stopes and Cairns Doctors (Belton 2017). Each deliver 
MA services, via the direct-to-woman model, in all Australian jurisdictions except 
for South Australia, where abortions need to be performed in a hospital. Due to 
a similar legislation, which was only amended in September 2018, women 
residing in the Australian Capital Territory needed to travel to Queanbeyan, a 
town in New South Wales located at the territory’s eastern border, to collect and 
take the medications (The Tabbot Foundation 2018). In addition, regulations in 
the Northern Territory, Queensland, Western Australia and New South Wales 
restrict telemedicine use to women who live within two hours’ drive from a 
medical facility that needs to be contacted for emergency care provision (The 
Tabbot Foundation 2018). Services from all three telemedicine providers are 
similar, and include the screening of women via a telephone consultation with a 
licensed physician, and ultrasound and pathology test arrangements at a 
convenient location (Belton 2017). If the woman is found eligible, all required 
medication and corresponding instructions are mailed to her directly (Belton 
2017; The Tabbot Foundation 2018). Abortion success is confirmed using serum 
hCG testing. The cost of an MA is lowest via the Tabbot Foundation, which 
charges $250 AUD, excluding services provided by diagnostic providers or 
procedures required to treat complications or failed terminations (The Tabbot 
Foundation 2018). 
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An independent evaluation of the Tabbot telehealth service was 
presented by Belton (2017) at the Australasian HIV/AIDS Conference in 
Canberra. The service was found to be a safe, acceptable and effective choice for 
the delivery of MA. Data, however, showed that approximately 25 percent of 
women decided not to proceed with the abortion. No additional information was 
provided about the reasons behind these decisions. Further, of the 717 women 
in the study, only 15 percent were from outer regional areas, including less than 
two percent from remote areas. Therefore, study results mainly relate to women 
from major cities and inner regional areas, and it is questionable if they can be 
extrapolated for telemedicine provision in the regional and rural locations of 
Victoria, where self-management of the procedure can be more challenging due 
to socio-economic disadvantages and local privacy and stigma issues (Saurman 
2016; Wakerman et al. 2008). 
Both the Gateway Health model and the use of telemedicine for MA 
provision appear to have benefits and limitations. Gateway Health is regionally 
located and offers MA at a much more much affordable price than private 
providers (Hulme-Chambers et al. 2018). However, the involvement and 
influence of GPs not connected with Gateway’s clinic, together with some 
reported long travel distances, demonstrate a need for a greater number of 
regional and rural providers in order to improve overall MA access and reduce 
indirect costs. Telemedicine, in particular when offered via the Tabbot 
Foundation, is relatively affordable. In addition, women who used this service 
reported fewer delays in obtaining the MA compared to in-person provision, and 
experienced more privacy, with less stigma and less travel time involved (Belton 
2017; Grindlay & Grossman 2017; Grindlay, Lane & Grossman 2013). However, 
telemedicine does not provide a direct woman/doctor interaction, a 
shortcoming mentioned by 25 percent of telemedicine users in Iowa, US 
(Grossman & Grindlay 2017). In-person interaction is specifically required for 
women who are not able to independently interpret the provided instructions 
correctly, for instance because of low education, when English is not the first 
language, and for women who are less confident about self-managing abortion 
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at home (Aiken et al. 2017; Grindlay & Grossman 2017). Grindlay and Grossman 
(2017) also expressed concerns about the use of telemedicine for hearing-
impaired women and those who are very emotional or unsure about their 
decision. 
The limitations of the two currently used approaches of MA provision 
show that an additional, more comprehensive model of MA provision is required 
in Victoria to complement the existing models. A nurse-led model of MA 
provision in Victoria’s regional and rural areas would be able to deliver MA at a 
personal level and closer to women’s homes. Additionally, local PHC provision 
would allow providers to build valuable relationships with other local health 
professionals, required for pathology assessments and for emergency care, 
which would improve service access and reduce stigma. Further, it is 
hypothesised that locally provided MA and associated support will potentially 
improve post-abortion contraception follow-up and positively influence 
contraception adherence. 
 
2.7 A NURSE-LED MODEL OF MA CARE FOR THE PHC 
SETTING OF REGIONAL AND RURAL VICTORIA 
In a highly developed country such as Australia, safe abortions should be 
legally obtainable on request, or for a wide range of social and economic 
reasons, and abortion services should be easily accessible and available (CRR, 
2004; WHO, 2012). However, until now, even in liberal Victoria, this aim has not 
been achieved. The current logistic and ethical barriers necessitate an alternative 
solution for the shortage in abortion provision, especially in regional and rural 
areas (Rice 2008). 
The two MA provision approaches, as discussed in Section 2.6, namely 
regional public PHC sector provision and telemedicine, are currently employed in 
Victoria, yet both have their limitations. International evidence has consistently 
demonstrated the substantial contribution of skilled PHCNs to the accessibility of 
safe, first-trimester abortion care (Kishen & Stedman 2010). The inclusion of 
PHCNs in the MA provision process, and the development of a nurse-led MA 
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model of care, will not only define and enhance the role of the PHCN and 
advocate for policy change, but may ultimately improve abortion access in 
regional and rural areas of Victoria, the setting of this study. While it seems likely 
that there is potential for a nurse-led model, there is no literature available on 
the current role and/or involvement of PHCNs in the provision of MA in Victoria, 
and up until now, only a few studies have explored the uptake of MA provision 
among GPs. To address these gaps, this study aimed to assess, via a cross-
sectional study, current MA practice among GPs and PHCNs in regional and rural 
Victoria, prevailing MA knowledge and overall abortion views, and intentions of 
becoming a future MA provider. Further, the study aimed, via the Delphi 
method, to explore the possibility of a nurse-led model of care for MA provision 
that could be widely applied in the PHC setting of regional and rural Victoria. 
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CHAPTER 3 
STUDY CONTEXT 
 
This chapter provides a brief overview of the context of the study. The 
chapter starts with stating the overall aim and research questions, and follows 
with a discussion of the methodological approach. Then, the geographical 
boundaries of the regional and rural areas of Victoria, the setting of the study, 
are described, and finally, the ethical considerations of this research are 
detailed. 
 
3.1 AIM AND RESEARCH QUESTIONS 
The aim of this study was to develop a nurse-led model of care for MA 
provision in the primary health care setting of regional and rural Victoria to 
improve abortion access. The research was guided by the following research 
questions and corresponding objectives: 
1. What are the current and potential future roles of GPs and PHCNs in regional 
and rural Victoria in the delivery of medication abortion services? 
• Establish the current role of GPs and PHCNs in regional and rural Victoria 
in the provision of MA. 
• Understand the overall attitude of GPs and PHCNs in regional and rural 
Victoria towards abortion.  
• Identify the familiarity of GPs and PHCNs in regional and rural Victoria 
with MA.  
• Assess Victoria’s regional and rural GPs’ and PHCNs’ interest in MA 
provision. 
• Identify the anticipated and perceived challenges of MA provision by GPs 
and PHCNs in regional and rural Victoria. 
• Identify the scope of practice of a range of health practitioners for MA 
provision. 
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2. What would a nurse-led model of care for MA provision in regional and rural 
Victoria look like? 
• Develop recommendations and guidelines for the development of a 
nurse-led model of care for MA provision in regional and rural Victoria 
• Identify what a nurse-led model of care for MA provision in regional and 
rural Victoria looks like. 
3. What are the anticipated barriers and solutions to the implementation of a 
nurse-led model of care for MA provision in the PHC setting of regional and 
rural Victoria? 
• Communicate opinions about the factors that can hinder or facilitate the 
implementation of a nurse-led model of care for MA provision in the PHC 
setting of regional and rural Victoria. 
• Collect recommendations of what needs to be done to overcome the 
barriers for implementation of a nurse-led model of care for MA 
provision in the PHC setting of regional and rural Victoria. 
In order to answer these research question, two separate but 
interconnected sequential studies were undertaken. First, a cross-sectional 
study, followed by a Delphi study. The purpose of the cross-sectional study was 
to answer research question one. The second study used the Delphi technique to 
explore research questions two and three, and to reach consensus about the 
feasibility of a nurse-led MA model. Data collection and analysis procedures are 
reported separately for each study, which is typical for a sequential mixed-
method study (Creswell 2009). 
The quantitative dominant cross-sectional study surveyed personal 
beliefs and attitudes of GPs and PHCNs in regional and rural Victoria on MA, 
current and potential future MA provision and the anticipated barriers and 
solutions of MA provision. Qualitative questions were incorporated in the 
questionnaire to get a better understanding of the findings (Creswell 2009). 
Chapter Four describes the methods for the cross-sectional study. 
The Delphi study used a mixed-methods approach, which is a useful way 
to collect a variety of data to address complex social and health problems that 
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cannot be adequately dealt with when using a single method approach (Creswell 
2009). In addition, mixed-method approaches offer a deeper and more 
comprehensive understanding of the research problem and increase validity and 
credibility of results (Creswell 2009; Greene, Benjamin & Goodyear 2001). The 
study employed a ‘sequential exploratory strategy’, one of the six classification 
types of mixed methods that are described by Creswell (2009, p. 214), with 
qualitative data (open-ended questions) collected in the first round, followed by 
two rounds of quantitative data collection (Creswell 2009). For some of the 
quantitative data collection, however, a ‘concurrent embedded strategy’ was 
applied, meaning that qualitative questions were added to expand and clarify 
the findings (Creswell 2009). Chapter Six details the Delphi methods adopted for 
this study. 
The integration of both studies occurred after analysis in Chapter Eight, 
the discussion chapter. Here, the cross-sectional study findings and the findings 
of the Delphi study are combined and discussed together, within the context of 
the existing research literature. 
 
3.2 THE STUDY SETTING 
Victoria is geographically the second-smallest state in Australia but has 
the second largest population of about 6.32 million people, of which 23 percent 
live outside Greater Melbourne (Australian Bureau of Statistics 2018). The state 
is divided into nine regions: four metropolitan and five regional/rural regions 
(ABS 2015). The regional and rural areas of Victoria, as defined by the DHHS 
(2012a), are Barwon South West, Grampians, Loddon Mallee, Hume and 
Gippsland (see Figure 3.1). These regions were the setting of this study. 
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Figure 3.1 Map of Victoria’s geographical regions 
Source: Dental Health Services Victoria (2015). 
 
The geographic boundaries of these regions, however, vary, depending 
on what they are used for, including policy development, census collection, or 
the description of metropolitan/rural differences regarding employment and 
education (The National Rural Health Alliance 2018). While over the years, 
several geographical classification systems have been developed to define 
regional, rural and remoteness boundaries, the following two systems currently 
lead Australia’s rural health policy. 
The Accessibility/Remoteness Index of Australia (ARIA) was created in 
1998 and is currently maintained by the Hugo Centre for Migration and 
Population Research, University of Adelaide (2017). ARIA provides a measure of 
the road distance residents of non-metropolitan Australia have to travel in order 
to gain access to the nearest service centre, which can be a large city or small 
town (Hugo Centre for Migration and Population Research 2017). The longer the 
road distance, the more remote the individual resides from accessible services 
(National Centre for Social Applications of Geographical Information Systems 
2008). One of the most widely used versions of ARIA is ARIA+, which is expressed 
in scores that range from 0 (high accessibility) to 15 (high remoteness). Scores 
are classified into remoteness areas categories (see Table 3.1) (Queensland 
Government Statistician’s Office 2017). The ARIA+ method thus uses a pure 
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geographical approach and does not include socio-economic factors, urban/rural 
aspects or population size in the calculation (Hugo Centre for Migration and 
Population Research 2017). 
 
Table 3.1 Remoteness areas categories ARIA+ 
Remoteness area ARIA+ score Accessibility to goods, services and opportunities for 
social interaction 
Major Cities 0 ≤ 0.20 Relatively unrestricted  
Inner Regional  0.21 - 2.40 Some restrictions  
Outer Regional  2.41 - 5.92 Significantly restricted  
Remote  5.93 - 10.53 Very restricted  
Very Remote  10.54 - 15 Almost none  
Source: Accessibility/Remoteness Index of Australia (Queensland Government Statistician’s Office 
2017). 
 
The second geographical classification system, the Australian Statistical 
Geography Standard (ASGS), has been used by the ABS (2014) since 2011. The 
ASGS provides a more comprehensive framework, where remoteness categories, 
defined with ARIA+ (Hugo Centre for Migration and Population Research 2017), 
are represented by population characteristics and environmental survey data 
(ABS 2014). Part of the ASGS is the concept of Greater Capital City Statistical 
Areas (GCCSAs), which represent the socio-economic extent of each of the eight 
Australian capital cities and satellite urban centres (ABS 2014). All the areas that 
are not part of GCCSAs are defined as ‘Rest of State Regions’ (ABS 2014). 
Melbourne’s Greater Capital City boundaries are shown in Figure 3.2. 
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Figure 3.2 Melbourne Greater Capital City area (the red line represents the boundary 
before 2011) 
Source: The new Melbourne Greater Capital City boundaries (Capuano 2011). 
 
 
The GCCSA classification system provides a practical geographic 
distinction between metropolitan and non-metropolitan areas, and this research 
has therefore adopted this classification. For the clarity of this thesis, ‘Greater 
Melbourne’ will be referred to as ‘metropolitan Melbourne’, and the ‘Rest of 
State Regions’ will be referred to as Victoria’s ‘regional and rural areas’. 
 
3.3 ETHICAL CONSIDERATIONS 
The cross-sectional study and the Delphi study were approved by the 
Deakin University Human Research Ethics Committee (DUHREC 2015-313 and 
DUHREC 2015-314). Although there was no specific risk involved in study 
participation, especially since partaking was entirely voluntary and, thus, only 
participants with an interest in the subject would choose to do so, the sensitive 
research topic could elicit a fear of social stigmatisation and negative judgement. 
Further, it should be noted that even though, in theory, a Delphi study would 
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allow a diverse group of specialists to anonymously express their views without 
any restrictions, peer pressure or influence from expert dominance, it is 
acknowledged that most panel members of expert groups often know each 
other. The arising ‘quasi-anonymity’ could make participants feel pressured to 
conform to the group's view, resulting in either adapting or abandoning the 
process (Hsu & Sandford 2007; Keeney, Hasson & McKenna 2011). 
Therefore, the principal ethical issue of both studies was to acknowledge 
and ensure data security, and the privacy and confidentiality of the participants. 
All participants were informed, via the Plain Language Statement and Consent 
form (PLSC), that participation was voluntary and confidential, that participants 
could skip questions that made them feel uncomfortable, and that withdrawal 
was possible at any time until the ‘submit’ button was pressed, which implied 
consent. Further, it was explained that all identifying information was removed 
from data upon receipt, linked to each panellist’s unique ID code, and stored in 
separate databases. Responses were, therefore, fully anonymous and could not 
be directly linked to any of the participants. A prize was offered for GPs 
participating in the cross-sectional study, which required participants to provide 
their name and contact details if they wished to enter the draw. Details of 
eligible participants were separated from their responses and entered in a 
Microsoft Excel (2013) spreadsheet, which allowed for random selection of a 
winner. The winner of the $500 AUD travel voucher was notified by email. ID 
codes of the Delphi panellists were re-matched with corresponding email 
addresses for the second and third round questionnaire, as the Delphi process 
requires that the researcher can link back responses to individual panel 
members. 
All data were handled and processed according to the rules of the 
National Statement on Ethical Conduct in Human Research (National Health and 
Medical Research Council 2007), meaning that data were safely stored on a 
password-protected University server or in a locked cabinet, and that back-up 
USBs as well as any written paper copies were put in a locked filing cabinet, only 
accessible by the researchers. After the completion of the study, all digital data 
Chapter 3 | Study context 
 
64 
 
were transferred to a USB, which will be, together with paper documents, 
securely stored within Deakin University for at least five years after the last 
publication. 
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CHAPTER 4 
CROSS-SECTIONAL STUDY METHODS 
 
In this chapter, the methods of the cross-sectional study will be 
described, including the study design, sampling and recruitment, instrument 
development, data collection and data analysis. 
 
4.1 STUDY DESIGN 
This study employed a cross-sectional study design to answer research 
question one: What are the current and potential future roles of GPs and PHCNs 
in regional and rural Victoria in the delivery of MA services? This design was 
chosen as the most suitable approach to obtain a quantitative description of the 
attitudes, opinions and behaviours of the study’s target population (GPs and 
PHCNs) in a short period of time (Creswell 2009). Further, cross-sectional studies 
are simple to execute, quick and relatively cheap (Webb & Bain 2011). 
Drawbacks of cross-sectional studies, however, are that the findings will only 
reflect a snapshot in time, and that they are prone to non-response bias, owing 
to high non-response rates (Sedgwick 2014; Webb & Bain 2011). Outcomes of 
this study will, therefore, not necessarily provide a true reflection of the sample 
population. These advantages and disadvantages are further discussed in the 
following sections. 
 
4.2 SAMPLING AND RECRUITMENT 
Multiple sampling and recruitment strategies were used in this study to 
obtain a sample from the target population: all nurses and GPs working in the 
PHC setting of regional and rural Victoria. The two groups are discussed 
separately. 
 
Chapter 4 | Cross-sectional study methods 
 
66 
4.2.1 Primary Health Care Nurses 
The first target population of interest consisted of all nurses currently 
registered with the Nursing and Midwifery Board of Australia (NMBA) who work 
in the PHC setting of regional and rural Victoria. This group comprises enrolled 
nurses, registered nurses and nurse practitioners who work in general practice, 
community health service, education and sexual health clinics. While there are 
no accurate data available on the number of nurses, a 2012 report estimated 
that of the 2,425 practice nurses working in Victoria, approximately 45 percent 
(1,090) are employed outside major cities (Australian Medicare Local Alliance 
2012). 
The absence of a sampling frame required convenience sampling, a non-
probability sampling technique whereby participants are selected in the most 
convenient way (Blair & Blair 2015). This technique has shown to be fast, easy 
and economical (Babbie 2010). The sample generated with convenience 
sampling, however, is vulnerable to selection bias (Babbie 2010). It can lead to 
an under-representation of certain groups within the sample, like those who are 
not in contact with any of the recruiting organisations or have no Internet access 
(Bethlehem 2010). Further, just as in probability sampling approaches, 
participation bias is an issue, because it is up to potential respondents to decide 
if they want to participate (Bethlehem 2010). Although this self-selection factor 
cannot be influenced, the choice to approach a broad and diverse group of 
organisations can reduce under-coverage (Bethlehem 2010). Overall, however, it 
cannot be assured that the sample obtained in this way will be a representation 
of the target population (Babbie 2010). 
For non-probability samples, it is not possible to pre-assign a sample size 
or to obtain a random sample (Blair & Blair 2015). Consequently, an informal 
approach needs to be considered to yield a representative cross-section of the 
target group. One often-used method to obtain a sample size estimate is the use 
of a sample number that is typical for similar research in the field (Blair & Blair 
2015). Research showed sample sizes in similar Australian studies ranged from 
100 to 300; however, because of the contentious subject, lower responses were 
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to be expected (Australian General Practice Network 2009; Joyce & Piterman 
2011; Merrick et al. 2012). To recruit the PHCN participants, the study used a 
multifaceted approach, consisting of convenience sampling and snowball 
sampling techniques (Babbie 2010). 
For the convenience sampling method, a total of 27 professional nursing 
organisations, regional Primary Health networks and women’s health services, as 
well as a range of other key organisations with a focus on regional health, were 
approached as they were identified as suitable sources for nurse recruitment. 
Additionally, a publically accessible Facebook page, named ‘Medication abortion 
access in regional Victoria’, was established to promote the study. Facebook is 
known to be an effective recruitment tool as it enables organisations to “share” 
and “like” the page (Kapp, Peters & Oliver 2013). A convenience sample was also 
obtained from the publicly accessible National Health Services Directory (NHSD 
2017), an online joint initiative of Australia’s federal government and the 
governments of all states and territories, which allowed potential participants to 
be approached directly instead of via third parties. The directory was explored 
for regional and rural general and primary care practices with a specific interest 
in sexual or women’s health and who employed practice nurses. To increase the 
chance of recruiting nurses, GP practice selection was restricted to relatively 
large (consisting of, approximately, more than six GPs) practices, as they appear 
to employ relatively more nurses. This search resulted in a list of 164 practices. 
Eighteen of the 27 approached organisations promoted the study on 
their website, in their newsletter, mail-outs or on social media. Over the next 
four months, ongoing contact with the organisations that agreed to promote the 
study resulted in up to three published reminders and/or re-invitations to 
participate. The Facebook page included a short invitation letter, pinned to the 
top of the page, and an embedded link to the online questionnaire. To increase 
page engagement, the content of the page was updated on a regular base, for 
example with reminders and encouragements. 
The PHCNs nurses working in the selected sample of 164 practices 
received an invitation letter by mail or email, depending on the contact 
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information provided in the NHSD. A reminder was sent four weeks after the 
initial invitation to all participating practices, as, due to the anonymous nature of 
the online questionnaire, it was not possible to identify who had participated. 
Depending on the medium that was used, the invitation either included an 
embedded link to the online questionnaire, or it directed the reader to a 
webpage that provided the same embedded link. All potential participants were 
additionally encouraged to forward the study information to eligible colleagues, 
thus creating a snowball effect (Babbie 2010). 
 
4.2.2 General Practitioners 
All qualified GPs who were actively practicing in the non-metropolitan 
areas of Victoria, as defined in Section 3.2, were eligible to be included in the 
cross-sectional study. According to data from the Rural Workforce Agency 
Victoria (RWAV) (2016) there were 1,861 GPs located in areas outside major 
cities. A probability sampling technique was used with the help of the Medical 
Directory of Australia (MDA), which is the leading online medical database for 
searching and locating doctors and health facilities nationwide, endorsed by the 
Australian Medical Association (AMA) (2017). The use of the directory allowed 
for contacting potential participants directly and is, therefore, less reliant on 
practice gatekeepers, like practice managers and practice assistants. The MDA 
subscription, however, did not permit for the compilation and use of a mailing 
list. Therefore, the contact details of all GPs that, according to the MDA, worked 
at that time in the PHC system of non-metropolitan Victoria, were looked up, 
one by one, on screen. Their names were then manually entered in a temporary 
file, producing a sampling frame of 1568 GPs. It was suspected that this number 
differed from the 1,861 GPs documented by the RWAV because of potential 
variations in the classification of geographic boundaries of regional/rural regions, 
and because not all GPs are registered with the MDA. 
Using STATA (StataCorp 2015), a sample of 309 GPs, identified by their 
MDA identification number and corresponding name, was randomly selected 
from the sampling frame. The sample size required was calculated based on a 95 
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percent confidence interval and a five percent margin of error (Creative 
Research Systems 2012; O'Leary 2004). Of the selected sample, 22 GPs were 
either not found or they did not work in general practice, and two GPs were 
removed because their practice towns were not classified as a non-metropolitan 
area. To replete the loss of these 24 GPs, an additional random sample of 41 GPs 
was taken to provide for doubles and other exclusions. After screening, five 
names of this sample were indeed duplicates and, therefore, removed. A 
systematic sampling approach was then used, as this was the easiest and 
quickest way to obtain the desired sample size (Creswell 2009). Every fifth GP on 
the list was chosen until the 24 additional GPs were acquired to complete the 
sample. Contact details of the 309 GPs were then obtained from the National 
Health Service directory (2017), a database of Australian health and related 
services, and the White Pages, and used to compile a mailing list. 
Additionally, as the initial response of the GPs to the online questionnaire 
was low, a non-probability, purposive snowball sampling method was employed 
to recruit more non-metropolitan GPs with the required specifications. A contact 
person of Deakin University’s regional/rural clinical schools was asked to 
introduce the study to GPs associated with these schools by sending them (non-
personalised) invitation letters. 
While it is widely acknowledged that primary care research is important 
for recommending clinical practice and to develop necessary evidence, GP 
recruitment for studies, and particularly for surveys, has proven to be 
challenging (Pit, Vo & Pyakurel 2014; Zwar et al. 2006). As the validity of survey 
results dependents on a sufficient number of responses, a variety of strategies 
have been developed to increase response rates, most of them consistent with 
the principles of Dillman’s Total Design Approach (Dillman, Smyth & Christian 
2014). This approach emphases five elements in survey design and 
administration: inclusion of monetary incentives; a respondent-friendly survey 
layout; a multitude of reminders; enclosure of a stamped return envelope; and 
personalisation of the questionnaire. Four of Dillman’s strategies were employed 
in this study, as the enclosure of a stamped envelope was not required because 
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an online questionnaire was used for data collection. All GP participants 
completing the questionnaire by the stated deadline were offered the 
opportunity to enter a random prize draw for a $500 AUD weekend away 
voucher (Dillman, Smyth & Christian 2014; McLaren & Shelley 2000). Further, the 
mailed invitation letter sent to the 309 eligible GPs was personally addressed. All 
invitation letters, including the ones sent to GPs recruited via purposive snowball 
sampling, described the aim and purpose of the overall study and included a link 
to the questionnaire. The questionnaire was administered via the online survey 
tool Qualtrics (2015), which creates respondent-friendly and easy-to-use 
questionnaire layouts. Upon opening the questionnaire link, potential 
participants were first guided to the PLSC form (Appendix A), after which they 
were required to click the text that outlined that they had read the statement, 
understood their rights as a participant, and that they wished to continue. Two 
reminders were sent with two months’ interval each. 
 
4.3 INSTRUMENT DEVELOPMENT 
No existing instruments were available to determine the current and 
potential future roles of GPs and PHCNs in regional and rural Victoria in the 
delivery of MA services. Therefore, a new instrument was constructed drawing 
on the items of two existing questionnaires and the development of new items. 
Items were drawn from the Californian questionnaire by Hwang et al. (2005), 
who surveyed advanced practice clinicians, consisting of nurse practitioners, 
physician assistants and certified nurse-midwives, about their clinical experience 
with MA, personal beliefs and attitudes, clinical practices, possible interests in 
MA provision and their perceived barriers to providing such care. Their 
instrument, consisting of 22 items, was modelled, after extensive feedback and 
pilot-testing, on earlier questionnaires (McKee & Adams 1994). Additionally, 
items were drawn from a research instrument that was previously used in the US 
in 1997 and 2008 and in Canada in 2011 and 2013 to establish the practices and 
opinions of abortion providers (Lichtenberg, Paul & Jones 2001; Norman et al. 
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2013; Wiegerinck et al. 2008). Permission from all above-mentioned authors was 
obtained.  
The newly developed instrument was modified according to each health 
provider group, with differences that mainly related to items that asked about 
occupation description, and the involvement with MA provision. The 
questionnaires consisted of five sections: socio-demographic characteristics; 
clinical experience; MA knowledge and involvement; personal beliefs and 
attitudes regarding abortion; and potential interest in MA provision. Items were 
mainly presented in multiple-choice, matrix, checkbox and Likert-scale format, 
and included a specification option, where appropriate, that allowed participants 
to write down additional responses to avoid the exclusion of significant data 
(Babbie 2010). Additionally, text boxes were employed to obtain numerical data 
regarding the age of participants, the number of years working in clinical 
practice, the year of commencing MA provision, and the numbers of provided 
MA. 
The socio-demographic characteristics, the first section of the 
instrument, included items about gender, age, years of practice, part-time versus 
full-time work and current occupation/registration. They were based upon items 
used in similar studies (Hwang et al. 2005; Lichtenberg, Paul & Jones 2001; 
McKee & Adams 1994; Norman et al. 2013; Wiegerinck et al. 2008). Items 
regarding country of qualification and practice structure were only included for 
GPs, as not deemed relevant for PHCNs. 
The four remaining sections of the questionnaire consisted of 24 items 
(the GP version) and 23 items (the PHCN version). The first section related to the 
clinical experience of the participants and consisted of items that measured the 
percentage of work time spent providing care to women of reproductive age, 
practice experience with women with unintended pregnancies, and the inclusion 
of abortion counselling and/or abortion referrals in consultations. All items were 
based on Hwang et al.’s (2005) instrument; however, wording was modified to 
reflect the Australian context. 
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The next section measured participants’ knowledge and involvement 
with MA and consisted of 12 (GPs) and 10 (PHCNs) items. Two items determined 
participants’ familiarity with MA. They were derived from Hwang et al.’s (2005) 
questionnaire. However, the phrase medication abortion was used instead of 
medical abortion. The next six (GPs) versus three (PHCNs) items related to 
personal and/or practice involvement with MA provision and estimated MA 
numbers. These items were also adapted from Hwang et al.’s (2005) 
questionnaire, but modified to reflect both target populations in the current 
Australian context. The last four (GPs) and five (PHCNs) items of this section 
were only applicable to current MA providers or to participants working in MA 
providing practices. These items included travel distance of abortion-requesting 
women to the clinic, encountered problems related to the MA provision process, 
encountered harassment, as well as disclosure issues regarding participants’ 
work environments. The items relating to travel distance and potential problems 
encountered in the MA provision process were based on the literature review 
(de Moel-Mandel & Shelley 2017; Hwang et al. 2005; Lichtenberg, Paul & Jones 
2001; McKee & Adams 1994; Nickson, Smith & Shelley 2006; Norman et al. 2013; 
Wiegerinck et al. 2008). The final two multiple-option items were adapted and 
modified for the Australian context from the Lichtenberg, Paul and Jones (2001) 
questionnaire. The items enquired about encountered harassment and 
challenges of MA providers as well as disclosure issues regarding their work 
environment. 
The four items that were part of the third section concerned participants’ 
personal beliefs and attitudes regarding (medication) abortion. Three items were 
drawn from Hwang et al.’s (2005) questionnaire. Extra response options, 
however, were added to the item that explored a range of health practitioners 
and their potential scope of practice regarding MA provision, to relate all options 
to the Australian context. The fourth item asked about circumstances that the 
participants believed justified abortions, with the answer choices reflecting the 
discourse that can be found in the current Australian literature (de Costa et al. 
2015). 
Chapter 4 | Cross-sectional study methods 
 
73 
In the final section, three items were included that explored participants’ 
interest in MA training and potential barriers for MA provision uptake. After the 
first item enquired about the interest in MA training, the next two items asked 
non-MA providing participants to identify reasons for never wanting to provide 
or assist with MA and to identify reasons for not providing or assisting with MA, 
even though willing. Again, these items were derived from Hwang et al.’s (2005) 
questionnaire, with response options modified or added to reflect uptake 
barriers in the current Australian literature (de Moel-Mandel & Shelley 2017; 
Newton et al. 2016a). Participants were asked to mark all relevant choices for 
not or never wanting to provide or assist with MA from the checkbox list of 
potential responses. To finish, the GP questionnaire asked if participants wanted 
to enter the prize draw, and both questionnaires included an open invitation for 
the Delphi study at the end. 
The GP and PHCN questionnaires were subsequently pre-tested and 
pilot-tested to identify problems related to language, relevance to the Australian 
context, size, flow and format of the questionnaires, browser compatibility and 
analysis methods (Radhakrishna 2007). First, a pre-test was conducted to assess 
the clarity and accuracy of the questionnaire instructions and to receive 
feedback on questionnaire design, language and technical aspects (Dillman, 
Smyth & Christian 2014). The pre-test procedure ensured that the 
questionnaires would function as consistent research tools to reduce both 
sampling (for example due to non-response) and non-sampling errors (like 
question misunderstandings or skip pattern problems) (Grimm 2010; Ruel, 
Wagner III & Gillespie 2016). A pre-test invitation email was sent out to a 
convenience sample of 17 friends and colleagues, which allowed for evaluations 
from people with a variety of backgrounds and knowledge (Dillman, Smyth & 
Christian 2014). The invitation explained, in short, the purpose of the pre-test 
and the approximate time it would take to complete the questionnaire items and 
feedback form. The questionnaires and feedback forms were returned within a 
week by 12 participants, a response rate of 70 percent. The feedback responses 
included problems regarding the flow and accessibility of the questionnaires, as 
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well as some typographical errors and language issues. Changes regarding the 
survey flow were made, and items were revised and reworded to improve the 
understanding of what was being asked and to enable satisfactory responses. 
Following these amendments, the revised versions of the questionnaires 
were piloted among a convenience sample of the target population, which 
consisted of GPs and PHCNs working in metropolitan Melbourne. The pilot 
tested the whole research procedure, including the recruitment process, data 
collection and data analysis, in order to identify whether the proposed 
questionnaires would be suitable for the actual study and if they would be able 
to generate significant data that, after analysis, were able to answer the 
research questions (Ruel, Wagner III & Gillespie 2016). For logistic reasons, 
participants were sought in the direct neighbourhood of Deakin University. 
Thirteen local medical centres were contacted. An invitation to participate in the 
pilot questionnaires, with an explanation of the purpose of the pilot procedure 
and a link to the questionnaire, was either sent to the centres by email, via the 
centre’s website, or delivered in person. Additionally, a personal invitation email 
was sent to five GPs based at the medical centre at Deakin’s campus in Burwood 
(Melbourne). The GPs were encouraged to pass on the invitation to colleagues 
and practice nurses. 
A few days after delivery, all practices, except for the Deakin practice, 
were contacted by phone to ensure that the invitations were received and 
distributed to potential participants. A reminder email was sent two weeks later 
to the Deakin GPs. From the 14 approached centres, which all together 
comprised approximately 100 GPs and around 20 practice nurses, only six 
questionnaires were returned. Three of them originated from GPs and three 
from nurses. It was hypothesised that the low response rate could be attributed 
to the role of practice managers, who appeared to be the person in control of 
the distribution of the questionnaires. On top of that, some practice managers 
explained that the distribution of questionnaires first required approval by the 
board of directors. 
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The feedback responses and suggestions resulted in the rewording and 
revision of two items (Rattray 2007). The item that asked about abortion 
counselling was reworded due to ambiguity, and an extra response option (‘I 
would not feel comfortable personally being involved’) was added to the item 
that enquired about reasons for not providing MA even though wiling. Further, 
one item was added to the socio-demographic characteristics section of the 
PHCN questionnaire, to assess the highest qualification obtained. In addition, a 
problem with the sequence of the displayed questions was solved. Copies of the 
final versions of the PHCN and GP questionnaire are included in Appendix B and 
C, respectively. 
 
4.4 DATA COLLECTION 
An online, self-administered questionnaire was chosen as the method of 
data collection, because online questionnaires provide time-convenience for the 
participants in regards to answering the questions and they are environmentally 
friendly (Bourque 2004; Monroe & Adams 2012). Additionally, they are low in 
costs, easy to implement, and they have convenient built-in features for usage 
and data analysis (Bourque 2004; Dillman, Smyth & Christian 2014; Monroe & 
Adams 2012). Online questionnaires also remove a major possible cause of social 
desirability bias, as their (relative) anonymity can yield more comprehensive and 
candid answers on a sensitive topic like abortion (Bourque 2004; Brace 2013). 
Even though the use of standardised questions provides significant strength in 
regards to the measurements, they can also weaken the design as they provide 
less room for creative answers, and the initial questions cannot be changed 
during the study period (Babbie 2010; Schutt 2015). Debate around response 
rates to online questionnaires in comparison to mail or phone questionnaires is 
ongoing. Some studies (Dillman, Smyth & Christian 2014; Scott et al. 2011; Shih 
& Fan 2008) point out that online questionnaires have lower response rates than 
mail or phone questionnaires, while other studies (Ansolabehere & Schaffner 
2014; Cobanoglu, Moreo & Warde 2001) provide evidence that online 
questionnaires produce comparable or even better response rates. The use of 
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online questionnaires for the participants recruited via Deakin University’s 
regional/rural clinical schools, however, hinders a personalised approach with 
options for reminders, as access depends on the link forwarded via a third party 
(Dillman, Smyth & Christian 2014). It should be noted, though, that this 
disadvantage is caused by the recruitment approach rather than the data 
collection method and it would also have been the case with a paper based 
questionnaire. 
All data was collected between March and September 2016, using 
Qualtrics (2015), an online survey administering tool that can build surveys to 
conduct survey research, distribute surveys and analyse responses. An important 
feature of the program is that it can export data directly into statistical software 
programs, such as Excel and SPSS. 
 
4.5 DATA MANAGEMENT AND ANALYSIS 
All data from completed questionnaires were imported from Qualtrics 
into Microsoft Excel (2013), checked for errors and cleaned by removing all 
metadata, such as response submission dates, IP addresses, as well as any 
embedded data. As all Qualtrics data were exported in text format, data were 
recoded into numeric values. For example, Yes or No answers were recoded with 
1 and 2, respectively, and Likert answers that involved ‘strongly disagree’ to 
‘strongly agree’ were recoded into the numeric values 1-5. In addition, all 
statements in the matrix questions were divided in SPSS into separate variables 
and the scale answer options were assigned with appropriate values. The matrix 
question, for example, that asked participants if they hide the fact that they 
work in an MA-providing clinic from a range of people, was divided in SPSS into 
five single variables, which represented: hiding from spouse or partner; children; 
parents; friends; and/or neighbours. For each variable, the answer options ‘yes’, 
‘no’ and ‘not applicable’, were recoded into the values 1, 2 and 3. Continuous 
data depicting ‘age’ and ‘years in practice’ were converted into three and four 
groups of ordinal categorical data, respectively. 
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After all data were checked, cleaned and manipulated, they were 
exported into IBM SPSS Statistics for Windows (Ver. 23, Armonk, NY: IBM Corp) 
for analysis. Descriptive statistics were used to examine the participants’ socio-
demographic characteristics, clinical experience, MA knowledge and 
involvement, personal beliefs and attitudes regarding abortion, and potential 
interest in MA provision of the whole cohort and of GPs and PHCNs separately. 
Further analysis was done to assess potential statistically significant differences 
in the responses of the GPs and PHCNs. Similarly, differences were assessed 
between the sample GP characteristics and the characteristics of the regional GP 
workforce of Victoria (RWAV 2016). The Pearson chi square test (χ), or Fisher's 
Exact Test for small samples, was used to examine differences between sample 
GPs and regional GPs, and GPs and PHCNs for binary variables, for example: do 
you see women with unintended pregnancies as part of your practice, have you 
ever referred women for abortions, and I would support my colleagues in 
providing abortions (du Prel et al. 2010; Kroonenberg & Verbeek 2018). The non-
parametric Mann Whitney U test (MWU) was performed to analyse differences 
between the GPs and the PHCNs for the ordinal scaled variables, such as Likert 
scale questions (du Prel et al. 2010). A characteristic of the Mann Whitney U test 
is that it can be used on small samples (du Prel et al. 2010). 
Pearson’s chi square test (χ), or the Fisher exact test for small samples, 
was also used to examine possible statistically significant differences between 
the GPs and PHCNs for the items that asked for reasons for never and not 
wanting to provide or assist with MA training. The item that related to the scope 
of practice of health care practitioners for MA provision was analysed with the 
Mann Whitney U test, because the answers were provided in an ordinal scale. 
For all tests a p-value less than 0.05 was used as a cut-off point for statistical 
significance (du Prel et al. 2010). 
Thematic analysis was undertaken on the qualitative data obtained from 
the items that included a specification option. This qualitative data analysis 
technique is described by Braun and Clarke (2006, p. 79) as ‘a method for 
identifying, analysing and reporting patterns (themes) within data’. Thematic 
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analysis has proven to be a reliable research tool that can provide a rich-detailed 
interpretation of the data without the requirement of theoretical knowledge 
(Braun & Clarke 2006). Data were read and coded for additional themes. All 
transcripts were anonymised and assigned with a unique identification code 
which indicated profession (GP or PHCN) and participant number. Transcripts 
that provide further explanation or deepen the understanding of the presented 
data are used in Chapter Five to strengthen the study’s findings. Responses are 
attributed to the participants via the unique code assigned, which is denoted in 
brackets. 
This chapter has described the methods for the cross-sectional study. The 
next chapter presents the findings of study. 
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CHAPTER 5 
CROSS-SECTIONAL STUDY FINDINGS 
 
This chapter presents the findings from the cross-sectional study with a 
sample of PHCNs and GPs working in the regional and rural areas of Victoria. The 
results are presented in four sections. The first section describes the socio-
demographic characteristics of the participants. The second section aims to 
identify the current status of MA provision in regional and rural Victoria. It 
includes participants’ current role in MA provision, MA knowledge, their views 
on abortion, and their interest in becoming a MA provider. This section 
additionally explores the problems experienced by MA providers in regards to 
MA provision. The third section describes the perceived personal and logistical 
barriers for the uptake of MA provision, and the final section presents 
participants’ views on the scope of practice of a range of health practitioners for 
MA provision. 
 
5.1 SOCIO-DEMOGRAPHIC CHARACTERISTICS 
A total of 69 participants, 39 GPs and 30 PHCNs completed the online 
questionnaire. The GPs’ response rate from the selected sample was 11 percent. 
The characteristics of the participants are presented in Table 5.1. Most PHCN 
participants (96.6%; n=28) were female, while in the GP group the female 
(53.8%; n=21) to male (46.2%; n=18) distribution was similar. According to data 
from regional Victoria, the actual percentage of male GPs in 2016 was 59.0 
percent, which is 12.8 percentage points higher than the percentage of GP 
participants in this study (Rural Workforce Agency Victoria (RWAV) 2016). 
However, this difference was not statistically significant (χ2 = 2.6; df = 1; p = 
0.14). More than half (53.6%; n=37) of the participants were aged between 45 
and 59 years. Each professional group had a mean sample age of 49 years, which 
was also similar to the overall mean age of regional GPs (B. Metherall, 
Data/Business Analyst, RWAV, email, 9 June 2017). The older age of the 
participants reflected the number of years the participants had worked in 
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general or clinical practice. More than half of the GPs (59.4%; n=22), compared 
with 48.1 percent (n=13) of PHCNs, had worked for more than 15 years in a 
clinical setting (MWU = 447.5; p = 0.46). Over two-thirds (64.1%; n=25) of the 
GPs worked full-time, which is congruent with RWAV (2016) findings, but 
statistically significantly higher than the 33.3 percent (n=10) of full-time working 
PHCN participants (χ2 = 6.4; df = 1; p = 0.015). Statistically significantly more GPs 
(64.1%; n=25) than PHCNs (34.5%; n=10; MWU = 380.5; p = 0.012) spent less 
than a third of their work time providing care to women of reproductive age. 
The majority (82.1%; n=32) of the GP participants were qualified in 
Australia, which is statistically significantly higher than the overall 50 percent of 
Australian trained GPs currently practicing in regional and rural Victoria (χ2 = 
15.7; df = 1; p<0.001) (RWAV2016).
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Table 5.1 Characteristics of the participants (n=69: GPs=39, PHCNs=30)1 and comparable regional GP data (n=1861) 
 Overall  
% (n) 
Regional 
GPs2  % (n) 
GPs  
% (n) 
PHCNs  
% (n) 
GPs versus 
PHCNs 
χ23 (df) / MWU4 
p value GPs sample versus 
regional GPs χ23 (df) 
p value 
Gender (n=68)         
   Male 27.9 (19) 59 (1098) 46.2 (18) 3.4 (1) 15.13 (1) <0.001 2.6 (1) 0.14 
   Female 72.1 (49) 40.9 (763) 53.8 (21) 96.6 (28)     
Age         
   30-44  30.4 (21)  38.5 (15) 20 (6)     
   45-59  53.6 (37)  38.5 (15) 73.3 (22)     
   > 60  15.9 (11)  23.1 (9) 6.7 (2)     
   mean rank   34.4 35.8 561.04 0.75   
Mean age (years) 49.2 49.1 49.4 48.9     
Years in clinical practice (n=64)         
   < 5  12.5 (8)   8.1 (3) 18.5 (5)     
   5-14  32.8 (21)  32.4 (12) 33.3 (9)     
   15-24  21.9 (14)  27.0 (10) 14.8 (4)     
   > 25  32.8 (21)  32.4 (12) 33.3 (9)     
   mean rank   33.9 30.6 447.54 0.46   
Employment status         
   Full-time 50.7 (35) 61 (1135) 64.1 (25) 33.3 (10) 6.43 (1) 0.015 0.2 (1) 0.74 
   Part-time 49.3 (34) 39 (726) 35.9 (14) 66.7 (20)     
Country of qualification          
   Australia  50 (931) 82.1 (32) -   15.7 (1) <0.001 
   Other  50 (931) 17.9 (7) -     
Provide care women 13-44 
years (n=68) 
        
   0-33% 51.5 (35)  64.1 (25) 34.5 (10) 380.54 0.012   
   33-100% 48.5 (33)  35.9 (14) 65.5 (19)     
Notes: 1 Due to missing data, the number of participants is not the same for all variables; 2 Where possible, data is compared to information on the regional 
workforce of Victoria (RWAV 2016); 3 Chi-square test, including degrees of freedom; 4 Mann-Whitney U test statistic.
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5.2 THE CURRENT STATUS OF MA PROVISION IN REGIONAL 
AND RURAL VICTORIA 
 
The findings presented in this section aim to identify the current status of 
MA provision in regional and rural Victoria. First, participants’ clinical experience 
with women presenting with unplanned pregnancies is described, followed by 
participants’ knowledge of and involvement with MA provision. Next, the 
participants’ views on abortion and interest in becoming a MA provider are 
described as well as encountered problems with MA provision. 
 
5.2.1 Clinical experience with unplanned pregnancies, MA 
familiarity, MA involvement and interest in MA training 
All GPs (100%; n=39) and 86.7 percent (n=26) of the PHCNs reported that 
they were consulted by women with unintended pregnancies as part of their 
practice (χ2 = 3.3; df = 1; p = 0.032). Statistically significantly more GPs (94.9%; 
n=37) than PHCNs (53.8%; n=14; χ2 = 15.5; df = 1; p = <0.001) included abortion 
counselling in their consultations with women experiencing an unplanned 
pregnancy. In this study, counselling was defined as providing information and 
assisting with the decision-making process of the unplanned pregnancy. Further, 
all GP participants (100%; n=39), compared with almost half (46.7%; n=14) of the 
PHCNs, referred women requesting an abortion to abortion providers (χ2 = 27.1; 
df = 1; p = <0.001). Referral was either local (26.4% overall; n=14), to 
metropolitan Melbourne (20.8% overall; n=11), or to both local and 
metropolitan providers (37.7% overall; n=20). In addition, 15.1 percent (n=8) of 
all participants reported that they referred in a different way, for example 
because their practice was involved in MA provision (see Table 5.2). 
Familiarity with MA was assessed, as well as personal MA involvement. 
Only 17.9 percent of both GPs (n=7) and PHCNs (n=5) reported that they were 
‘very familiar’ with MA and the procedures involved in the MA process (Table 
5.2). Five (20.0%) GPs reported they were directly involved in MA provision (see 
Table 5.2), and two (7.1%) PHCNs indicated to be a current MA provider when 
they were asked if they liked to be trained to provide MA (Table 5.3). One GP 
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and three PHCNs did not provide MA themselves but worked in a practice where 
other practitioners provide the service. Of the seven (11.1%) participants who 
were currently MA providers, three started MA provision in 2015, two in 2014, 
and two did not specify. Only six participants provided data on the total number 
of MA performed (either personally or in their practice). GPs reported between 
15 and 150 MA, while PHCNs reported between 10 and 100 MA performed in 
2015. 
 
Table 5.2 Clinical experience with unplanned pregnancies, MA familiarity and MA 
involvement (n=69: GPs=39, PHCNs=30) 1 
 
 Overall  
% (n) 
GPs 
 % (n) 
PHCNs  
% (n) 
GPs versus 
PHCNs 
χ22 (df) / 
MWU3 
p value 
Do you see women with unintended 
pregnancies as part of your practice?    
  
   Yes 94.2 (65) 100 (39) 86.7 (26) 3.32 (1) 0.0324 
   No 5.8 (4) 0 (0) 13.3 (4)   
Do you include abortion counselling in 
your consultation? (n=65) 
     
   Yes 78.5 (51) 94.9 (37) 53.8 (14) 15.52 (1) <0.001 
   No 21.5 (14) 5.1 (2) 46.2 (12)   
Have you ever referred women for 
abortions? 
     
   Yes 76.8 (53) 100 (39) 46.7 (14) 27.12 (1) <0.001 
   No 23.2 (16) 0 (0) 53.3 (16)   
If yes, where did you refer to?  (n=53)      
   To a local abortion provider 26.4 (14) 23.1 (9) 26.4 (5) 4.52 (3) 0.214 
   To Melbourne 20.8 (11) 23.1 (9) 14.3 (2)   
   To both 37.7 (20) 43.6 (17) 21.4 (3)   
   Other 15.1 (8) 10.3 (4) 26.4 (4)   
How familiar are you with MA?  (n=67)      
   Not very familiar 23.9 (16) 17.9 (7) 32.1 (9)   
   Somewhat familiar 58.2 (39) 64.1 (25) 50.0 (14)   
   Very familiar 17.9 (12) 17.9 (7) 17.9 (5)   
   Mean rank  35.6 31.7 482.03 0.36 
Do you provide MA? (n=25)      
   Yes  20.0 (5)    
   No  80.0 (20)    
Does your practice provide MA? (n=65)      
   Yes 15.9 (10) 13.9 (5) 18.5 (5) 2.42 (1) 0.564 
   No 84.1 (53) 86.1 (31) 81.5 (22)   
Notes: 1 Due to missing data, the number of participants is not the same for all variables; 2 Chi-
square test, including degrees of freedom; 3 Mann-Whitney U test; 4 p-value of the Fisher exact 
test. 
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Ten (90.9%) of the 11 participants that were either directly, or via their 
practice, involved in MA provision, supplied information about the estimated 
distance MA requesting women had to travel to reach their clinic. Figure 5.1 
shows that on average 76.7 percent of abortion-requesting women lived within 
25 km of the MA-providing clinic, 14.0 percent of the women needed to travel 
between 25 and 50 km, and 5.4 percent travelled between 50 and 100 km. 
About four percent of abortion-requesting women had to travel more than 100 
km. 
 
 
Figure 5.1 The mean distance participants involved with MA provision indicated women 
had to travel to reach their clinic 
 
5.2.2 Views on abortion and interest in becoming an MA provider 
Seventy-eight percent (n=50) of the participants agreed with the 
statement that surgical and medication abortions should be ‘legal in all 
circumstances’. There was no difference in opinion between the GPs (71.4%; 
n=25) and the PHCNs (86.2%; n=25; χ2 = 2.0; df = 1; p = 0.23) regarding the 
legality of abortions (see Table 5.3). Further, there was an overall substantial 
interest among participants who were not yet MA providers to receive MA 
training to manage unintended pregnancies. This interest, however, was 
statistically significantly higher among PHCNS (76.9%; n=20; χ2 = 5.3; df = 2; p = 
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0.03) than among GPs (46.7%; n=14). Most GPs (97.1%; n=33) and PHCNs 
(96.6%; n=28) also indicated to support a colleague in providing abortions. 
 
Table 5.3 Participants’ view on abortion, their interest in receiving MA training and their 
support for abortion providing colleagues 
 
 Overall 
% (n) 
GP % (n) PHCN  
% (n) 
GPs 
versus 
PHCNs 
χ22 (df)  
p value 
Surgical and medication abortions 
should be (n=64): 
     
    Legal under any circumstances 78.1 (50) 71.4 (25) 86.2 (25) 2.02 (1) 0.23 
    Legal under certain circumstances 21.9 (14) 28.6 (10) 13.8 (4)   
    Illegal in all circumstances 0 (0) 0 (0) 0 (0)   
Are you interested in MA training? 
(n=63) 
     
   Already providing 11.1 (7) 14.3 (5) 7.1 (2) 6.02  (2) 0.0513 
   Yes 54.0 (34) 40.0 (14) 71.4 (20)   
   No 34.9 (22) 45.7 (16) 21.4 (6)   
Interest in MA training among those 
not yet providing (n=56) 
     
  Yes 60.7 (34) 46.7 (14) 76.9 (20) 5.32 (2) 0.03 
  No 39.3 (22) 53.3 (16) 23.1 (6)   
I would support my colleagues in 
providing abortions (n=63) 
     
    Yes 96.8 (61) 97.1 (33) 96.6 (28) 0.02 (1) 1.03 
    No 3.2 (2) 2.9 (1) 3.4 (1)   
Notes: 1 Due to missing data, the number of participants is not the same for all variables; 2 Chi-
square test, including degrees of freedom. 3 p-value of the Fisher exact test. 
 
 
The majority of participants (81.1%; n=50) indicated that abortions 
should be legal in all circumstances. Of the 14 (21.9%) participants who found 
abortions only justifiable ‘under certain circumstances’, all disapproved of 
gender-selection abortions, but approved of abortion after rape or incest, the 
detection of a foetal abnormality or a pregnancy that is life threatening (see 
Figure 5.2). Further, among these 14 participants, all (n=4) PHCNs and all but one 
GP (90%; n=9) agreed that abortion should be available for pregnancies up to 12 
weeks’ gestation (see Figure 5.2). 
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Figure 5.2 Circumstances that justify an abortion (for participants that justify abortion 
only ‘under certain circumstances’) (n=14). 
 
 
The most commonly reported reason among non-providing participants 
for never wanting to provide or assist with MA was the concern about the need 
for surgical back-up in case of complications (see Table 5.4). This concern was 
statistically significantly higher among PHCNs (33.3%; n=9) than among GPs 
(9.4%; n=3; χ2 = 5.2; df = 1; p = 0.03). The main other reason for GPs never 
wanting to provide MA was the lack of support from colleagues (9.4%; n=3). For 
PHCNS, the main other reason was ‘too many legal restrictions’ (14.8%; n=4).  
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Table 5.4 Reasons for never wanting to provide or assist with MA (n=62: GPs=34, 
PHCNs=28)1, 2 
 
 Overall 
% (n) 
GPs % (n) PHCNs  
% (n) 
GPs 
versus 
PHCNs 
χ22 (df) 
P value 
I am morally/ ethically opposed 1.7 (1) 3.1 (1) 0 (0) 0.9 (1) 1.04 
There is no need for more 
abortion providers 
5.1 (3) 6.3 (2) 3.7 (1) 0.2 (1) 1.04 
Anti-abortion harassment 1.7 (1) 0 (0) 3.7 (1) 1.2 (1) 0.464 
Too many legal restrictions 8.5 (5) 3.1 (1) 14.8 (4) 2.6 (1) 0.174 
I worry about the need for 
surgical back-up 
20.3 (12) 9.4 (3) 33.3 (9) 5.2 (1) 0.03 
My colleagues would not be 
supportive 
5.1 (3) 9.4 (3) 0 (0) 2.7 (1) 0.244 
My community would not be 
supportive 
0 (0) 0 (0) 0 (0) - - 
My friends and family would not 
be supportive 
0 (0) 0 (0) 0 (0) - - 
Financially unviable - 6.3 (2) n/a - - 
Notes: 1 Participants already providing MA were excluded from answering the item; 2 Percentages 
do not add up to 100% as more than one answer could be provided; 3 Chi-square test, including 
degrees of freedom; 4 p-value of the Fisher exact test. 
 
The qualitative data analysis of the data obtained from the specification 
option box did discover some additional reasons for why participants never 
wanted to provide MA. Some participants stated they did not feel comfortable 
being personally involved in MA services, even though they were not against 
abortion practices: 
I am not opposed to abortion and believe all women should have the right 
to choose, and I am happy to work where abortion can be organized or 
patient referred to someone who can help, but I personally don't wish to 
be involved (PHCN8). 
One GP did not see the need to become an MA provider because of 
locally easily accessible services: 
Where I work we can refer patients to an unwanted pregnancy clinic at 
the local hospital (GP22). 
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Another GP saw their part-time work as a barrier for MA provision: 
As I work part-time I would not be available to deal with any 
complications that might arise that needed urgent medical intervention 
and at this point I am uncertain if my colleagues would be happy to be 
involved (GP16). 
In addition, one PHCN considered MA to be a medical procedure: 
I feel this is a medical procedure and thus a doctor should be involved. 
Would support the patient in decision making and after care (PHCN2). 
In regards to the concerns expressed for the need of surgical back-up in 
case of complications, one PHCN commented: 
Although surgical back up may be an issue in some areas I do not see how 
this differs from a spontaneous abortion. I have seen shock and pain 
occur from this due to retained products being stuck in the cervix. It was 
fairly easy for the GP to remove these prior to transfer to hospital 
(PHCN28). 
 
5.2.3 Problems experienced when providing MA 
Participants who indicated current involvement with MA provision, either 
directly or via their practice, were asked to specify if they had experienced any 
problems related to this service. None of the participants reported they had 
experienced acts of harassment and/or stigma issues related MA provision. 
Further, none of the GPs felt the need to be secretive about their work or work 
environment in relation to MA provision, towards their partner, children, 
parents, friends or neighbours. However, one PHCN reported feeling the need to 
hide the fact that she works in a clinic that provides abortion from at least one 
good friend and a neighbour. One GP indicated a lack of a 24-hour contact advice 
service to be a problem. Another GP who worked in an MA-providing clinic 
stated that their practice had encountered problems with the access to surgical 
back-up in the case of complications. No other problems were reported. 
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5.3 PERSONAL AND LOGISTICAL BARRIERS TO BECOMING 
AN MA PROVIDER 
To investigate personal and logistical barriers to providing or assisting 
with MA, non-providing participants were asked to indicate all factors, applicable 
to their personal situation, that contribute to their decision to not become an 
MA provider even though willing (see Table 5.5). A lack of training opportunities 
was reported by nearly half of the participants as the most common reason for 
not providing MA (45.2%; n= 28). Statistically significantly more PHCNs (64.3%; 
n=18) than GPs (29.4%; n=10; χ2 = 7.5; df = 1; p = 0.01) indicated the lack of 
training as an up-take barrier. About one-third (37.1%; n=23) of the participants 
stated a reason for not providing MA was their lack of familiarity regarding the 
legal restrictions related to the MA process. PHCNs (64.3%; n=18) were 
statistically significantly more concerned about the legal restrictions involved 
with MA provision than GPs (14.7%; n=5; χ2 = 16.2; df = 1; p<0.001). 
In regards to the follow-up phase after the MA procedure, nearly one-
third (30.6%; n=18) of the participants reported concern about the absence of 
surgical back-up when MA complications arise (GPs 20.6%; n=7; PHCNs 42.9%; 
n=12; χ2 = 3.6; df = 1; p = 0.1). Further, about one-quarter (27.4%; n=17) of the 
participants were concerned there would be no physician available for back-up 
in the case of questions or complications after the MA procedure (GPs 17.6%; 
n=6; PHCNs 39.3%; n=11; χ2 = 3.6; df = 1; p = 0.09). Finally, participants (22.6%; 
n=14) also indicated a lack of a 24-hour contact advice services to be an MA up-
take barrier (GPs 23.5%; n=8; PHCNs 21.4%; n=6; χ2 = 0.04; df = 1; p = 1.0). 
In addition, participants reported local logistical issues as reasons for not 
providing MA services (see Table 5.5). A lack of access to ultrasound required for 
pregnancy dating and the exclusion of ectopic pregnancies, was deemed as an 
MA up-take barrier by 24.2 percent (n=15) of the participants. This barrier was 
statistically significantly more often reported by PHCNs (39.3%; n=11) than GPs 
(11.8%; n=4; χ2 = 6.3; df = 1; p = 0.02). Further, approximately 13 percent (n=8) 
of the participants stated that MA provision was not permitted by the facility 
where they worked (GPs 8.8%; n=3; PHCNs 17.9%; n=5; χ2 = 1.1; df = 1; p = 0.5). 
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Other reported barriers were unsupportive colleagues (GPs 11.8%; n=4; PHCNs 
3.6%; n=1; χ2 = 1.4; df = 1; p = 0.4) and the unwillingness of the local pharmacist 
to supply mifepristone (GPs 0%; n=0; PHCNs 7.1%; n=2; χ2 = 2.5; df = 1; p = 0.2). 
Feeling uncomfortable being personally involved in MA provision was 
reported by approximately 10 percent (n=6) of the participants (GPs 5.9%; n=2; 
PHCNs 14.3%; n=4; χ2 = 1.2; df = 1; p = 0.4) (see Table 5.5). Of particular note is 
the small number of participants who reported fear of anti-abortion harassment 
as a barrier for not providing MA (GPs 2.9%; n=1; PHCNs 10.7%; n=3; χ2 = 1.5; df 
= 1; p = 0.3). Only two (5.9%) GPs mentioned MA provision being financially 
unviable. 
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Table 5.5 Reasons for not providing or assisting with MA even though willing (n=62: 
GPs=34, PHCNs=28)1  
  
Overall  
% (n) 
GPs  % (n) PHCN  
% (n) 
GPs 
versus 
PHCNs 
χ22 (df)) 
p value  
No training opportunities  45.2 (28) 29.4 (10) 64.3 (18) 7.5 (1) 0.01 
Unsure of legal restrictions 37.1 (23) 14.7 (5) 64.3 (18) 16.2 (1) <0.001 
Follow-up concerns      
    No access to surgical back-up in         
    case of complications 
30.6 (19) 20.6 (7) 42.9 (12) 3.6 (1) 0.1 
    No physicians for back-up 27.4 (17) 17.6 (6) 39.3 (11) 3.6 (1) 0.09 
    Lack of 24-hour contact advice 22.6 (14) 23.5 (8) 21.4 (6) 0.04 (1) 1.0 
Local logistical problems      
    No access to ultrasound 24.2 (15) 11.8 (4) 39.3 (11) 6.3 (1) 0.02 
    The facility where I work does               
    not permit it 
12.9 (8) 8.8 (3) 17.9 (5) 1.1 (1) 0.54 
    My colleagues would not be  
    supportive 
8.1 (5) 11.8 (4) 3.6 (1) 1.4 (1) 0.44 
    Unwillingness of local  
    pharmacist to supply MA 
3.2 (2) 0 (0) 7.1 (2) 2.5 (1) 0.24 
Personal issues      
    I would not feel comfortable  
    being personally involved 
9.7 (6) 5.9 (2) 14.3 (4) 1.2 (1) 0.44 
    Fear of anti-abortion   
    harassment 
6.5 (4) 2.9 (1) 10.7 (3) 1.5 (1) 0.34 
    My community would not be  
    supportive (fear of   
    stigmatisation) 
3.2 (2) 2.9 (1) 3.6 (1) 0.02 (1) 1.04 
    My friends and family would  
    not be supportive 
1.6 (1) 0 (0) 3.6 (1) 1.2 (1) 0.54 
    Financially unviable (GPs only) - 5.9 (2) - - - 
Notes: 1 Percentages do not add up to 100% as more than one answer could be provided; 3 Chi-
square test, including degrees of freedom; 4 p-value of the Fisher exact test. 
 
The qualitative data analysis of the data obtained from the specification 
option box revealed some additional reasons for participants not wanting to 
provide MA even though willing. One reason provided was the local low demand 
for MA provision, illustrated in the following quotes: 
My practice is small and the number of requests I encounter is 
insignificant. I do not intend embarking on further training for a skill I will 
rarely, if ever need to use (GP25). 
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In my community, the safest and easily accessible option is through 
specialist gynaecologist... I believe they should provide the treatment 
(GP28). 
Reasons also included the mandatory requirement for medical practitioners of 
passing the online training module to be able to provide MA (see section 1.4.3): 
I attempted the on-line training a few years ago. I didn’t pass the final 
exam! … I didn’t go back to study harder for 2 reasons- 1- I don’t have the 
time to do this!! 2 - I work in a small community the numbers of 
unwanted pregnancies are very low … Took about 6 hours of my precious 
time. They should change the training!!!! I am more than happy to 
provide the service (GP18). 
PHCNs highlighted specific barriers they perceived they would encounter when 
wanting to become involved with MA provision. Those barriers included an 
anticipated oppositional stance of involved professional organisations: 
The AMA [Australian Medical Association] will prevent any nurse 
involvement in advanced practice wherever possible and the nurses’ 
board will not be much better (PHCN28). 
Further, a comment was made about the role of Marie Stopes in regards to their 
online MA training module, which is only available to prescribing physicians (MS 
Health 2017): 
Marie Stope only trains medical officers and makes MS2step available for 
their use (PHCN25). 
 
5.4 SCOPE OF PRACTICE FOR MA PROVISION 
In order to assess participants’ views on the scope of practice of a range 
of health care practitioners for MA provision, participants were asked to indicate 
which practitioners they believed were permitted to provide MA services (see 
Table 5.6). All agreed that the provision of MA falls within the scope of practice 
of obstetricians and gynaecologists. Most GPs (83.8%; n=31) and PHCNs (96.6%; 
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n=28) also recognised the GP as a potential MA provider. While more PHCNs 
(62.1%; n=18) than GPs (45.9%; n=17) agreed that MA could be provided by rural 
endorsed nurses, this difference was not statistically significant (MWU test=456; 
p=0.3). In addition, most GPs (81.1%; n=30) and PHCNs (72.4%; n=21) disagreed 
with enrolled nurses becoming MA providers. 
PHCNs (79.3%; n=23), however, were statistically significantly more likely 
than GPs (32.4%; n=12; MWU test=243.5; p<0.001) to agree that MA provision 
falls within the scope of practice of nurse practitioners. Similarly, more PHCNs 
(44.8%; n=13) than GPs (10.8%; n=4; MWU test=318.5; p=0.02) agreed that MA 
provision falls within the scope of practice of registered nurses or midwives 
(PHCNs 65.5%; n=19; GPs 21.6%; n=8; MWU test=288.5; p=0.001). 
 
Table 5.6 Participants’ views around the scope of practice for MA provision of a range of 
health care practitioners (GPs: n=37; PHCNs: n=29) 
 
 Level of agreement 
Disagree 
 % (n) 
Neutral  
% (n) 
Agree  
% (n) 
GPs versus 
PHCNs 
MWU1 
p value  
Obstetrician/Gynaecologist    499.5 0.1 
     GP 0 0 100 (37)   
     PHCN 6.9 (2) 0 93.1 (27)   
General practitioner     467.5 0.1 
     GP 2.7 (1) 13.5 (5) 83.8 (31)   
     PHCN 0   3.4 (1) 96.6 (28)   
Nurse practitioner    243.5 <0.001 
     GP 48.6 (18) 18.9 (7) 32.4 (12)   
     PHCN 3.4 (1) 17.2 (5) 79.3 (23)   
Rural endorsed nurse    456 0.3 
     GP 21.6 (8) 32.4 (12) 45.9 (17)   
     PHCN 17.2 (5) 20.7 (6) 62.1 (18)   
Registered nurse    318.5 0.02 
     GP 62.2 (23) 27.0 (10) 10.8 (4)   
     PHCN 31.0 (9) 24.1 (7) 44.8 (13)   
Enrolled nurse    467 0.3 
     GP 81.1 (30) 18.9 (7) 0    
     PHCN 72.4 (21) 13.8 (4) 13.8 (4)   
Midwife    288.5 0.001 
     GP 45.9 (17) 32.4 (12) 21.6 (8)   
     PHCN 17.2 (5) 17.2 (5) 65.5 (19)   
Notes: 1 Mann-Whitney U test statistic. 
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This chapter has described the findings from the cross-sectional study. 
Although most participants reported they are consulted by women with 
unintended pregnancies and they include abortion counselling in their 
consultation, the familiarity with MA provision was limited. Additionally, only 
seven (10.1%) (five GPs and two PHCNs) of the total sample of 69 participants 
indicated they were currently MA providers. A high level of interest was 
expressed in receiving MA training, especially among PHCNs. However, the 
findings also showed a wide range of personal and logistical barriers to MA 
provision, with distinct differences in perceived barriers between the two 
participant groups. Further, PHCNs and GPs differed in their opinion about the 
potential of MA provision by nurse practitioners, registered nurses and 
midwives. The differences are to be further discussed in Chapter Eight. The 
following two chapters present the methods and the findings of the Delphi 
study.
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CHAPTER 6 
DELPHI STUDY METHODS 
 
A Delphi study was conducted to explore research questions two and 
three: what would a nurse-led model of care for MA provision in regional and 
rural Victoria look like, and what are the anticipated barriers and solutions to the 
implementation of a nurse-led model of care for MA provision in regional and 
rural Victoria? 
The chapter starts by describing and explaining the rationale for the use 
of the Delphi technique. Next, the panel sampling and recruitment methods are 
discussed, followed by a detailed description of the instrument development and 
data collection methods for each round. Lastly, the data management and 
analysis procedures employed in this study are explained. 
 
6.1 STUDY DESIGN 
The Delphi method is a strategy dating from the 1950s that uses the 
knowledge and experience of experts to reach consensus about a practical 
problem (Bleijenbergh, Korzilius & Verschuren 2011). The method can be used as 
a predicting or decision-aiding instrument applied to program planning or model 
construction, since it can gather knowledge about not yet identified data 
(Linstone & Turoff 2002; Skulmoski, Hartman & Krahn 2007). The original format, 
known as the Classical Delphi, was developed by the RAND corporation for the 
US Air Force to forecast technological and social developments (Dalkey 1969; 
Keeney, Hasson & McKenna 2011). 
Generally, the classical format consists of a group communication process 
that aims to achieve expert consensus by using a minimum of two successive 
rounds of questionnaires (Hsu & Sandford 2007). The first round collects 
qualitative data and the subsequent rounds collect quantitative data (Keeney, 
Hasson & McKenna 2006). Each round is analysed and the results are 
anonymously reported back to the panel, which helps the panellists to 
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reconsider their initial opinions in later iterations, until full consensus is reached 
(Boulkedid et al. 2011; Linstone & Turoff 2002; Skulmoski, Hartman & Krahn 
2007). The technique has three important features (Dalkey 1969). The first 
feature is the anonymity of the experts who participate in the study. 
Disadvantages associated with other group communication methods, such as 
manipulation or intimidation to approve a particular standpoint, are thus 
reduced (Hsu & Sandford 2007). The second feature relates to the controlled 
feedback of the results of the previous round, which reduces tangential and 
excessive communications, and the final feature is the use of statistical group 
response, such as agreement percentages, the spread of the responses and the 
overall group median rating, which aims to minimise group pressure toward 
conformity (Hsu & Sandford 2007). 
From the late-1960s, the Delphi method became increasingly accepted 
and used within health care research. In the absence of globally approved 
guidelines, a large range of different formats emerged. Examples include the 
‘modified Delphi’, which involves face-to-face interviews or a focus group for the 
first round, the ‘policy Delphi’, used in policy development, the ‘real-time 
Delphi’, a shorter, more efficient method, and the e-Delphi, which is carried out 
online (Gordon & Pease 2006; Keeney, Hasson & McKenna 2011). 
There is, however, still debate over the ideal design of the Delphi 
technique (Goluchowicz & Blind 2011). This applies specifically to the following 
four Delphi characteristics: the optimal number of rounds; the optimal type of 
feedback; the selection of experts; and the sufficient level of agreement. 
While the number of Delphi rounds can vary from two to 10, studies 
show that judgmental accuracy improved the most between the first and second 
round (Goluchowicz & Blind 2011). Therefore, most Delphi studies only require 
three iterations, even though in theory the iterative process of the Delphi 
method can be repeated continuously until consensus is reached (Hsu & 
Sandford 2007). The use of too many rounds, however, has been shown to cause 
participant fatigue resulting in lower response rates (Boulkedid et al. 2011; 
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Skulmoski, Hartman & Krahn 2007). The number of rounds used in this study was 
three, and this choice is discussed in Section 6.1.1. 
There is no documented consensus regarding the optimal feedback 
method delivered to panellists between each round. Feedback can either be 
provided as ‘statistical’ feedback (of median values and range of estimates) or 
‘reasons’ feedback (involving arguments from the Delphi panellists along with 
their numerical estimates) (Goluchowicz & Blind 2011; Rowe, Wright & McColl 
2005). Additionally, Rowe, Wright and McColl (2005) take into consideration the 
influence of the iteration process itself, which allows panellists, even without 
feedback, to reconsider their earlier responses. It has also been emphasised that 
a change in judgement of a panel member should be caused by new information 
only and not by conformity pressure (Goluchowicz & Blind 2011). Section 6.1.1 
reports the feedback method used in this study. 
The use of an expert panel is a fundamental feature of the Delphi 
method. It is suggested that a panel should reflect all stakeholders concerned 
with the study results, as they all have a different position on the subject matter 
(Boulkedid et al. 2011). The debate regarding the selection of experts is further 
discussed in Section 6.2. 
Although a Delphi study aims to obtain consensus, the literature does not 
offer exact requirements about what is a sufficient level of agreement among 
participants (Powell 2003). Some studies pre-define consensus at a certain 
minimal percentage of agreement, ranging from 51 percent to 100 percent, 
while others derive consensus levels after data analysis or completely fail to 
mention them (Keeney, Hasson & McKenna 2011; Powell 2003). It has also been 
suggested to seek consensus in the stability of participants’ responses during a 
series of Delphi rounds (Keeney, Hasson & McKenna 2011). Stability of responses 
is defined as ‘the consistency of responses between successive rounds of a 
study’ (Dajani, Sincoff & Talley 1979, p. 84) and occurs when the response-
category frequencies of two different Delphi rounds show to be not significantly 
different from each other. The pre-defined 75 percent level, however, is the 
most commonly used and recommended level in a wide range of Delphi studies, 
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and has been adopted for the current study (Hewitt & Cappiello 2015; Keeney, 
Hasson & McKenna 2011; von der Gracht 2012). Regardless of the method and 
agreement levels used for obtaining consensus, it is important to note that final 
consensus depends on the specific group of panellists, which means that results 
are not generalisable, and that they do not automatically imply the correct way 
to go (Clayton 1997). 
Besides methodological ambiguities like the lack of universal guidelines 
on formats and consensus levels, the Delphi method also lacks any original 
support in a theoretical foundation (Gordon & Pease 2006; Hewitt & Cappiello 
2015; Keeney, Hasson & McKenna 2011; Powell 2003). It is presumed that the 
absence of a theoretical underpinning, which provides guidance on how the 
study needs to be conducted and is essential to research integrity, originates 
from the fact that the Delphi method was developed in an era when science 
ruled over philosophy (Guzys et al. 2015). There is, therefore, an ongoing and 
unresolved debate in the literature about the Delphi’s epistemological stance 
and most Delphi studies are unclear about which theoretical framework criteria 
should be applied (Keeney, Hasson & McKenna 2011; Powell 2003). This was 
confirmed by Guzuys et al. (2015), who utilised a scoping review method to 
identify the methodological underpinnings used in Delphi research. They found 
that many researchers did not include a methodological rationale of their work, 
either because of indifference or uncertainty. 
As the classical Delphi method consists of the collection of qualitative 
data followed by a structured process with quantitatively described results, it is 
difficult to place the method in a specific methodological category (Sekayi & 
Kennedy 2017). Because of the inclusion of a qualitative as well as a quantitative 
approach, it is juxtaposed between interpretative and positivist (scientific) 
paradigms (Hasson & Keeney 2011; Keeney, Hasson & McKenna 2011). The main 
argument against the positivist paradigm is that the technique is intended to 
share expertise in order to develop consensus and that it is not a scientific 
method that creates new knowledge (Hasson & Keeney 2011; Powell 2003). On 
the other hand, there is a discussion around the positioning of the Delphi 
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method within the interpretive paradigm, which considers the nature of the 
method to be subjective and qualitative (Keeney, Hasson & McKenna 2011). 
Some researchers, however, suggest the interpretive paradigm, and specifically 
social constructivism, to be particularly suited to the Delphi, due to the iterative 
feedback nature of the Delphi method that results in the construction of a 
consensus (Keeney, Hasson & McKenna 2011). Day and Bobeva (2005), on the 
other hand, argued to apply both qualitative and quantitative standpoints, or, as 
the technique develops quantitative data through qualitative methods, to give it 
a ‘hybrid’ epistemological status (Critcher & Gladstone 1998). 
Mitroff and Turoff (2002) examined what the epistemologies of Western 
philosophers like Locke, Leibniz, Kant, Hegel and Singer could offer for insights 
into the Delphi process. They contended that while the original Delphi is closely 
aligned with the Lockean inquiry systems approach, which aimed to reach for 
consensus with the use of an informed group with a similar background of 
knowledge, nowadays more and more studies are using the Kantian approach 
that allows ‘many informed individuals in different disciplines or specialties to 
contribute information or judgments to a problem area which is much broader in 
scope than the knowledge that any one of the individuals possess’ (Mitroff & 
Turoff 2002, p. 27). The Kantian inquiry system is unambiguously goal-oriented 
and it aims to present an array of alternative models for the issue in question to 
acquire a comprehensive overview (Mitroff & Turoff 2002). The theoretical 
approaches used in this study are discussed in the next section. 
 
6.1.1 The design used in this study 
The Delphi method was well suited for this study because it allowed for 
the collection of opinions of a broad range of geographically spread-out 
professionals, without the need for face-to-face contact (McIlrath et al. 2010; 
Snyder-Halpern, Thompson & Schaffer 2000). All features of the Classical Delphi 
were utilised in the current study. First, all identities and responses of the 
experts remained anonymous throughout the Delphi process. This allowed the 
diverse group of specialists to express their views without any restrictions, peer-
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pressure or influence from expert dominance (Hsu & Sandford 2007). Identities 
were only known by the researcher. Second, it was decided to adopt a mixed-
method approach through three rounds of questionnaires, in order to expand 
the scope of the study and improve its analytical power (Sandelowski 2000). 
Three rounds are most commonly used in Delphi studies and often successfully 
lead to full consensus (Hsu & Sandford 2007). Further, a limited number of 
rounds maximises continuity of expert participation (Landeta 2006). 
Round One employed a qualitative design in order to solicit extensive 
expert opinions on the issue (Clibbens, Walters & Baird 2012; Hasson, Keeney & 
McKenna 2000). This acquired a broader set of responses as compared with the 
use of more focused and structured questions. The disadvantage, however, is 
the more time-consuming analysis (Skulmoski, Hartman & Krahn 2007). The two 
subsequent rounds used a quantitative design to establish consensual opinions. 
Further details about the data collection instruments are provided in Section 6.3. 
Finally, following the recommendations of Keeney, Hasson and McKenna (2006), 
this study provided feedback to the panel of experts between the rounds in a 
‘reasons’ form, that included arguments from the Delphi panellists along with 
their numerical estimates (Goluchowicz & Blind 2011; Rowe, Wright & McColl 
2005) (see section 6.3.3). The statements generated from the collected data of 
the first-round questionnaire created the qualitative feedback, and the statistical 
summaries of the mutual opinions obtained in the subsequent rounds generated 
the numerical feedback. Simple numerical feedback, in the form of a measure of 
central tendency and (dis)agreement percentages, was favoured (Greatorex & 
Dexter 2000). 
The Delphi study was administered online, as opposed to the pen-and-
paper method. An e-Delphi approach was chosen, because online Delphi 
questionnaires are increasingly used among populations, such as health 
professionals, who regularly use Internet (Gill et al. 2013). Further, the method is 
recognised to be environmentally friendly, cost-effective, time-efficient and it 
facilitates direct import of data into analysis software (Gill et al. 2013). 
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As discussed in Section 6.1, it was pre-determined that consensus for the 
current study was reached when at least 75 percent of the panellists either 
‘agreed’ or ‘strongly agreed’ with a statement and, additionally, if the spread of 
the scores in the distribution (interquartile range) was equal or less than one 
(Keeney, Hasson & McKenna 2011). Moderate consensus was set at 60-74 
percent, and no consensus was defined for all statements with less than 60 
percent of agreement. 
This study positioned the used Delphi technique within the hybrid 
epistemological stance, not only because it used qualitative as well as 
quantitative data, but also because it acknowledged the position of Blass (cited 
in Keeney, Hasson & McKenna 2011, p. 19), who claimed that Delphi 
methodologies should not be positioned in one single paradigm (Critcher & 
Gladstone 1998). Further, the Delphi method adopted for this study was Kantian, 
as a mix of experts from a range of disciplines, each with a different perspective 
on the topic, were asked to express all their opinions and views about the 
proposed problem and possible solutions (Mitroff & Turoff 2002). A Kantian 
inquiry system, as explained by Mitroff and Turoff (2002), best suits problems 
that are essentially poorly structured and have a much broader scope than the 
problem knowledge that any one of the individuals possesses, whereas a 
Lockean inquiry system is more suited to well-structured problems that already 
have a certain degree of consensus. 
 
6.2 PANEL SAMPLING AND RECRUITMENT 
There is no agreement regarding the ideal sample size of panellists for a 
Delphi study (Hsu & Sandford 2007). The literature identifies a variety of sample 
sizes, ranging from as low as 10 (for groups with a homogeneous background), to 
more than 50 (Hsu & Sandford 2007). A sample size that is too small can result in 
non-representative conclusions, while a sample size that is too large will 
complicate the management and data analysis process (Hsu & Sandford 2007; 
Skulmoski, Hartman & Krahn 2007). Ideally, a Delphi panel needs to reflect a full 
range of professionals in order to capture all their opinions, which would enrich 
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the study’s results and enhance its credibility (Boulkedid et al. 2011). 
Additionally, a panel should include laypeople, with relevant expertise by virtue 
of their experience (Rowe & Wright 2011). According to Skulmoski, Hartman and 
Krahn (2007, p. 10), Delphi panellists should meet four ‘expertise’ criteria:  
1) knowledge and experience with the issues under investigation; 2) capacity and 
willingness to participate; 3) sufficient time to participate in the Delphi; and 4) 
effective communication skills. 
In this study, panellists were required to meet the four ‘expertise’ 
criteria, and were considered to be an expert if they belonged to one of the 
following groups: 
o Experts by profession: 
• General practitioners from regional and rural Victoria and 
gynaecologists/obstetricians from Victoria, already involved or interested 
to become involved in the provision of MA. 
• Clinicians involved in sexual and reproductive health or abortion reform 
activities working in academia, education or policy development. 
• Clinicians involved in the professional bodies responsible for the different 
aspects of the nursing profession, such as nursing colleges and 
associations, regulatory authorities and unions. Additionally, this group 
includes those that work at management level within organisations like 
women's health, community health services, sexual health centres, family 
planning, pregnancy counselling services and private abortion clinics. 
• Nurses or midwives working in the primary health care setting of regional 
and rural areas of Victoria (general practice or community settings). 
o Experts by experience: 
• Professionals who have an interest in, experience with, or are an 
advocate for induced abortions. 
• Women with experience with, or who are an advocate for, induced 
abortions. 
. 
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Non-probability, purposive and convenience sampling techniques were 
used for the establishment of the panel, including the snowball sampling 
technique. PHCNs, GPs and other clinicians actively working in MA, were located 
via an Internet search. A literature search for peer-reviewed publications and 
organisational reports of nurse-led models and/or abortion reform activities in 
Victoria identified professionals working in academia, politics or for women’s 
health organisations. Additionally, websites were explored for the identification 
of leaders of professional or government groups or organisations involved in 
nurse education, registration or reform. This search resulted in a total of 45 
potential professional panel members in addition to the 22 GPs and 15 PHCNs 
from the cross-sectional study who expressed their interest in participating in 
the Delphi study. Of the identified 45 potential panel members, nine were 
clinicians and an additional 36 worked in universities, for professional 
organisations or in politics. Therefore, the total number of potential panel 
members invited to participate was 82. All these experts by profession were 
contacted directly via their available email or mail address (see Appendix D for a 
copy of the invitation letter). 
Additionally, 22 organisations, such as professional nursing organisations, 
women’s health agencies and Primary Health Networks in regional and rural 
Victoria, were approached and asked to publish the study invitation for the 
professional experts by experience on their website, Facebook page or in their 
newsletter. The contact letter and the study invitation explained the purpose 
and structure of the study and the anticipated amount of time and effort that 
was to be expected from participation. In addition, the invitation requested to 
be forwarded to eligible colleagues (snowball sampling). 
The other group of experts by experience, consisting of women with 
experience with, or who are an advocate for, induced abortions, were recruited 
with the help of a flyer that was circulated via the regional and rural Women's 
Health Victoria agencies (see Appendix E for a copy of the flyer). Some of the 
approached agencies also published the invitation in their newsletter or on their 
Facebook page. 
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6.3 INSTRUMENT DEVELOPMENT AND DATA COLLECTION 
The following sections describe the development of the instrument for 
each Delphi round and the corresponding data collection method. As explained 
in Section 6.1.4, the study used a Kantian approach with a ‘hybrid’ 
epistemological framework over three rounds of web-based questionnaires 
(Critcher & Gladstone 1998; Mitroff & Turoff 2002). Round One employed a 
qualitative design, consisting of demographic and open-ended questions. The 
answers to the open-ended questions were transformed into statements. The 
two subsequent rounds used a quantitative design to establish consensual 
opinions. Feedback was required after each round. Statements that had not 
achieved the pre-set consensus levels of 75 percent (and an IQR ≤ 1) were sent 
back to the panel for reconsideration. This process is depicted in Figure 6.1 and 
is detailed in the following sections. 
 
Figure 6.1 The Delphi process 
 
6.3.1 Round One 
The instrument for Round One comprised of two parts. The first part 
collected socio-demographic data on contact details (name, work title, email 
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address and phone number), gender, age, country of origin, geographical work 
location, work title, current occupation, main activity in current job, years of 
experience in this role and their interest in the study. Obtaining this data allowed 
for clustering of the responses of the different expert groups and allowed for 
matching respondents data across rounds, and for sending follow-up rounds to 
panellists, including statistical feedback (Mead & Moseley 2001a). The items 
were developed by the researcher, informed by a literature review on 
demographic questionnaires in similar studies, and limited to ones directly 
relevant to the purpose of the study (Kotowski 2015; Lane et al. 2017; McKenna 
et al. 2015). 
The second part of the instrument consisted of seven open-ended 
questions, typical for the first round of a Delphi process (Hsu & Sandford 2007). 
These open-ended questions were designed to directly address the second and 
third research questions of the study. Panellists’ responses depend on the exact 
wording of the questions, which is vulnerable to researcher bias and to errors in 
comprehension (Mead & Moseley 2001b). A strong instrument design is 
therefore essential to the success of the study and vital for replicability (Mead & 
Moseley 2001b). To minimise researcher bias and comprehension errors, a pre-
test was undertaken to test the Round One instrument, the choice of the web-
based survey tool Qualtrics (2015) and associated analysis (Clibbens, Walters & 
Baird 2012). It has been argued that the complexity of managing pre-tests and a 
full study simultaneously can result in considerable intervals between rounds 
and, therefore, participant attrition (Clibbens, Walters & Baird 2012). For this 
reason, most researchers only pre-test their first round (Clibbens, Walters & 
Baird 2012). This procedure was adopted in this study. The instruments of Round 
Two and Three were only checked for wording, flow, grammatical errors and 
technical problems by a few known contacts of the researcher. 
For the pre-test of the instrument, an invitation letter was sent to a 
convenience sample of 25 experts. All experts were connected to Deakin 
University, Melbourne, and had a similar professional or interest background as 
the intended panel members. The pre-test asked participants to provide 
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feedback, via a short questionnaire, on the language and phrasing of the PLSC, 
the demographic and open-ended questions, and on potential ambiguities in the 
questions. Further, feedback was sought on the instructions provided; for 
example, if they were easy to follow, and if participants encountered any 
technical problems (Clibbens, Walters & Baird 2012). Feedback was specifically 
requested regarding the wording of the seven open-ended questions, as correct 
wording was crucial to the outcome of the study. Seven people participated. Five 
were ‘experts by profession’, and two panellists were classified as ‘experts by 
experience’. 
The feedback resulted in the correction of typographical errors and a 
rephrasing of some of the Round One questions to clarify intended meaning. 
Additionally, the question: ‘What do you think needs to be done to improve this 
role of general practitioners/the primary health care nurse?’ (in the provision of 
early MA in regional/rural Victoria) was changed into: ‘How do you think the role 
of general practitioners/primary health care nurses in the provision of MA could 
be improved?’ Further, feedback from an ‘expert by experience’ resulted in the 
inclusion of an explanation of the term ‘MA’ in the instrument. 
The final Round One instrument included the following open-ended 
questions: 
1. What do you think is the current role of general practitioners and primary 
health care nurses in the provision of early medication abortion in 
regional/rural Victoria? 
2. How do you think the role of general practitioners in the provision of 
medication abortion could be improved? 
3. How do you think the role of primary health care nurses in the provision of 
medication abortion could be improved? 
4. What factors facilitate or hinder regional and rural primary health care 
nurses when they are or want to be involved in the delivery of medication 
abortion services in regional/rural Victoria? 
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5. What do you believe are solutions or recommendations to improve primary 
health nurse participation in the provision of medication abortion in 
regional/rural Victoria? 
6. What obstacles can potentially prevent these improvements? 
7. How do you think the obstacles of question six can be addressed? 
The full instrument is provided in Appendix F. 
Data were collected online using Qualtrics (2015). A link to the Round 
One instrument was included in the invitation letter or flyer. This link directed 
potential panellists to the PLSC, which provided information about the study’s 
background, the Delphi procedure, confidentiality and privacy guidelines, the 
contact details of the researcher and a consent statement (Boulkedid et al. 
2011). Clicking on the consent statement opened the instrument (see Appendix 
G for the PLSC of the Delphi study). 
In the following three months, a total of 52 experts opened the link. 
Three did not read the PLSC and 12 decided, after reading the PLSC, not to 
continue. Nine experts expressed their wish to continue but never opened the 
questionnaire, and five only finished the demographic questions. The most 
common reason provided for not continuing with the Round One questionnaire 
related to not knowing enough of the subject. A first reminder was sent six 
weeks after the start of the study, and a final reminder was sent four weeks 
later. This resulted in a total panel size of 23. 
 
6.3.2 Round Two 
The data collected in Round One resulted in the development of 82 
statements that were grouped into three broad themes. The analysis process 
that led to the development of these statements is discussed in Section 6.4.1. In 
Round Two, panellists were asked to rate the statements for agreement on a 
five-point scale. After each set of statements that focused on a particular aspect, 
panellists were also given the opportunity to elaborate on their ratings by 
providing additional and/or supportive remarks in a comment box. The use of 
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open-ended questions added breadth and further insight to the information 
gained from the rating scales (Clibbens, Walters & Baird 2012; Hasson, Keeney & 
McKenna 2000). 
Rating scales often use a Likert-type scale, a technique developed in 1931 
to measure attitudes, character and personality traits (Croasmun & Ostrom 
2011; Likert 1932). They provide a range of response options for a certain 
statement or a group of statements, ranging from strongly agree to strongly 
disagree (Croasmun & Ostrom 2011). Likert scales are easy to implement and 
they primarily measure agreement and consensus (Keeney, Hasson & McKenna 
2011). This approach was, therefore, the most appropriate to use in the current 
Delphi study. Much research has been conducted on the optimal number of 
response choices in a Likert-type scale, but the debate is still ongoing. Some 
researchers suggest that an optimal reliability is provided by a 7-point scale, 
while others claim that the number of used scale points does not affect the 
reliability and validity of an instrument (Croasmun & Ostrom 2011). Usually, 
however, there are five categories of responses, which range from strongly 
agree to strongly disagree with a neutral type of response in the middle 
(Jamieson 2004). The addition of a neutral response option, included in nearly all 
odd-numbered Likert scales, does not force the panellist to commit to a certain 
position and therefore reduces response bias (Croasmun & Ostrom 2011). This 
approach was adopted for the current study. 
The generated statements for the Round Two questionnaire were 
subsequently tested by a panel of five ‘experts by experience’, all known 
contacts of the researcher. They were asked to provide their feedback via a 
questionnaire on Qualtrics. The pre-test questions asked about the instructions, 
the order of the questionnaire, the order and content of the statements, the 
language used, spelling or typographical errors, any emotions that the questions 
evoked and if the Qualtrics process worked without technical problems. Minor 
typographical corrections and edits were made based on the feedback. 
Round Two commenced four months after the start of the Delphi study. 
All Round One panel members, including four additional Victorian ‘experts by 
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profession’ who were identified during the continuing search of the literature, 
were contacted via email. They were asked to participate in the Round Two 
questionnaire that was accessible via the provided link. Two reminders were 
sent over a period of six weeks. This follow-up strategy is consistent with 
Dillman, Smyth and Christian’s Total Design Method (2014) and is particularly 
important in the last two Delphi rounds, which are known for their high dropout 
rates (Keeney, Hasson & McKenna 2011; Sandrey & Bulger 2008). Efforts were 
made to keep the panel members motivated to participate. Strategies included a 
clear and repeated communication of the goal and benefits of the study, the 
inclusion of contact details for questions, clear information about the required 
time for each questionnaire, as well as the assurance of confidentiality and 
anonymity (Keeney, Hasson & McKenna 2011). The questionnaire closed 
approximately two months after opening. Of the 27 experts invited to 
participate in Round Two (23 panellists from Round One and four new potential 
panellists), 20 experts completed Round Two: Four former respondents did not 
participate and one of the four newly contacted experts joined.  
 
6.3.3 Round Three 
The analysis of the Round Two data, which is described in Section 6.4, 
showed that 57 of the 82 statements had reached the pre-determined 
consensus level of 75 percent. These statements were not included in Round 
Three. The remaining 25 statements that had not obtained consensus and two 
newly constructed statements, developed based on the data from the open-
ended questions of Round Two (see section 6.4.2), were included in the Round 
Three questionnaire. Before release, the five known contacts of the researcher 
(‘experts by experience’) were again asked to pre-test the statements and the 
flow of the Round Three questionnaire. Again, only minor typographical 
corrections and edits were necessary. 
All 23 panel members who had participated in Round One, as well as the 
additional panellist that was recruited in Round Two, were contacted by email 
one month after Round Two was completed. The email explained how consensus 
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on Round Two statements was defined, and that 57 out of the 82 Round Two 
statements (70%) had reached consensus. Panellists were asked to rate the 27 
remaining statements for agreement on a 5-point Likert scale, and to include 
responses to open-ended questions with additional information about their 
statement ratings. Moreover, to improve consensus convergence, panellists 
were asked to first review the provided results of Round Two that were included 
in the email invitation for Round Three, to reflect on how their individual Round 
Two responses related to the rest of the panel, and if this encouraged them to 
reconsider and change their initial answer. A table showing Round Two 
agreement and disagreement percentages, the spread of the responses (inter-
quartile range), the overall group median rating and individual Round Two 
ratings is included in Appendix H (Greatorex & Dexter 2000). A second table 
included in the invitation displayed all statements that were revised for the Third 
Round. 
Two reminders were sent over a six-week period. The Delphi study closed 
eight weeks after opening and seven months after the start of the study. 
Nineteen experts participated in Round Three. 
 
6.4 DATA MANAGEMENT AND ANALYSIS 
This section describes the data management and analysis process of the 
three Delphi rounds. As the study used a mixed-method approach, qualitative 
and quantitative data analysis was undertaken. This process is described for each 
Delphi round separately in the following sections. 
 
6.4.1 Round One 
Demographic data of Round One were exported from Qualtrics (2015) to 
SPSS (IBM Corp. 2013). All dichotomous and multiple-answer questions were 
transformed from text into numeric variables. For example, the values for 
gender were labelled as female = 1 and male = 2, and the values for the age 
groups were classified from one to six, with 1 = 18-24-year-old and 6 = 65 years 
and older. All other qualitative questions were left as provided. Descriptive 
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statistics were used to analysis data regarding panellists’ characteristics, which 
included the classification of panellists into expert groups. While panel members 
were originally categorised as ‘experts by profession’ and ‘experts by 
experience’, this classification was redefined into the following three groups to 
better contextualise the study findings: 
1. Physicians: GPs, gynaecologists/obstetricians or other 
2. Nurses: PHCNs and nurses/midwives working in general practice, community 
health- or sexual/reproductive health primary care setting, academia or for a 
professional organisation 
3. Others: academics, politicians and health promotion officers without a 
medical background. 
No women with abortion experience or who were advocates of induced 
abortions agreed to participate in the study. The main characteristics of the 
panellists are displayed in Chapter Seven, Table 7.1. 
The qualitative data obtained from the responses to the seven open-
ended questions were first exported into Microsoft Word files, where they were 
sorted by question and then transferred into the computer software package 
NVIVO 11 (QSR International Pty Ltd. 2015), a data analysis software tool that 
helps to improve the rigor of a study (Leech & Onwuegbuzie 2011). The data 
generated from the question ‘what factors facilitate or hinder regional and rural 
PHC nurses when they are or want to be involved in the delivery of MA?’ were, 
for convenience of analysis, divided into facilitating factors and hindering factors. 
Thematic analysis (see section 4.5) was used to enable the reduction of this vast 
amount of data into overarching themes. Initial coding was performed across all 
seven questions and not within each question, which allowed for the 
identification of similarities in the overall data. This process was done 
deductively, meaning that the coding and the development of the themes was 
guided by pre-existing frameworks (Braun & Clarke 2006). While it has been 
argued that this particular analysis produces less rich data descriptions, 
literature engagement often provides more detailed data analysis, and allows 
coding for specific research questions (Braun & Clarke 2006). The evidence-
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based pre-existing frameworks that were used to guide the analysis process 
were: WHO’s (2015b) guideline ‘health worker roles in providing safe abortion 
care and post abortion contraception’; Costescu et al.’s (2016) clinical practice 
guideline for the provision of first-trimester MA in Canada; and the RCN (2017) 
guideline, covering England, Scotland and Wales, regarding the role of the nurse 
in termination of pregnancy services. From these guidelines, a range of 
predetermined codes were developed, which corresponded with all the different 
steps and processes involved in MA provision. Findings of the cross-sectional 
study relating to the perceived challenges of MA provision were also used as a 
guidance tool for the content analysis process, as they disclosed recurrent 
barrier themes in the data. All transcripts were anonymised and assigned with a 
unique identification code, which indicated profession (GP or PHCN) and 
participant number. Transcripts that provide further explanation or deepen the 
understanding of the presented data are used in Section 7.2 to strengthen the 
study’s findings. These responses are presented anonymously with a unique 
identification code in brackets, which indicates expert group and participant 
number. The deductive thematic analysis comprised six phases, which are 
displayed in Table 6.2, reproduced from Braun and Clarke (2006, p. 87). 
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Table 6.2 Phases of thematic analysis 
1 Familiarising with data Reading and rereading the data, noting down initial ideas 
2 Generating initial codes Coding interesting features of the data in a systematic 
fashion across the entire data set, collating data relevant to 
each code 
3 Searching for themes Collating codes into potential themes, gathering all data 
relevant to each potential theme 
4 Reviewing themes Checking if the themes work in relation to the coded extracts 
and the entire data set, generating a thematic ‘map’ of the 
analysis 
5 Defining and naming 
themes 
Ongoing analysis to refine the specifics of each theme, and 
the overall story the analysis tells, generating clear 
definitions and names for each theme 
6 Producing the report The final opportunity for analysis. Selection of vivid, 
compelling extract examples, final analysis of selected 
extracts, relating back of the analysis to the research 
question and literature, producing a scholarly report of the 
analysis 
Source: (Braun & Clarke 2006, p. 87). 
 
In the first stage of the analysis, the textual data were read multiple 
times to enable data familiarisation and immersion, and to develop an 
understanding of what overall information was provided. Next, all data were 
coded systematically using NVIVO 11 (QSR International Pty Ltd. 2015), which 
involved assigning fragments of text to specific codes. This process was 
intensified and broadened with the help of NVIVO’s auto-code and query 
functions, which identified recurring terms in sentences. The researcher, 
however, remained in charge of the overall analysis as to not overlook additional 
underlying relationships (Leech & Onwuegbuzie 2011). Additionally, some codes 
emerged inductively, which means that the coding and the development of the 
themes were guided by the content of the data and not driven by existing ideas 
(Braun & Clarke 2006). 
Following this phase, all codes were searched for similarities and 
organised into categories. It was checked that the phrasing of the categories still 
matched the phrasing of the original expert responses. Responses that were too 
broad or vague, on the other hand, were left out to not introduce bias by 
attempting to interpret the meaning. The resulting categories were then 
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converted in a total of 118 statements. Nineteen of the statements concerned 
the belief that a nurse-led model of MA provision in regional and rural Victoria 
would improve access for women. All data showed that panellists already fully 
agreed with this belief, using arguments that included decreased costs, less 
stigma and privacy issues, reduced waiting times and easy communication. 
Those 19 statements were therefore not included in Round Two. The 99 
remaining statements were reviewed and grouped into three themes. The 
themes were: 
1. Views on a nurse-led model of care for MA provision in regional and rural 
Victoria. 
2. Perceptions of current barriers to the implementation of a nurse-led model 
of care for MA provision in regional and rural Victoria. 
3. Overcoming perceived current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria. 
In the last phase of the thematic analysis, all statements were once again 
reviewed, defined and further searched for overarching topics that could be 
grouped together, resulting in a final total of 82 statements (Braun & Clarke 
2006). Seventeen statements were assigned to the first theme: ‘Views on a 
nurse-led model of care for MA provision in regional and rural Victoria’; 25 
statements were assigned to the second theme: ‘Perceptions of current barriers 
to the implementation of a nurse-led model of care for MA provision in regional 
and rural Victoria’; and 40 statements were assigned to the third theme: 
‘Overcoming perceived current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria’. 
All statements were pre-tested before the development of the Round 
Two questionnaire by a panel of known contacts of the researcher and her 
supervisors, to check for typographical errors, flow and understanding. 
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6.4.2 Round Two 
All data obtained from the questionnaire were exported from Qualtrics 
into SPSS23 (IBM Corp. 2013). Response options were assigned with a value that 
ranged from one (strongly agree) to five (strongly disagree). Descriptive analysis 
was undertaken to describe the frequency and associated percentage of each 
statement as well as to determine the median and the inter-quartile range (IQR). 
The IQR, which is the difference between the 75th and 25th percentiles, showed 
the spread of scores in the distribution (von der Gracht 2012). The median was 
favoured as the measure of central tendency because Likert scale data should be 
considered ordinal, as it cannot be assumed that the difference between the 
different values have equal intervals (Keeney, Hasson & McKenna 2011; von der 
Gracht 2012). Consensus was reached for a statement if at least 75 percent of 
the experts agreed on the 5-point Likert scale in the top two (strongly 
agree/somewhat agree) or bottom two (somewhat disagree/strongly disagree) 
categories, and if the spread of the scores in the distribution (IQR) was equal or 
less than one, which is considered to be an appropriate consensus indicator (von 
der Gracht 2012). For statements that were negatively worded (such as: 
‘completion of an abortion cannot be totally assessed by a PHC nurse’), 
consensus was reached if at least 75 percent of the experts disagreed with the 
statement and if the spread of the scores in the distribution (IQR) was equal or 
less than one. Fifty-seven out of the 82 generated statements (70%) reached the 
pre-defined consensus level and were, therefore, not included in Round Three. 
The data collected from the open-ended questions were exported from 
Qualtrics into Excel (2013) for sorting, imported into NVIVO 11 (QSR 
International Pty Ltd. 2015) and analysed using deductive thematic analysis as 
per Round One (see section 6.4.1). This process enabled the merging of data 
with similar content into categories. The analysis of data regarding the phrasing 
of the statements resulted in a rewording of seven of the 25 statements that had 
not achieved consensus in Round Two, and the development of two new 
statements (see Table 6.3). 
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Table 6.3 Seven revised statements and two new statements for Round Three 
Original statements Revised and new statements 
The PHC nurse can manage post-
abortion contraception, including the 
insertion of implants, PHC or the 
provision of injectable contraception 
The appropriately trained PHC nurse can manage 
post-abortion contraception, including the insertion of 
implants, PHC or the provision of injectable 
contraception 
All steps in the MA process that are 
handled by a PHC nurse should only be 
allowed under the supervision of a GP 
All steps in the MA process that are handled by an 
appropriately trained PHC nurse should only be allowed 
under the supervision of a GP 
Allow all registered nurses to be 
responsible for the whole MA process 
without a GP's approval. The GP 
should only be required for the 
prescription of the abortion 
medication 
Allow all appropriately trained registered nurses to be 
responsible for the whole MA process without a GP's 
approval. The GP should only be required for the 
prescription of the abortion medication 
GPs fear ramifications on both time 
and negative outcomes 
(complications) when providing MA 
services 
GPs fear ramifications on negative outcomes 
(complications) when providing MA services 
 GPs concerns regarding MA service provision appear to 
be based mainly on workload and time  
The government is nervous about 
discussing and/or promoting MA. They 
fear community backlash or anti-
choice campaigns in parliament and 
their own party 
The Victorian government is nervous about discussing 
and/or promoting MA. They fear community backlash or 
anti-choice campaigns in parliament and their own party 
 The Victorian government is negligent about discussing 
and/or promoting MA  
PHC nurses prefer locally organised 
MA group training sessions over on-
line training 
PHCNs require flexibility and choice regarding online 
training and locally organised MA group training 
sessions to maximise training opportunities  
GP clinics should offer ultrasound and 
blood test services so women do not 
need to go somewhere else 
GP clinics located in areas with limited local health 
services should offer ultrasound (after appropriate 
training) and blood tests so women do not need to go 
somewhere else 
 
Through the analysis process, three sub-themes were identified from the 
data belonging to the second theme ‘perceptions of current barriers to the 
implementation of a nurse-led model of care for MA provision in regional and 
rural Victoria’. These sub-themes were: logistical barriers to the implementation 
of a nurse-led model of care for MA provision in regional and rural Victoria; 
confidentiality, privacy, stigma and safety issues; and MA funding and public 
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perceptions. Overall, in the instrument of Round Three, the 27 remaining 
statements were subdivided into the themes as follows: 
1. Views on a nurse-led model of care for MA abortion provision in regional and 
rural Victoria (five statements). 
2. Perceptions of current barriers to the implementation of a nurse-led model 
of care for MA provision in regional and rural Victoria 
a. Logistic barriers to the implementation of a nurse-led model of care 
for MA provision in regional and rural Victoria (three statements) 
b. Confidentiality, privacy, stigma and safety issues (10 statements) 
c. MA funding and public perceptions (three statements). 
3. Overcoming perceived current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria (six statements). 
 
6.4.3 Round Three 
Similar to the analysis of Round Two, data were exported into a SPSS23 
database (IBM Corp. 2013) and response options were assigned with values 
ranging from one (strongly agree) to five (strongly disagree). Descriptive analysis 
provided the frequency and associated percentage of each statement, as well as 
the median and the IQR. In this last round, 12 of the remaining 27 statements 
additionally reached the pre-set level of consensus of at least 75 percent 
agreement in the top two (strongly agree/somewhat agree) or bottom two 
(somewhat disagree/strongly disagree) Likert categories and had an IQR of one 
or less. 
All findings of Round Two and Three, including the 15 statements that did 
not reach the set level of agreement, are discussed in Section 7.5, and presented 
into two newly defined themes. In the first newly defined theme, the previously 
used term ‘views’ on a nurse-led model was changed into ‘views on the 
construction’ of a nurse-led model, as findings converged towards the 
construction of a nurse-led MA provision model. The second newly defined 
theme comprised the perceived current barriers to the implementation of a MA 
nurse-led model of care, as well as the solutions to overcome those barriers. Just 
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as in the first round, anonymous transcripts of Round Two and Three are used to 
strengthen the study’s findings. They are assigned with a unique identification 
code in brackets, indicating expert group and participant number. 
The Kruskal-Wallis H-test (KW test), a rank-based non-parametric test, 
was conducted on all statement data assembled over Round Two and Three, 
using SPSS23 (IBM Corp. 2013) (Argyrous 2011). This test was performed to 
identify potential differences between the responses provided by the three 
panellist groups, consisting of physicians, nurses, and others. Test results with a 
statistically significant difference, a p-value < 0.05, suggested a difference 
between at least one pair of the three panellist groups. To further analyse 
potential differences, a post-hoc test using Dunn’s test with Bonferroni 
correction was applied, which allowed for in-between group comparisons 
(Argyrous 2011). 
The next chapter presents the findings of the Delphi study, and includes 
the different components involved in a nurse-led MA provision model.
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CHAPTER 7 
DELPHI STUDY FINDINGS 
This chapter presents the findings of the Delphi study. The first section 
summarises the socio-demographic characteristics of the panellists. Next, the 
generation of the 82 statements in Round One is presented. The third and fourth 
section describe all statements from Round Two and Three that reached the pre-
determined level of consensus. In the final section, a nurse-led model of care for 
MA abortion provision in regional and rural Victoria is presented, based on all 
findings, including the barriers and solutions to the implementation of the model 
(see Figure 7.1). Verbatim quotes from Round Two and Three are included for 
illustrative purposes, and differences in data between the three panellists’ 
groups (physicians, nurses and others) are shown. 
 
 
Figure 7.1 Overview of the findings of the three-round Delphi study 
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7.1 SOCIO-DEMOGRAPHIC CHARACTERISTICS OF THE 
DELPHI PANELLISTS 
A total of 24 panellists participated in the Delphi study, of which 17 
responded to all three rounds. Two panellists were only involved in Round One 
and Two, one panellist responded to Round One and Three, and one panellist 
entered in Round Two and also participated in Round Three (see Figure 7.2). The 
response rates of Round Two and Three were 87 percent and 78 percent, 
respectively. 
 
Figure 7.2 Participant attrition over three Delphi rounds 
 
At Round One, 82.6 percent (n=19) of the panellists were females. Thirty 
percent (n=7) of the panellists were physicians, 43.5 percent (n=10) were nurses, 
either working as a PHCN, in academia or for a professional body, and 26.1 
percent (n=6) were classified as ‘other’, which included academics, Victorian 
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politicians and health promotion officers without a medical background. Among 
all profession groups, 73.9 percent indicated a regional or rural location as their 
workplace setting. For GPs and PHCNs, a regional or rural location was required 
for participation in the study. 
Most panellists (78.2%; n=18) were aged 45 years and over, and more 
than half (56%; n=10) were aged over 55 years. Forty three percent (43.4%; 
n=10) of the panellists had more than 10 years’ work experience. Most (87.0%; 
n=3) were qualified in Australia (see Table 7.1). 
 
Table 7.1 Characteristics of the Round One panellists (n=23) 
Characteristic n % 
Gender   
    Male 4 17.4 
    Female 19 82.6 
Age (years)   
    18-24 1 4.3 
    25-34  3 13.0 
    35-44  1 4.3 
    45-54 8 34.8 
    55-64 9 39.1 
    ≥65 1 4.3 
Occupation   
    Physician 7 30.4 
    Nurse 10 43.5 
    Other 6 26.1 
Years of experience   
    ≤5  9 39.1 
    5-10  4 17.4 
    11-15 1 4.3 
    16-20  3 13.0 
    ≥21 6 26.1 
Geographical work location   
    Urban 6 26.1 
    Regional 12 52.2 
    Rural 5 21.7 
Country of qualification   
    Australia 20 87.0 
    Other 3 13.0 
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7.2 ROUND ONE: THE DEVELOPMENT OF STATEMENTS 
The analysis of the seven open-ended questions of Round One resulted in 
the formation of three themes and informed the development of 82 statements 
for Round Two. The statements were grouped under one of the three themes: 1) 
views on a nurse-led model of care for MA provision in regional and rural 
Victoria; 2) perceptions of current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria; and 3) overcoming 
perceived current barriers to the implementation of a nurse-led model of care 
for MA provision in regional and rural Victoria. The following sections discuss the 
statements belonging to each of the three themes. Verbatim quotes from 
panellists are added to support the findings. 
 
7.2.1 Views on a nurse-led model of care for MA provision in 
regional and rural Victoria 
This theme describes the panellists’ opinions regarding current MA 
provision in regional and rural Victoria and the potential roles of PHCNs in the 
provision of MA. 
Most first round panellists reported the current role of GPs in the 
provision of MA in their regional and/or rural areas to be very limited, as 
illustrated in the following quotes: 
Almost all GPs would not provide medical abortions in my region, and the 
ones who do - you would not know as they don’t openly promote that 
they provide it. So its luck of the draw with which GP you get and if they 
provide it (Other2). 
Often women are forced to source where and who they can see to discuss 
the options for an unplanned pregnancy as few doctors provided MTOP's 
[medical termination of pregnancy] and often they only provide this 
service to their own clients (Nurse4). 
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In my area it is just difficult, if not impossible, to find a GP who will 
facilitate this service. Because it isn't readily available women are having 
to have later surgical terminations (Nurse1). 
It was acknowledged that women with an unwanted pregnancy should be 
referred to an appropriately trained PHCN: 
All women with this presentation [unplanned pregnancy] should be 
referred to a well-trained PHCN during the consultation for 
supplementary care and management. PHCNs are also very well 
connected and aware of the resources/clinics/supports available locally to 
refer the woman to (Nurse6). 
If services do not offer MTOP their [PHCNs] role should be one of 
advocacy and referral, linking women up with all options pregnancy 
counselling or other practitioners who provide MTOP (Other6). 
If they [PHCNS] could take this on, instead of waiting for a doctor - that 
would reduce the waiting time for women and make it easier - then this 
should be considered and delivered (Other2). 
Generally, PHCNs were regarded as highly capable of delivering MA 
services, with roles including non-directive pregnancy support counselling, 
information provision, organising pregnancy dating ultrasounds and blood tests, 
and eligibility checks. These views are illustrated in the following quotes: 
PHCNs have excellent skills generally in having challenging conversations 
about difficult topics, have more time to discuss the wellbeing of the 
patient and provide a more empathetic ear to listen to a woman’s 
concern. We also know patients are more likely to disclose sensitive issues 
to a nurse than a doctor (Nurse6). 
Nurses could provide the initial appointment - organise dating scan, 
bloods etc., do a preliminary check for eligibility criteria's, explain the 
process, cost etc. (Nurse4). 
Allow Ultrasound and bloods to be ordered by nurses (Physician7). 
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The non-directive pregnancy support counselling item number for women 
who are concerned about a pregnancy could be extended to nurses who 
have undergone training in non-directive pregnancy counselling (Nurse5). 
Additionally, panellists recognised that the PHCNs’ role can include the 
management of post-abortion contraception and the provision of emotional 
support if required: 
Practice nurses could provide morning after contraception, pregnancy 
testing and chlamydia checks. Routine procedures for nurses in other 
countries... …Nurses also need to be able to explain to women what 
contraception options are available rather than just the pill (Nurse5). 
Nurses can provide assistance with understanding how medication 
termination works, what is likely to happen and provide emotional 
support following the procedure (Nurse1). 
Some panellists mentioned a lack of funding for nurse-led MA provision: 
I think that there is no funding for the nurses to provide these services. At 
GPs clinics the nurses would need the GPs involvement to enable payment 
to be provided for this service (Nurse4). 
Funding [required] - either direct funding for nurses to provide the service 
or for the primary health clinics to enable the employment of nurses 
(Other4). 
Hinder: funding, no Medicare item number for nurse's time (Physician7). 
Overall, the panellists expressed different opinions for the independent 
provision of MA by PHCN: 
I think that they [PHCNs] should be able to manage the client without 
need for GP intervention unless there is a complication (Other5). 
Increase training for nurse-led models of care in collaboration with clinic 
medical staff. Increase multidisciplinary models of primary care provision 
(Other1). 
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Up skill primary health care nurses to assist in the provision of medication 
abortion (Other3). 
They [PHCNs] could be trained to explain and support women and doctors 
through this process and to educate e.g. through media, schools 
(Physician4). 
Based on the findings of the qualitative data of Round One, 17 
statements were developed for Round Two to reach consensus regarding 
panellists’ views on a nurse-led model of care for MA provision in regional and 
rural Victoria (see Table 7.2). 
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Table 7.2 Statements derived from panellists’ views on a nurse-led model of care for MA 
provision in regional and rural Victoria 
Statements: Views on a nurse-led model of care for MA provision in regional and rural 
Victoria 
1 All women with an unwanted pregnancy should be referred to an appropriately trained 
PHCN 
2 The PHCN role should include non-directive pregnancy counselling 
3 The PHCN role should include contraception 
4 A PHCN should be able to communicate the pros and cons of the medication abortion 
5 A sufficiently trained PHCN is not able to independently rule out any contraindications to 
the use of abortion medication 
6 It is within the scope of practice of a registered PHCN to independently refer a woman 
for an ultrasound (for pregnancy dating and ectopic pregnancy screening) and blood 
tests 
7 PHCNs are able to interpret the results of an ultrasound and blood test in such a way that 
they can assess if MA provision is advisable 
8 The administration of mifepristone can be independently handled by a PHCN 
9 PHCNs can independently manage prophylactic pain medication 
10 Non-life-threatening complications of MA, like haemorrhages or infections, should be 
managed by doctors only 
11 Completion of an abortion cannot be totally assessed by a PHCN 
12 The PHCN role can include the provision of emotional support following the procedure if 
required 
13 The PHCN can manage post-abortion contraception, including the insertion of implants, 
IUDs or the provision of injectable contraception 
14 All steps in the MA process that are handled by a PHCN should only be allowed under the 
supervision of a GP 
15 MA in the primary health care sector can be provided by a PHCN in cooperation with a 
GP 
16 Allow all registered nurses to be responsible for the whole MA process without a GP's 
approval. The GP should only be required for the prescription of the abortion medication 
17 General practice funding for nurse-led MA provision is currently included in the quarterly 
Practice Nurse Incentive Program payment, which includes a rural loading of up to 50% 
and is independent of Medicare item numbers. There is sufficient allowance in the 
Practice Nurse Incentive Program payment to cover nurse-led MA provision 
 
 
7.2.2 Perceptions of current barriers to the implementation of a 
nurse-led model of care for MA provision in regional and rural 
Victoria 
The second theme, ‘perceptions of current barriers to the 
implementation of a nurse-led model of care for MA provision in regional and 
rural Victoria’, describes the multitude of barriers, as perceived by the panellists 
that can hinder the development of a nurse-led MA provision model. One often 
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mentioned barrier related to the stigma associated with abortions, and the fear 
of moral judgement and harassment when providing abortions in regional and 
rural communities. These concerns are illustrated in the following quotes: 
Fear of moral judgment by other health professionals who do not agree 
with termination of pregnancy - strong factor in smaller regions/towns 
(Physician5). 
Concerns about privacy, especially in small communities; stigma 
associated with providing this service; negative publicity from members of 
conservative communities (Other1). 
There is probably a greater stigma in rural areas to accessing medication 
abortions and there is more chance that the woman will know the health 
care provider (Nurse4). 
The government may be nervous about discussing and/or promoting 
medication abortion. They will fear a community backlash or a campaign 
by anti-choice politicians in the parliament and possibly within their own 
parties (Nurse5). 
Additionally, panellists recognised the importance of the availability of 
GPs providing MA services, and of the GP’s support for PHCNs being involved 
with MA provision. 
Nothing happens without the GP being on board … Therefore, the more 
GP's are providing or even supportive of MTOP's the better chance a 
nurse has to help with the process (Nurse4). 
If the GP's themselves will not take on this role there is little likelihood 
they will support the nurse (Nurse5). 
Concern by doctors that nurses unable to provide adequate service 
(Physician7). 
Further, it was emphasised that communities are not well informed 
about MA as an option for pregnancy terminations, as reflected in the following 
quotes: 
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There is a distinct lack of information in the general community about 
medication termination (Nurse1). 
More education on the need for women to have a choice - it should be a 
right not a privilege (Nurse4). 
Panellists also acknowledged that change to current MA funding 
arrangements was required:  
No Medicare item number for nurse’s time (Physician7). 
MBS item numbers govern the scope of practice nurses more than 
anything else (Nurse5). 
Other identified barriers to MA provision in regional and rural Victoria 
were the lack of MA training opportunities for PHCNs and the lack of locally 
accessible health care services. Some panellists raised concern about a lack of 
support from other health professionals and professional bodies, influenced by 
religious, ethical and personal principles. This concern was expressed by one 
participant as follows: 
Conscientious objection to abortion by individual GPs, Board members or 
other allied health professionals working in rural and regional health care 
settings can greatly hinder provision of the service in the first place 
(Other3). 
A total of 25 statements were developed for Round Two relating to the 
second theme: The perceptions of current barriers to the implementation of a 
nurse-led model of care for MA provision in regional and rural Victoria (Table 
7.3). 
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Table 7.3 Statements derived from panellists’ perceptions of current barriers to the 
implementation of a nurse-led model of care for MA provision in regional and rural 
Victoria 
 
Statements: Perceptions of current barriers to the implementation of a nurse-led model of 
care for MA provision in regional and rural Victoria 
1 There is a lack of professional development and further training possibilities for PHCNs 
(including MA provision) 
2 Not all local pharmacies supply, or wish to supply, medication abortion drugs 
3 There is insufficient availability of MA trained GP providers in regional and rural Victoria 
4 Without a GP's approval for MA provision, nurse involvement is not supported 
5 Traditionally, GPs prefer to be in charge over some services, which includes MA provision 
6 There is a well-established positive collaboration between the Australian Medical 
Association and nursing authorities 
7 There is a lack of local access to surgical back-up in regional and rural Victoria in the case 
of MA complications 
8 There is a lack of local allied professionals and accessible services for women (such as 
radiographers) in regional and rural Victoria 
9 There is a lack of after-hours care in small towns for women who go through a MA 
10 Women in regional and rural areas worry about confidentiality and privacy issues 
11 The rural population does not complain about poor MA services in their area, because it 
is a private and contentious subject 
12 GPs fear moral judgement by other health professionals if they were to provide MA 
services to their patients 
13 There is pressure on GPs to conform to the conservative views of their colleagues 
regarding the provision of MA services 
14 GPs are concerned about their safety and wellbeing if they were to provide MA services 
15 GPs fear ramifications on both time and negative outcomes (complications) when 
providing MA services 
16 There is a lack of specialist and other health professionals’ support available to GPs and 
PHCNs that provide MA services 
17 There is no support from local hospitals and community health services to GPs and 
PHCNs who provide MA services 
18 GPs and PHCNs fear negative publicity from members of conservative communities 
and/or fear of personal vilification if they were to provide MA services 
19 GPs and PHCNs fear the presence of anti-choice protestors outside the facility if they 
were to provide MA services 
20 The Government is nervous about discussing and/or promoting MA. They fear 
community backlash or anti-choice campaigns in parliament and their own party 
21 There is not enough funding to make nurse-led MA provision profitable 
22 GP involvement is required to enable payment for this service 
23 Many GPs are not aware that they can offer medication abortion 
24 Most GPs are aware of the online MA training currently available 
25 It appears that public expectations about equitable availability of abortion services are 
ahead of the actual implementation 
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7.2.3 Overcoming perceived current barriers to the implementation 
of a nurse-led model of care for MA provision in regional and rural 
Victoria 
A range of ideas and solutions were provided by the panellists to help 
overcome perceived barriers for the implementation of a nurse-led MA model in 
regional and rural Victoria. Most solutions related to increased education and 
training options. The training of more GPs was recognised as an important first 
step: 
Education for GP's and clinic staff - you can get all the nurses on board 
but with [without] doctor's to support it they are powerless to assist 
(Nurse4). 
Provide education and peer support to improve the numbers [of GPs] who 
consider abortion within the normal scope of general practice (Other1). 
More [GPS] could be trained, supported, and protected (privacy wise, 
legally, from protesters and opponents, violence, etc). We could make 
medical termination a widely known and easily available option 
(Physician4). 
Training of PHCNs was also deemed very important, and financial support 
in the form of scholarships, funding and remuneration was highlighted: 
Incentives for rural and regional private and community health care 
providers to up skill primary health care nurses to assist in the provision of 
medication abortion. Affordable and accessible professional development 
and training offered on line and/or in regional centres rather than 
Melbourne (Other3). 
Inclusion of an MTOP component in the nurses’ sexual and reproductive 
courses in Victoria (Nurse9). 
I think that training and financial incentives could improve the provision 
of medication abortion (Other4). 
Local Training for practice nurses so they feel confident to take on the 
work (Nurse9). 
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Better education. Set guidelines. Easy access for patients both cost wise 
and logistically (Physician6). 
If education is to be made available for them, there has to be financial 
support for the nurses to attend (e.g. scholarships) (Nurse6). 
Education needs to be free, locally available and practices need to be 
remunerated for the time when nurses attend the education. We know 
from surveying our students that scholarship and distance education are 
the great enablers to education but we also know that many do not like 
distance education and want a more interactive format (Nurse5). 
We know that a significant limitation for nurses expanding their scope is 
the cost of education - so if education is to be made available for them, 
there has to be financial support for the nurses to attend (e.g. 
scholarships) (Nurse6). 
Another often provided solution to overcome perceived barriers for the 
implementation of a nurse-led MA model involved empowerment and support 
from health practitioners, the local community and government, as illustrated in 
the following quotes: 
Empowerment - nurses are resourceful, connected, caring individuals who 
operate naturally within an interdisciplinary team. They are often 
unaware of their potential role and scope though and self-limit their 
professional development unnecessarily. Leadership, mentors and 
encouragement is needed. 'Endorsement' by their medical colleagues is 
vital too - this will empower nurses and avoid territory wars or people 
feeling threatened in their professional roles. (Nurse6). 
Greater support from state health departments might be a possible 
solution (Nurse5). 
Strong partnerships with doctors, non-hierarchical work places 
(Physisican7). 
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Perhaps push from AMA or RACGP [The Royal Australian college of 
General Practitioners], govt [Government] to say this is a service that all 
women should be able to access (Physician6). 
Adequate support from local community, government and GPs (Other6). 
It was also suggested to improve mutual communication, MA funding 
models, stigma and legal regulations. Some of these suggestions are reflected in 
the following quotes: 
Regular education/discussion sessions with health care providers - via 
PHN [Primary Health Network], local conferences, hospital grand rounds, 
articles in journals/medical magazines (Physician1). 
Facilitate networking; Telephone access to specialist support (Physician5). 
MBS item numbers govern the scope of practice nurses more than 
anything else- these can also be the facilitator. Create an item number for 
nurses to be involved and they will be (Nurse5). 
Providing the services [by GPs and PHCNS] helps reduce stigma by making 
it part of a mainstream service (Physician7). 
Need to promote that the service is offered in the settings (perhaps as "all 
option pregnancy counselling" or similar). More work on getting GPs and 
doctors on board and aware of medical abortion which will allow for 
more registration of nurses to provide medical abortion. More that is 
provided, more the stigma will go away and privacy/knowing the person 
will become less of an issue (Nurse2). 
Support for nurses and GPs who wish to offer a service but are afraid of 
community backlash (Nurse5). 
Allow nurse practitioner prescription of MS-2 Step (Physician7). 
Make recommendations to parliament & working parties to change the 
laws allow a wider scope of practice (Nurse3). 
Finally, it was acknowledged that evidence is required to demonstrate 
the effectiveness of nurse-led MA provision:  
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Nursing research to validate the role of nurses and demonstrate 
effectiveness (Nurse6). 
Continue to challenge traditional nursing duty ‘norms’ and ensure 
stringent use of evidence, best practice and regulation as boundaries to 
practice scope are shifted (Nurse7). 
Data collection systems so that the extent of the problem can be seen and 
improvements can be documented (Other1). 
A total of 40 developed statements were developed for Round Two to 
reach consensus on how to overcome perceived current barriers to the 
implementation of a nurse-led model of care for MA provision in regional and 
rural Victoria (see Table 7.4). 
 
Table 7.4 Statements derived from panellists’ solutions on how to overcome current 
barriers to the implementation of a nurse-led model of care for MA provision in regional 
and rural Victoria 
 
Statements: Overcoming perceived current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria 
1 The State Government should establish an action plan in partnership with Primary 
Health Care Networks to prioritise, promote and provide affordable, accessible MA 
professional development and training for GPs and PHCNs working in regional and rural 
Victoria 
2 Incentives like scholarships should be offered to upskill PHCNs for MA provision 
3 Incentives and support should be offered for rural and regional GPs to undertake MA 
training and service provision 
4 Remuneration needs to be offered to practices when nurses attend professional 
development courses on MA 
5 PHCNs prefer locally organised MA group training sessions over on-line training 
6 Professional development courses in sexual and reproductive health for nurses should 
include a MA provision component 
7 A funded coordinator role needs to be established that offers guidance and help for 
PHCNs who want to do the MA training 
8 Professional development programs for GP accreditation should include MA provision 
9 Nurses need leaders and mentors to encourage and empower them in their 
professional development, which includes MA provision 
10 Establish a PHCN network for MA practice which includes mentoring, networking, and 
opportunities to share experiences and learn 
11 Create a MA provision model for PHCNs, which can provide guidance, support and help 
to develop their roles 
12 Direction is required from the Australian Health Practitioner Regulation Agency on the 
nurses’ scope of practice in MA provision 
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Statements: Overcoming perceived current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria 
13 Encourage nursing research to validate the role of PHCNs and demonstrate 
effectiveness of nurse-led MA provision 
14 Continue to challenge traditional nursing duty ‘norms' for MA, and ensure a stringent 
use of evidence and best practice, as scope of practice boundaries are shifted 
15 Introduce data collection systems for monitoring and evaluation of nurse-led MA 
provision in regional and rural Victoria 
16 Supportive information should be freely available to all MA providing nurses (e.g. 
resources on the MS Health website) 
17 Create a Medicare Benefits Schedule (MBS) item number for PHCN consultations 
related to MA provision 
18 Payment for nurse-led MA provision should be independent of any GP involvement 
19 Guarantee access to quality specialist back-up when needed 
20 Improve communication about MA between local hospitals, GPs and PHCNs 
21 Develop best practice service models for MA which includes access to radiography and 
after care services 
22 GP clinics should stock and supply abortion mediation so women do not need to go 
somewhere else 
23 GP clinics should offer ultrasound and blood test services so women do not need to go 
somewhere else 
24 When practice GPs refuse to provide MA, PHCNs should be able to initiate pre-testing 
before referral 
25 GPs who provide MA should be made visible (e.g. advertise with "all-option pregnancy 
counselling offered at this general practice") 
26 Financially support women to facilitate MA access (e.g. for travel and childcare costs) 
27 Change legislation to allow prescription of abortion medication by registered nurses in 
regional and rural Victoria 
28 Make recommendations to parliament and working parties to change legislation to 
allow a wider scope of practice for PHCNs 
29 Public awareness about the availability of MA can lead to increased public demand. 
This can act as a driver for improved service provision 
30 Increase and improve the availability of medication abortion drugs in local pharmacies 
through MA education programs for pharmacists 
31 Develop a dedicated team of MA-trained PHCNs to support the provision of MA 
services in smaller or more remote health care settings 
32 Ensure that PHCNs who provide MA are covered by insurance 
33 There should be support and endorsement of MA from local health professionals 
(including Boards of hospitals and community centres) 
34 Emergency department staff should respond in a non-judgmental way in cases of 
abortion complications 
35 There should be open endorsement of MA from peak bodies such as the Australian 
Medical Association, Royal Australian College of General Practitioners, nursing 
authorities and Government 
36 There should be a statement of expectation from the Department of Health that 
medication abortion should be core business for primary health systems in regional 
and rural areas 
37 There should be support and protection for PHCNs and GPs who wish to offer MA 
services but are afraid of community backlash, harassment or legal issues 
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Statements: Overcoming perceived current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria 
38 All GP practices should provide independent pregnancy counselling 
39 Conscientious objection should be out in the open. The public needs to know if a 
doctor is a conscientious objector 
40 Abortion should be seen as being part of comprehensive sexual and reproductive 
health care, consequently reducing abortion stigma 
 
 
7.3 ROUND TWO 
The findings from Round Two are described in the following sections. The 
first section shows the consensus ratings on the statements relating to panellists’ 
views on a nurse-led model of care for MA provision in regional and rural 
Victoria. The second section regarding panellists’ perceptions of current barriers 
to the implementation of a nurse-led model of care for MA provision in regional 
and rural Victoria, presents panellists’ levels of consensus across three sub-
themes: logistical barriers to the implementation of a nurse-led model of care 
for MA provision in regional and rural Victoria; confidentiality, privacy, stigma 
and safety issues; and barriers concerning MA funding and public perceptions. 
Finally, consensus levels are described of panellists’ solutions on how to 
overcome current barriers to the implementation of a nurse-led model of care 
for MA provision in regional and rural Victoria. 
 
7.3.1 Views on a nurse-led model of care for MA provision in 
regional and rural Victoria 
Of the 17 statements regarding panellists’ views on a nurse-led model of 
care for MA provision in regional and rural Victoria, 11 (65%) statements 
obtained the pre-determined consensus level of at least 75 percent of 
(dis)agreement and an IQR equal or less than one. The statement that the PHCN 
role should include contraception achieved full consensus (100% agreement) 
(see Table 7.5). Nearly full consensus (95% agreement) was obtained for three 
statements: a PHCN should be able to communicate the pros and cons of the 
MA; PHCNs are able to interpret the results of an ultrasound and blood test in 
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such a way that they can assess if MA provision is advisable; and the 
administration of mifepristone can be independently handled by a PHCN. 
Two of the six statements that did not obtain the 75 percent consensus 
level received low levels of agreement (Table 7.5). These statements were: non-
life-threatening complications of MA, like haemorrhages or infections, should be 
managed by doctors only (45% disagreement, IQR = 2); and allow all registered 
nurses to be responsible for the whole MA process without a GP's approval, the 
GP should only be required for the prescription of the abortion medication (40% 
agreement, IQR = 2.75). 
 
Table 7.5 Consensus reached in Round Two for statements regarding panellists’ views 
on a nurse-led model of care for MA provision in regional and rural Victoria 
 
 Statements Median IQR 
 
Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
1 All women with an unwanted 
pregnancy should be referred to an 
appropriately trained PHCN 
1 2 65 - - 
2 The PHCN role should include non-
directive pregnancy counselling 
1 1 90 - + 
3 The PHCN role should include 
contraception 
1 0 100 - + 
4 A PHCN should be able to 
communicate the pros and cons of 
the medication abortion 
1 0 95 - + 
5 A sufficiently trained PHCN is not 
able to independently rule out any 
contraindications to the use of 
abortion medication 
4 0 - 80 + 
6 It is within the scope of practice of 
a registered PHCN to 
independently refer a woman for 
an ultrasound (for pregnancy 
dating and ectopic pregnancy 
screening) and blood tests 
1 1 80 - + 
7 PHCNs are able to interpret the 
results of an ultrasound and blood 
test in such a way that they can 
assess if MA provision is advisable 
2 1 95 - + 
8 The administration of mifepristone 
can be independently handled by a 
PHCN 
1 1 95 - + 
9 PHCNs can independently manage 
prophylactic pain medication 
1 1 90 - + 
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 Statements Median IQR 
 
Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
10 Non-life-threatening complications 
of MA, like haemorrhages or 
infections, should be managed by 
doctors only  
3.5 2 - 45 - 
11 Completion of an abortion cannot 
be totally assessed by a PHCN 
4 1 - 85 + 
12 The PHCN role can include the 
provision of emotional support 
following the procedure if required 
1 0.75 90 - + 
13 The PHCN can manage post-
abortion contraception, including 
the insertion of implants, PHC or 
the provision of injectable 
contraception 
2 1.75 75 - - 
14 All steps in the MA process that are 
handled by a PHCN should only be 
allowed under the supervision of a 
GP 
4 1 - 70 -  
15 MA in the primary health care 
sector can be provided by a PHCN 
in cooperation with a GP 
2 0.75 75 - + 
16 Allow all registered nurses to be 
responsible for the whole MA 
process without a GP's approval. 
The GP should only be required for 
the prescription of the abortion 
medication 
3 2.75 40 - - 
17 General practice funding for nurse-
led ma provision is currently 
included in the quarterly practice 
nurse incentive program payment, 
which includes a rural loading of up 
to 50% and is independent of 
Medicare item numbers. There is 
sufficient allowance in the practice 
nurse incentive program payment 
to cover nurse-led MA provision 
4 2 - 65 - 
Notes: 1 Consensus for agreement was obtained (+) if valid percent agreement (or disagreement 
for negatively worded statements) was ≥ 75 percent and IQR ≤ 1. Consensus for agreement was not 
obtained (-) if valid percent agreement (or disagreement for negatively worded statements) was < 
75 percent and IQR > 1. 
 
 
7.3.2 Perceptions of current barriers to the implementation of a 
nurse-led model of care for MA provision in regional and rural 
Victoria 
 
This theme relates to panellists’ perceptions of current barriers to the 
implementation of a nurse-led model of care for MA provision in regional and 
rural Victoria, and includes three sub-themes: 1) logistical barriers to the 
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implementation of a nurse-led model of care for MA provision in regional and 
rural Victoria; 2) confidentiality, privacy, stigma and safety issues; and 3) MA 
funding and public perceptions. 
Of the 11 statements assigned to the first theme regarding logistical 
barriers, nine statements (82%) obtained the pre-determined level of consensus 
(see Table 7.6). No statement achieved full (100%) consensus; however, 95 
percent consensus was achieved for three statements: there is insufficient 
availability of MA trained GP providers in regional and rural Victoria; 
traditionally, GPs prefer to be in charge over some services, which includes MA 
provision; and there is a lack of local allied professionals and accessible services 
for women (such as radiographers) in regional and rural Victoria. Two 
statements did not reach the pre-determined 75 percent consensus and IQR 
level: not all local pharmacies supply, or wish to supply, medication abortion 
drugs (75% agreement, IQR = 1.75); and there is a well-established positive 
collaboration between the Australian Medical Association and nursing 
authorities (40% disagreement, IQR = 1). 
Of the 11 statements that were assigned to the second theme that 
focused on perceived confidentiality, privacy, stigma and safety issues in relation 
to MA provision, only two (18%) statements reached consensus (see Table 7.6). 
These statements were: women in regional and rural areas worry about 
confidentiality and privacy issues; and there is no support from local hospitals 
and community health services to GPs and PHCNs who provide MA services. Two 
statements, however, reached 75 percent consensus, but without the IQR ≤ 1 
requirement. They were: the rural population does not complain about poor MA 
services in their area, because it is a private and contentious subject (75% 
agreement, IQR = 1.75); and GPs and PHCNs fear negative publicity from 
members of conservative communities and/or fear of personal vilification if they 
were to provide MA services (75% agreement, IQR = 1.75). 
Of the three statements that were assigned to the third theme that 
focused on MA funding and public perceptions in relation to MA provision, only 
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one statement reached consensus (see Table 7.6). This statement was that GP 
involvement is required to enable payment for this service (80%). 
 
Table 7.6 Consensus reached in Round Two for statements regarding panellists’ 
perceptions of current barriers to the implementation of a nurse-led model of care for 
MA provision in regional and rural Victoria 
 
 Statements Median IQR Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
Logistical barriers to the implementation of a nurse-led model of care for MA provision in regional 
and rural Victoria 
1 There is a lack of professional 
development and further training 
possibilities for PHCNs (including MA 
provision) 
2 1 85 - + 
2 Not all local pharmacies supply, or 
wish to supply, medication abortion 
drugs 
1 1.75 75 - - 
3 There is insufficient availability of 
MA trained GP providers in regional 
and rural Victoria 
1 1 95 - + 
4 Without a GP's approval for MA 
provision, nurse involvement is not 
supported 
2 1 85 - + 
5 Traditionally, GPs prefer to be in 
charge over some services, which 
includes MA provision 
2 1 95 - + 
6 There is a well-established positive 
collaboration between the Australian 
Medical Association and nursing 
authorities 
3 1 - 40 - 
7 There is a lack of local access to 
surgical back-up in regional and rural 
Victoria in the case of MA 
complications 
2 0.75 80 - + 
8 There is a lack of local allied 
professionals and accessible services 
for women (such as radiographers) in 
regional and rural Victoria 
2 0.75 95 - + 
9 There is a lack of after-hours care in 
small towns for women who go 
through MA 
1 1 90 - + 
10 Many GPs are not aware that they 
can offer medication abortion 
2 1 85 - + 
11 Most GPs are aware of the online MA 
training currently available 
4 0 - 80 + 
Confidentiality, privacy, stigma and safety issues 
12 Women in regional and rural areas 
worry about confidentiality and 
privacy issues 
1 0.75 90  + 
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 Statements Median IQR Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
13 The rural population does not 
complain about poor MA services in 
their area, because it is a private and 
contentious subject 
2 1.75 75  - 
14 GPs fear moral judgement by other 
health professionals if they were to 
provide MA services to their patients 
2 2 70  - 
15 There is pressure on GPs to conform 
to the conservative views of their 
colleagues regarding the provision of 
MA services 
2 2 70  - 
16 GPs are concerned about their safety 
and wellbeing if they were to provide 
MA services 
2 1 65  - 
17 GPs fear ramifications on both time 
and negative outcomes 
(complications) when providing MA 
services 
2 2 70  - 
18 There is a lack of specialist and other 
health professionals’ support 
available to GPs and PHCNs that 
provide MA services 
2 1.75 70  - 
19 There is no support from local 
hospitals and community health 
services to GPs and PHCNs who 
provide MA services 
2 0.75 75  + 
20 GPs and PHCNs fear negative publicity from members of 
conservative communities and/or 
fear of personal vilification if they 
were to provide MA services 
1.5 1.75 75  - 
 
21 GPs and PHCNs fear the presence of 
anti-choice protestors outside the 
facility if they were to provide MA 
services 
2 2.75 60  - 
22 The government is nervous about 
discussing and/or promoting MA. 
They fear community backlash or 
anti-choice campaigns in parliament 
and their own party 
1.5 2 70  - 
MA funding and public perceptions 
23 There is not enough funding to make 
nurse-led MA provision profitable 
2 2 65 - - 
24 GP involvement is required to enable 
payment for this service 
2 1 80 - + 
25 It appears that public expectations 
about equitable availability of 
abortion services are ahead of the 
actual implementation 
2 1.5 65 - - 
Notes: 1 Consensus for agreement was obtained (+) if valid percent agreement (or disagreement 
for negatively worded statements) was ≥ 75 percent and IQR ≤ 1. Consensus for agreement was not 
obtained (-) if valid percent agreement (or disagreement for negatively worded statements) was < 
75 percent and IQR > 1. 
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7.3.3 Overcoming perceived current barriers to the implementation 
of a nurse-led model of care for MA provision in regional and rural 
Victoria. 
The final theme centred on panellists’ views on what needs to be done to 
overcome barriers to implementation of a nurse-led MA model. Thirty-four 
(85%) of the 40 statements obtained consensus, with 11 statements reaching 
100 percent consensus. Six statements did not reach the pre-determined 
minimum requirements for consensus, although most agreement levels were 
close to 75 percent. All statements are presented in Table 7.7. 
 
Table 7.7 Consensus reached in Round Two for statements regarding panellists’ 
solutions on how to overcome current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria 
 
 Statements Median IQR Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
1 The state government should 
establish an action plan in 
partnership with primary health 
care networks to prioritise, 
promote and provide affordable, 
accessible MA professional 
development and training for GPs 
and PHCNs working in regional and 
rural Victoria 
1 0 95 - + 
2 Incentives like scholarships should 
be offered to upskill PHCNs for MA 
provision 
1 1 100 - + 
3 Incentives and support should be 
offered for rural and regional GPs 
to undertake MA training and 
service provision 
1 0 100 - + 
4 Remuneration needs to be offered 
to practices when nurses attend 
professional development courses 
on MA 
1 0.75 85 - + 
5 PHCNs prefer locally organised MA 
group training sessions over on-line 
training 
2 1.75 70 - - 
6 Professional development courses 
in sexual and reproductive health 
for nurses should include a MA 
provision component 
1 0 95 - + 
7 A funded coordinator role needs to 
be established that offers guidance 
and help for PHCNs who want to 
do the MA training 
1 1.75 75 - - 
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 Statements Median IQR Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
8 Professional development 
programs for GP accreditation 
should include MA provision 
1 0.75 95 - + 
9 Nurses need leaders and mentors 
to encourage and empower them 
in their professional development, 
which includes MA provision 
1 1 95 - + 
10 Establish a PHCN network for MA 
practice which includes mentoring, 
networking, and opportunities to 
share experiences and learn 
1 0.75 100 - + 
11 Create a MA provision model for 
PHCNs, which can provide 
guidance, support and help to 
develop their roles 
1 0.75 100 - + 
12 Direction is required from the 
Australian health practitioner 
regulation agency on the nurses’ 
scope of practice in MA provision 
1 1 90 - + 
13 Encourage nursing research to 
validate the role of PHCNs and 
demonstrate effectiveness of 
nurse-led MA provision 
1 0.75 90 - + 
14 Continue to challenge traditional 
nursing duty ‘norms' for MA, and 
ensure a stringent use of evidence 
and best practice, as scope of 
practice boundaries are shifted 
1 0.75 90 - + 
15 Introduce data collection systems 
for monitoring and evaluation of 
nurse-led MA provision in regional 
and rural Victoria 
1 0.75 90 - + 
16 Supportive information should be 
freely available to all MA providing 
nurses (e.g. Resources on the MS 
health website) 
1 0 95 - + 
17 Create a Medicare benefits 
schedule (MBS) item number for 
PHCN consultations related to MA 
provision 
1 1 90 - + 
18 Payment for nurse-led MA 
provision should be independent of 
any GP involvement 
1.5 1.75 75 - - 
19 Guarantee access to quality 
specialist back-up when needed 
1 0 100 - + 
20 Improve communication about ma 
between local hospitals, GPs and 
PHC nurses 
1 0 100 - + 
21 Develop best practice service 
models for MA which includes 
access to radiography and after 
care services 
1 1 100 - + 
22 GP clinics should stock and supply 
abortion mediation so women do 
not need to go somewhere else 
1 1 85 - + 
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 Statements Median IQR Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
23 GP clinics should offer ultrasound 
and blood test services so women 
do not need to go somewhere else 
2 1 70 - - 
24 When practice GPs refuse to 
provide MA, PHCNs should be able 
to initiate pre-testing before 
referral 
1 1 85 - + 
25 GPs who provide MA should be 
made visible (e.g. advertise with 
"all-option pregnancy counselling 
offered at this general practice") 
1.5 1.75 75 - - 
26 Financially support women to 
facilitate MA access (e.g. for travel 
and childcare costs) 
2 2 65 - - 
27 Change legislation to allow 
prescription of abortion medication 
by registered nurses in regional 
and rural Victoria 
1 1 85 - + 
28 Make recommendations to 
parliament and working parties to 
change legislation to allow a wider 
scope of practice for PHCNs 
1 1 89.5 - + 
29 Public awareness about the 
availability of MA can lead to 
increased public demand. This can 
act as a driver for improved service 
provision 
1 1 95 - + 
30 Increase and improve the 
availability of medication abortion 
drugs in local pharmacies through 
MA education programs for 
pharmacists 
1 0 95 - + 
31 Develop a dedicated team of MA-
trained PHCNs to support the 
provision of MA services in smaller 
or more remote health care 
settings 
1 0 95 - + 
32 Ensure that PHCNs who provide 
MA are covered by insurance 
1 0 95 - + 
33 There should be support and 
endorsement of MA from local 
health professionals (including 
boards of hospitals and community 
centres) 
1 0 100 - + 
34 Emergency department staff 
should respond in a non-
judgmental way in cases of 
abortion complications 
1 0 100 - + 
35 There should be open 
endorsement of MA from peak 
bodies such as the Australian 
Medical Association, royal 
Australian College of General 
Practitioners, nursing authorities 
and government 
1 0 95 - + 
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 Statements Median IQR Percent 
agree 
Percent 
disagree  
Consensus 
Round 21 
36 There should be a statement of 
expectation from the department 
of health that medication abortion 
should be core business for 
primary health systems in regional 
and rural areas 
1 0.75 85 - + 
37 There should be support and 
protection for PHCNs and GPs who 
wish to offer MA services but are 
afraid of community backlash, 
harassment or legal issues 
1 0 100 - + 
38 All GP practices should provide 
independent pregnancy counselling 
1 1 90 - + 
39 Conscientious objection should be 
out in the open. The public needs 
to know if a doctor is a 
conscientious objector 
1 0.75 90 - + 
40 Abortion should be seen as being 
part of comprehensive sexual and 
reproductive health care, 
consequently reducing abortion 
stigma 
1 0 100 - + 
Notes: 1 Consensus for agreement was obtained (+) if valid percent agreement (or disagreement 
for negatively worded statements) was ≥ 75 percent and IQR ≤ 1. Consensus for agreement was not 
obtained (-) if valid percent agreement (or disagreement for negatively worded statements) was < 
75 percent and IQR > 1. 
 
 
 
7.4 ROUND THREE 
In Round Two, 57 of the 82 statements reached consensus. Based on the 
analysis of the data from the open-ended questions of Round Two, seven of the 
25 statements that did not reach consensus were reworded, and an additional 
two statements were developed for inclusion in Round Three (see section 6.4.2). 
Round Three, therefore, included 27 statements, of which 12 reached 
consensus. The statements are presented in similar themes as Round Two, 
except for the first theme, where the term ‘views’ was changed into ‘views on 
the construction’ (see section 6.4.3). The three themes are discussed in the 
following sections and include: 1) views on the construction of a nurse-led model 
of care for MA provision in regional and rural Victoria; 2) perceptions of current 
barriers to the implementation of a nurse-led model of care for MA provision in 
regional and rural Victoria; and 3) overcoming current barriers to the 
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implementation of a nurse-led model of care for MA provision in regional and 
rural Victoria. 
 
7.4.1. Views on the construction of a nurse-led model of care for 
MA abortion provision in regional and rural Victoria  
Two of the five remaining statements regarding the construction of a 
nurse-led model of care for MA abortion provision in regional and rural Victoria 
achieved consensus in Round Three: all women with an unwanted pregnancy 
should be referred to an appropriately trained PHCN (84% agreement, IQR=1); 
and the appropriately trained PHCN can manage post-abortion contraception, 
including the insertion of implants, intrauterine devices (IUDs) or the provision of 
injectable contraception (95% agreement, IQR=1) (see Table 7.8). 
 
Table 7.8 Consensus reached in Round Three for statements regarding panellists’ views 
on the construction of a nurse-led model of care for MA provision in regional and rural 
Victoria 
 
 Statements Percent 
agree  
Round 2 
IQR 
Round 2 
Percent 
agree 
Round 3 
IQR 
Round
3 
 
Consen-
sus 
Round 31 
1 All women with an unwanted 
pregnancy should be referred to an 
appropriately trained PHCN 
65 2 84 1 + 
2 Non-life-threatening complications 
of MA, like haemorrhages or 
infections, should be managed by 
doctors only  
452 2 472 2 - 
33 The appropriately trained PHCN can 
manage post-abortion 
contraception, including the 
insertion of implants, IUDs or the 
provision of injectable contraception 
75 1.75 95 1 + 
43 All steps in the MA process that are 
handled by an appropriately trained 
PHCN should only be allowed under 
the supervision of a GP 
702 1 472 1 - 
53 Allow all appropriately trained 
registered nurses to be responsible 
for the whole MA process without a 
GP's approval. The GP should only be 
required for the prescription of the 
abortion medication 
40 2.75 58 2 - 
Notes: 1 Consensus for agreement reached (+) if valid percent agreement was ≥ 75% and IQR ≤ 1; 2 
Percentage disagreement; 3 Newly worded statement in Round Three. 
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7.4.2 Perceptions of current barriers to the implementation of a 
nurse-led model of care for MA provision in regional and rural 
Victoria 
Of the 16 remaining statements regarding panellists’ perceptions of 
current barriers to the implementation of a nurse-led model of care for MA 
provision in regional and rural Victoria, five reached the pre-determined 
consensus level in Round Three (see Table 7.9). Consensus statements are 
presented by sub-themes: 1) logistical barriers to the implementation of a nurse-
led model of care for MA provision in regional and rural Victoria; 2) 
confidentiality, privacy, stigma and safety issues; and 3) MA funding and public 
perceptions. 
One statement assigned to ‘logistical barriers’, reached consensus in 
Round Three: Eighty-four percent of panellists agreed (IQR=1) that not all local 
pharmacies supply, or wish to supply, MA drugs. The agreement levels of the 
other two statements remained the same. Three out of the 10 statements 
relating to ‘confidentiality, privacy, stigma and safety issues’ also reached 
consensus in Round Three. Ninety percent agreement (IQR=0) was achieved for 
the statement that declared that there is pressure on GPs to conform to the 
conservative views of their colleagues regarding the provision of MA services. 
The other two statements that reached consensus were: GPs fear moral 
judgement by other health professionals if they were to provide MA services to 
their patients (84% agreement, IQR=0); and GPs and PHCNs fear negative 
publicity from members of conservative communities and/or fear of personal 
vilification if they were to provide MA services (84% agreement, IQR=1). Finally, 
one of the three statements regarding ‘MA funding and public perception 
barriers’ reached consensus. The statement implied there is not enough funding 
to make nurse-led MA provision profitable (79% agreement, IQR=1). 
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Table 7.9 Consensus reached in Round Three for statements regarding panellists’ 
perceptions of current barriers to the implementation of a nurse-led model of care for 
MA provision in regional and rural Victoria 
 
 Statements Percent 
agree  
Round 2 
IQR 
Round 2 
Percent 
agree 
Round 3 
IQR 
Round 3 
 
Consen-
sus 
Round 31 
Logistical barriers to the implementation of a nurse-led model of care for MA provision in regional 
and rural Victoria 
1 Not all local pharmacies supply, 
or wish to supply, medication 
abortion drugs 
75 1.75 84 1 + 
2 There is a well-established 
positive collaboration between 
the Australian Medical 
Association and nursing 
authorities 
402 1 472 1 - 
3 There is a lack of specialist and 
other health professionals’ 
support available to GPs and 
PHCNs that provide MA services 
70 1.75 74 1 - 
Confidentiality, privacy, stigma and safety issues 
4 The rural population does not 
complain about poor MA services 
in their area, because it is a 
private and contentious subject 
75 1.75 74 3 - 
5 GPs fear moral judgement by 
other health professionals if they 
were to provide MA services to 
their patients 
70 2 84 0 + 
6 There is pressure on GPs to 
conform to the conservative 
views of their colleagues 
regarding the provision of MA 
services 
70 2 90 0 + 
7 GPs are concerned about their 
safety and wellbeing if they were 
to provide MA services 
65 1 74 2 - 
83 GPs fear ramifications on 
negative outcomes 
(complications) when providing 
MA services 
70 2 72 1 - 
94 GPs concerns regarding MA 
service provision appear to be 
based mainly on workload and 
time 
- - 42 2 - 
10 GPs and PHCNs fear negative 
publicity from members of 
conservative communities and/or 
fear of personal vilification if they 
were to provide MA services 
75 1.75 84 1 + 
11 GPs and PHCNs fear the presence 
of anti-choice protestors outside 
the facility if they were to provide 
MA services 
60 2.75 68 2 - 
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 Statements Percent 
agree  
Round 2 
IQR 
Round 2 
Percent 
agree 
Round 3 
IQR 
Round 3 
 
Consen-
sus 
Round 31 
123 The Victorian government is 
nervous about discussing and/or 
promoting MA. They fear 
community backlash or anti-
choice campaigns in parliament 
and their own party 
70 2 58 2 - 
134 The Victorian Government is 
negligent about discussing and/or 
promoting MA 
- - 47 3 - 
MA funding and public perceptions 
14 General practice funding for 
nurse-led MA provision is 
currently included in the 
quarterly practice nurse incentive 
program payment, which 
includes a rural loading of up to 
50% and is independent of 
Medicare item numbers. There is 
sufficient allowance in the 
practice nurse incentive program 
payment to cover nurse-led MA 
provision 
652 2 632 2 - 
15 There is not enough funding to 
make nurse-led MA provision 
profitable 
65 2 79 1 + 
16 It appears that public 
expectations about equitable 
availability of abortion services 
are ahead of the actual 
implementation 
65 1.5 68 2 - 
Notes: 1 Consensus for agreement reached (+) if valid percent agreement was ≥ 75% and IQR ≤ 1; 2 
Percentage disagreement; 3 Newly worded statement in Round Three; 4 New statement in Round 
Three. 
 
 
7.4.3 Overcoming perceived current barriers to the implementation 
of a nurse-led model of care for MA provision in regional and rural 
Victoria 
This theme focuses on the potential solutions to overcome perceived 
barriers to the implementation of a nurse-led model of care for MA provision in 
regional and rural Victoria. Of the six statements that had not yet reached 
consensus in Round Two, all but one statement obtained consensus (see Table 
7.10). Full (100% agreement, IQR = 1) consensus was achieved for the statement 
that PHCNs require flexibility and choice for online training or locally organised 
MA training session, to maximise training opportunities. The statement that GPs 
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who provide MA should be made visible (e.g., advertise with ‘all-option 
pregnancy counselling offered at this general practice’) did not achieve 
consensus. It received an even lower agreement level in Round Three (68% 
agreement, IQR = 2) compared to Round Two (75% agreement, IQR = 1.75). 
 
Table 7.10 Consensus reached in Round Three for statements regarding panellists’ 
solutions on how to overcome current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria 
 
 Statements Percent 
agree  
Round 2 
IQR 
Round
2 
Percent 
agree 
Round 3 
IQR 
Round 3 
Consen-
sus 
Round 31 
12 PHCNs require flexibility and choice 
for online training or locally 
organised MA training session, to 
maximise training opportunities 
- - 100 1 + 
2 A funded coordinator role needs to 
be established that offers guidance 
and help for PHCNs who want to do 
the MA training 
75 1.75 79 1 + 
3 Payment for nurse-led MA provision 
should be independent of any GP 
involvement 
75 1.75 90 1 + 
42 GP clinics located in areas with 
limited local health services should 
offer ultrasound (after appropriate 
training) and blood test services so 
women do not need to go 
somewhere else 
70 1 95 1 + 
5 GPs who provide MA should be 
made visible (e.g. advertise with "all-
option pregnancy counselling offered 
at this general practice") 
75 1.75 68 2 - 
6 Financially support women to 
facilitate MA access (e.g. for travel 
and childcare costs) 
65 2 84 1 + 
Notes: 1 Consensus for agreement reached (+) if valid percent agreement was ≥ 75% and IQR ≤ 1; 2 
Newly worded statement in Round Three. 
 
 
 
7.5 A NURSE-LED MODEL OF MA PROVISION AND THE 
BARRIERS AND SOLUTIONS TO IMPLEMENTATION 
Based on the Delphi findings, a nurse-led model for MA provision in 
regional and rural Victoria was constructed, together with the identified barriers 
and solutions to the implementation of the model. The construction of the 
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model and the implementation barriers and solutions are presented in the 
following two sections. Verbatim quotes from Round Two and Three are added 
to illustrate the findings, and differences in views between panellists’ profession 
groups are shown. 
 
7.5.1. Construction of a nurse-led model of care for MA abortion 
provision in regional and rural Victoria 
Similar to existing frameworks (Costescu et al. 2016; RCN 2017; WHO 
2015b), the following three phases of a nurse-led model of care for MA provision 
in regional and rural Victoria were identified: 
1. Assessment of MA eligibility 
2. Medication administration and management of side-effects 
3. Evaluation of abortion completion and post-abortion care.  
The statements from the three Delphi rounds that relate to the 
construction of a nurse-led MA model are structured around these three phases. 
The statements are presented in Table 7.11 and include the level of consensus 
reached and a comparison of the ratings between the three groups using the 
Kruskall-Wallis test. They are further explored per phase in the three sections 
following the table. 
 
Table 7.11 Construction of a nurse-led model of care for MA provision in regional and 
rural Victoria 
 
 Consensus statements IQR Consen-
sus1 (%) 
KW3 
test 
KW 
p-
value 
Dunn 
test4 
Dunn 
p-value 
Assessment of MA eligibility 
1 All women with an unwanted 
pregnancy should be referred 
to an appropriately trained 
PHCN 
1 84 5.895 0.052   
2 The PHCN role should include 
non-directive pregnancy 
counselling 
1 90 1.596 0.5   
3 A PHCN should be able to 
communicate the pros and cons 
of the medication abortion 
0 95 3.512 0.2   
Chapter 7 | Delphi study findings 
 
151 
 Consensus statements IQR Consen-
sus1 (%) 
KW3 
test 
KW 
p-
value 
Dunn 
test4 
Dunn 
p-value 
4 A sufficiently trained PHCN is 
not able to independently rule 
out any contraindications to the 
use of abortion medication 
0 802 0.819 0.7   
5 When practice GPs refuse to 
provide MA, PHCNs should be 
able to initiate pretesting 
before referral 
1 85 7.968 0.02 
N-P 
N-O 
P-O 
0.03 
1.0 
0.051 
6 It is within the scope of practice 
of a registered PHCN to 
independently refer a woman 
for an ultrasound (for 
pregnancy dating and ectopic 
pregnancy screening) and blood 
tests 
1 80 4.096 0.1   
7 MA in the primary health care 
sector can be provided by a 
PHCN in cooperation with a GP 
0.75 75 6.670 0.04 N-P 
N-O 
P-O 
1.0 
0.03 
0.4 
85 All steps in the MA process that 
are handled by an appropriately 
trained PHCN should only be 
allowed under the supervision 
of a GP 
1 472 3.304 0.4   
95 Allow all appropriately trained 
registered nurses to be 
responsible for the whole MA 
process without a GP's 
approval. The GP should only be 
required for the prescription of 
MA 
2 58 8.766 0.2   
Medication administration and management of side-effects 
10 PHCNs are able to interpret the 
results of an ultrasound and 
blood test in such a way that 
they can assess if MA provision 
is advisable 
1 95 3.639 0.2   
11 The administration of 
mifepristone can be 
independently handled by a 
PHCN 
1 95 4.172 0.1   
12 The PHCN role should include 
contraception 0 100 1.166 0.6   
13 PHCNs can independently 
manage prophylactic pain 
medication 
1 90 0.976 0.6   
Evaluation of abortion completion and post-abortion care 
145 Non-life-threatening 
complications of MA, like 
haemorrhages or infections, 
should be managed by doctors 
only 
2 472 4.293 0.7   
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 Consensus statements IQR Consen-
sus1 (%) 
KW3 
test 
KW 
p-
value 
Dunn 
test4 
Dunn 
p-value 
15 Completion of an abortion 
cannot be totally assessed by a 
PHCN 
1 852 0.671 0.7   
16 The appropriately trained PHCN 
can manage post-abortion 
contraception, including the 
insertion of implants, IUDs or 
the provision of injectable 
contraception 
1 95 2.934 0.8 
  
17 The PHCN role can include the 
provision of emotional support 
following the procedure if 
required 
0.75 90 0.8378 0.02 
N-P 
 N-O 
P-O 
1.0 
0.01 
0.1 
Notes: 1 Consensus for agreement reached if valid percent agreement was ≥ 75% and IQR ≤ 1; 2 
Negatively worded, reverse coded with percentage disagreement; 3 Kruskal-Wallis H-test for the 
comparison of ratings between groups; 4 Post-hoc Dunn-Bonferroni test on each pair of groups, 
consisting of nurses (N), physicians (P) and others (O); 5 Non-consensus statements. 
 
 
7.5.1.1 Assessment of MA eligibility 
Nine statements were identified as tasks and components associated 
with the first phase of the nurse-led model of MA provision. In this phase, the 
pregnant woman contacts the PHC professional and the eligibility for MA is 
assessed. Panellists agreed (84%, IQR = 1) that all women with an unwanted 
pregnancy should be referred to an appropriately trained PHCN (Table 7.11, no. 
1); however, it was noted that women should also have the option to visit a GP: 
I think women should have a choice of who manages their medical top 
[termination of pregnancy] esp. in country areas for confidentiality 
/privacy, some may prefer to see only a dr or only a nurse (Physician4). 
In addition, the importance of having one provider in charge of the whole 
MA process was highlighted: 
It is important for women to have a one stop shop which meets all their 
needs. It is often difficult to tell your story to several people (Nurse1). 
While most (90%, IQR = 1) panellists agreed a PHCN’s role should include 
non-directive pregnancy counselling (Table 7.11, no. 2), it was expressed by one 
Chapter 7 | Delphi study findings 
 
153 
panellist that most women already know that they want an abortion and, 
therefore, do not need to be counselled on the choice to terminate: 
…clearly communicate the pros and cons for ALL pregnancy options, as 
well as the steps involved in referral pathways. The latter is important for 
women living in rural and regional areas to have all information, including 
costs related to services, waiting times, distance & travel, service 
procedure & post health care & support (Other3). 
When a woman decides to undergo a MA to terminate her pregnancy, 
panellists disagreed (80%, IQR = 0) that a sufficiently trained PHCN is not able to 
independently rule out any contra-indications to the use of MA (Table 7.11, no. 
4). The tasks involved with the clinical assessment of contra-indications include 
taking a medical history, a physical examination, and assessing any comorbidities 
(RANZCOG 2016). There was overall consensus (80%, IQR = 1) that it is within the 
scope of practice of a registered PHCN to independently refer a woman for an 
ultrasound (for pregnancy dating and ectopic pregnancy screening) and blood 
tests (Table 7.11, no. 6). 
Consensus (85%, IQR = 1) was also achieved for the statement that when 
practice GPs refuse to provide MA, PHCNs should be able to initiate pre-testing 
before referral (Table 7.11, no. 5). There was, however, a statistically significant 
difference in ratings between the panellists’ groups (KW test statistic = 7.968; p = 
0.02), with physicians (24%) less likely to agree with the statement than nurses 
(41%; p = 0.03). 
Opinions regarding the overall responsibilities of the PHCN in MA 
provision differed. While overall most panellists agreed (75%, IQR = 0.75) that 
MA provision in the PHC sector can be provided by a PHCN in cooperation with a 
GP (Table 7.11, no. 7), there was a statistically significant difference between the 
panellists’ groups (KW test statistic = 7.968; p = 0.02). Nurses (53%) were more 
likely to agree with the statement than panellists in the ‘other’ group (20%; p = 
0.03). The scenario of MA provision by a PHCN in cooperation with a GP was 
welcomed by one PHCN: 
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...it would be fantastic if nurses had extended skills like ordering of tests 
etc. Then nurses could do all the work up and the GP would have all the 
information in consultation with the nurse and after seeing the client to 
order the medication (Nurse9). 
One physician, however, questioned a prescription-only role of GPs:  
As a GP, I would not feel comfortable with a prescription only role for 
abortion (Physician4). 
Some panellists, on the other hand, favoured an alternative scenario, in 
which the PHCN becomes fully responsible for the MA process: 
Appropriately trained PHCN led provision of MA, including authority to 
prescribe is the preferred model to significantly improve access to non-
directive pregnancy choices counselling AND abortion services in rural 
areas (Other3). 
Nurses can be trained to provide all steps of MTOP independently. ….If 
nurses were able to prescribe they could be trained to provide the 
treatment autonomously (Physician7). 
It was additionally recommended that for PHCNs working in community 
health care settings, partnerships with service GPs should be set up: 
There needs to be varying models that would allow nurse working in 
areas such as women's health clinics or community health to 
independently prescribe and a collaborative model for use in a GP 
practice with a supportive GP (Nurse1). 
While all steps of the first phase of the nurse-led model of MA provision 
are grounded within the PHCNs’ scope of practice (Australian Primary Health 
Care Nurses Association 2017), PHCNs in Victoria are currently not able to be 
independently responsible for the whole first phase MA process. They have to 
adhere to the MBS requirements (Department of Health 2017b) that request the 
personal attendance of the GP for specific services in order to qualify abortion 
requesting women for benefit refunds. Therefore, in addition to a first phase, 
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fully autonomous nurse-led MA model, another first phase ‘legally feasible’ 
nurse-led model was constructed that takes into account the required 
involvement of a GP. A third nurse-led model, referred to as the ‘absence of a 
(supportive) GP’ model, is included for PCHNs who work in settings that lack 
immediate support of a GP. In this situation, PHCNs would be able to initiate pre-
testing before referral, albeit within the limits of above-described current MBS 
boundaries. This model only consists of the first phase of the MA provision 
process, as the following two phases are provided at another location by another 
provider. A framework of the first phase of the three proposed nurse-led MA 
models is shown in Figure 7.3. The steps specific for each model are depicted in a 
different colour. 
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Figure 7.3 Framework for the first phase of the three proposed nurse-led models of MA 
provision 
 
 
7.5.1.2 Medication administration and management of side-effects 
Four statements were identified as tasks and components associated 
with the second contact of the pregnant woman with the PHCN, in which the MA 
is administered and expected side-effects are managed. Most (95%, IQR = 1) 
panellists agreed that PHCNs are able to interpret the results of ultrasounds and 
blood tests in such a way that they can assess if MA provision is advisable (Table 
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7.11, no. 10). Two panellists commented on their support for PHCNs’ ability to 
perform these tasks. 
With appropriate training, qualifications, and ongoing assessment of 
skills, updates etc, this should be safe (Physician4). 
The issue is with the Medicare rebate for the ultrasound and pathology 
not the nurses’ ability to interpret (Nurse1). 
It was additionally acknowledged by most (95%, IQR = 1) panellists that 
the administration of mifepristone can be independently handled by a PHCN 
(Table 7.11, no. 11) and that PHCNs can autonomously manage prophylactic pain 
medication (90%, IQR = 1) (Table 7.11, no. 13). Further, panellists agreed (95%) 
that the PHCN’s role should include contraception (Table 7.11, no. 12). 
As ‘fully autonomous’ nurse-led MA provision in the second phase of the 
nurse-led MA procedure is currently not possible in Victoria because PHCNs are 
not allowed to prescribe MA drugs (VLRC 2008), the ‘legally feasible’ model is 
included as a different in the framework (see Figure 7.4). 
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Figure 7.4 Framework for the second phase of the fully autonomous and the legally 
feasible nurse-led MA provision model 
 
 
7.5.1.3 Evaluation of abortion completion and post-abortion care 
Four statements were recognised as being part of the third phase of the 
nurse-led MA provision procedure, in which post-abortion care, if required, is 
provided and abortion completion is evaluated. No consensus (47%) was 
reached in relation to which health practitioner should manage non-life-
threatening MA complications, such as haemorrhages or infections (Table 7.11, 
no. 14). Some panellists commented that, if appropriately trained, PHCNs should 
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be able to manage non-life-threatening complications and that, if necessary, 
consultation or referral can be organised. It was suggested that: 
Appropriately trained nurses could have protocols for managing 
complications (Physician7). 
Others questioned this strategy and advised that management of 
complications should always be done in collaboration with a physician. One 
panellist worried about access issues: 
…a women experiencing a non-life threatening haemorrhage following 
MA may have greater access to a doctor after hours at a hospital than an 
appropriately trained PHCN (Other3). 
It was additionally recognised that independent management of post-
abortion complications by PHCNs could be problematic in more isolated rural 
areas. 
Most (85%, IQR = 1) panellists disagreed with the statement that 
completion of an abortion cannot be totally assessed by a PHCN (Table 7.11, no. 
15) and most (90%, IQR = 0.75) agreed that the PHCN’s role can include the 
provision of emotional support following the procedure if required (Table 7.11, 
no. 17). This last statement, however, showed a statistically significant difference 
in agreement ranking between the three panellists’ groups (KW test statistic = 
8.378; p = 0.02). Nurses (44%) were more likely to agree with the statement than 
panellists in the ‘other’ group (22%; p = 0.01). The difference in rating was 
somewhat reflected in the following comment: 
…professional counselling should be offered where available, if not 
available then the PHC nurse could provide support (Other2). 
Finally, consensus (90%, IQR = 1) was reached for the statement that 
appropriately trained PHCNs can manage post-abortion contraception, including 
the insertion of implants, IUDs or the provision of injectable contraception 
(Table 7.11, no. 16). However, despite reaching consensus, the views among 
panellists regarding PHCNs inserting implants and IUDs were diverse. 
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Would be great if we could insert Implanon and give depo after training 
(Nurse7). 
Nurses can council or refer but should not be trained for Implanon or IUD 
insertions (Physician1). 
All steps belonging to the third phase of the nurse-led MA provision 
model (see Figure 7.5) can be independently handled by the PHCNs, and phase 
three is, therefore, identical for the fully autonomous and legally feasible nurse-
led MA provision model. 
 
Figure 7.5 Framework for the third phase of the fully autonomous and the legally feasible 
nurse-led MA provision model 
 
 
 
7.5.2 Barriers and solutions to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria 
Six overarching themes of barriers and solutions to the implementation 
of the three nurse-led models of care for MA provision in regional and rural 
Victoria emerged from the consensus statements. The first five themes focus on 
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different aspects of the MA process, while the final theme emphasises the 
importance of evidence validation and policy change: 
1. Professional development and training opportunities 
2. Support systems for health care professionals 
3. Funding for a nurse-led model of MA provision 
4. Accessibility support services 
5. Confidentiality, privacy, stigma and safety issues 
6. Evidence validation and policy change. 
The statements that were perceived by the panellists, over the three 
Delphi rounds as current barriers to the implementation of the three nurse-led 
models of care for MA provision in regional and rural Victoria are presented in 
Table 7.12 and include the level of consensus reached and a comparison of the 
ratings between the three groups using the Kruskall-Wallis test. 
 
Table 7.12 Barriers to the implementation of a nurse-led model of care for MA provision 
in regional and rural Victoria 
  
Consensus statements IQR Consensus1 
(%) 
KW test3 KW test      
p-value 
Professional development and training opportunities 
1 Most GPs are aware of the online 
MA training currently available 
0 802 4.375 0.1 
2 There is insufficient availability of 
MA trained GP providers in 
regional and rural Victoria 
1 95 2.359 0.3 
3 There is a lack of professional 
development and further training 
possibilities for PHCNs (including 
MA provision) 
1 85 3.385 0.2 
4 Many GPs are not aware that 
they can offer MA 
1 85 0.323 0.3 
Support systems for health care professionals 
5 Traditionally, GPs prefer to be in 
charge over some services, which 
includes MA provision 
1 95 0.512 0.8 
6 Not all local pharmacies supply, 
or wish to supply, MA drugs 
1 84 2.188 0.3 
7 Without a GP's approval for MA 
provision, nurse involvement is 
not supported 
1 85 0.163 1.0 
8 There is no support from local 
hospitals and community health 
0.75 75 0.151 0.9 
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Consensus statements IQR Consensus1 
(%) 
KW test3 KW test      
p-value 
services to GPs and PHCNs who 
provide MA services 
94 There is a well-established 
positive collaboration between 
the Australian Medical 
Association and nursing 
authorities 
1 472 0.745 0.689 
104 There is a lack of specialist and 
other health professionals’ 
support available to GPs and 
PHCNs that provide MA services 
1 74 0.664 0.717 
114 The Victorian Government is 
negligent about discussing and/or 
promoting MA 
3 47 2.443 0.295 
124 GPs fear ramifications on both 
time and negative outcomes 
(complications) when providing 
MA services 
1 72 0.226 0.893 
134 It appears that public 
expectations about equitable 
availability of abortion services 
are ahead of the actual 
implementation 
2 68 5.067 0.079 
Funding for a nurse-led model of MA provision 
14 GP involvement is required to 
enable payment for this service 
1 80 1.397 0.5 
15 There is not enough funding to 
make nurse-led MA provision 
profitable 
1 79 0.305 0.9 
164 General practice funding for 
nurse-led MA provision is 
currently included in the 
quarterly practice nurse incentive 
program payment, which includes 
a rural loading of up to 50% and 
is independent of Medicare item 
numbers. There is sufficient 
allowance in the practice nurse 
incentive program payment to 
cover nurse-led MA provision 
2 632 1.139 0.566 
Accessibility support services 
17 There is a lack of after-hours care 
in small towns for women who go 
through a MA 
1 90 1.583 0.5 
18 There is a lack of local allied 
professionals and accessible 
services for women (such as 
radiographers) in regional and 
rural Victoria 
0.75 95 1.154 0.6 
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Consensus statements IQR Consensus1 
(%) 
KW test3 KW test      
p-value 
19 There is a lack of local access to 
surgical back-up in regional and 
rural Victoria in the case of MA 
complications 
0.75 80 1.466 0.5 
Confidentiality, privacy, stigma and safety issues 
20 Women in regional and rural 
areas worry about confidentiality 
and privacy issues 
0.75 90 2.744 0.3 
21 GPs and PHCNs fear negative 
publicity from members of 
conservative communities and/or 
fear of personal vilification if they 
were to provide MA services 
1 84 3.112 0.2 
22 There is pressure on GPs to 
conform to the conservative 
views of their colleagues 
regarding the provision of MA 
services 
0 90 0.427 0.8 
23 GPs fear moral judgement by 
other health professionals if they 
were to provide MA services to 
their patients 
0 84 0.354 0.8 
244 The rural population does not 
complain about poor MA services 
in their area, because it is a 
private and contentious subject 
3 74 0.971 0.615 
254 GPs are concerned about their 
safety and wellbeing if they were 
to provide MA services 
2 74 1.557 0.455 
264 GPs and PHCNs fear the presence 
of anti-choice protestors outside 
the facility if they were to provide 
MA services 
2 68 0.577 0.749 
274 The Victorian government is 
nervous about discussing and/or 
promoting MA. They fear 
community backlash or anti-
choice campaigns in parliament 
and their own party 
2 58 2.495 0.287 
284 GPs concerns regarding MA 
service provision appear to be 
based mainly on workload and 
time 
2 42 3.711 0.156 
Notes: 1 Consensus for agreement reached if valid percent agreement was ≥ 75% and IQR ≤ 1; 2 
Negatively worded, reverse coded with percentage disagreement; 3 Kruskal-Wallis H-test for the 
comparison of ratings between groups; 4 Non-consensus statements. 
 
 
Similarly, Table 7.13 presents all statements that were recognised to 
overcoming perceived barriers to the implementation of the three nurse-led 
models of care for MA provision in regional and rural Victoria. Included in the 
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table are the consensus levels reached and a comparison of the ratings between 
the three groups using the Kruskall-Wallis test.  
The six overarching themes of barriers and solutions to nurse-led MA 
model implementation are separately discussed in the following sections. The 
findings are supported by the qualitative data. 
 
Table 7.13 Overcoming perceived current barriers to the implementation of a nurse-led 
model of care for MA provision in regional and rural Victoria 
  
Consensus statements IQR Consen-
sus1 (%) 
KW 
test2 
KW test 
p-value 
Dunn 
test3 
Dunn 
p-value 
Professional development and training opportunities 
1 Incentives and support should 
be offered for rural and 
regional GPs to undertake MA 
training and service provision 
0 100 0.062 1.0   
2 Professional development 
courses in sexual and 
reproductive health for nurses 
should include a MA provision 
component 
0 95 2.969 0.2   
3 The State Government should 
establish an action plan in 
partnership with PHC networks 
to prioritise, promote and 
provide affordable, accessible 
MA professional development 
and training for GPs and PHCNs 
working in regional and rural 
Victoria 
0 95 0.15 1.0   
4 Supportive information should 
be freely available to all MA 
providing nurses (e.g. 
Resources on the MS health 
website) 
0 95 5.299 0.07   
5 PHCNs require flexibility and 
choice for online training or 
locally organised MA training 
session, to maximise training 
opportunities 
1 100 0.629 0.7   
6 Incentives like scholarships 
should be offered to upskill 
PHCNs for MA provision 
1 100 2.224 0.3   
7 Professional development 
programs for GP accreditation 
should include MA provision 
0.75 95 0.610 0.7   
8 Remuneration needs to be 
offered to practices when 
nurses attend professional 
development courses on MA 
0.75 85 0.190 0.9   
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Consensus statements IQR Consen-
sus1 (%) 
KW 
test2 
KW test 
p-value 
Dunn 
test3 
Dunn 
p-value 
Support systems for health care professionals 
9 Direction is required from the 
Australian health practitioner 
regulation agency on the 
nurses’ scope of practice in MA 
provision 
1 90 1.094 0.6   
10 Improve communication about 
MA between local hospitals, 
GPs and PHCNs 
0 100 2.333 0.3   
11 There should be open 
endorsement of MA from peak 
bodies such as the Australian 
Medical Association, royal 
Australian College of General 
Practitioners, nursing 
authorities and government 
0 95 1.016 0.6   
12 There should be support and 
endorsement of MA from local 
health professionals (including 
boards of hospitals and 
community centres) 
0 100 0.968 0.6   
13 Establish a PHCN network for 
MA practice which includes 
mentoring, networking, and 
opportunities to share 
experiences and learn 
0.75 100 2.744 0.3   
14 Create a MA provision model 
for PHCNS, which can provide 
guidance, support and help to 
develop their roles 
0.75 100 2.744 0.3   
15 Develop a dedicated team of 
MA-trained PHCNs to support 
the provision of MA services in 
smaller or more remote health 
care settings 
0 95 1.166 0.6   
16 Nurses need leaders and 
mentors to encourage and 
empower them in their 
professional development, 
which includes MA provision 
0.75 95 0.811 0.7   
Funding for a nurse-led model of MA provision 
17 Ensure that PHCNs who provide 
MA are covered by insurance 
0 95 4.912 0.09   
18 Create a Medicare benefits 
schedule (MBS) item number 
for PHCN consultations related 
to ma provision 
1 90 4.711 0.1   
19 A funded coordinator role 
needs to be established that 
offers guidance and help for 
PHCNs who want to do the MA 
training 
1 79 1.473 0.5   
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Consensus statements IQR Consen-
sus1 (%) 
KW 
test2 
KW test 
p-value 
Dunn 
test3 
Dunn 
p-value 
20 Payment for nurse-led MA 
provision should be 
independent of any GP 
involvement 
1 90 0.436 0.8   
21 Financially support women to 
facilitate MA access (e.g. for 
travel and childcare costs) 
1 84 0.845 0.7   
Accessibility support services 
22 Develop best practice service 
models for MA which includes 
access to radiography and after 
care services 
1 100 2.333 0.3   
23 Guarantee access to quality 
specialist back-up when needed 
0 100 0.968 0.6   
24 Increase and improve the 
availability of MA drugs in local 
pharmacies through MA 
education programs for 
pharmacists 
0 95 5.078 0.8   
25 GP clinics located in areas with 
limited local health services 
should offer ultrasound (after 
appropriate training) and blood 
test services so women do not 
need to go somewhere else 
1 95 1.433 0.5   
26 Public awareness about the 
availability of MA can lead to 
increased public demand. This 
can act as a driver for improved 
service provision 
1 95 0.564 0.7   
27 There should be a statement of 
expectation from the 
department of health that MA 
should be core business for 
primary health systems in 
regional and rural areas 
0.75 85 0.519 0.8   
28 GP clinics should stock and 
supply abortion medication so 
women do not need to go 
somewhere else 
1 85 2.673 0.3   
Confidentiality, privacy, stigma and safety issues 
29 Emergency department staff 
should respond in a non-
judgmental way in cases of 
abortion complications 
0 100 0.00 1.0   
30 Abortion should be seen as 
being part of comprehensive 
sexual and reproductive health 
care, consequently reducing 
abortion stigma 
0 100 0.968 0.6   
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Consensus statements IQR Consen-
sus1 (%) 
KW 
test2 
KW test 
p-value 
Dunn 
test3 
Dunn 
p-value 
31 There should be support and 
protection for PHCNs and GPs 
who wish to offer MA services 
but are afraid of community 
backlash, harassment or legal 
issues 
0 100 4.898 0.09   
32 Conscientious objection should 
be out in the open. The public 
needs to know if a doctor is a 
conscientious objector 
0.75 90 3.605 0.2   
334 GPs who provide MA should be made visible (e.g. Advertise 
with "all-option pregnancy 
counselling offered at this 
general practice") 
2 68 8.217 0.02 N-P 
N-O 
P-O 
0.082 
1.0 
0.017 
Evidence validation and policy change 
34 Encourage nursing research to 
validate the role of PHCNs and 
demonstrate effectiveness of 
nurse-led MA provision 
0.75 90 8.378 0.02 N-P 
N-O 
P-O 
0.014 
1.0 
0.119 
35 Continue to challenge 
traditional nursing duty ‘norms' 
for MA, and ensure a stringent 
use of evidence and best 
practice, as scope of practice 
boundaries are shifted 
0.75 90 8.378 0.02 N-P 
N-O 
P-O 
0.014 
1.0 
0.119 
36 Introduce data collection 
systems for monitoring and 
evaluation of nurse-led MA 
provision in regional and rural 
Victoria 
0.75 90 7.157 0.03 N-P 
N-O 
P-O 
0.024 
1.0 
0.247 
37 Make recommendations to 
parliament and working parties 
to change legislation to allow a 
wider scope of practice for 
PHCNs 
1 90 7.887 0.02 N-P 
N-O 
P-O 
0.017 
1.0 
0.205 
38 Change legislation to allow 
prescription of abortion 
medication by registered nurses 
in regional and rural Victoria 
1 85 1.749 0.4   
Notes: 1 Consensus for agreement reached if valid percent agreement was ≥ 75% and IQR ≤ 1; 2 
Kruskal-Wallis H-test for the comparison of ratings between groups; 3 Post-hoc Dunn-Bonferroni 
test on each pair of groups, consisting of nurses (N), physicians (P) and others (O); 4 Non-consensus 
statements. 
 
 
7.5.2.1 Professional development and training opportunities 
Four statements were identified as model implementation barriers 
relating to a professional development and training opportunities. Panellists for 
instance agreed (85%, IQR = 1) that there is a lack of professional development 
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and training possibilities for PHCNs, which includes MA provision (Table 7.12, no. 
3). This view is reflected in the following quote: 
There is very limited training available for nurses re providing MTOP all 
the clinical training up to date is for GP's (Nurse4). 
Although it was recognised that MA education for PHCNs was offered, 
training seemed to be restricted to specific regional areas, which is illustrated as 
follows: 
There are possibilities for PHC professional development and training 
from a number of providers in the Goulburn Valley & North East Victoria 
(Other3). 
The knowledge the nurses at our clinic have obtained has come from 
attending education days and sharing information on how other places 
provide MTOP services (Nurse4). 
Further, reasons were provided for the generally low attendance at these 
education days. One panellist stated: 
Attendance of PHCNs working in the primary health care sector is 
generally low. Anecdotal evidence through partnership programs & 
existing SH [sexual health] networks suggests that Practice Nurses 
working in GP clinics are already overworked (Other3). 
Most panellists additionally agreed (95%, IQR = 1) there is insufficient 
availability of MA trained GP providers in regional and rural Victoria (Table 7.12, 
no. 2). Moreover, panellists acknowledged (85%, IQR = 1) that GPs are often not 
aware that they can offer MA (Table 7.12, no. 4). It was, therefore, commented 
to expand MA education for GPs: 
Still need to push GP education (Physican1). 
Some respondents, however, thought that the low up-take of MA 
provision had other reasons, as reflected in the following quote: 
Busy workloads and time constraint may prevent more serious 
consideration (Other3). 
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Besides from model implementation barriers related to professional 
development and training opportunities, eight statements were recognised as 
solutions to overcome perceived barriers (see Table 7.13). It was, for example, 
acknowledged (95%, IQR = 1) that sexual and reproductive health courses for 
nurses and professional development programs for GP accreditation should 
include a MA provision component (Table 7.13, no. 2 and 7). Although it was 
noted that such an implementation would not guarantee an increase in MA 
providers, additional screening of health practitioners could be a solution. This 
thought was reflected in the following quote: 
A moral objection to providing any primary care service could be screened 
out in the future, e.g. those doctors with a moral objection cannot 
practice in an area where their beliefs stop them from providing a service 
that is part of the suit of primary care (Physician7). 
Further, it was agreed (95%, IQR = 0) that the State Government should 
establish an action plan in partnership with PHC networks to prioritise, promote 
and provide affordable, accessible MA professional development and training for 
GPs and PHCNs working in regional and rural Victoria (Table 7.13, no. 3). A 
funded coordinator could offer guidance and help for PHCNs who want to do the 
MA training (agreement level 79%, IQR = 1) (see Table 7.13, no. 19). To facilitate 
any financial burden, it was additionally agreed (85-100%, IQR = 0-1) that 
incentives (like scholarships for PHCNs), support and remuneration for practices 
with PHCNs attending MA courses needed to be offered (Table 7.13, no. 1, 6 and 
8). One panellist emphasised the use of scholarships and incentives: 
[Scholarships and incentives] may be useful for PHCNs and GPs based in 
more isolated and/or disadvantaged communities, including health 
professionals working with newly arrived or aboriginal communities or 
those based in lone, smaller health services in towns and more isolated 
rural areas (Other3). 
Another panellist suggested that MA training should not be provided to 
GPs without involving their practice PHCN(s): 
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I feel that you actually need to have PHCN who is able to spend the time 
that GP's do not have to perform this process within a Best Practice 
model. Training GP's is great but they also need a trained nurse working 
with them (Nurse7). 
 
7.5.2.2 Support systems for health care professionals 
Nine statements focused on model implementation barriers relating to 
support systems for health care professionals. Panellists agreed (85%, IQR = 1) 
that without a GP’s approval for MA provision, nurse involvement is not 
supported (Table 7.12, no. 7). It was recognised that GPs without an interest in 
women’s health were not likely to become involved in MA provision: 
Therefore, if doctors aren't interested in providing MTOP services and the 
nurses in the practice have little influence on the services that are 
provided then…it is hard to imagine how the service will be implemented 
into those clinics (Nurse4). 
GPs in private practice may not identify women's sexual and reproductive 
health services as a priority for PHCN professional development and 
training (Other3). 
Panellists also believed (95%, IQR = 1) that, traditionally, GPs prefer to 
maintain control over some services, including MA provision (Table 7.12, no. 5), 
and, therefore, do not want nurses to fully take on specific roles. One reason for 
maintaining control was, according to a panellist, an underlying concern about 
earnings: 
GP services are also a livelihood for the doctors. Some may see this as 
affecting their income (Nurse2). 
Another barrier relating to support systems concerned the supply of 
mifepristone. Panellists agreed (84%, IQR = 1) that not all local pharmacies 
supply, or wish to supply, MA drugs (Table 7.12, no. 6). Some argued that this 
lack of support from pharmacists was mainly caused by financial reasons: 
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…the fact that the medications are expensive and a potential financial 
liability (Physician7). 
Others thought that the lack of pharmacists’ support could be related to 
the pharmacy’s infrastructure, or that had to do with a pharmacist’s moral 
judgement. These ideas are illustrated in the following quotes: 
There was no private area in the pharmacy for patient consultation 
(Nurse1). 
I have worked in a rural area where the pharmacist would not provide the 
morning after pill to anyone under 16 and preferred not to provide it at all 
(Nurse1). 
A lack of support from local hospitals and community health services for 
GPs and PHCNs who provide MA services was also identified by the majority 
(75%, IQR = 0.75) of panellists (Table 7.12, no. 8). This was further defined by 
one participant as a: 
…lack of encouragement but not actual support like theatre time for 
complications etc (Physician1). 
No consensus (74%, IQR = 1) was reached for the statement that there 
was a lack of specialist and other health professionals’ support available to GPs 
and PHCNs that provide MA services (Table 7.12, no. 10), and views were 
diverse. For example, some participants believed there was a lack of support, 
while others thought there was an already positive shift in support. These 
differences in beliefs are highlighted in the following quotes: 
There is a lack of support for MA across the board. This should be an 
easily accessible treatment for women. It should be as acceptable as 
going for a pill script (Nurse1). 
The only specialist who would support this in our region is a 1 hour drive 
away for a patient (Physician6). 
It has already started but needs more development and resources - a 
central nurse led model could facilitate this well (Physician4). 
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There is a great network of doctors who help other doctors out, but no 
organised assistance or supervision. It would be great to have a doctor's 
hot line (or nurse if they were allowed to prescribe and manage) 
(Physician7). 
Also, there was no agreement (47%, IQR = 1) reached regarding the 
presence of a well-established collaboration between the AMA and nursing 
authorities (Table 7.12, no. 9). Some panellists questioned the existence of such 
a collaboration, as the following quotes show: 
Feel the AMA has a negative view of what nurses are capable of 
(Physician7). 
The AMA will object to this and any other proposal that takes any power 
from the medical profession. The RACGP will object unless it can be seen 
to benefit GP's (Nurse1). 
Eight statements involved solutions to overcome some of the above-
mentioned implementation barriers that relate to support systems for health 
care professionals. Most (95-100%, IQR = 0.75) panellists agreed that PHCNs 
need leaders, mentors and networks to support, encourage and empower them 
in providing MA services (Table 7.13, no. 13 and 16). It was acknowledged (95%, 
IQR = 0) that it is particularly important for smaller or more remote health care 
settings to have a dedicated team of MA-trained PHCNs that can support the 
provision of MA (Table 7.13, no. 15). One panellist recognised that independent 
management of the PHCN could be problematic in more isolated rural areas. The 
use of teleconference or the establishment of a local expert team for 
consultation purposes was suggested: 
…supervision could be provided via teleconference should the local 
physician be unhappy to provide termination services or if there is no local 
physician (Nurse1). 
Links to a 'team' or rural network of appropriately trained PHCNs and 
GPs, may be a practical strategy to assist the management of 
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prophylactic pain and non-life threatening complications for PHCNs 
working in more isolated rural areas (Nurse1). 
The importance of local MA provision in those areas, however, was 
emphasised by one panellist: 
Best for local services to be the primary providers, not fly in fly out teams 
(Physician1). 
Overall, the development of a MA provision model for PHCNs was 
recognised (100%, IQR = 0.75) as being essential, as such a model can provide 
guidance, support and help to develop the PHCNs’ roles (Table 7.13, no. 14). This 
is illustrated in the following quote: 
We all need a strong structure on which to base our practice (Nurse2). 
Further, it was agreed (90%, IQR = 1) that direction is required from the 
Australian health practitioner regulation agency on the nurses’ scope of practice 
in MA provision (Table 7.13, no. 9). In addition, most panellists (95-100%, IQR = 
0) thought that peak bodies, such as the AMA, the RACGP and nursing 
authorities, the government and local health professionals (including boards of 
hospitals and community centres) should show support and an open 
endorsement of MA provision (Table 7.13, no. 11 and 12). One panellist 
explained: 
These actions would lead to the demystifying of abortion in general and 
build community and professional knowledge and awareness. Ultimately 
these actions would go a long way in reducing stigma and to normalising 
access to comprehensive, safe abortion services as a legitimate and 
normal reproductive health service provided by health professionals in a 
range of mainstream health settings (Other3). 
Finally, in order to tackle the recognised lack of current support from 
local hospitals and community health services for GPs and PHCNs who provide 
MA services, all panellists agreed that communication between hospitals, GPs 
and PHCNs need to be improved (Table 7.13, no. 10). 
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7.5.2.3 Funding for a nurse-led model of MA provision 
Three statements were recognised as model implementation barriers 
relating to the funding for a nurse-led model of MA provision, and five 
statements related to overcoming those funding barriers. Although there was no 
consensus (63% disagreement, IQR = 2) reached for the statement that there is 
sufficient allowance in the PNIP payment to cover nurse-led MA provision (Table 
7.12, no. 16), several panellists expressed their concern regarding the current 
general practice funding for nurse-led MA provision: 
There will be greater remuneration in nurses providing services related to 
mental health or chronic disease plans (Physician7). 
Under the current funding model nurses working in general practice will 
not be allowed to provide MA (Nurse1). 
Unless there are financial incentives for the clinic it is hard to imagine 
how the service will be implemented (Nurse4). 
Funding will be a real barrier to be overcome (Physician1). 
Most panellists agreed (79%, IQR = 1) about a lack of funding to make 
nurse-led MA provision profitable (Table 7.12, no. 14). Several comments, 
however, were made related to the word ‘profitable’: 
I would feel uncomfortable about seeing such a service as being 
profitable… surely only costs need to be covered (Nurse2). 
Would nurses not be salaried? Should MA provision be funded by the 
public health system and therefore not require a profit motive? (Other1). 
Additionally, most panellists agreed (80%, IQR = 1) that GP involvement is 
required to enable payment for the MA service (Table 7.12, no. 14). Therefore, it 
was recognised (90%, IQR = 1) that payment for nurse-led MA provision outside 
GP practices should be independent of any GP involvement (Table 7.13, no. 20): 
If nurses are to provide this service in community health and outreach 
services the funding must not be to the GP (Nurse1). 
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While most (90%, IQR = 1) panellists thought that an MBS item number 
should be created for PHCN consultations related to MA provision (Table 7.13, 
no. 18), it was at the same time emphasised that a woman’s confidentiality 
needed to be maintained: 
Creating an item number could be a confidentiality concern, perhaps 
incorporated into another suit of services (Physician7). 
The recommendation to financially support women to facilitate MA 
access (e.g., for travel and childcare costs) was supported by the majority (84%, 
IQR = 1) of panellists (Table 7.13, no. 21), although the implementation of this 
support was questioned, as illustrated by the following quotes: 
This is generous idea and would benefit many women, but I'm not sure 
about where the funding would come from or who would administer it 
(Other1). 
Providing travel costs would have huge cost implications. Better to be 
aware of where help can be accessed and facilitate this (Nurse2). 
 
7.5.2.4 Accessibility support services 
Three statements related to the accessibility of support services as a 
barrier to the implementation of a nurse-led model of care for MA provision in 
regional and rural Victoria. Most panellists agreed (95%, IQR = 0.75) about the 
lack of local allied professionals and accessible services for women (such as 
radiographers) in regional and rural Victoria (Table 7.12, no. 18). This was 
explained by one panellist as being attributed to the ongoing stigma associated 
with abortion provision: 
This [stigma] contributes to fragmented or incomplete information about 
current abortion providers, local allied professionals and services in rural 
and regional Victoria (Other3). 
Other access problems that were recognised (80-90%, IQR = 0.75-1) were 
the lack of after-hours care in small towns for women who go through an MA, 
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and a lack of local access to surgical back-up in the case of MA complications 
(Table 7.12, no. 17 and 19). Most hospitals are located in regional centres, which 
are not always closely situated to some regional and rural areas. One panellist, 
however, did not see this lack of local services as a particular barrier for MA use: 
Yes there is a lack of services but there is a similar lack when a woman 
has a spontaneous abortion or a PPH [postpartum haemorrhage] or a 
placental abruption etc. (Nurse1). 
A total of seven statements were identified as solutions to barriers 
related to the accessibility of support services. Panellists agreed (85%, IQR = 
0.75) that there should be a statement of expectation from the Department of 
Health that MA should be core business for primary health systems in regional 
and rural areas (Table 7.13, no. 27). The importance of this statement was 
stressed by two panellists, and is demonstrated in the following quote: 
Is the absolute key issue in this whole area - not just rural, all public 
hospitals incl. Catholic ones … should be providing all legal options that 
women want and are in their best interests - just like all doctors should 
(Physician1). 
Further, panellists acknowledged (95%, IQR = 1) that public awareness 
about the availability of MA can lead to increased public demand, which can act 
as a driver for improved service provision (Table 7.13, no. 26). There was an 
overall agreement (95%, IQR = 1) that GP clinics located in areas with limited 
local health services should offer ultrasound (after appropriate training) and 
blood test services so women do not need to go somewhere else (Table 7.13, no. 
25). Several panellists, however, conveyed their concern regarding ultrasound in 
general practice. This was expressed the following quote: 
It would be difficult for general practices to buy US [ultrasound] 
equipment and have degree of training necessary. Might be better placed 
in a super clinic (Physician7). 
Additionally, it was agreed (95%, IQR = 1), and deemed as ‘very 
important’ (Physician1) that GP clinics should stock and supply abortion 
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medication in the absence of a supporting pharmacist, so women do not need to 
go somewhere else (Table 7.13, no. 28). Some panellists, however, questioned 
the practicality of this solution, as reflected in the following quotes: 
There's no current mechanism to do this within drug prescribing 
legislation in Victoria (Physician7). 
Stocking of drugs would depend on storage requirements, expiry dates 
and cost. If supplied like vaccinations on the National Immunisation 
Schedule where there is no financial risk to the GP it would work (Nurse1). 
The importance of pharmacists’ support was recognised by most (95%, 
IQR = 0) panellists. They agreed that education programs for pharmacists could 
increase and improve the availability of MA drugs in local pharmacies (Table 
7.13, no. 24). 
Overall, there was full consensus (100%, IQR = 1) that in order to improve 
access to MA support services, best practice service models for MA need to be 
developed, which include access to radiographers and after-care services (Table 
7.13, no. 22). Further, all (100%, IQR = 0) panellists identified that access to 
quality specialist back-up should be guaranteed when needed (Table 7.13, no. 
23). 
 
7.5.2.5 Confidentiality, privacy, stigma and safety issues 
Nine statements were identified as model implementation barriers 
relating to confidentiality, privacy, stigma and safety issues. The study findings 
reflect that sexual and reproductive health is still a highly contentious issue in 
many rural and regional communities (Doran & Hornibrook 2014; Doran & 
Hornibrook 2016). Nearly all (90%, IQR = 0.75) panellists agreed that women in 
regional and rural areas worry about confidentiality and privacy issues (Table 
7.12, no. 20). Some panellists elaborated on the lack of privacy in small 
communities: 
Anonymity is almost impossible, especially in health service settings and 
pharmacies (Other3). 
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Often in smaller communities it is harder to access such services 
discreetly. Everyone knows everyone's business (Nurse2). 
It is very hard for women to speak out about abortion and there is often 
less anonymity in a rural community (Physician7). 
In contrast, no agreement (74%, IQR = 3) was reached for the statement 
that the rural population does not complain about poor MA services in their area 
for privacy reasons and because it is a contentious subject (Table 7.12, no. 24). It 
was thought that this was caused by a lack of public knowledge regarding 
barriers to health and other services for people living in rural and regional 
communities: 
There is a lack of community knowledge and understanding about 
abortion services and MA in general (Other3). 
I think the [rural] public are not aware of the option for MA, and I think 
they expect to have to travel to Melbourne for abortion services. ...I don’t 
know if they actually think about the equitable availability of it (Other2). 
Another issue that can affect physicians and PHCNs in providing MA care 
and pregnant women in seeking an abortion is the anticipation of abortion 
stigma from colleagues and family or friends when they learn about it. Most 
(84%, IQR = 1) panellists agreed that GPs and PHCNs fear negative publicity from 
members of conservative communities and/or fear of personal vilification if they 
were to provide MA services (Table 7.12, no. 21). Many added that health 
professionals worry the most about reactions from within the community: 
For most GPs biggest concern is their patients and how they (the provider) 
would be perceived if they live in the community of their practice 
(Physician7). 
I am aware of one female GP who provides the service but does not 
advertise it as she is afraid of people targeting her children verbally at 
school (Nurse1). 
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...worry more about being known negatively in the community as 'the 
abortion clinic' (Physician1). 
It was also perceived (84%, IQR = 0) that GPs fear moral judgement by 
other health professionals if they were to provide MA services (Table 7.12, no. 
23), although one panellist expressed a different view: 
Overall, abortion stigma and community backlash may be based more on 
perception than reality (Other3). 
Further, nearly all panellists (90%, IQR = 0) thought that there is pressure 
on GPs to conform to the conservative views of their colleagues regarding MA 
provision (Table 7.12, no. 22). This is illustrated in the following quote: 
I heard that [name of town] doctors in the not very distant past, who 
offered terminations, were then declined admitting rights at the only 
private hospital (of catholic background) - which was/is career limiting 
(Physician4). 
Safety and wellbeing of GPs seemed not to be perceived (74%, IQR = 2) as 
an issue in regard to MA provision (Table 7.12, no. 25). Also, panellists did not 
agree (68%, IQR = 2) that GPs and PHCNs fear the presence of anti-choice 
protestors outside the facility if they were to provide MA services (Table 7.12, 
no. 26). However, it was mentioned that harassment from anti-abortion 
protesters is still an ongoing problem for health workers and women attending 
fertility clinics: 
Anti-abortion groups and protesters in [name of town] still negatively 
impact access to surgical abortion for women living in NE Victoria and 
have an influence on the readiness of GPs to provide MA (Other3). 
Panellists, therefore, recognised that future MA providers in the primary 
health care sector should be protected, as the following quote illustrates: 
Safe access legislation in Victoria should reassure GPs and PHCNs 
interested in providing MA services (Other3). 
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Opinions were divided, though, about the role of the Victorian 
government regarding the discussion and/or promotion of MA provision (Table 
7.12, no. 11 and 27). They ranged from a positive to more sceptical views: 
I think the recent Vic governments both labour and liberal have been 
supportive (Physician1). 
The government is not nervous it is negligent in its attitude to these 
services. They cannot even stop pregnancy counselling services from 
pretending they offer unbiased advice when they are right to life services 
in disguise (Nurse1). 
Nevertheless, the development of the Victorian Women's Sexual and 
Reproductive Health Key Priorities 2017-2020 (Department of Health and Human 
Services 2017), which includes increasing the access to MA of women in the PHC 
sector as a key area, was mentioned by multiple panellists as evidence that the 
Victorian government is prepared to discuss abortion services, including MA. 
One panellist, though, questioned this development: 
…recent consultation with DHHS suggests that the focus may be on 
improving access to particular reproductive health services rather [than 
on] abortion services (Other3). 
There were five statements that related to solutions for confidentiality, 
privacy, stigma and safety barriers to the implementation of a nurse-led model 
of care for MA provision. To reduce abortion stigma, it was perceived by all 
panellists (100%, IQR = 0) that abortion should be seen as being part of 
comprehensive sexual and reproductive health care (Table 7.13, no. 30). One 
panellist, however, questioned a compulsory inclusion of MA in sexual and 
reproductive health care: 
GPs are usually independent small businesses who will determine the 
range of services they provide and access to these services (Physician5). 
Further, it was agreed (100%, IQR = 0) that there should be support and 
protection for PHCNs and GPs who wish to offer MA services but are afraid of 
community backlash, harassment or legal issues (Table 7.13, no. 31). 
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Additionally, panellists recognised (100%, IQR = 0) that emergency department 
staff should respond in a non-judgmental way in cases of abortion complications 
(Table 7.13, no. 29). Although, one panellist expressed that potential judgements 
made by emergency department staff should not be a concern: 
The woman need not declare that the abortion was induced. It could be 
spontaneous and therefore hospital service should be available if it is 
located close enough (Other1). 
It was agreed (90%, IQR = 0.75) that conscientious objection should be 
out in the open. The public needs to know if a doctor is a conscientious objector 
(Table 7.13, no. 32): 
If a dr's objection isn't known, and a patient books in to see that GP, the 
patient could then feel even more distress and may even avoid the 
discussion for fear of further judgement (Nurse6). 
One panellist, however, did not agree, stating: 
It is not possible, nor is it ethically appropriate, to mandate whether or 
not a GP has an obligation to make their views on abortion widely known 
(Physician5). 
No agreement (68%, IQR = 2) was reached for the statement that GPs 
who provide MA should be made visible, for example with a notification that all-
option pregnancy counselling is offered at the general practice (Table 7.13, no. 
33). Nevertheless, there was a statistically significant difference in agreement 
ranking between the three panellists’ groups (KW test statistic = 8.217; p = 0.02). 
Panellists in the ‘other’ group were more likely to agree (39%) with the 
statement than physicians (8%; p = 0.02). This difference in opinions is illustrated 
in the following two quotes: 
This could be something that happens in the future, but for now would be 
major disincentive for provision (Physician7). 
Women need to be able to know what practice provides MA. …health 
professionals let alone women do not know which ones do this (Other4). 
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7.5.2.6 The importance of evidence validation and policy change 
An additional five statements were identified as solutions to overcoming 
current barriers to the implementation of a nurse-led model of MA provision in 
regional and rural Victoria. Those statements all related to the importance of 
evidence validation and policy change. 
Overall agreement (90%, IQR = 0.75) was expressed for promotion of 
nursing research to validate the role of PHCNs and demonstrate effectiveness of 
nurse-led MA provision (Table 7.13, no. 34). There was, however, a statistically 
significant difference between the panellists’ group ratings (KW test statistic = 
8.378; p = 0.02). Nurses (44%) were more likely to agree with the statement than 
physicians (22%; p = 0.01). A similar outcome (90%, IQR = 0.75) was found for 
the statement that expressed to continue to challenge traditional nursing duty 
‘norms' for MA, and ensure a stringent use of evidence and best practice, as 
scope of practice boundaries are shifted (Table 7.13, no. 35). This statement also 
showed a statistically significant difference between the panellists’ groups (KW 
test statistic = 8.378; p = 0.02), with nurses (44%) more likely to agree with the 
statement than physicians (22%; p = 0.01). A statistically significant difference 
(KW test statistic = 7.157; p = 0.03) in agreement rating was additionally found 
between nurses (44%) and physicians (28%; p = 0.02) for the statement that 
recognised that data collection systems for monitoring and evaluation of nurse-
led MA provision should be introduced in regional and rural Victoria (Table 7.13, 
no. 36). This difference is expressed in the following two quotes: 
Having a quality aspect to data collection, such as that used by VCS 
[Victorian Cytology Service] for nurse led cervical screening, is vital to 
ensure a good service (Nurse2). 
[Data collection systems should be introduced]…for all TOP [termination 
of pregnancy] services though (Physician1). 
There was, however, some concern that data collection systems on MA 
can support anti-choice propaganda: 
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It's problematic to collect data on provision of terminations as it can be 
used by anti-choice protesters to say that there are too many abortions 
occurring in Victoria or even a specific area. If this data was collected 
there would need to be strict confidentiality guidelines (Other4). 
Consensus (90%, IQR = 1) was additionally obtained on the statement 
that advocated to make recommendations to parliament and working parties to 
change legislation to allow a wider scope of practice for PHCNs (Table 7.15, no. 
37). Again, there was a statistically significant difference between the ratings of 
the panellists’ groups (KW test statistic = 7.887; p = 0.02). Nurses (47%) were 
more likely to agree with the statement than physicians (24%; p = 0.02). Further, 
most (85%, IQR = 1) panellist identified that legislation change is required to 
allow prescription of abortion medication by registered nurses in regional and 
rural Victoria (Table 7.13, no. 38). However, mandatory training as a 
requirement for prescription right were emphasised: 
Access to prescription of abortion medication should be available to PHC 
& SH nurses [sexual health] with appropriate MA training and 
professional development (Other3). 
Would need to be appropriately trained, not just as part of general 
registration (Physician7). 
This chapter presented the findings of the three-round Delphi study, 
which led to the construction of three nurse-led models of care for MA provision 
in regional and rural Victoria and a discussion of the perceived barriers and 
potential solutions to the implementation of the models. The three models are: 
1. A fully autonomous model: PHCNs are fully responsible for all steps 
involved in the MA process. 
2. A legally feasible model: the involvement of GPs is required for specific 
tasks because of the boundaries of the Abortion Law Reform Act 2008 
(Vic) and the MBS requirements (Department of Health 2017b). 
3. An absence of a (supportive) GP model: PHCNs initiates pre-testing and 
referral to a MA provider in settings that lack immediate support of a GP. 
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The next chapter draws together and discusses the findings from both 
the cross-sectional study and the Delphi study in relation to the current 
literature.
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CHAPTER 8 
DISCUSSION 
 
A nurse-led model of MA provision in the PHC setting does not currently 
exist in Australia. Evidence, however, supports that an expansion of the role of 
appropriately trained PHCNs in the MA provision process can improve access to 
abortion, especially in areas that lack available providers (WHO 2015b). The fact 
that women will choose to self-manage abortions via alternative sources when 
abortion services are not available, should serve as an impetus for allowing 
nurses greater responsibility in providing MA (Aiken et al. 2018; Kapp et al. 
2018). 
This study, therefore, aimed to develop a nurse-led model of MA 
provision in the PHC setting of regional and rural Victoria, where, despite the 
legalisation of abortion in 2008, access in the rural and regional areas is still 
limited (de Moel-Mandel & Shelley 2017). The proposed nurse-led models of 
care for MA provision do not only address the current shortage of MA providers, 
but may also improve equity in access and an overall acceptability of abortion 
services (WHO 2015b). 
Based on the findings from the Delphi study, three nurse-led models of 
MA provision were developed, which are displayed and discussed in the 
following sections. In the first and ideal ‘fully autonomous’ model, PHCNs are 
independently responsible for all steps involved in the three phases of the MA 
process. The second nurse-led model of MA provision is the ‘absence of a (MA 
supportive) GP’ model that can provide guidance to PCHNs that work in settings 
that lack immediate support of a GP. In this model, PHCNs can assess MA 
eligibility and initiate pre-testing before the woman is adequately and timely 
referred to a local MA provider. The third nurse-led model of MA provision is the 
model that is ‘legally feasible’ in Victoria, taking into account the current 
boundaries of the Victorian Abortion Law Reform Act 2008, TGA (2012) 
prescription regulations, and the MBS requirements (Department of Health 
Chapter 8 | Discussion 
 
186 
2017b), which request the involvement of practice GPs in some of the steps of 
the MA provision process. 
The fully autonomous and legally feasible nurse-led model acknowledge 
and include three consecutive phases of MA care, which take place over several 
days. The ‘absence of a (MA supportive) GP’ model, however, only involves the 
first phase of the MA provision process, as the next two phases are delivered by 
an off-site MA provider. The three phases of MA care are: 
1. Assessment of MA eligibility  
2. Medication administration and management of side-effects 
3. Evaluation of abortion completion and post-abortion care. 
Figure 8.1 shows a framework of the phases of the nurse-led MA models. 
The high interest for MA provision among the PHCN participants of the 
cross-sectional study shows that the implementation of a three-phase nurse-led 
MA model of care in regional and rural Victoria could be feasible, especially since 
PHCNs in Victoria are allowed to be involved in the prevention and management 
of unintended pregnancies, which includes MA provision (ANMF 2011; 2014; 
VLRC 2008). Further, task-sharing roles are already implemented in numerous 
other PHC areas in Australia, such as type 2 diabetes, hypertension and 
ischaemic heart disease management, and cervical cancer screening (Eley et al. 
2013; Howe 2016). 
Drawing on the findings from both studies and within the context of the 
existing research literature, this chapter discusses the three research questions 
of the study: 
1. What are the current and potential future roles of GPs and PHCNs in 
regional and rural Victoria in the delivery of medication abortion 
services? 
2. What would a nurse-led model of care for MA provision in regional and 
rural Victoria look like? 
3. What are the anticipated barriers and solutions to the implementation of 
a nurse-led model of care for MA provision in regional and rural Victoria? 
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First, the ideal fully autonomous nurse-led MA provision model is 
discussed, including current limitations to implementation, followed by the 
absence of a (MA supportive) GP model. Next, the currently legally feasible 
model is presented and anticipated barriers and solutions to implementation are 
addressed. Finally, the study strengths and limitations are identified. 
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Figure 8.1 Phases of the nurse-led models of care for MA provision 
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8.1 A FULLY AUTONOMOUS NURSE-LED MODEL OF CARE 
FOR MA PROVISION 
The ideal and most effective model for nurse-led MA provision would be 
a fully autonomous model, with PHCNs being solely and independently 
responsible for all steps in the three-phase MA process (see Figure 8.2). All tasks 
and components of the first phase of this model match the ‘assessment of MA 
eligibility’ criteria, as described by RCN (2017) and WHO (2015b) guidelines. The 
PHCN is the first person of contact for women who want to discuss their 
unplanned pregnancy options, although the option of seeing a GP as the point of 
first contact would still be available. PHCNs will be appropriately trained to be 
able to provide non-directive pregnancy counselling, and, when the choice has 
been made for pregnancy termination, to discuss abortion options, including the 
pros and cons of an MA procedure. Next, the PHCN independently assesses a 
woman’s eligibility for an MA, with the tasks involved grounded within their 
scope of practice (Australian Primary Health Care Nurses Association 2017). Any 
contra-indications for MA are ruled out by obtaining a medical history, assessing 
comorbidities and performing a physical examination. When found eligible, the 
PHCN refers the woman for a blood test and a pelvic ultrasound. 
All steps of the second phase of the nurse-led MA provision procedure 
also match existing guidelines for nurse-led MA provision (Costescu et al. 2016; 
RCN2017; WHO 2015b) and the PHCNs’ scope of practice (Australian Primary 
Health Care Nurses Association 2017). When the MA-requesting woman revisits 
the PHC setting, the qualified and appropriately trained PHCN reviews the 
pathology and ultrasound results to confirm the woman’s eligibility for the MA 
procedure. Next, the PHCN prescribes the MA scripts and provides 
comprehensive information for medication use, the expected procedure, 
potential side-effects, and the follow-up arrangements. According to RANZCOG 
(2016) guidelines, the woman also receives prophylactic pain medication and 
extensive instructions on how to access advice or what to do when 
complications such as haemorrhages or infections occur. Finally, the PHCN 
discusses potential post-abortion contraception options. 
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The third phase of the nurse-led MA provision procedure involves the 
period after the woman has taken the abortion medication. In this phase, the 
PHCN manages all non-life-threatening complications, and in the case of more 
severe complications, organises a referral to a local physician. In addition, the 
PHCN assesses abortion completion, which includes clinical evaluation and an 
indication serum hCG determination and/or sonography, and a contraception 
plan is initiated (RANZCOG 2016). Additionally, if necessary, the PHCN can 
provide emotional support following the procedure. 
All Delphi expert groups agreed that a PHCN can independently manage 
all steps involved in the MA procedure, except for the management of non-life-
threatening MA complications, such as haemorrhages or infections. For nurses, 
the belief that they are unable to manage non-life-threatening complications 
could be based on the findings of Halcomb et al. (2014), who described low 
confidence levels among general practice nurses for some more complicated key 
activities. For GPs, this belief could be related to a general lack of trust in the 
skills and capability of practice nurses in regards to abortion provision (Newton 
et al. 2016a). Moreover, GPs seem to underestimate the scope of practice of 
practice nurses (The Australian Primary Health Care Nurses Association 2015). All 
those beliefs, however, are not consistent with the recommendations of WHO 
(2015b) that recognise post-abortion infection and bleeding to be within the 
scope of practice of trained PHCNs and midwives. PHCNs should be able to 
manage questions related to common medication side-effects and any non-life-
threatening complications, with the guidance of (newly drafted) protocols, such 
as the ‘algorithm for phone triage of bleeding with medication abortion’, 
published by the Reproductive Health Access Project (2014). 
The total number of visits to the clinic required for all the steps in the 
nurse-led model of MA provision can differ. In the Gateway Health model, for 
instance, at the end of phase two, mifepristone is taken at the pharmacy and 
misoprostol at home (Tomnay et al. 2018). Another option, endorsed by the 
RANZCOG (2016), is that mifepristone is taken at the clinic and misoprostol at 
home. This, however, implies that the woman must return to the clinic after her 
Chapter 8 | Discussion  
191 
visit to the pharmacy, which can be problematic if the pharmacy is not close by. 
Alternatively, the abortion medication can be picked up at the pharmacy, and 
both mifepristone and misoprostol are to be taken at home, such as done when 
using telemedicine services provided by the Tabbot Foundation and Marie 
Stopes (Hyland, Raymond & Chong 2018). 
The follow-up, or third phase of the model, can either be provided at the 
clinic or via a telephone consultation if women do not wish or are not in the 
position to return to the clinic. The Gateway Health model offers both these 
options (Tomnay et al. 2018). It was demonstrated that abortion completion can 
be safely and effectively assessed at home, using ultrasound and/or serial 
pregnancy tests combined with a clinical history over the phone (Costescu et al. 
2016; Oppegaard et al. 2014). 
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Figure 8.2 A fully autonomous nurse-led model of care for MA provision 
Note: Step 1 and step 11 only need to be provided if required. 
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While the ‘fully autonomous’ nurse-led model of MA provision has the 
potential to considerably improve access to abortion services in regional and 
rural areas, the findings of the cross-sectional study show that PHCNs and GPs 
have significant different opinions regarding the potential of MA provided by 
nurse practitioners and registered nurses. GPs were less supportive of this group 
of health practitioners becoming involved with MA provision. Although this 
finding can have implications for the implementation of a nurse-led MA model, 
the Delphi panellists, including GPs, generally agreed that a nurse-led MA model 
is acceptable and feasible in the PHC setting of regional and rural Victoria. 
Further, in light of the increasing roles of PHCNs in general practice and because 
of the time-consuming nature of MA provision, it is to be expected that a nurse-
led provision model is more likely to be successful compared to a solo GP model 
(Tomnay et al. 2018). The Delphi panellists, however, did not reach consensus 
for the statement to allow all appropriately trained registered nurses to be 
responsible for the whole MA process without a GP’s approval, with the GP only 
required for the prescription of the abortion medication. This outcome seems to 
imply that panellists do not agree with PHCNs taking on independent 
responsibilities regarding MA provision. However, the fact that panellists agreed 
that legislation change is required to allow PHCNs’ abortion medication 
prescription right suggests that panellists actually disagree with the last part of 
the statement (regarding GPs only being required for the prescription of the 
abortion medication), therefore indicating to support autonomous provision of 
MA by PHCNs. 
Notwithstanding the overall support for a fully autonomous nurse-led MA 
model, this model is currently not implementable in Victoria due to three main 
factors. First, there is no separate remuneration system in place for PHCNs 
delivering MA-related consultations, and thus, to make the service viable, GP 
consultations need to be included during the MA process. Second, ultrasound 
and blood test referrals required for the assessment of MA eligibility, need to be 
provided by GPs to enable women to receive Medicare rebates. The PNIP, 
introduced in 2012 (see section 2.7.2), does not appear to incentivise PHCNs to 
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expand their scope of practice as it does not allow PHCNs to access MBS items 
that relate to associated activities, such as pathology referrals (Joyce & Piterman 
2011; McKenna et al. 2015). The third reason why the fully autonomous model is 
currently not implementable in Victoria is that abortion medication prescriptions 
in Australia can only be supplied by physicians (TGA 2012). 
Therefore, to be able to implement a three-phase, fully autonomous 
nurse-led MA provision model, the Delphi participants recommended the 
introduction of task-specific funding and remuneration, for example, in the form 
of a Medicare item number for MA provision. Further, the Delphi panellist 
supported a legislation change to allow prescription of abortion medication by 
registered nurses in regional and rural Victoria. 
 
8.2 ABSENCE OF A (MA SUPPORTIVE) GP NURSE-LED 
MODEL OF CARE FOR MA PROVISION IN REGIONAL AND 
RURAL VICTORIA 
In the situation that there are no MA providing or supporting GPs at a 
clinic, PHCNs can use an alternative model of MA provision. This ‘absence of a 
(MA supportive) GP’ model (see Figure 8.3) only consists of the first phase of the 
MA provision process. The specific step of this one-phase model is that before 
adequate referral, the PHCN autonomously arranges the ultrasound and blood 
test required for the assessment of the woman’s eligibility for MA. This 
procedure allows an off-site MA provider, such as a local GP, a private abortion 
clinic, or a telemedicine service, to immediately continue the MA procedure in 
phase two. The model, therefore, not only speeds up the MA process in the 
absence of a (MA supportive) GP but also bypasses any obstructions to referrals, 
which consequently will not only improve access to MA abortion, but also 
improve abortion options that are restricted by pregnancy duration (Dawson et 
al. 2017). While overall consensus was achieved for the statement that lead to 
the construction of this model, physicians were less likely to agree with the 
statement than nurses, which could be explained by the previously mentioned 
belief that doctors want to remain in control over provided services (see section 
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7.5.2.2). Still, just as in the fully autonomous model, the pathology test referrals 
for the assessment of MA eligibility require the involvement of GPs to enable 
women to receive Medicare rebates. This condition, therefore, currently restricts 
implementation of the ‘absence of a (MA supportive) GP’ nurse-led model in 
regional and rural Victoria. 
 
Figure 8.3 Absence of a (MA supportive) GP nurse-led model of MA provision 
Note: Step 1 only needs to be provided if required 
 
8.3 A LEGALLY FEASIBLE NURSE-LED MODEL OF CARE FOR 
MA PROVISION IN REGIONAL AND RURAL VICTORIA 
Although the fully autonomous model is the preferred model to 
significantly improve abortion access in the regional and rural areas of Victoria, 
restrictions in the current health care system signify that this model is currently 
not a viable option. Given this, the next best approach is a model that can work 
within the current system. The implementation of a ‘legally feasible’ nurse-led 
model, however, can still be advantageous, as similar models are successfully 
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used in most developed countries, such as Sweden, the UK and France. In these 
so-called full-service models (see section 2.5.1), the physician’s involvement is 
merely required for prescriptions and consultations (Berer 2009; Kishen & 
Stedman 2010). All the tasks performed by PHCNs in the legally feasible nurse-
led MA model (see Figure 8.4) received a high level of support from the Delphi 
panel. 
Most steps in the legally feasible model are similar to the steps in the 
fully autonomous model with PHCNs performing (nearly) all of the consecutive 
tasks in the three-phase process. However, to enable remuneration for the MA 
consultations, GP supervision or GP consultations are required at certain stages. 
Pathology referrals (in phase one) and MA scripts (in phase two) need to be 
provided by GPs to allow women to receive Medicare rebates, and to comply 
with current legal requirements of the Abortion Law Reform Act 2008 (Vic) and 
the TGA (2012). 
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Figure 8.4 A legally feasible nurse-led model of care for MA provision 
Note: Step 1 and step 13 only need to be provided if required. 
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To bypass abortion prescription by GPs, a range of solutions are 
described in the literature. In one study, for example, trained PHCNs delivered 
free, safe and effective MA to 554 women visiting referral and family planning 
centres located in isolated rural communities of Kyrgyzstan (Johnson Jr et al. 
2018). Prior to the study, the PHCNs received mifepristone–misoprostol 
composite packs, pain relief medicines, pregnancy tests and a full range of 
contraceptives. The nurse-led MA process included pre-abortion counselling, 
assessment of gestational age (through ultrasounds referrals) and MA eligibility, 
as well as medication provision and post-abortion contraception discussions. The 
intervention was effective and reported an extremely successful follow-up 
(100%), which was ascribed to the fact that the PHCNs were known, respected 
and trusted members of the local communities (Johnson Jr et al. 2018). A similar 
system was used in Iowa, US, where the on-site stocking of mifepristone allowed 
for MA provision with telemedicine in remote clinics without a physician (Wiebe 
& Grossman 2014). While the Kyrgyzstan model can offer a good solution to 
avoid the involvement of GPs in the second phase of the model, the storage of 
low turnover medication can be challenging, due to the costs involved and the 
strict legislative requirements in Victoria. Requirements, for example, dictate 
that medication need to be stored in cool and dry lockable facilities and that 
PHCNs can only administer medication following written or oral instructions of a 
physician (DHHS 2015b). 
A second solution to bypass GP involvement for prescription is by 
sourcing the abortion medication via the Tabbot Foundation (2017), the 
telemedicine service that is available since 2015 in five Australian jurisdictions, 
including Victoria. Although at present the foundation arranges the required 
ultrasound and blood tests, and organises telephone consultations with 
experienced medical practitioners, these tasks can potentially, in consultation, 
also be performed by local PHCNs, which enables an in-person interaction and a 
continuity of care (Grossman & Grindlay 2017). In this case, the foundation’s 
remaining process will be to send the abortion medication to the eligible 
confirmed women, who will receive the package within 24-72 hours, depending 
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on their location. Such a shared care model with the private sector is encouraged 
by the Victoria Government’s plan (2017) to improve the sexual and 
reproductive health of Victorian women. A model like this, however, is complex, 
and requires extensive discussions with both parties involved. Further, 
prescription still depends on physicians associated with the Tabbot Foundation, 
and would potentially increase the costs involved with the total MA process. 
A final solution to bypass GP prescription is to introduce a model that 
allows registered nurses to prescribe abortion medication as a designated 
prescriber. A similar model has been introduced in 2011 in New Zealand for 
diabetes nurses, which allowed them to prescribe most diabetes related 
medicines (NMBA 2017). However, to be able to develop such a model the 
NMBA needs to develop registration standards that determines educational and 
practice requirements for the permission of prescription under supervision 
(NMBA 2017). 
 
8.4 BARRIERS AND SOLUTIONS TO THE IMPLEMENTATION 
OF A LEGALLY FEASIBLE MODEL IN VICTORIA 
Despite the reported support for the steps involved in the legally feasible 
nurse-led MA process, there are a range of factors that can influence effective 
implementation of a legally feasible nurse-led MA model in regional and rural 
Victoria. In the following sections, barriers and potential solutions to model 
implementation are assessed and addressed along each of the six independent 
yet interconnected access dimensions of Saurman’s framework: acceptability, 
awareness, availability, affordability, accessibility and adequacy (see Chapter 
One, section 1.3) (Gulliford et al. 2002; Saurman 2016). The accessibility and 
adequacy dimensions, however, are combined and discussed as one due to the 
overlap in influences found in this study. 
 
8.4.1 The acceptability of nurse-led MA provision 
An acceptable service, according to Saurman (2016, p. 37), ‘responds to 
the attitude of the provider and the consumer regarding characteristics of the 
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service and social or cultural concerns’. The acceptability of a legally feasible 
nurse-led MA model in regional and rural Victoria, therefore, not only relies on 
the attitude and consequential support of all involved key stakeholders on the 
supply-side of the service, but also on the opinions of regional and rural 
communities regarding nurse-led MA provision. 
Regarding the supply-side, the Delphi panellists recognise that for the 
successful implementation of a nurse-led MA model unconditional support and 
approval is first and foremost required from practice GPs, as their involvement 
remains currently essential. The cross-sectional study findings, however, suggest 
that GPs consider obstetricians/gynaecologists and GPs as potential MA 
providers but less so nurse practitioners and registered nurses, and that in 
general, GPs still prefer to maintain control over services such as MA provision. It 
is plausible that medical professionals might limit nurse practitioner’s scope of 
practice because of their perceived traditional and hierarchical view on the 
relationship between nurses and doctors and because they worry about 
responsibility and trust (Barton 2006; Jakimowicz, Williams & Stankiewicz 2017; 
Newton et al. 2016a; Phillips et al. 2009). Australian research (Newton et al. 
2016a), on the other hand, has demonstrated that GPs and other health 
professionals do support advanced nursing roles, including MA provision. The 
overall study findings, and particularly the fact that only seven (17.9%) GPs of 
the cross-sectional study indicated to be very familiar with the MA procedure, 
thus implicate a need for improved awareness and valuation of PHCNs’ scope of 
practice, as well as for further education on MA, as discussed below. The 
‘absence of a (MA supportive) GP’ nurse-led model can bypass the need for a 
supportive GP and deliver speedy and competent referrals. However, 
unfortunately, pathology tests ordered by PHCNs to assess MA eligibility are 
currently not rebated by Medicare to women. 
Panellists additionally agreed that for a successful expansion of the PHCN 
role in MA provision, support and approval is required from other health care 
professionals who are directly or indirectly involved with all steps of the nurse-
led MA provision process. They include practice reception staff members, 
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involved with the appointments for the different phases of the nurse-led MA 
model, local ultrasonographers required for the pregnancy-dating ultrasounds, 
local accredited pharmacists for the dispensing of the abortion medication, and 
emergency department staff of local hospitals for the treatment of potential MA 
complications. These professionals should deliver their service in a dignified way, 
respecting the woman’s privacy and her needs (WHO 2012). 
The findings also show that support and approval is required from the 
key stakeholders who are directly or indirectly involved with the MA procedure, 
such as local hospitals, to assist women in the case of complications and 
community health settings involved with nurse-led MA provision outside general 
practice. The importance of collaborative support and partnerships is identified 
in the national and international literature, while a lack of this support was 
found to be one of the main reasons for MA trained physicians in the US for not 
taking up abortion provision (Dawson et al. 2016; Freedman et al. 2010; Newton 
et al. 2016a; Sorhaindo & Morris 2016). 
Similarly, support and endorsement of the implementation of a nurse-led 
MA model is required from educational and professional peak bodies, such as 
the AMA, the RACGP and nursing authorities. The Delphi panellists, however, 
recognised a different outlook of AMA on the involvement of PHCNs in the MA 
process. Their point of view was demonstrated in AMA’s General Practice Nurse 
Position Statement (2015), which, among other things, indicated that a general 
practice nurse’s role should not include the making of diagnoses, specialist 
referrals, independent ordering of pathology, or the prescription of medication. 
The declaration caused a strong reaction from APNA’s policy adviser Simon 
Howe (2015), who expressed his strong disagreement with AMA’s view around 
PHCNs’ scope of practice. 
Finally, support is required from the Department of Health, who, 
according to the study findings, should declare MA provision, being part of 
sexual and reproductive health services, to be a core business for primary health 
systems in regional and rural areas. This would improve the acceptability of MA, 
including MA provided by PHCNs. 
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The acceptability of a legally feasible nurse-led MA model in regional and 
rural Victoria also heavily relies on the attitude and opinions of regional and 
rural communities. The current study found that issues of confidentiality and 
privacy in relation to nurse-led MA provision were perceived to be a well-
recognised concern for women in regional and rural areas. An advantage of MA 
provision in the PHC setting over provision in private clinics is, that privacy and 
confidentiality can be more easily maintained as women visiting a general 
practice for a MA cannot be distinguished from other patients seeking medical 
care (Tomnay et al. 2018). This benefit can positively influence women’s 
acceptance of MA service provision in PHC settings. The value of nurse-led MA 
provision at community level has been demonstrated in a study by Johnson Jr et 
al. (2018) who reported that women’s trust in locally known and respected 
PHCNs resulted in a 100 percent follow-up rate after MA provision. 
Similar to previous research (Dawson et al. 2017; Freedman et al. 2010; 
Martin et al. 2014), this study suggests that GPs and PHCNs anticipate negative 
publicity and reactions from conservative members of the community if they 
were to provide abortion services. Further, they fear being morally judged by 
other health professionals and are therefore easily pressured to conform to their 
colleagues’ conservative views regarding MA provision. Taken together, these 
findings suggest that community-level abortion stigma, as well as practice 
restrictions imposed by ideologically opposed colleagues, do influence health 
workers in their decision to provide abortion care, especially in rural and 
regional communities where sexual and reproductive health, including abortion, 
is still a highly contentious topic (Doran & Hornibrook 2016). 
One solution to improve the acceptability of a nurse-led MA model is to 
reduce abortion stigma. The panellists unanimously agreed that abortion should 
be seen as a standard component of comprehensive sexual and reproductive 
health care in order to build community and professional knowledge and 
awareness. This viewpoint highlights the importance of education on abortion as 
a primary target for change, emphasising facts relating to the safety, the 
commonality and frequency of the procedure in Australia and in the rest of the 
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world (Levandowski et al. 2012). While it is not likely that negative beliefs and 
standpoints around abortion will ever disappear, increased knowledge and 
experience have shown to decrease negative attitudes towards abortion (Lipp 
2011). Similar anti-stigma approaches for other health issues, such as mental 
illness and HIV/AIDS, have shown positive results (Corrigan et al. 2012). 
The cross-sectional and Delphi study findings both indicate that GPs and 
PHCNs are not concerned about safety, wellbeing or harassment factors if they 
were to provide MA services. These findings are congruent with the observation 
of Sifris (2013), who stated that overall harassment experience in Australia has 
been moderate. Although pro-life activity outside abortion clinics is still an 
ongoing problem in most parts of Australia, which requires, according to the 
panellists, support and protection for MA providers, this is less of an issue in 
Victoria, where a safe access zone legislation was introduced in 2015 (Public 
Health and Wellbeing Amendment (Safe Access) Bill 2015 (Vic)). Further, it is to 
be expected that providers will experience less harassment in the PHC setting 
where they are less likely to be identified. Indeed, Tomnay et al. (2018) do not 
mention any form of experienced harassment in their study regarding the nurse-
led MA service provided in the Gateway Health clinic. 
 
8.4.2 The awareness of effective nurse-led MA provision and legal 
regulations 
Saurman (2016) outlined that a service retains awareness through 
effective communication and information provision among users and providers 
involved. To be able to successfully implement a nurse-led MA provision model, 
awareness among health professionals and the public of this safe, legal and 
effective alternative to surgical abortions is required. Retaining awareness is 
especially important in rural and remote communities, as they are often affected 
by a high mobility of the population and low stability rates of health practitioners 
(Saurman 2016). Low levels of awareness and familiarity with the MA procedure 
were identified among the participants of the cross-sectional study, despite their 
overall positive attitude to abortion and extensive practice experience with 
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women with unplanned pregnancies. This finding is in line with previous studies. 
Ganatra, Guest and Berer’s (2015), for instance, reported a worldwide lack of 
accurate knowledge of MA regimes and process management, even in locations 
where MA is legalised and among current MA providers. Similarly, only a few GP 
and PHCN participants of the cross-sectional study indicated that they were 
currently directly, or via their practice, involved in MA provision. The lack of MA 
knowledge and provision among this sample of predominantly pro-abortion GPs 
and PHCNs suggests a need for improved education on abortion practices, 
especially since it can be anticipated that participating GPs and PHCNs will be 
more knowledgeable with MA because of their interest in the topic, than their 
colleagues in the rest of regional and rural Victoria. 
The identified uncertainty among the cross-sectional study participants 
regarding the legal restrictions involved with the provision of MA in Victoria 
needs to be addressed to improve MA awareness. This finding, however, is not 
very surprising, considering that the law that regulates abortion practice in 
Australia, and which originated from the English ‘Offences against the Person Act 
1861’, has been amended over the years in a different way in every state and 
territory, resulting in a complex mix of inconsistent and unclear abortion laws 
(de Costa et al. 2015; de Moel-Mandel & Shelley 2017). Victoria is currently one 
of only three jurisdictions, together with the Australian Capital Territory and 
Tasmania, where abortion has been decriminalised (de Moel-Mandel & Shelley 
2017). These legal inconsistencies and the threat of significant ramifications for 
being involved in a practice that is still considered a criminal act in the rest of 
Australia, may influence those considering providing MA services. Improving 
awareness and knowledge of MA provision via the medical curricula of medical 
and nurse students can potentially facilitate future MA uptake, specifically 
among PHCNs, which will increase nurse-led MA provision (Akin et al. 2012; 
Dawson et al. 2017; Myran et al. 2015). 
A growing body of knowledge on nurse-led MA provision will improve 
overall awareness of the model and improve implementation. The Delphi 
panellists agreed upon the importance of evidence validation and the use of a 
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data collection system to monitor and evaluate nurse-led MA provision. Further, 
they acknowledged that nursing research needs to be encouraged to validate the 
role of PHCNs and to evaluate the effectiveness of nurse-led MA provision. 
Nurses, however, were more likely to recognise the importance of further 
research than physicians, which hypothetically could be related to the fact that 
these research projects will mainly focus on nurses. This finding thus implies that 
evidence-based practice research needs to be initiated by nurses. Studies about 
the evolving roles of PHCNs in Australian general practice have already been 
conducted for a range of other nurse-led roles, as discussed in Section 8.1, and 
findings demonstrate that increased roles of PHCNs show possible benefits for 
PHCNs, GPs and patients (Abbott et al. 2013; Lorch et al. 2015; Phillips et al. 
2009). The evaluation report of the Victorian Cervical Cytology Registry for 
nurse-led cervical screening can serve as a good example for evidence validation, 
showing numbers of cervical screening tests performed by nurses, as well as the 
health setting and location of where the Pap smear was collected (Ang & 
McAllen 2016). By monitoring MA providing PHCNs, an ongoing quality and 
professional accountability can be guaranteed. 
Overall, the Delphi findings suggest that public awareness about MA 
provision can lead to increased public demand, which can act as a driver for 
improved service provision, specifically in the form of a nurse-led MA provision. 
Further, raising awareness of MA service provision and related regulations 
among health care professionals may remove MA uptake barriers, increase the 
number of MA providers, and improve the potential of a nurse-led MA provision 
service. The importance of awareness and knowledge of MA among health 
professionals is also recognised in the Victorian Government’s strategy (2017) to 
improve the sexual and reproductive health of all Victorian women. To increase 
access, the strategy specifically encourages innovative PHC models of MA 
provision in the regional and rural areas of Victoria. 
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8.4.3 The availability of nurse-led MA provision services and 
providers 
An available service is defined as having ‘adequate services and resources 
to meet the volume and needs of the consumers and communities served’ 
(Saurman 2016, p. 37). The availability of nurse-led MA provision in regional and 
rural Victoria thus mainly depends on the success of implementation of the 
model, which relates to the willingness of GPs and PHCNs to take up the service. 
In the cross-sectional study, nearly half (46.7%) of the GPs and three-quarters of 
the PHCNs (76.9%) expressed their interest in MA training. The high interest of 
PHCNs in receiving MA training reflects the increasing development of nurses’ 
roles in general practice, stimulated by the growing burden of chronic disease 
management and preventative health services (Ehrlich, Kendall & John 2013; 
Halcomb et al. 2008b; Halcomb et al. 2014; McKenna et al. 2015). Participants 
not interested in providing MA indicated a range of reasons for their decision, 
which were classified as reasons for never wanting to provide or assist with MA. 
In addition, most participants who were interested in MA training also 
anticipated a range of barriers to MA uptake, which may directly hinder the 
implementation of a nurse-led model of MA provision in regional and rural 
Victoria. These barriers were classified as reasons for not considering to provide 
or assist with MA, even though willing. 
To increase the availability of nurse-led MA provision models, 
interventions that improve MA uptake by clinicians need to target those barriers 
that are typical for the clinician’s particular stage of readiness to consider the 
service (Seelig et al. 2006). Seelig et al. (2006) relate this recommendation to 
Prochaska’s transtheoretical model of change, which emerged from the analysis 
of principal theories of psychotherapy and behaviour change (Prochaska, 
Redding & Evers 2008). The model hypothesises that in order to achieve a 
successful behavioural change in people, the change needs to be considered as a 
process that unfolds through a series of stages, each requiring a specific 
intervention program (Prochaska, Redding & Evers 2008) (see Figure 8.5). This 
section only discusses the first two stages of Prochaska’s transtheoretical model, 
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as the remainder stages relate to the implementation and maintenance of the 
nurse-led MA model, which are outside the scope of the current study. 
In the earliest stage of Prochaska’s transtheoretical model, called the pre-
contemplation stage, individuals do not have the intention to change their 
behaviour, most often because they are under-informed and/or unmotivated 
(Prochaska, Redding & Evers 2008). It was postulated that the participants in the 
cross-sectional study who indicated never wanting to be involved with MA were 
situated in this pre-contemplation stage of change. Most of the study 
participants provided reasons for never wanting to provide or assist with MA 
indeed involved overall concerns, such as the need for surgical back-up in case of 
complications, the existence of too many legal restrictions or the lack of support 
from colleagues, and were not related to religious, moral or ethical beliefs. These 
findings are in accordance with the findings reported in the qualitative Australian 
study by Dawson et al. (2017). Seelig et al. (2006), therefore, suggest to 
stimulate the interest of those pre-contemplating providing MA in such a way 
that they will move to the next, contemplating stage. They advise focusing 
interventions on the benefits and feasibility of MA provision via conference 
presentations and media articles, rather than highlighting specific concerns. 
Action-oriented interventions, however, can influence those clinicians 
that have progressed to the contemplation stage, the next stage of Prochaska’s 
transtheoretical model (Prochaska, Redding & Evers 2008). This stage relates to 
the cross-sectional study participants who provided reasons for not considering 
taking up MA provision, even though they were willing. Although those clinicians 
are actively contemplating becoming an MA provider, their final decision is still 
hindered by a range of concerns about training, stigma, and the professional and 
administrative practicalities that are associated with abortion care. These 
findings are in line with research from the US (Hwang et al. 2005; Whaley & 
Betstadt 2016) and Australia (Dawson et al. 2017), and have been shown to be 
the main reason for the shortage of abortion providers in settings where 
abortion is legal. The MA uptake barrier most frequently indicated by the PHCNs 
was the lack of MA training opportunities, and this finding was also discovered in 
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the Delphi study. Some PHCNs related this lack of training to Marie Stopes’ 
online MA training module, which is currently only available to prescribing 
physicians (MS Health 2017). There are a range of training programs and 
guidelines available for medical practitioners, including GPs (RACGP 2005; 2016, 
2017; 2017). However, only the Centre of Excellence in Rural Sexual Health 
(CERSH), in collaboration with the University of Melbourne (Stephens 2018), 
periodically provides training and support sessions in MA provision that are 
suitable for GPs as well as PHCNs. Training, though, is critical as it has been 
shown that health providers who receive educational as well as clinical 
experience with abortion care are more likely to accept abortion provision within 
their scope of practice (Jackson 2011). Further, training builds confidence and 
prepares health professionals for new roles (WHO 2015b). The Delphi study 
findings suggest that all sexual and reproductive health courses for PHCNs (and 
GPs) should include an MA provision component and that these programs need 
to be promoted and provided via the Victorian Government in partnership with 
primary health care networks. This strategy can potentially improve PHCN 
uptake of MA provision and facilitate nurse-led MA provision model 
implementation in regional and rural Victoria. Additionally, PHCNs seem to worry 
more than GPs about the need for surgical back-up in the case of complications 
and the absence of local ultrasound facilities. This finding suggests that PHCNs 
are potentially less informed about the availability of local support services, 
which implies that this group of health practitioners particularly needs to be 
provided with information to ameliorate their apprehensions. 
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Figure 8.5 Prochaska’s transtheoretical stages of change 
 
 
8.4.4 Affordability of the nurse-led MA model 
Affordable services relate to the costs involved for the service provider as 
well as for the user (Saurman 2016). The study findings indicate that full 
integration of PHCNs in the MA process is hindered by a shortage of funding to 
make a nurse-led model successful, as there is no remuneration system in place 
for PHCNs delivering MA related consultations. Further, GPs in Australia receive 
most of their income on a fee-for-service basis through third party insurers such 
as Medicare (RACGP 2015). There is no specific Medicare item number for MA 
provision and, therefore, many MA providing GPs charge an out-of-pocket fee on 
top of the Medicare rebate to make the service viable (Children by Choice 2017). 
A mixture of two to three long and short consultations, sometimes combined 
with MBS item 4001 (GP-provided pregnancy support counselling) results in 
patients’ costs that range from $350 to $580 AUD upfront and after (partial) 
Medicare rebate from $200-300 AUD (Children by Choice 2018a). These amounts 
exclude the necessary pathology and ultrasound tests, which can sometimes be 
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bulk-billed5, and the cost of the abortion medication, which varies from $12 to 
$50 AUD depending on Health Care Card6 availability. 
To facilitate MA access, the study findings additionally indicate that 
financial support for abortion requesting women is required. This support relates 
not only to the in general high cost of MA provision, but also to the additional 
expenditures often required for travel, accommodation and childcare (Nickson, 
Smith & Shelley 2006). The cost of an MA provided in the PHC sector, while still 
high, is more affordable then when early MA is provided in the private sector, 
such as at Marie Stopes clinics where women pay approximately $440 AUD (after 
Medicare) for an early MA (Marie Stopes International Australia 2018). In 
contrast, when the MA service is delivered through the public system, such as at 
Gateway Health clinics, all appointments are bulk-billed and women only pay for 
the medication (Gateway Health 2018a; Tomnay et al. 2018). In these settings, 
the sexual health nurse employed by the clinic is funded by the Government 
(Tomnay et al. 2018). 
 
8.4.5 The accessibility and adequacy of support services 
The final factors that need to be addressed to make the nurse-led MA 
model successful relate to the accessibility and adequacy dimensions of 
Saurman’s framework (Saurman 2016). Locally accessible and adequate, well-
organised MA services are essential for the improvement of abortion access in 
regional and rural areas. Of particular importance for the establishment of these 
services is the presence of local allied health professionals and diagnostic 
facilities, which are essential for the assessment of MA eligibility, the first phase 
of the nurse-led MA model. The study findings, however, suggest a lack of these 
support systems in rural and remote Victoria. These findings confirm previously 
reported socio-economic and geographic inequities in access to health services, 
                                            
5 Bulk billing is a payment option under the Medicare health insurance system of Australia, in 
which a medical service provider can bill Medicare directly for a range of health services listed in 
the MBS, and the patient does not pay any fees. 
6 A Health Care Card is a concession card which enables eligible persons to get cheaper 
prescription medicines under the PBS. 
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which can cause lower health outcomes for Australian residents in rural and 
remote communities compared to people living in metropolitan areas 
(Humphreys 2009; Thomas, Wakerman & Humphreys 2015). A lack of local 
ultrasound access, for instance, was one of the main reasons indicated by cross-
sectional study participants for not wanting to be involved with MA provision. An 
ultrasound examination before the termination of a pregnancy is currently 
mandated by the RANZCOG (2016) for pregnancy dating, to ascertain the 
appropriate dose and regimen of the abortion medications, and to exclude 
ectopic pregnancies or uterine abnormalities. Ultrasounds, however, are 
expensive and their requirement limit the locations where abortions can be 
offered (RCOG 2011). Further, it has been recognised that most women know 
with certainty the date of their last menstrual period and/or the date of 
conception (RCOG 2011). The mandatory use of ultrasound dating is, therefore, 
often questioned in the literature, and ultrasound outcomes have been 
compared with those of solely clinical assessments, such as the woman’s last 
menstrual date and/or a pelvic examination. A study by Schonberg et al. (2014), 
and a systematic review by Kulier and Kapp (2011), for instance, found that for 
MA before 63 days’ gestation, the use of clinical methods was as safe, efficient 
and accurate as using ultrasounds. Currently, guidelines from the UK (RCOG 
2011), Canada (Costescu et al. 2016), the American College of Obstetricians and 
Gynecologists (Creinin & Grossman 2014) and WHO (2012) all state that routine 
pre-abortion ultrasounds are unnecessary. In France, for example, ultrasounds 
are presently only employed in 30 percent of induced abortion procedures 
(Costescu et al. 2016). 
While the study findings recommend that, to address the lack of local 
ultrasound access, GP clinics should offer this service after appropriate training, 
the evidence highlights the fact that an ultrasound is arguably not required for 
pregnancy dating. The current lack of ultrasounds in regional and remote 
settings should, therefore, in theory, not limit MA provision, unless there is a 
discrepancy between the date of the last menstrual period and the size of the 
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uterus or in the case of symptoms that suggest an ectopic pregnancy (RCOG 
2011). 
Another factor that was recognised in this study as being important to 
the implementation of a nurse-led MA model is the access to local and 
supportive pharmacists. To improve the collaboration of pharmacists with 
general practices in MA provision services, it was advised to increase the 
knowledge of pharmacists with the help of education programs. Additionally, the 
study findings recommend that in the absence of cooperating pharmacists, GP 
clinics should stock and supply abortion medication (see also section 8.4). While 
under the National Health Act 1953 (s. 92), a GP can obtain permission to supply 
PBS subsidised pharmaceuticals in areas without convenient access to an official 
pharmacy, this solution is unfortunately not currently possible in areas where 
pharmacists are present but non-supportive (Department of Human Services 
2017a). A collaboration with local pharmacists can also lead, as suggested by 
Children by Choice (2017), to arrangements, that enable women to take the 
medication, in private and under observation, at the pharmacy. This practice, 
implemented by Gateway Health, makes the process of drug prescription and 
the subsequent intake of the medication easier and less time-consuming for 
women (Tomnay et al. 2018). 
Locally accessible support services are also required during the third 
phase of the nurse-led MA model, specifically in regards to the management of 
non-life threatening complications in regional and rural areas. The cross-
sectional study participants expressed their concern regarding the lack of a 24-
hour contact advice service in case of complications. It should be noted, 
however, that this concern is unfounded, as women obtaining abortion 
medication are provided with the MS-2 Step Consumer Medicines Information 
instruction insert (MS Health 2014), a requirement of the TGA (2014). This insert 
contains the number of the MS Health Nurse After-Care Telephone Service, 
which can be contacted for questions on a 24-hour basis. The effectiveness and 
safety of such a contact number has been demonstrated by the evaluation study 
(Belton 2017) of a similar 24-hour telephone service, delivered by the Tabbot 
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Foundation (2018), an organisation that provides telemedicine MA services to 
women residing in most parts of Australia. 
The study findings additionally revealed concerns regarding insufficient 
access to after-hours care and surgical back-up in the case of complications for 
women who go through an MA in small towns. These concerns, however, can be 
refuted by a study from Ireland (Aiken et al. 2017) that evaluated self-
management with self-administration of abortion medication, obtained through 
the online telemedicine service of Women on Web (2017). It was concluded that 
concerned women were able to successfully self-screen potentially serious 
complications, and to seek, after advice over the telephone, medical assistance 
at the nearest hospital. Surgical intervention after the MA procedure was 
required in 4.5% of the cases, which is equivalent to the percentage found in 
clinical settings, but lower than comparable complications reported during 
childbirth in the UK, or complications associated with spontaneous terminations 
outside the medical system, in which case women need to cope with the shock 
of the unexpected bleeding, cramping and expulsion as well (Aiken et al. 2017; 
Kapp et al. 2017; Ngo et al. 2011). A study from Norway (Lokeland et al. 2014) 
reported a similar percentage of women (4.9%) in need of a surgical intervention 
after taking mifepristone in a clinic and then self-administering misoprostol at 
home. This study (2014) additionally reported that nearly all complications 
occurred more than 24 hours after misoprostol administration, but that travel 
distance did not influence treatment outcome. This conclusion contradicts the 
requirements of the RANZCOG (2016) and the Tabbot Foundation (2018), who 
indicate that MA should not be performed in isolated settings with driving times 
of more than two hours from emergency care. Overall, restrictions on travel 
distance to emergency clinics seem to be of minor importance in preventing 
adverse events, as they are comparable to the distance women need to travel 
for a delivery, which is in fact a less safe procedure than an MA. Lokeland et al. 
(2014) concluded that MA should be offered to all women irrespective of where 
they live. Overall, concerns regarding the management of MA complications in 
the third phase of the model are unfounded, as systems are in place to support 
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women who experience MA complications regardless of who provides the MA or 
where the women live. 
While the study findings suggest that the developed legally feasible 
model could be implemented in rural and regional Victoria, with the potential 
barriers addressed, the findings must be interpreted within the context of the 
strengths and limitations of the study. 
 
8.5 STUDY STRENGTHS AND LIMITATIONS 
This section discusses the study’s strengths and limitations, and how they 
can affect the interpretation of the findings. A key strength of the cross-sectional 
study is the multiple sampling methods used to obtain large enough sample sizes 
for the two target populations. The characteristics of the GP sample are 
comparable with data from the regional and rural GP workforce of Victoria in 
terms of gender, mean age and employment status (full-time) (RWAV 2016). The 
over-representation of Australian-trained GPs is most likely related to the study’s 
contentious topic, which mainly attracted health care providers with a strong 
positive stance on abortion (80% of participants approved of abortions in all 
circumstances), reflecting the overall acceptance of abortion among the wider 
Australian-born population (RWAV 2016). The religious backgrounds of the 50 
percent of overseas-trained doctors in the current regional and rural GP 
workforce of Victoria, could possibly explain their reluctance to participate in 
this study. As Jelen (2009, pp. 223-4) noted: 
Given the relationship of the abortion issue to ultimate concerns of 
human life, and to questions of sexual morality, it is not surprising that 
much opposition to legal abortion has had a religious basis. 
The PHCN sample was also broadly similar to the known characteristics of 
the Australian practice nurse in regards to gender and age (Australian Medicare 
Local Alliance 2012). Overall, the participants seem to be a reasonable 
representation of GPs and PHCNs working in regional and rural Victoria, and the 
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study’s findings may, therefore, be transferable to the general population of GPs 
and PHCNs in this setting. 
A key strength of the Delphi study was the selection of the panellists. The 
literature about the criteria for selection of a Delphi panel, however, is 
undecided, which is unfortunate as this selection relates directly to the quality of 
the study’s outcome (Hsu & Sandford 2007). Who can be assessed to be an 
expert, as knowledge does not equal expertise, and experience does not equal 
knowledge or being an expert (Keeney, Hasson & McKenna 2011)? Without the 
existence of proper guidelines, it has been suggested that Delphi panellists 
should represent the whole range of stakeholders who not only need to have 
knowledge and experience with the specific topic, but also the ability, willingness 
and time to participate, and all of this combined with valuable communication 
skills (Adler & Ziglio 1996; Boulkedid et al. 2011; Hasson, Keeney & McKenna 
2000; Hsu & Sandford 2007). With these suggestions in mind, considerable effort 
was undertaken for the selection of the Delphi experts in this study, however, it 
cannot be assumed that the final panellists were a good representation of all key 
professionals involved in women’s sexual and reproductive health issues and 
were well-positioned to advocate for women’s rights. 
Another strength was the Delphi’s sample size, which fit well within the 
commonly acceptable range (Day & Bobeva 2005; Hsu & Sandford 
2007). Moreover, the study’s 17 percent overall attrition rate over the three 
rounds is relatively low compared to similar e-Delphi studies, which showed 
rates between 23 and 28 percent (Gephart et al. 2013; Haines & Critchley 2009; 
Hewitt & Cappiello 2015; Thomas, Wakerman & Humphreys 2014). This low 
attrition rate, as well as the extensive and perceptive comments provided by the 
panellists, indicate an ongoing commitment of the panellists to the study’s topic. 
Although the anonymous nature of the study allowed panellists to express their 
views about the topic without any restrictions, peer pressure or influence from 
expert dominance, anonymity can also potentially lead to nondisclosure or limit 
exploratory thinking (Hsu & Sandford 2007; Keeney, Hasson & McKenna 2011). 
Further, as most panel members of an expert group often know each other, the 
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arising ‘quasi-anonymity’ could make panellists feel pressured to conform, 
resulting in either adapting or abandoning the process, both influencing the 
outcomes (Hsu & Sandford 2007; Keeney, Hasson & McKenna 2011). There 
seemed, however, to be no evidence of both phenomena in this study. 
The response rates to the cross-sectional questionnaires, however, were 
low. Of the 309 regional and rural GPs invited to participate in the study, 34 GPs 
were recruited from the selected sample (11%). An additional five GPs were 
recruited via snowball sampling. These results are not unexpected, first of all, 
because GP recruitment for online questionnaires has shown to be challenging, 
and GP response rates are generally much lower than those of the general 
population (Bonevski et al. 2011; McKinn et al. 2015; Pit et al. 2007). A multitude 
of Australian studies reported GP response rates that ranged from <0.1% to 8.7% 
(Aitken, Power & Dwyer 2008; Crouch, Robinson & Pitts 2011; Parkinson et al. 
2014), and even the yearly Australian benchmark study of GP activity generally 
obtains response rates under 30 percent (Bonevski et al. 2012; Britt et al. 2015; 
Britt et al. 2014). Second, response rates could have been influenced by the 
contentious subject of the questionnaire. The relationship between sensitive 
topics and non-response has previously been raised as an issue in other 
research, and seems to be linked to the respondent’s concerns that 
confidentiality will not be maintained (Booth-Kewley, Larson & Miyoshi 2007; De 
Schrijver 2012; Kays, Gathercoal & Buhrow 2012). Sensitive topic questionnaires, 
therefore, tend to have higher non-response rates than questionnaires that 
relate to less-sensitive topics (Tourangeau & Yan 2007). Overall, however, it can 
be determined that, despite the contentious subject, the GP return rate of the 
questionnaire in this study was slightly higher than rates achieved in similar 
studies. Response rate determination was, however, not possible for the PHCNs, 
due to the absence of a national database and sampling frame, although the 
sample size of 30 participants was low compared to sample sizes in two similar 
studies, which ranged from 104 (Australia-wide) to 160 (New South Wales) 
(Joyce & Piterman 2011; Merrick et al. 2012). While the cross-sectional study 
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samples seemed to be representative of the target population, the opinions of 
the participants may differ from the opinions of non-respondents. 
With the absence of an existing instrument, the GP and PHCN 
questionnaires were partly modelled on ones used in previous studies, with the 
remaining items developed for the purpose of this study. To improve the 
reliability and validity of these non-validated instruments, a pre-test and pilot 
test were conducted prior to data collection (Rattray 2007). Pre-tests and pilot 
tests were also conducted on the Delphi questionnaires. These procedures 
helped to identify content ambiguities and technical problems, improved 
content validity, and allowed for an optimisation of the quality and achievability 
of the Delphi process (Shariff 2015). 
A study strength was using online data collection methods. Online data 
collection has shown to result in more legible responses, an ease of use of data 
entry and processing, a fast delivery and response time, and a reduction in 
overall costs (Snyder-Halpern, Thompson & Schaffer 2000). Further, online 
questionnaires can be accessed at participants’ most convenient place and time 
(Donohoe, Stellefson & Tennant 2012). Other advantages are that response rates 
for sensitive topic questionnaires tend to be higher if conducted online rather 
than by other methods, that participants demonstrate less inhibition in 
answering questions, and that the questions tend to cause less social desirability 
bias (Kays, Gathercoal & Buhrow 2012; Tourangeau & Yan 2007). While online 
data collection has many advantages, its use can potentially limit study 
participation for panellists residing in rural areas. Despite the rapid 
developments and popularisation of the internet, internet access outside 
metropolitan areas in Australia can still be very poor and unreliable (AMA 2017). 
It is, however, unlikely that these limitations have impacted this study as it can 
be expected that health services in regional and rural Victoria generally have 
good and reliable internet. 
Even though the researcher was solely responsible for undertaking the 
qualitative analysis of the seven open-ended questions of Round One, the 
ongoing discussions about the analysis of the identified themes with researcher’s 
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supervisors enhanced the reliability of the coding process (Alhojailan 2012). 
Discussions around the external and internal validity of Delphi studies and the 
influence of bias are, however, ongoing (Hasson & Keeney 2011; Keeney, Hasson 
& McKenna 2011). Similarly, the reliability of the Delphi method remains 
questionable, as there is no proof that similar results can be obtained if the same 
information was given to a different panel (Hasson, Keeney & McKenna 2000). 
However, all steps were taken to ensure the results were as reliable and valid as 
possible given the Delphi limitations. 
Overall, the use of a large heterogeneous group of knowledgeable and 
interested panellists, during multiple Delphi rounds with good response rates, as 
well as the comparison of findings with a second methodological technique (the 
cross-sectional study) and related published evidence, increased the study’s 
methodological rigour and supported the overall findings of the study for the 
development of a nurse-led model of MA provision in the PHC setting of regional 
and rural Victoria (Efstathiou, Ameen & Coll 2008; Hasson & Keeney 2011; 
Hasson, Keeney & McKenna 2000). Whether response bias had an influence on 
the study outcomes is unclear: although the respondents’ general positive 
attitude towards abortion may systematically differ from non-respondents, the 
absence of information about the overall Victorian GPs’ and PHCNs’ stance 
towards abortion does not allow for comparison between the two groups. 
Finally, as this study was conducted in regional and rural Victoria, legal and 
geographical differences between jurisdictions do not make the findings 
generalisable to the rest of Australia. 
The next, concluding chapter of this thesis will address the implications of 
this study for practice, policy and future research.
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CHAPTER 9 
CONCLUSION 
 
A nurse-led model of MA provision is a viable option to expanding 
abortion access in rural and regional Victoria. Although a number of barriers to 
implementation were identified, including stigma, lack of MA training, and a lack 
of support systems, it is possibly to overcome these barriers within the 
constraints of the health service system. While currently used approaches of MA 
provision, such as the Gateway model (Hulme-Chambers et al. 2018) and the use 
of telemedicine for MA provision (Belton 2017), have many benefits, this study 
proposes more comprehensive nurse-led MA provision models that allow the 
delivery of MA at a more personal level and close to where women live. Access 
to safe abortion is considered a fundamental reproductive right for women, and 
the developed nurse-led MA models have the potential to increase access to 
equitable, affordable, safe and confidential abortion services for women residing 
in underserved communities (CRR 2004; 2013; United Nations 1994). 
The extensive and rich data provided by the participants of this study, 
informed by the prevailing literature, resulted in the development of three 
nurse-led models of care for MA provision: a fully autonomous nurse-led model; 
a legally feasible nurse-led model; and an absence of a (MA supportive) GP 
nurse-led model, which allows PHCNs to initiate pre-testing before referral. The 
fully autonomous and the legally feasible nurse-led model consist of three 
phases: 1) assessment of MA eligibility; 2) medication administration and 
management of side-effects; and 3) post-abortion care. The absence of a (MA 
supportive) GP nurse-led model only consists of the first phase of the MA 
provision process, as the next two phases are delivered by an off-site MA 
provider. 
The extent of the PHCN involvement in the delivery of the MA services in 
the PHC setting of Victoria is currently limited by legal restrictions that do not 
allow PHCNs to prescribe abortion medication, by MBS restrictions, which 
require GP involvement for pathology referrals to enable Medicare rebates, and 
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by the lack of PHCN remuneration for MA-related consultations (Abortion Law 
Reform Act 2008 (Vic)  ; Department of Health 2017b). These limitations imply 
that the preferred fully autonomous nurse-led model and the absence of a (MA 
supportive) GP nurse-led model are not yet achievable in Victoria. Nonetheless, 
implementation of a legally feasible model also has the potential to increase 
abortion access in regional and rural Victoria. 
This study reports a high level of interest among GPs and PHCNs in 
receiving MA training, however, it suggests that a lack of training opportunities 
and local support services are deterrents to MA provision uptake, as well as 
stigma and the uncertainty about the legality of abortion, although harassment 
is not. Due to the increasing roles of PHCNs in general practice and because MA 
provision is a time-consuming process, nurse-led MA provision is more likely to 
be successful than solo GP provision (Tomnay et al. 2018). While a legally 
feasible nurse-led MA model is acceptable in the PHC setting of regional and 
rural Victoria, the study findings show a range of barriers that can hinder model 
implementation. 
In this final chapter, implications for practice and policy are outlined to 
overcome recognised model implementation barriers, and recommendations are 
made to address them. The implications for practice relate to the lack of: 
support for nurse-led MA provision; MA awareness and knowledge; MA training 
options; and MA-related health services. The implications for policy relate to the 
federal MBS and policy restrictions. In addition, recommendations for future 
research are listed. 
 
9.1 IMPLICATIONS AND RECOMMENDATIONS FOR 
PRACTICE AND POLICY 
Although all the different components of the legally feasible nurse-led 
MA model fall within the scope of practice of most PHCNs, the following 
implications and recommendations for practice need to be considered. All 
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practice and policy implications and recommendations relate to the six access 
dimensions of Saurman’s (2016) framework. 
For the implementation of a nurse-led model of MA provision, 
unconditional support and endorsement is required from practice GPs, other 
local health professionals, community health services, local public hospitals, 
professional organisations and government (Saurman’s acceptability dimension). 
The findings of this study, however, indicate a perceived lack of support and 
endorsement for nurse-led MA provision, in particular from GPs who often seem 
to hold a traditional view on the PHCNs’ scope of practice. The overall 
acknowledged unfamiliarity with the potential roles of PHCNs in general practice 
demonstrates the importance of awareness and valuation of PHCNs’ scope of 
practice. Similarly, the recognised unawareness and unfamiliarity with the MA 
procedure has implications for intervention strategies. It is, therefore, 
recommended that further education for GPs (and PHCNs) is required to address 
underlying unfounded concerns about the legality of abortion, procedure 
complications, potential lawsuits and/or the lack of a specialised infrastructure. 
Additionally, workshops, symposia, conferences and journal/media articles 
should provide more general information that focuses on the benefits, safety 
and legality of MA provision in the PHC sector, particularly when provided by 
PHCNs (DHHS 2017). Information provision is particularly required for key 
stakeholders such as the AMA, as their attitude and more opposing point of view 
to PHCNs’ scope of practice can have a major influence on policy and the 
implementation of nurse-led MA provision (AMA 2015; WHO 2015b). 
The ongoing stigma that surrounds abortion provision, and the resulting 
negative publicity and judgements of colleagues and community members, 
especially in regional and rural areas, can also affect the implementation of a 
nurse-led MA model (Saurman’s awareness dimension). While negative beliefs 
and standpoints around abortion may never totally disappear, the findings of 
this study demonstrate the importance of educational interventions with an 
emphasis on facts relating to safety, the commonality and frequency of induced 
abortions in Australia (Lipp 2011). These interventions, together with the 
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establishment of relationships with local businesses and community members, 
will signal that abortion is an essential part of sexual and reproductive health 
care and should, therefore, not be treated differently to other health care 
provisions. This study, therefore, recommends building community and 
professional abortion knowledge and awareness to shift social and cultural 
attitudes and norms, and to put mechanisms in place to guarantee ongoing 
support and protection for MA providers against community backlash, 
harassment or legal issues. 
Successful implementation of a legally feasible nurse-led model of MA 
provision in regional and rural Victoria is hindered by the reported lack of MA 
training options for PHCNs (Saurman’s availability dimension). This calls for a 
strategy that includes regulatory structures for competency-based training and 
accreditation, combined with ongoing guidance, support and mentoring of 
PHCNs (WHO 2015b). It is, therefore, recommended that MA training should be 
expanded beyond MS Health and integrated within the programs provided 
and/or coordinated by professional GP and nurse organisations, including sexual 
and reproductive health courses. Further, it is recommended to make locally 
organised accredited MA training for GPs and PHCNs affordable and accessible, 
with incentives and practice remunerations for training attendance provided. A 
funded coordinator needs to be appointed to offer guidance and help for PHCNs 
who want to do the MA training, and a PHCN network should offer MA 
mentoring to learn and share experiences. All these recommendations are in 
accordance with the key priorities of the recently released plan of the Victorian 
Government that aims to improve the sexual and reproductive health of 
Victorian women (DHHS 2017). While leaders and mentors are required for the 
professional development of PHCNs, including MA provision, direction on the 
nurse’s scope of practice for MA provision ought to be provided by the 
Australian Health Practitioner Regulation Agency. 
The study findings also identified that poor accessibility to supportive 
health services, such as ultrasound facilities, pharmacists and emergency 
departments, can serve as a barrier for the implementation of nurse-led MA 
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provision in rural and regional Victoria (Saurman’s accessibility and adequacy 
dimensions). By declaring MA provision to be a core service for primary health 
systems in underserved areas, abortion access may potentially improve. At the 
same time, PHCNs should strengthen or newly create local partnerships with 
supportive health services to ensure the overall success of nurse-led MA 
provision. In the absence of local support services, however, the following 
should be considered. First, concerns regarding the lack of closely available 
health practitioners for surgical interventions can be addressed by clearly 
instructing women on when to seek medical help, using a 24-hour contact advice 
service, such as the one provided by Marie Stopes, as a back-up service. It was 
suggested that PHCNs should be able to recognise, after proper instructions and 
with the use of protocols, when consultation or referral is needed in the case of 
complications. Likewise, restrictions on driving times to hospitals need to be less 
explicit, as similar driving times are required for deliveries or spontaneous 
abortions (Lokeland et al. 2014). Second, general practices in areas without an 
easily accessible pharmacist, could consider supplying and dispensing the 
abortion medication themselves (Department of Human Services 2017a). 
Otherwise, in the situation where a pharmacist is present but unsupportive, 
shared care models with private MA providers, such as the Tabbot Foundation, 
could be explored to improve medication access (DHHS 2017). Third, when local 
ultrasound facilities are absent, GP clinics could offer (after appropriate training) 
in-house ultrasounds. The literature, on the other hand, suggests that the use of 
a pre-abortion ultrasound is often medically unnecessary (Kapp et al. 2017; 
RANZCOG 2016). By making the current mandatory pre-abortion ultrasound 
optional and only necessary when gestational duration is uncertain or when an 
ectopic pregnancy is suspected, the nurse-led MA procedure will be simplified 
and MA access will improve (Kapp et al. 2017). It is, therefore, recommended 
that regulatory structures and/or mechanisms need to be adjusted to improve 
access to MA-related supportive health services. 
Besides the implications and recommendations for practice that need to 
be considered for the implementation of a legally feasible nurse-led model of 
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MA care in the regional and rural areas of Victoria, the following implications 
and recommendations for policy arise when a fully autonomous model is to be 
implemented. 
The establishment of a fully autonomous nurse-led MA provision model 
is currently restricted by the PHCNs’ lack of access to MBS item numbers for the 
independent reimbursement of their activities related to MA provision, and by 
the lack of a financial remuneration for MA consultations provided by PHCNs 
(Saurman’s affordability dimension). This implicates that alternative funding 
models are required that facilitate PHCNs to be independently responsible for 
MA provision. It is thus recommended to introduce task-specific funding for 
PHCNs to enable Medicare rebates, and to change PHCN remuneration, for 
example, in the form of a Medicare item number for nurse-led MA provision, or 
to adapt the Gateway Health model that employs a sexual health nurse funded 
by the Government (Tomnay et al. 2018). 
Currently, in Australia, only physicians can prescribe MA drugs. 
Consequently, the implementation of a fully autonomous nurse-led MA 
provision model implies that this regulation needs to be addressed (Saurman’s 
availability dimension). Alternative solutions, such as the onsite storage of MA 
and solitary handling of the medication by the PHCN or the development of 
shared care models with telemedicine providers, will give PHCNs a more 
autonomous role in the MA provision process, even though GPs remain the 
actual prescribers. Additionally, PHCNs can be granted a designated prescriber 
status, which allows them to prescribe independently, albeit under the 
supervision of a GP (NMBA 2017). Nonetheless, to implement a fully 
autonomous nurse-led MA provision model, prescription policy change is 
recommended to include abortion medication in the list of scheduled medicines 
that are approved by the NMBA. However, NMBA approved scheduled 
medicines can only be prescribed by nurse practitioners, midwives, and rural and 
isolated practice endorsed registered nurses, and not many of them actually 
work in general practice (NMBA, 2017). Therefore, besides policy change, it is 
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also recommended to extend prescribing rights to suitably qualified registered 
nurses. 
 
9.2 RECOMMENDATIONS FOR FUTURE RESEARCH 
This study raises several opportunities for future research. First, full 
implementation of the legally feasible model in the PHC sector of regional and 
rural Victoria requires a trial of the model, which should include an assessment 
of the feasibility, effectiveness, safety and acceptability of the proposed model 
from the perspectives of GPs, PHCNs and patients. Further research needs to 
establish if implementation of the nurse-led model will indeed improve access to 
safe abortion services in the regional and rural areas of Victoria. Next, when the 
role of the PHCN in MA provision increases over time, continuing monitoring and 
evaluation is warranted to ensure that provided care remains effective and safe. 
Second, it is recommended to extend the geographical base of this study to 
other jurisdictions in Australia where abortion access for women is limited. 
Future research may focus on the implementation of jurisdiction-specific formats 
of the nurse-led model in these areas. 
Although abortion in Victoria is legal, women from regional and rural 
areas still encounter access barriers. The provision of MA in the PHC setting is a 
globally recognised solution to the shortage of surgical abortion providers, but 
this study, supported by the existing evidence base, showed that only a few GPs 
and PHCNs from regional and rural Victoria are currently involved in this 
procedure. The developed legally feasible nurse-led MA provision model may 
have the potential to improve abortion access in underserved regions of Victoria, 
while reform is required to allow the implementation of the more effective fully 
autonomous model. The study additionally recommends a range of support 
elements that would enable PHCNs to develop their newly defined autonomous 
roles and to take on these new responsibilities.
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APPENDICES 
APPENDIX A: PLAIN LANGUAGE STATEMENT AND CONSENT 
FORM CROSS-SECTIONAL STUDY 
   
To: The participant  
  
Plain Language Statement Date: January 2016 
  
Full Project Title: 
Towards a collaborative model of care for medication abortion provision in regional and 
rural Victoria 
  
Ethical approval: 
Obtained from Deakin University Human Research Ethics Committee (nr 2015-313) 
  
Principal Researchers: 
Dr Melissa Graham and Associate Professor Julia Shelley (School of Health and Social 
Development, Deakin University, Burwood) 
  
Student Researcher:  
Caroline de Moel, PhD candidate (School of Health and Social Development, Deakin 
University, Burwood)            
   
 
Dear participant, 
   
You are invited to take part in a research project that is being conducted by Deakin 
University. You have been randomly selected from the Medical Directory of Australia 
database as a general practitioner working in rural / regional Victoria (GPs only). 
This Plain Language Statement contains detailed information about the project and it will 
explain all the procedures involved so that you can make a fully informed decision whether 
you would like to participate or not. 
Please read this statement carefully and feel free to contact us if you have any questions 
related to this project or the information in this document. 
   
Purpose 
The aim of this study is to develop a nurse-led collaborative model of care for the provision 
of medication abortion in regional/rural Victoria. 
   
Background 
In Australia about half of all pregnancies are unplanned and about one in four pregnancies 
will end in a termination. While abortion was legalised in Victoria in 2008, there is still a 
range of barriers that can undermine safe and easy access to abortion services, particularly 
for women who live in regional/rural areas. These barriers, mostly related to the shortage 
of regional providers, necessitate an alternative and viable solution. Nurses, who are an 
integral part of the primary health care setting, could potentially play an enhanced and 
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valuable role in the provision of abortion, and medication abortion in particular. This 
approach has been extensively used and tested in a range of overseas countries. 
For the development of a nurse-led collaborative model of care for the provision of 
medication abortion in regional/rural Victoria, two separate but interconnected studies will 
be conducted. 
The first one is this questionnaire, targeted at general practitioners and primary health 
nurses in regional/rural Victoria. Both groups will be surveyed separately about their views 
and attitudes on, and experiences with (medication) abortion provision. This inventory will 
provide an insight into the current provision of medication abortion in regional/rural 
Victoria. Additionally, it will guide the context of the second study that will use the Delphi 
technique* to query the opinions and knowledge of experts in the field in order to reach 
consensus for the development of the model. 
   
Procedure 
This online questionnaire consists of multiple-choice questions and should take 
approximately 10 minutes to complete. 
If you would like to go into the draw to win a weekend away to the value of about $500, 
please fill in the form at the end of the questionnaire (GPs only). 
   
Possible risks and benefits of participation 
Risks: This study contains questions that can relate to your personal beliefs, experiences 
and practices. If any question makes you feel uncomfortable, please either skip this 
question or discontinue your participation in the questionnaire. 
   
Benefits: This study will look at an alternative solution for the shortage of abortion 
provision in Victoria’s regional areas. It will explore the possibilities and challenges of 
medication abortion provision via a nurse-led model of care. The development of such a 
model can be used to define and enhance the role of the practice nurse, alleviate the work-
load of the general practitioner, change the position of abortion provision in our present-
day health care system, and ultimately improve access to safe abortions in regional areas. 
   
Privacy and Confidentiality 
Please be assured that no data will be published that would allow individual participants to 
be identified. This questionnaire is completely anonymous. The contact details you provide 
if you wish to go into the prize draw (for GPs only) or be part of the Delphi panel will be 
separated from your data upon receipt and deleted immediately after the prize draw. Data 
will be stored on password-protected University servers. In accordance with Deakin 
University management policies, all data will be destroyed after a minimum of five years 
after last publication: paper documentation will be shredded and all electronic files will be 
deleted from computer hard drives and backups. 
   
Results of the project 
The results will be published in the Doctoral thesis of the student researcher and in 
academic journals and presented at professional conferences. If you wish to receive a copy 
of the summary findings please contact Caroline via email cdemoel@deakin.edu.au. 
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Voluntary participation 
Your participation in this project is entirely voluntary and you can refuse to participate or 
stop answering the questions at any time you choose to do so. As the questionnaire is 
anonymous it will not be possible to withdraw your data once you have submitted. 
 
 *The Delphi technique is a structured group communication process between a panel of experts 
about a practical problem. In successive rounds of questionnaires, the experts will answer a range of 
questions that will all be reviewed and reported back. This process will encourage the participants to 
reconsider their initial answers in the following rounds until consensus is reached. 
   
 
Consent 
By completing this survey you have consented to our use of the information you provide, in 
the manner we have described above. 
This study has not received funding from any source. 
   
Questions 
If you have any concerns or questions about this project, please contact one of the 
researchers: 
Caroline de Moel, PhD candidate       0479 173 590             cdemoel@deakin.edu.au 
Dr. Melissa Graham, supervisor         +61 3 92517271         melissa.graham@deakin.edu.au 
  
Complaints 
A human ethics panel at Deakin University has approved the ethical aspects of this research 
project. If you have any complaints about any aspect of the project, the way it is being 
conducted or any questions about your rights as a research participant, then you may 
contact: 
The Manager, Ethics and Biosafety, Deakin University, 221 Burwood Highway, Burwood 
Victoria 3125, Telephone: 9251 7129, research-ethics@deakin.edu.au 
Please quote project number 2015-313 
   
  
o I have read the Plain Language Statement and Consent form, understand my rights 
as a participant, and wish to complete the following survey 
o I have read the Plain Language Statement and Consent form and no longer wish to 
participate in this study 
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APPENDIX B: NURSE QUESTIONNAIRE 
 
Start of Block: Section A: Background information 
 
Q1 What is your current occupation? 
o General practice nurse  (1)  
o Community health service nurse  (2)  
o Other, please specify  (3) 
________________________________________________ 
 
 
 
Q2 What is the highest nursing degree you have completed? 
o Enrolled nurse  (1)  
o Registered nurse  (2)  
o Rural and isolated practice endorsed registered nurse  (3)  
o Nurse practitioner  (4)  
o Other, please specify  (5) 
________________________________________________ 
 
 
 
Q3 What is the postcode of your work address? 
_______________________________________________________________ 
 
 
Q4 Do you work: 
o Full-time  (1)  
o Part-time (hours/week)  (2) 
________________________________________________ 
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Q5 What is your gender? 
o Male  (1)  
o Female  (2)  
o Other  (3)  
 
 
 
Q6 What is your age (in years)? 
  _______________________________________________________________ 
 
End of Block: Section A: Background information  
Start of Block: Section B: Your clinical experience 
 
Q7 How many years have you been working in clinical practice? 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
 
 
Q8 What percentage of your current clinical work is spent providing care for 
women aged 13-45 years? 
o 0%  (1)  
o 0-33%  (2)  
o 33-66%  (3)  
o 66-100%  (4)  
 
 
 
Q9 Do you see women with unintended pregnancies as part of your practice? 
o No  (1)  
o Yes  (2)  
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Display This Question: 
If Do you see women with unintended pregnancies as part of your practice? = Yes 
 
Q10 Do you include abortion counselling in your consultation? 
 (Providing information to assist with a decision) 
o Yes  (1)  
o No  (2)  
 
 
 
Q11 Have you ever referred women for abortions? 
o No  (1)  
o Yes  (2)  
 
 
Display This Question: 
If Have you ever referred women for abortions? = Yes 
 
Q12 I refer most women for abortions: 
 
o To a local abortion provider  (1)  
o To Melbourne  (2)  
o I do both  (3)  
o Other:  (4) ________________________________________________ 
 
End of Block: Section B: Your clinical experience  
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Start of Block: Section C: Medication abortion 
 
Q13 For the next several questions the term MEDICATION ABORTION will be 
used to describe an early abortion (before 63 days of gestation), performed 
with the use of pharmaceutical agents such as mifepristone and 
misoprostol.     Have you ever heard of medication abortion?    
o No  (1)  
o Yes  (2)  
 
Skip To: End of Block If For the next several questions the term MEDICATION ABORTION 
will be used to describe an early abo... = No 
 
 
Q14 How familiar are you with medication abortion? 
o Not very familiar  (1)  
o Somewhat familiar  (2)  
o Very familiar  (3)  
 
 
 
Q15 Does your practice provide medication abortions? 
o No  (1)  
o Yes  (2)  
 
Skip To: End of Block If Does your practice provide medication abortions? = No 
 
 
Q16 Since when does your practice provide medication abortion? 
_______________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
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Q17 What is your best estimate about the numbers of early medication 
abortions (i.e. before 63 days of gestation) that were performed in your 
practice in 2015? 
________________________________________________________________ 
________________________________________________________________ 
________________________________________________________________ 
 
 
 
Q18 What is your best estimate about the distance abortion-
requesting women live from your clinic? (please provide percentages for each 
answer) 
 
Within 25 kilometres of your clinic : _______  (1) 
25-50 kilometres from your clinic : _______    (2) 
50-100 kilometres from your clinic : _______  (3) 
50-100 kilometres from your clinic : _______  (4) 
Total : ________  
 
 
 
Q19 In the past 12 months, how many times have you: 
 Never (1) Less than 5 times (2) 
Equal to or 
greater than 5 
times (3) 
Assisted a doctor in 
providing 
medication 
abortion? (1)  
o  o  o  
Provided and 
managed a 
medication 
abortion? (2)  
o  o  o  
Treated and/or 
referred women for 
medication abortion 
related 
complications? (3)  
o  o  o  
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Q20 During the time that your practice has prescribed medication 
abortion have you, other staff members or your practice encountered any acts 
of harassment or challenges? (check all that apply) 
 Not at all (7) Occasionally (8) Frequently (9) 
Picketing (1)  o  o  o  
Vandalism (2)  o  o  o  
Threats to family 
members (3)  o  o  o  
No support from 
other health 
professionals in 
region (4)  
o  o  o  
Other, please 
specify: (5)  o  o  o  
 
 
 
 
Q21 Do you hide the fact that you work in a clinic that provides medication 
abortion from any of the following people? (check all that apply) 
 Yes (1) No (2) Not applicable (3) 
My spouse or 
partner (1)  o  o  o  
At least one of my 
children (2)  o  o  o  
At least one parent 
(3)  o  o  o  
At least one close 
friend (4)  o  o  o  
At least one 
neighbour (5)  o  o  o  
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Q22 Do you know if any of the following problems are encountered by the 
medication abortion provider(s) at your practice  (mark all that apply)?    
▢  Unclear legal restrictions  (2)  
▢  The facility where I work does not permit it  (3)  
▢  No physicians available for back-up  (4)  
▢  Unwillingness of local pharmacist to supply mifepristone  (12)  
▢  Lack of 24-hour contact advice  (13)  
▢  No access to ultrasound  (5)  
▢  No access to surgical back-up in case of complications  (6)  
▢  No support from colleagues  (7)  
▢  No support from community  (8)  
▢  No support from friends and family  (9)  
▢  Fear of anti-abortion harassment  (10)  
▢  Other, please specify  (11) 
________________________________________________ 
 
End of Block: Section C: Medication abortion  
Start of Block: Section D: Personal beliefs and attitudes 
 
Q23 Please indicate which of the following statements you mostly agree 
with:     I think surgical and medication abortions should be 
o Legal under any circumstances  (1)  
o Illegal in all circumstances  (2)  
o Legal only under certain circumstances  (3)  
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Display This Question: 
If Please indicate which of the following statements you mostly agree with:   I think 
surgical and m... = Legal only under <u>certain</u> circumstances 
 
Q24 What circumstances do you think justifies an abortion (mark all that apply): 
▢  A gestational age of 12 weeks or less  (1)  
▢  A gestational age of 20 weeks or less  (2)  
▢  A pregnancy that is the result of rape or incest  (3)  
▢  A pregnancy that is life threatening  (4)  
▢  The detection of a fetal abnormality  (5)  
▢  A problem with the gender of the foetus  (6)  
▢  The woman already has too many children  (7)  
▢  The woman is too young (under 17 years old)  (8)  
▢  Other, please specify  (9) 
________________________________________________ 
 
 
 
Q25 I would support my colleagues in providing abortions  
o Yes  (1)  
o No  (2)  
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Q26 I believe that medication abortions fall within the scope of practice of the 
following health practitioners (please indicate the degree to which you agree 
with the following statements): 
 
Strongly 
disagree 
(6) 
Disagree 
(7) 
Neither 
agree nor 
disagree 
(8) 
Agree (9) Strongly agree (10) 
Obstetrician / 
Gynaecologist 
(1)  o  o  o  o  o  
General 
Practitioner 
(2)  o  o  o  o  o  
Nurse 
Practitioner 
(3)  o  o  o  o  o  
Rural and 
isolated 
practice 
endorsed 
Registered 
Nurse (4)  
o  o  o  o  o  
Registered 
Nurse (5)  o  o  o  o  o  
Enrolled 
Nurse (6)  o  o  o  o  o  
Midwife (7)  o  o  o  o  o  
 
 
End of Block: Section D: Personal beliefs and attitudes  
Start of Block: Section E: Interest in medication abortion provision 
 
Q27 I would like to be trained to provide medication abortions to manage 
unintended pregnancies  
o Already providing  (1)  
o Yes  (2)  
o No  (3)  
 
Skip To: End of Block If I would like to be trained to provide medication abortions to manage 
unintended pregnancies   = Already providing 
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Q28 What are the possible reasons for NOT providing or assisting with 
medication abortions EVEN THOUGH you are willing (mark all that apply):    
▢  No training opportunities  (1)  
▢  Unsure of legal restrictions  (2)  
▢  The facility where I work does not permit it  (3)  
▢  No physicians available for back-up  (4)  
▢  Unwillingness of local pharmacist to supply mifepristone  (12)  
▢  Lack of 24-hour contact advice  (13)  
▢  No access to ultrasound  (5)  
▢  No access to surgical back-up in case of complications  (6)  
▢  I would not feel comfortable being personally involved  (22)  
▢  My colleagues would not be supportive  (7)  
▢  My community would not be supportive (fear of stigmatisation)  (8)  
▢  My friends and family would not be supportive  (9)  
▢  Fear of anti-abortion harassment  (10)  
▢  Other, please specify  (11) 
________________________________________________ 
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Q29 What are your reasons for NEVER wanting to provide or assist with 
medication abortions (mark all that apply):    
▢  I am morally / ethically opposed  (1)  
▢  There is no need for more abortion providers  (2)  
▢  Anti-abortion harassment  (3)  
▢  Too many legal restrictions  (4)  
▢  I worry about the need for surgical back-up  (5)  
▢  My colleagues would not be supportive  (6)  
▢  My community would not be supportive  (7)  
▢  My friends and family would not be supportive  (8)  
▢  Other, please specify  (9) 
________________________________________________ 
 
End of Block: Section E: Interest in medication abortion provision  
Start of Block: Block 6 
 
Q30 This was the last question of the questionnaire. After this point editing is 
no longer possible. 
The following part of the questionnaire will ask for your interest in the Delphi 
study.      
  You will now be redirected 
 
End of Block: Block 6  
Start of Block: Section F: Interest in Delphi study 
The data provided in this part of the questionnaire will not be shared and will not be 
connected with the responses you provided in the above questions. 
  
 All contact details will be deleted immediately after Delphi panel completion. 
 For any questions, please contact: cdemoel@deakin.edu.au 
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Q1 Would you be interested in participating in the next phase of the study? This 
Delphi study* will aim to gain consensus on the development of a nurse-led 
collaborative model of care for medication abortion provision in regional Victoria. 
  
 *It will involve your online participation in three successive rounds of questionnaires. After 
each round all the aggregated anonymous responses of the panel will be shared with the 
group and will allow participants to reconsider their previous answers in the following rounds 
until consensus is reached. 
   
   
o No  (1)  
o Yes  (2)  
 
 
Display This Question: 
If Would you be interested in participating in the next phase of the study? This Delphi 
study* will... = Yes 
 
Q34 Please provide your name and email address below: 
o First name  (1) ________________________________________________ 
o Surname  (2) ________________________________________________ 
o Email address  (3) ____________________________________________  
o Telephone number (optional)  (4) ________________________________ 
 
End of Block: Section F: Interest in Delphi study  
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APPENDIX C: GP QUESTIONNAIRE 
 
  
Start of Block: Section A: Background information 
 
Q1 What is your gender? 
o Male  (1)  
o Female  (2)  
o Other  (3)  
 
 
 
Q2 What is your age (in years)? 
_______________________________________________________________ 
 
 
 
Q3 How many years have you been working as a general practitioner? 
________________________________________________________________ 
 
 
 
Q4 Do you work: 
o Full-time  (1)  
o Part-time (hours/week)  (2)  
______________________________________ 
 
 
Q5 Are you: 
o Vocationally registered  (1)  
o Non-vocationally registered  (2)  
o A registrar  (3)  
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Q6 In which country did you receive your original qualification? 
o Australia  (1)  
o Other, namely  (3) 
________________________________________________ 
 
 
 
Q7 How do you describe your practice 
o Solo practice  (1)  
o Group practice with 2-4 general practitioners  (2)  
o Group practice with more than 4 general practitioners  (3)  
o Other, namely  (4) 
________________________________________________ 
 
 
Q8 What is the postcode of your main work address? 
________________________________________________________________ 
 
 
 
Q8b If you work at multiple sites, please provide corresponding postcodes. 
________________________________________________________________ 
________________________________________________________________ 
 
Q9 Are other primary health care providers part of your team? 
o No  (1)  
o Yes  (2)  
 
 
Display This Question: 
If Are other primary health care providers part of your team? = Yes 
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Q10 The other members of your primary care team include (check all that 
apply): 
▢  Practice nurse(s)  (1)  
▢  Allied health care provider(s)  (2)  
▢  Indigenous health worker(s)  (3)  
▢  Pharmacist(s)  (4)  
▢  Other, namely  (5) 
________________________________________________ 
 
End of Block: Section A: Demographics  
Start of Block: Section B: Your clinical experience 
 
Q11 What percentage of your current clinical work is spent providing care 
for women aged 13-45 years? 
o 0%  (1)  
o 0-33%  (2)  
o 33-66%  (3)  
o 66-100%  (4)  
 
 
 
Q12 Do you see women with unintended pregnancies as part of your 
practice? 
o No  (1)  
o Yes  (2)  
 
 
Display This Question: 
If Do you see women with unintended pregnancies as part of your practice? = Yes 
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Q13 Do you include abortion counselling in your consultation? (Providing 
information to help with a decision) 
o Yes  (1)  
o No  (2)  
 
 
 
Q14 Have you ever referred women for abortions? 
o No  (1)  
o Yes  (2)  
 
 
Display This Question: 
If Have you ever referred women for abortions? = Yes 
 
Q15 I refer most women for abortions: 
o To a local abortion provider  (1)  
o To Melbourne  (2)  
o I do both  (3)  
o Other:  (4) ________________________________________________ 
 
End of Block: Section B: Your clinical experience  
Start of Block: Section C: Medication abortion 
Q16 For the next several questions the term MEDICATION ABORTION will 
be used to describe an early abortion (before 63 days of gestation), 
performed with the use of pharmaceutical agents such as mifepristone and 
misoprostol.     Have you ever heard of medication abortion?    
o No  (1)  
o Yes  (2)  
 
Skip To: End of Block If For the next several questions the term MEDICATION 
ABORTION will be used to describe an early abo... = No 
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Q17 How familiar are you with medication abortion? 
o Not very familiar  (1)  
o Somewhat familiar  (2)  
o Very familiar  (3)  
 
 
 
Q18 Do you provide medication abortions? 
o Yes  (1)  
o No  (2)  
 
Skip To: Q21 If Do you provide medication abortions? = No 
 
 
Q19 Since when do you provide medication abortion? 
________________________________________________________________ 
________________________________________________________________ 
 
 
Q20 What is your best estimate about the numbers of early medication 
abortions (i.e. before 63 days of gestation) that were performed by you 
________________________________________________________________ 
 
Q21 Does your practice provide medication abortions? 
o No  (1)  
o Yes  (2)  
o Don't know  (3)  
 
Skip To: Q28 If Does your practice provide medication abortions? != Yes 
 
 
Q22 Since when does your practice provide medication abortion? 
________________________________________________________________ 
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Q23 What is your best estimate about the total numbers of early medication 
abortions (i.e. before 63 days of gestation) that were performed in 2015 in 
your practice ? 
________________________________________________________________ 
 
 
 
Q24 What is your best estimate about the distance abortion-requesting 
women live from your clinic? (please provide percentages for each answer) 
 
Not applicable : _______  (5) 
Within 25 kilometres of your clinic : _______  (1) 
25-50 kilometres from your clinic : _______  (2) 
50-100 kilometres from your clinic : _______ (3) 
> 100 kilometres from your clinic : _______  (4) 
Total : ________  
 
 
 
Q25 During the time that your practice has prescribed medication 
abortion have you, other staff members or your practice encountered any 
acts of harassment or challenges? (check all that apply) 
 Not at all (7) 
Occasionally 
(8) Frequently (9) 
not 
applicable 
(10) 
Picketing (1)  o  o  o  o  
Vandalism (2)  o  o  o  o  
Threats to 
family 
members (3)  o  o  o  o  
No support 
from other 
health 
professionals 
in region (4)  
o  o  o  o  
Other, please 
specify: (5)  o  o  o  o  
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Q26 Do you hide the fact that you work in a clinic that provides medication 
abortion from any of the following people? (check all that apply) 
 Yes (1) No (2) Not applicable (3) 
My spouse or 
partner (1)  o  o  o  
At least one of my 
children (2)  o  o  o  
At least one 
parent (3)  o  o  o  
At least one close 
friend (4)  o  o  o  
At least one 
neighbour (5)  o  o  o  
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Q27 Have you encountered any of the following problems in the process of 
medication abortion provision? 
▢  Not applicable  (30)  
▢  Unsure of legal restrictions  (2)  
▢  The facility where I work does not permit it  (3)  
▢  Financially unviable  (12)  
▢  No physicians available for back-up  (4)  
▢  Unwillingness of local pharmacist to supply mifepristone  (21)  
▢  Lack of 24-hour contact advice  (22)  
▢  No access to ultrasound  (5)  
▢  No access to surgical back-up in case of complications  (6)  
▢  My colleagues are not supportive  (7)  
▢  My community is not supportive  (8)  
▢  My friends and family are not supportive  (9)  
▢  Fear of anti-abortion harassment  (10)  
▢  Other, please specify  (11) 
________________________________________________ 
 
End of Block: Section C: Medication abortion  
Start of Block: Section D: Personal beliefs and attitudes 
 
Q28 Please indicate which of the following statements you mostly agree 
with:     I think surgical and medication abortions should be 
o Legal under any circumstances  (1)  
o Illegal in all circumstances  (2)  
o Legal only under certain circumstances  (3)  
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Display This Question: 
If Please indicate which of the following statements you mostly agree with:   I think 
surgical and m... = Legal only under <u>certain</u> circumstances 
 
Q29 What circumstances do you think justifies an abortion (mark all that 
apply): 
▢  A gestational age of 12 weeks or less  (1)  
▢  A gestational age of 20 weeks or less  (2)  
▢  A pregnancy that is the result of rape or incest  (3)  
▢  A pregnancy that is life threatening  (4)  
▢  The detection of a fetal abnormality  (5)  
▢  A problem with the gender of the foetus  (6)  
▢  The woman already has too many children  (7)  
▢  The woman is too young (under 17 years old)  (8)  
▢  Other, please specify  (9) 
________________________________________________ 
 
 
 
Q30 I would support my colleagues in providing abortions  
o Yes  (1)  
o No  (2)  
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Q31 I believe that medication abortions fall within the scope of practice of 
the following health practitioners (please indicate the degree to which you 
agree with the following statements): 
 
Strongly 
disagree 
(16) 
Disagree 
(17) 
Neither 
agree nor 
disagree 
(18) 
Agree 
(19) 
Strongly 
agree (20) 
Obstetrician / 
Gynaecologist 
(1)  o  o  o  o  o  
General 
Practitioner (2)  o  o  o  o  o  
Nurse 
Practitioner (3)  o  o  o  o  o  
Rural and 
isolated 
practice 
endorsed 
Registered 
Nurse (4)  
o  o  o  o  o  
Registered 
Nurse (5)  o  o  o  o  o  
Enrolled Nurse 
(6)  o  o  o  o  o  
Midwife (7)  o  o  o  o  o  
 
 
End of Block: Section D: Personal beliefs and attitudes  
Start of Block: Section E: Interest in medication abortion provision 
Q32 I would like to be trained to provide medication abortions to manage 
unintended pregnancies  
o Already providing  (1)  
o Yes  (2)  
o No  (3)  
 
Skip To: End of Block If I would like to be trained to provide medication abortions to 
manage unintended pregnancies   = Already providing 
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Q33 What are the possible reasons for NOT providing or assisting with 
medication abortions EVEN THOUGH you are willing (mark all that apply):    
▢  No training opportunities  (1)  
▢  Unsure of legal restrictions  (2)  
▢  The facility where I work does not permit it  (3)  
▢  Financially unviable  (12)  
▢  No physicians available for back-up  (4)  
▢  Unwillingness of local pharmacist to supply mifepristone  (21)  
▢  Lack of 24-hour contact advice  (22)  
▢  No access to ultrasound  (5)  
▢  No access to surgical back-up in case of complications  (6)  
▢  I would not feel comfortable being personally involved  (30)  
▢  My colleagues would not be supportive  (7)  
▢  My community would not be supportive (fear of stigmatisation)  (8)  
▢  My friends and family would not be supportive  (9)  
▢  Fear of anti-abortion harassment  (10)  
▢  Other, please specify  (11) 
________________________________________________ 
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Q34 What are your reasons for NEVER wanting to provide medication 
abortions (mark all that apply):    
▢  I am morally / ethically opposed  (1)  
▢  There is no need for more abortion providers  (2)  
▢  Anti-abortion harassment  (3)  
▢  Too many legal restrictions  (4)  
▢  Financially unviable  (10)  
▢  I worry about the need for surgical back-up  (5)  
▢  My colleagues would not be supportive  (6)  
▢  My community would not be supportive  (7)  
▢  My friends and family would not be supportive  (8)  
▢  Other, please specify  (9) 
________________________________________________ 
 
End of Block: Section E: Interest in medication abortion provision  
Start of Block: Section F: End Questionnaire 
This was the last question of the questionnaire. After this point editing is 
no longer possible. The following part will allow you to enter your contact 
details for the prize draw and will record your interest in the Delphi study.  
       
End of Block: Section F: End Questionnaire  
Start of Block: Second part: Interest in Delphi study and prize draw 
The data provided in this part of the questionnaire will not be shared and will not 
be connected with the responses you provided in the above questions. 
  
All contact details will be deleted immediately after the prize draw and after 
Delphi panel completion. For any questions, please contact: 
cdemoel@deakin.edu.au 
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Q1 Would you like to go into the prize draw for a weekend away for two? 
o Yes  (1)  
o No  (2)  
 
 
Display This Question: 
If Would you like to go into the prize draw for a weekend away for two? = Yes 
 
Q2 Please enter your contact details 
o First name  (3)_______________________________________________ 
o Surname  (7) _______________________________________________ 
o Email address  (5) ___________________________________________ 
o Contact phone number (optional)  (6) ____________________________ 
 
 
Q3 Would you be interested in participating in the next phase of the study? 
This Delphi study* will aim to gain consensus on the development of a 
nurse-led collaborative model of care for medication abortion provision in 
regional Victoria.     
 
 *It will involve your online participation in three successive rounds of questionnaires. 
After each round all the aggregated anonymous responses of the panel will be shared 
with the group and will allow participants to reconsider their previous answers in the 
following rounds until consensus is reached. 
   
o No  (1)  
o Yes  (2)  
 
 
Display This Question: 
If Would you be interested in participating in the next phase of the study? This Delphi 
study* will... = Yes 
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Q36 Please provide your name and email address below: 
o First name  (1) _____________________________________________ 
o Surname  (2) _______________________________________________ 
o Email address  (3) ___________________________________________ 
o Contact phone number (optional)  (4) ____________________________ 
 
End of Block: Second part: Interest in Delphi study and prize draw  
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APPENDIX D: INVITATION LETTER DELPHI STUDY EXPERTS 
BY PROFESSION 
Dear participant, 
It is a well-known fact that women who live in the non-metropolitan regions of Victoria 
face many barriers when they want to terminate an unwanted pregnancy. Although 
abortion with medication can potentially facilitate access, the uptake of this service by 
general practitioners still slow.  
Deakin University is conducting a study that will investigate how practice nurses can 
play an important role in the delivery of medication abortions. This model is already 
successfully used for many years in overseas countries and will increase the availability 
of early abortion services in regional / rural communities. 
The study will use the Delphi technique, an online anonymous group communication 
process between experts in the field over three rounds of questionnaires, in order to 
reach consensus between panellists for the development of this model in Victoria. 
You are invited as a professional expert to participate in this study. Although your 
involvement will require some time and commitment, it offers a unique opportunity to 
influence current abortion practice in Victoria. Your participation will be gratefully 
appreciated and will improve the quality of the study findings. 
Please forward this invitation to colleagues who may be interested in this study. 
The survey and additional information is accessible online via:  
https://deakinhealth.qualtrics.com/SE/?SID=SV_0NfKmiObWLHgNCJ or 
http://cdemoel.wixsite.com/delphi 
Thank you in advance for your participation. For any question or concerns feel free to 
contact me at cdemoel@deakin.edu.au. Ethics approval for the study is obtained from 
Deakin University Human Research Ethics Committee (nr 2015-314). 
 
Sincerely,  
 
Caroline de Moel, MD, MPH, PhD candidate  
School of Health and Social Development, Faculty of Health  
Deakin University  
Melbourne Burwood Campus www.deakin.edu.au  
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APPENDIX E: INVITATION FLYER DELPHI STUDY EXPERTS BY 
EXPERIENCE 
 
 
 
woman aged 18-44 years from regional or rural 
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APPENDIX F: ROUND ONE DELPHI QUESTIONNAIRE 
 
 
ROUND ONE QUESTIONNAIRE 
 
This questionnaire consist of two parts 
• Part A is a short demographic questionnaire. 
• Part B consists of seven open-ended questions. 
 
 PART A: DEMOGRAPHIC QUESTIONNAIRE 
 
Please provide your contact information 
 
What is your full name?  
 
What is your work title?  
 
What is your Email address?  
 
What is your telephone number?  
 
What is your gender? 
 Male 
 Female 
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What is your age? 
18-24 years old 
25-34 years old 
35-44 years old 
45-54 years old 
55-64 years old 
65 years or older 
 
What is your country of origin? 
Australia 
New Zealand 
The United Kingdom 
Other, please specify:  
 
Which of the following best describes your current occupation? Tick as many 
answers as possible: 
General practitioner from regional Victoria 
Practice nurse from regional Victoria 
Nurse Academic  
Nurse involved in policy development 
Nurse from professional body 
Sexual Health Nurse Practitioner 
Obstetrician/Gynecologist 
Politician 
Other, please specify:  
 
Please describe the main activity you undertake in your current job(s): 
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Please indicate the number of years of experience you have in this role: 
Not applicable 
Less than 5 years 
5-7 years 
8-10 years 
11-15 years 
16-20 years 
More than 21 years 
 
Which of the following best describes the primary geographical location 
you most frequently work in (if applicable): 
Not applicable 
Urban 
Suburban 
Regional  
Rural 
Other, please specify:  
 
Please explain your interest in the study: 
 
 
 
 
 
 
               PART B: SEVEN OPEN-ENDED QUESTIONS 
 
 
For the next questions the term MEDICATION ABORTION will be used to describe 
an early abortion (before 63 days of gestation), performed with the use of 
pharmaceuticcal agents such as mifepristine and misoprostol. 
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Please answer the following questions IN AS MUCH DETAIL AS POSSIBLE 
 
Q1: What do you think is the current role of general practitioners and primary 
health care nurses in the provision of early medication abortion in regional/rural 
Victoria? 
 
 
 
Q2: How do you think the role of general practitioners in the provision of 
medication abortion could be improved? 
 
 
 
Q3: How do you think the role of primary health care nurses in the provision of 
medication abortion could be improved? 
 
 
 
Q4: What factors facilitate or hinder regional and rural primary health care 
nurses when they are or want to be involved in the delivery of medication 
abortion services in regional/rural Victoria? 
 
 
 
Q5: What do you believe are solutions or recommendations to improve 
primary health nurse participation in the provision of medication abortion 
in regional/rural Victoria? 
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Q6: What obstacles can potentially prevent these improvements? 
 
 
 
Q7: How do you think the obstacles of question 6 can be addressed? 
 
 
 
 
Please use this box to add any additional comments. 
 
 
 
 
 
 
Thank you for your interest in the study and for completing round one. 
 
The findings of the round one questionnaires will be assembled, categorised 
and organised into key statements. You will receive a new questionnaire in due 
time that consists of these statements, and you will be asked to rate each of 
them on a scale for agreement or disagreement. This next questionnaire will 
probably only take 15 minutes to complete.
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APPENDIX G: PLAIN LANGUAGE STATEMENT AND CONSENT 
FORM DELPHI STUDY 
          
To: Participants 
PLAIN LANGUAGE STATEMENT 
Date: August 2016 
 
FULL PROJECT TITLE 
Towards a collaborative model of care for medication abortion provision in regional and 
rural Victoria 
 
ETHICAL APPROVAL:  
Obtained from Deakin University Human Research Ethics Committee 
(2015-314) 
 
PRINCIPAL RESEARCHERS 
Dr Melissa Graham and Professor Ann Taket (School of Health and Social Development, 
Deakin University, Burwood) 
 
STUDENT RESEARCHER 
Caroline de Moel, MD, MPH, PhD candidate (School of Health and Social Development, 
Deakin University, Burwood) 
 
Dear participant, 
You have been identified as an expert by profession or as an advocate for 
women's sexual and reproductive health and rights, and are invited to take part 
in a research project that is being conducted by Deakin University. 
This Plain Language Statement contains detailed information about the research 
project. It will explain all the procedures involved in this project so that you can make 
a fully   informed decision whether you are going to participate. 
Please read this statement carefully and feel free to contact us for questions related 
to this project or the information in this document. 
 
PURPOSE 
The aim of this study is to develop a nurse-led collaborative model of care for the 
provision of medication abortion in regional and rural Victoria. 
 
BACKGROUND 
In Australia about half of all pregnancies are unplanned and about one in four 
pregnancies will end in a termination. While abortion was legalised in Victoria in 
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2008, there are still a range of barriers that can undermine safe and easy access to 
abortion services, particularly for women who live in regional/rural areas. Those 
barriers, most related to the shortage of local providers, necessitate an alternative 
and conceivable solution. 
Nurses, who are an integral part of the primary health care setting, could potentially 
play an enhanced and valuable role in the provision of abortion, and medication 
abortion in particular. This approach has been extensively used and tested in a range 
of overseas countries. 
For the development of a nurse-led collaborative model of care for the provision of 
medication abortion in regional/rural Victoria, this study will use the Delphi technique 
to query the opinions and knowledge of experts in the field. 
 
PROCEDURE 
The Delphi technique consists of a group communication process that aims to achieve 
expert consensus about a specific topic with the use of successive rounds of 
questionnaires. The major benefit of this method is that it allows a diverse group of 
specialists from a widespread geographical area to anonymously express their views 
without any restrictions, peer pressure or influence from expert dominance. 
The key elements of the Delphi are as follows: 
1. The first round starts with some general demographic questions. Then you will 
be asked to give your opinion on three questions regarding medication 
abortion provision in regional/rural Victoria 
2. The researcher will generate a list of key statements from all the panel responses 
3. In the second round you will rate these statements on levels of agreement and 
include supporting arguments for your ratings to augment the scales. 
4. All results will be analysed and feedback will be provided, not only on the levels of 
agreement of all panel members for each statement but also on how your 
response compares to the rest of the group 
5. The third round questionnaire will contain the same statements as round two, but 
it will allow you, based on the feedback, to reconsider and revise your earlier 
responses 
6. The responses of the panel members therefore converge across the rounds of 
questionnaires. Consensus will be reached when 75% of the participants agree 
with the statement. 
Each round will take about 30-45 minutes to complete. 
 
POSSIBLE RISKS AND BENEFITS OF PARTICIPATION 
Risks: This study contains questions/statements that can relate to your personal 
beliefs, experiences or practices. If any of the questions/statements makes you feel 
uncomfortable, please either skip this question or discontinue your participation in 
the study. 
Benefits: This study will look at an alternative solution for the shortage of abortion 
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provision in Victoria’s regional areas. It will explore the possibilities and challenges of 
medication abortion provision via a nurse-led model of care. The development of such 
a model can be used to define and enhance the role of the practice nurse, alleviate the 
work-load of the general practitioner, change the position of abortion provision in our 
present-day health care system, advocate for policy change and ultimately improve the 
access to safe abortions for women living in regional/rural Victoria      
 
PRIVACY AND CONFIDENTIALITY 
Please be assured that no data will be published that would allow individual 
participants to be identified. All the personal data you provide will be kept completely 
anonymous to other participants, so responses cannot be attributed back to you. 
However, it should be noted that panel members of expert groups often know each 
other, which can result in feeling pressured to conform to the group's view. 
The names, addresses and identifying details of the participants, disclosed in the 
demographic questionnaire of round one, will remain confidential to the research 
team and will be separated from responses upon receipt. You can be assured that 
all data will be handled and processed confidentially according to the rules of 
National Statement on Ethical Conduct in Human Research. Following Deakin 
University management policies, all data will be stored on password-protected 
University servers and destroyed after a minimum of five years after last publication. 
 
 RESULTS OF THE PROJECT 
Results of this study will be published in the Doctoral thesis of the student researcher 
and in academic journals. Overall findings will be presented at professional 
conferences. If you wish to receive a copy of the summary findings, please contact 
Caroline via email: cdemoel@deakin.edu.au. 
 
VOLUNTARY PARTICIPATION 
Your participation in this project is entirely voluntary and you can refuse to participate 
or stop answering the questions at any time. 
 
CONSENT 
By completing and submitting each round of questionnaires you have consented to 
our use of the provided information in the manner we have described above. 
This study has not received funding from any source. 
 
QUESTIONS 
If you have any concerns or questions about this project, please contact one of the 
researchers:  
Caroline de Moel, PhD candidate, M: 0479 173 59, E: cdemoel@deakin.edu.au  
Dr. Melissa Graham, supervisor, T: +61 3 92517271, E: melissa.graham@deakin.edu.au 
Prof. Ann Taket, supervisor, T: +61 3 92443798, E: ann.taket@deakin.edu.au 
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COMPLAINTS 
A human ethics panel at Deakin University has approved the ethical aspects of this 
research project. If you have any complaints about any aspect of the project, the way it 
is being conducted or any questions about your rights as a research participant, then 
you may contact: The Manager, Ethics and Biosafety, Deakin University, 221 Burwood 
Highway, Burwood Victoria 3125, T: +61 3 92517129, E: research-
ethics@deakin.edu.au. Please quote project number (2015-314) 
Please forward this invitation to colleagues who may be interested in this study. 
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APPENDIX H: FEEDBACK FROM ROUND TWO PROVIDED TO 
PANELLISTS IN ROUND THREE 
 Statements Valid 
percent 
agree 
Valid 
percent 
disagree 
IQR1 Group 
Median2 
Person-
al 
rating3 
1 All women with an unwanted 
pregnancy should be referred to an 
appropriately trained PHC nurse 
65  2 1  
2 Non-life-threatening complications of 
MA, like haemorrhages or infections, 
should be managed by doctors only  
45 45 2 3.5  
3  The PHC nurse can manage post-
abortion contraception, including the 
insertion of implants, PHC or the 
provision of injectable contraception 
75  1.75 2  
4  All steps in the MA process that are 
handled by a PHC nurse should only be 
allowed under the supervision of a GP 
30 70 1 4  
5  Allow all registered nurses to be 
responsible for the whole MA process 
without a GP's approval. The GP 
should only be required for the 
prescription of the abortion 
medication 
40 45 2.75 3  
6 General practice funding for nurse-led 
MA provision is currently included in 
the quarterly practice nurse incentive 
program payment, which includes a 
rural loading of up to 50% and is 
independent of Medicare item 
numbers. There is sufficient allowance 
in the practice nurse incentive 
program payment to cover nurse-led 
MA provision 
15 65 2 4  
7 Not all local pharmacies supply, or 
wish to supply, medication abortion 
drugs 
75  1.75 1  
8 There is a well-established positive 
collaboration between the Australian 
Medical Association and nursing 
authorities 
15 40 1 3  
9 The rural population does not 
complain about poor MA services in 
their area, because it is a private and 
contentious subject 
75  1.75 2  
10 GPs fear moral judgement by other 
health professionals if they were to 
provide MA services to their patients 
70  2 2  
11 There is pressure on GPs to conform to 
the conservative views of their 
70  2 2  
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 Statements Valid 
percent 
agree 
Valid 
percent 
disagree 
IQR1 Group 
Median2 
Person-
al 
rating3 
colleagues regarding the provision of 
MA services 
12 GPs are concerned about their safety 
and wellbeing if they were to provide 
MA services 
65  1 2  
13 GPs fear ramifications on both time 
and negative outcomes 
(complications) when providing MA 
services 
70  2 2  
14 There is a lack of specialist and other 
health professionals’ support available 
to GPs and PHC nurses that provide 
MA services 
70  1.75 2  
15 GPs and PHC nurses fear negative 
publicity from members of 
conservative communities and/or fear 
of personal vilification if they were to 
provide MA services 
75  1.75 1.5  
16 GPs and PHC nurses fear the presence 
of anti-choice protestors outside the 
facility if they were to provide MA 
services 
60  2.75 2  
17 The government is nervous about 
discussing and/or promoting MA. They 
fear community backlash or anti-
choice campaigns in parliament and 
their own party 
70  2 1.5  
18 There is not enough funding to make 
nurse-led MA provision profitable 
65  2 2  
19 It appears that public expectations 
about equitable availability of abortion 
services are ahead of the actual 
implementation 
65  1.5 2  
20 PHC nurses prefer locally organised 
MA group training session over on-line 
training 
70  1.75 2  
21 A funded coordinator role needs to be 
established that offers guidance and 
help for PHC nurses who want to do 
the MA training 
75  1.75 1  
22 Payment for nurse-led MA provision 
should be independent of any GP 
involvement 
75  1.75 1.5  
23 GP clinics should offer ultrasound and 
blood test services so women do not 
need to go somewhere else 
70  1 2  
24 GPs who provide MA should be made 
visible (e.g. advertise with "all-option 
75  1.75 1.5  
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 Statements Valid 
percent 
agree 
Valid 
percent 
disagree 
IQR1 Group 
Median2 
Person-
al 
rating3 
pregnancy counselling offered at this 
general practice") 
25 Financially support women to facilitate 
MA access (e.g. for travel and childcare 
costs) 
65  2 2  
Notes: 1 Inter-quartile range: spread of scores in the distribution; 2 Middle value of all the 
responses; 3 Participant’s personal rating of each statement in Round Two  
 
 
